{"Title": ["Molecular Partners hopes for COVID-19 rebound after eye drug failure", "Study sees 'probable' higher heart risk for new Amgen osteoporosis drug", "QQQ, INTC, AMGN, TMUS: ETF Inflow Alert", "Amgen To Present At BMO Capital Markets 2020 Healthcare Conference; Webcast At 4:00 PM ET", "Meet the Pharma Company That Just Had a Bigger IPO Than Moderna's", "Why BeyondSpring Is Plunging Today", "Is Amgen Stock a Buy?", "U.S. appeals court rejects rule requiring drug prices in TV ads", "Molecular Partners hopes for COVID-19 rebound after eye drug failure", "Health Care Sector Update for 06/15/2020: LLY, BYSI, BBI, AMGN", "Notable Friday Option Activity: W, TIF, AMGN", "2 Top Small-Cap Stocks to Buy Right Now", "July 31st Options Now Available For Amgen (AMGN)", "Amgen To Present At Goldman Sachs 41st Annual Global Healthcare Conference; Webcast At 1:20 PM ET", "Noteworthy ETF Outflows: IYH, AMGN, MDT, DHR", "Moderna names Amgen executive David Meline as CFO", "Notable ETF Inflow Detected - QQQ, INTC, AMGN, TMUS", "Amgen To Present At The Jefferies 2020 Virtual Healthcare Conference; Webcast At 4:00 PM ET", "Nasdaq Today: Why Alexion and Workday Stock Are Soaring", "Peek Under The Hood: IUS Has 10% Upside", "Is Coherus BioSciences a Buy?", "Is Arrowhead Pharmaceuticals a Buy?", "VTV, T, KO, AMGN: ETF Inflow Alert", "Monday Sector Laggards: Healthcare, Technology & Communications", "3 Top Large-Cap Stocks to Buy in June", "Validea's Top Five Healthcare Stocks Based On David Dreman - 5/17/2020", "Notable Friday Option Activity: AMGN, UNH, TGT", "Ex-Dividend Reminder: AmerisourceBergen, Amgen and Sabra Health Care REIT", "What's Behind Adaptive Biotechnologies' Q1 Earnings Miss", "Is Now Still a Good Time To Buy Amgen?", "Here's Why Cytokinetics Is Skyrocketing 24.5% Today", "Why Amgen Soared in April", "Better Buy: Pfizer vs. Bristol Myers Squibb", "Amgen:FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure", "BUZZ-U.S. STOCKS ON THE MOVE-GM, Axcella, Beyond Meat, SmileDirect", "Amgen Reports Positive Results For Otezla In Phase 3 Trial", "Why Akebia Therapeutics Stock Is Crushing It Today", "Amgen: Court Ruling Prevents Cipla From Making Generic Version Of KYPROLIS", "BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Medigus, Aemetis", "Amgen Inc (AMGN) Q1 2020 Earnings Call Transcript", "AstraZeneca Completes Recovery Of Global Rights To Brazikumab From Allergan", "Amgen Stock Jumps on Earnings, Covid-19 Trial Announcement", "Amgen Inc. Q1 adjusted earnings Beat Estimates", "Here's Why Investors Should Follow Sanofi and GlaxoSmithKline's New Coronavirus Collaboration", "Better Buy: Illumina vs. Adaptive Biotechnologies", "How These 15 Stock Suggestions Fared Against the Market", "IYH, JNJ, ABT, AMGN: ETF Inflow Alert", "Here's Why Verastem Oncology Is Tanking Today", "Amgen studying Otezla for coronavirus, Q1 results beat Street estimates", "3 Dividend Stocks Weathering the Coronavirus Storm", "Better Buy: Amgen vs. Johnson & Johnson", "Artificial Intelligence and Drug Discovery: The Companies Leading The Way", "Here's Why Verastem Stock Is Jumping Today", "3 Stocks I'm Buying Right Now", "4 Healthcare Stocks to Buy For Coronavirus Innovation", "ITOT, ABT, COST, AMGN: ETF Outflow Alert", "3 Coronavirus Stocks to Buy Now", "3 Dividend Stocks Weathering the Coronavirus Storm", "Better Buy: Amgen vs. Johnson & Johnson", "Artificial Intelligence and Drug Discovery: The Companies Leading The Way", "Here's Why Verastem Stock Is Jumping Today", "Here Are All the Companies Working on COVID-19 Vaccines, Treatments, and Testing", "Why Gilead Sciences Is the Hottest Stock to Buy Today", "Why Amgen Stock Sailed Through March Without a Scratch", "1 Recent IPO to Add to Your Watch List", "Amgen, Adaptive Partner To Find Neutralizing Antibodies For COVID-19", "Amgen Purchases 49% Of Shares Of Amgen Astellas BioPharma", "Amgen Pauses Some Clinical Trials to Reduce Coronavirus Transmission Risk", "Notable ETF Inflow Detected - FTCS, PGR, LLY, AMGN", "4 Reasons Drug Stocks Are a Buy Right Now", "Why Amgen is the 'Top Dividend Stock of the Nasdaq 100' With 3.2% Yield (AMGN)", "Health Care Sector Update for 03/26/2020: JNJ, PFE, ABT, MRK, AMGN, HTGM, RKDA, BIOC", "Amgen Teams Up With Adaptive Biotechnologies to Develop COVID-19 Therapy", "4 Reasons Biotech Stocks Are a Buy Right Now", "Notable ETF Inflow Detected - TQQQ, GOOGL, AMGN, TXN", "Health Care Sector Update for 03/17/2020: JNJ, PFE, ABT, MRK, AMGN, DBVT, AVRO, MRNA", "7 Biotech Stocks to Buy and Hold in 2020", "Better Buy: Biogen vs. Amgen", "Noteworthy ETF Inflows: TQQQ, GOOGL, AMGN, TXN", "Health Care Sector Update for 03/11/2020: JNJ, PFE, ABT, MRK, AMGN, SPHS, CDMO, KALA", "Top Drug Stocks Under $5", "Daily Dividend Report: GD,HES,VZ,AMGN,PM", "Is iShares Nasdaq Biotechnology Index Fund a Buy?", "Health Care Sector Update for 03/04/2020: JNJ, PFE, ABT, MRK, AMGN, MRNA, REPH, CNC, DRRX", "ProShares ProShares UltraPro QQQ Experiences Big Inflow", "Health Care Sector Update for 03/04/2020: JNJ, PFE, ABT, MRK, AMGN, DRRX, VVUS, VYGR", "Thermo Fisher Scientific to Spend $11.5 Billion Upgrading Its DNA Testing Game", "Health Care Sector Update for 03/03/2020: JNJ, PFE, ABT, MRK, AMGN, KMPH, OMER, GNMK", "Better Buy: Amgen vs. Gilead Sciences", "FDA Approves Biohaven's Migraine Treatment Nurtec ODT", "Amgen Breaks Below 200-Day Moving Average - Notable for AMGN", "Health Care Sector Update for 02/27/2020: JNJ, PFE, ABT, MRK, AMGN, TDOC, ORMP, LHCG", "Analysts Forecast 11% Upside For The Holdings of FTCS", "Here's Why Karyopharm Therapeutics Has a Unique Growth Opportunity", "Amgen is Oversold", "3 Biotech Stocks That Surged Last Week", "3 Top Healthcare Stocks to Buy Right Now", "A Plan to Use Blockchain to Stop Counterfeit Drugs Moves Forward", "Investors Scrambled to Buy This Biotech IPO", "IWB, ABT, AMGN, LIN: Large Outflows Detected at ETF", "Health Care Sector Update for 02/19/2020: JNJ, PFE, ABT, MRK, AMGN, MREO, AMED, CTSO", "Notable Thursday Option Activity: ZBRA, AMGN, MMM", "AMGN April 3rd Options Begin Trading", "3 Biotech Stocks That Made Early Shareholders Millionaires", "FDA Approves Esperion Therapeutics' New Cholesterol Drug", "Is Amgen a Stock to Buy?", "Health Care Sector Update for 02/07/2020: JNJ, PFE, ABT, MRK, AMGN, ASRT, ZGNX, MYGN", "How Bristol-Myers Squibb Trounced Wall Street's Q4 Estimates", "Validea Joel Greenblatt Strategy Daily Upgrade Report - 2/6/2020", "Why Amgen Stock Dropped 10.4% in January", "PKW, AMGN, UNP, ORCL: ETF Inflow Alert", "Teva Pharmaceutical Just Got a Little Migraine Relief ", "Bristol-Myers Squibb Stock Is Too Cheap to Ignore", "Could Guardant Health Be a Millionaire-Maker Stock?", "Amgen Is Making 3 Big Bets -- Will They Pay Off for Investors?", "Amgen (AMGN) Shares Cross 3% Yield Mark", "Noteworthy Friday Option Activity: AMGN, EXPE, CVS", "Stock Market News: Amazon's Amazing; Amgen Falls Short", "Amgen's Shares Slip on Soft Guidance. Time to Buy?", "Nasdaq 100 Movers: AMGN, AMZN", "Amgen a Top Socially Responsible Dividend Stock With 3.0% Yield (AMGN)", "Amgen Inc (AMGN) Q4 2019 Earnings Call Transcript", "Amgen Revenue Slipped 1% in the Fourth Quarter", "Amgen Issues FY20 Guidance - Quick Facts", "Amgen Inc. Q4 adjusted earnings Beat Estimates", "Amgen Q4 19 Earnings Conference Call At 5:00 PM ET", "Amgen Q4 19 Earnings Conference Call At 5:00 PM ET", "Why Teva Stock Could Be the Next General Electric Stock", "Where Will Cara Therapeutics Be in 5 Years?", "Which Big Biotech Has the Safer Dividend -- Amgen or Gilead Sciences?", "Is Mylan Stock a Buy?", "Relative Strength Alert For Amgen", "Better Buy: Amgen vs. Gilead Sciences", "Better Buy: Exact Sciences vs. Qiagen", "3 Attractive Dividend Stocks Whose Dividends Could Double", "2 Biotechs Battling Immune Diseases", "iShares Core Dividend Growth ETF Experiences Big Inflow", "Noteworthy Thursday Option Activity: MOS, PPG, AMGN", "Health Care Sector Update for 01/14/2020: JNJ, PFE, ABT, MRK, AMGN, RTIX, TRXC, MREO", "Novartis' Heart Drug Gets Accelerated Review in Britain for High-Risk Patients", "Health Care Sector Update for 01/13/2020: JNJ, PFE, ABT, MRK, AMGN, IOVA, OCX, NVTA", "Health Care Sector Update for 01/10/2020: JNJ, PFE, ABT, MRK, AMGN, ACRS, MRNA, PTLA", "Noteworthy ETF Outflows: IWB, AMGN, LLY, QCOM", "These 25 Companies Laid Off Workers in 2019", "iShares Russell 1000 ETF Experiences Big Outflow", "Amgen a Top 25 Dividend Giant With 2.68% Yield (AMGN)", "AMGN February 14th Options Begin Trading", "3 of the Best Healthcare Stocks to Buy in 2020", "Amgen Completes Purchase Of About $2.8 Bln Of BeiGene Shares", "Better Buy: Abbott Laboratories vs. Pfizer", "Health Care Sector Update for 01/02/2020: JNJ, PFE, ABT, MRK, AMGN, IPHA, ONTX, AERI", "Breakingviews - A health craze for 2020: Chinese medicine", "Health Care Sector Update for 01/06/2020: JNJ, PFE, ABT, MRK, AMGN, LIFE, LPTX, NOVN", "Amgen a Top 25 Dividend Giant With 2.68% Yield (AMGN)", "The Success of Vascepa Actually Might Be a Problem for Amarin", "3 Biotech Stocks That Crushed It in 2019", "U.S. Cannabis Stocks Will Make Cheap, Smart Buys in 2020", "3 Blockbuster Cancer Drug Launches to Watch in 2020", "Better Buy: Amgen vs. Johnson & Johnson", "Vascepa\u2019s Future Looks Rosy, But It Could Still Be Fishy for Amarin Stock", "FDA Nod For BHC, Third Rituxan Biosim In The Offing, CBIO Soars, NERV Depressed", "3 Dividend Stocks That Hiked Their Payouts by More Than 100% in 5 Years", "Better Buy: Vertex Pharmaceuticals vs. Alexion Pharmaceuticals", "7 Biotech Stocks to Buy and Hold in 2020", "Amarin\u2019s Vascepa Approval Seems Fishy for Patients and AMRN Investors", "Is Amarin a $20 Billion Stock?", "Bristol-Myers Placed A Big Bet On Celgene\u2019s Pipeline. Will It Pay Off For Investors?", "How Gilead Sciences Is Helping Fund Bristol-Myers Squibb's Celgene Acquisition", "3 Reasons This Biotech is a Buy for Risk-Averse Investors", "Daily Dividend Report: AMGN, ZTS, PKI, PWR, AXP", "January 2020 Options Now Available For Amgen (AMGN)", "Here's Why You Should Own Amgen Stock in 2020", "Why BridgeBio Pharma Is Currently Trading At 2x Its IPO Price", "Health Care Sector Update for 12/11/2019: JNJ, PFE, ABT, MRK, AMGN, AQST, RCKT, MRNS", "Is Rigel Pharmaceuticals Stock a Buy?", "Better Buy: Gilead Sciences vs. Amgen", "Health Care Sector Update for 12/09/2019: JNJ, PFE, ABT, MRK, AMGN, PDLI, TGTX, TVTY, ARQL", "Health Care Sector Update for 12/09/2019: JNJ, PFE, ABT, MRK, AMGN, ARQL, THOR, MBIO, XBIT", "3 Healthcare Stocks to Buy Before the End of 2019", "Better Buy: Biogen vs. Amgen", "4 FDA Dates Biotech Investors Should Circle in December", "Health Care Sector Update for 12/06/2019: JNJ, PFE, ABT, MRK, AMGN, CYAD, SAVA, CRIS", "Health Care Sector Update for 12/06/2019: JNJ, PFE, ABT, MRK, AMGN, CYAD, ONCY, RCKT, SAVA", "Amgen: CANDOR Study Supports Combination Of KYPROLIS, DARZALEX - Quick Facts", "Health Care Sector Update for 12/09/2019: JNJ, PFE, ABT, MRK, AMGN, PDLI, TGTX, TVTY, ARQL", "Health Care Sector Update for 12/09/2019: JNJ, PFE, ABT, MRK, AMGN, ARQL, THOR, MBIO, XBIT", "Why Novartis's $9.7 Billion Purchase of The Medicines Company Is Bad News for Amgen", "Notable Monday Option Activity: M, AMGN, IBM", "Biotech Stocks Facing FDA Decision In December 2019", "Health Care Sector Update for 11/29/2019: JNJ, PFE, ABT, MRK, AMGN, CANF, REGN, AZN", "Health Care Sector Update for 11/27/2019: JNJ, PFE, ABT, MRK, AMGN, ARAV, TNXP, VRCA", "Can Cannabis 2.0 Kickstart Marijuana Stocks?", "Health Care Sector Update for 11/26/2019: JNJ, PFE, ABT, MRK, AMGN, CCXI, XFOR, SNOA", "A 45% Premium: Here's Why The Medicines Company Is Worth More to Novartis Than It Was to You", "Why The Medicines Company Stock Is Soaring Today", "Health Care Sector Update for 11/25/2019: JNJ, PFE, ABT, MRK, AMGN, SRNE, MDCO, NVS, ZIOP", "Healthcare Stocks That Hit New Highs (MTEM, AMGN, AMED...)", "Does Amarin Have a Dark Horse Suitor?", "Why I'm Holding On to My Bristol-Myers Squibb Shares Now That the Celgene Acquisition Has Closed", "Why AbbVie Is a Dividend Growth Stock That's Too Cheap to Ignore", "Health Care Sector Update for 11/26/2019: JNJ, PFE, ABT, MRK, AMGN, CCXI, XFOR, SNOA", "A 45% Premium: Here's Why The Medicines Company Is Worth More to Novartis Than It Was to You", "Why The Medicines Company Stock Is Soaring Today", "Missed the 310% Rise of Arrowhead Pharmaceuticals? Keep an Eye On This Competitor", "Amgen Boosts FY19 Outlook After Otezla Acquisition - Quick Facts", "Notable ETF Outflow Detected - ITOT, PG, XOM, AMGN", "Health Care Sector Update for 11/20/2019: JNJ, PFE, ABT, MRK, AMGN, ALC, BCRX, CRSP", "2 Stocks to Buy If You're Worried About a Recession", "Health Care Sector Update for 11/22/2019: JNJ, PFE, ABT, MRK, AMGN, SENS, ORGO, HSDT", "If Biosimilars Are Struggling, Someone Forgot to Tell Coherus BioSciences", "Here's Why The Medicines Company Moved Higher Today", "The Question is Not Why Amarin Stock May Go Up, But Should It?", "Amgen Says New Analysis Shows Benefit Of Repatha In High-Risk Patients", "Noteworthy Thursday Option Activity: AMGN, ROKU, SPLK", "Amarin's Stock Could Reach $50 Per Share Soon", "Looking for a Biotech Stock That's an Ideal Buyout Candidate? This Is It.", "Here\u2019s Why FibroGen\u2019s Stock Popped Friday", "Why Amgen's Stock Soared in October", "3 Cancer Treatment Stocks to Buy Right Now", "Here's Why Cytokinetics Stock Tanked on Thursday", "Noteworthy Thursday Option Activity: LH, CSX, AMGN", "Buy These 2 Stocks to Access China's Huge Healthcare Market", "Breakingviews - Biotech upstarts will be Big Pharma's China tonic", "Ex-Dividend Reminder: Teleflex, Amgen and Sabra Health Care REIT", "Amgen Reaches Analyst Target Price", "Better Buy: Mirati Therapeutics vs. Amgen", "Health Care Sector Update for 11/01/2019: BGNE,AMGN,AMED,BLUE", "Health Care Sector Update for 11/01/2019: BGNE,AMGN,AMED,BLUE", "Here's Why Beigene Stock Is Soaring Today", "iShares Russell 3000 ETF Experiences Big Inflow", "BGNE Soars, DRNA Hits New High On Roche Deal, FDA Heeds REPH's Request", "2020 Election Could Hurt Amgen Stock\u2019s Healthy Dividend", "What Should Investors Think of Biogen's Alzheimer's Drug Candidate?", "Notable Thursday Option Activity: AMGN, AMD, COST", "Bristol-Myers Squibb Beats Expectations in Q3 as Its Celgene Acquisition Nears the Finish Line", "Can This Tiny Biotech Take Down Amgen?", "Amgen Inc (AMGN) Q3 2019 Earnings Call Transcript", "Amgen Updates Guidance - Quick Facts", "Amgen Inc. Q3 adjusted earnings Beat Estimates", "Amgen To Acquire 20.5% Stake In BeiGene For Approx. $2.7 Bln - Quick Facts", "Is Gossamer Bio a Buy?", "Why Shockwave Medical Is Not a Buy", "Amgen Q3 19 Earnings Conference Call At 5:00 PM ET", "5 Top Healthcare ETFs", "Amgen Decides To Discontinue Original List Price Option For Repatha", "Daily Dividend Report: AEP, LECO, BAC, WFC, AMGN", "ProShares ProShares UltraPro QQQ Experiences Big Outflow", "Here's Why Mirati Therapeutics Stock Is on the Move Again Today", "Is Gossamer Bio a Buy?", "Amgen: FDA Approves Earlier Use Of Nplate To Treat Immune Thrombocytopenia", "Amgen : EVENITY Gets Positive CHMP Opinion For Treatment Of Severe Osteoporosis", "Will The Pace of M&A Pick Up Following The Biotech Sector\u2019s Pounding?", "Noteworthy Monday Option Activity: PD, AMGN, IBM", "Health Care Sector Update for 10/07/2019: JNJ, ABT, PFE, MRK, AMGN, MREO, XENT, CAPR", "How Amazon Is Shaking Up Telemedicine, Plus 1 Winner and 1 Loser Exiting ESMO", "Amgen Appoints Peter Griffith As CFO, Succeeding David Meline, Effective Jan. 1", "2 Great Stocks You Can Buy on Sale", "Winners and Losers of Europe\u2019s Big Cancer Meeting", "The Medicines Company Surges on Positive Drug Trial Results", "The Medicines Company Is Up 161% Year to Date, but Here's a Better Way to Play the Drugmaker's Success", "Is Amgen Really as Cheap as It Looks?", "Notable Friday Option Activity: AMGN, OKE, AXDX", "Cancer Results to Watch at This Weekend\u2019s European Society of Medical Oncology Congress", "Interesting AMGN Put And Call Options For November 22nd", "Interesting AMGN Put And Call Options For November 8th", "TQQQ, ADBE, COST, AMGN: Large Inflows Detected at ETF", "3 Biotechs With the Biggest Cash Stockpiles", "Could Amgen's Latest Bad News Boost the Chances of More Acquisitions?", "Health Care Sector Update for 09/17/2019: IMMP,ABT,ACRS,ADPT,AMGN", "Health Care Sector Update for 09/17/2019: ABT,ACRS,ADPT,AMGN", "Here's Why Alder Biopharmaceuticals Is Rocketing Higher Today", "Better Buy: Biogen vs. Amgen", "Amgen's Phase 3 CANDOR Study Meets Primary Endpoint Of PFS - Quick Facts", "Analysts See 10% Gains Ahead For The Holdings of EQWL", "Does Acadia Pharmaceuticals Have More Room to Run?", "Why Amgen Stock Perked Up Last Month", "5 Things You'll Want to Know About Amgen's Future", "Notable ETF Outflow Detected - FBT, AMGN, NBIX, ALNY", "Amgen To Present At The Morgan Stanley Global Conference; Webcast At 9:10 AM ET", "Is iShares Nasdaq Biotechnology Index Fund a Buy?", "Amarin: Keep Your Dry Powder Ready", "Nasdaq 100 Movers: AMGN, NFLX", "S&P 500 Movers: AMGN, LB", "Health Care Sector Update for 09/09/2019: ACAD, AXNX, AMGN, JNJ, PFE, ABT, MRK", "Novartis: Aimovig Shows Long-term Efficacy In Treatment Of Episodic Migraine", "Here's Why Arrowhead Pharmaceuticals Rose 17.6% in August", "Amgen Drug Shrinks 54% Of Lung Cancer Tumors In Study", "Noteworthy Monday Option Activity: YUM, AMGN, EVRI", "Why Amgen's Spending Billions to Buy This 1 Drug; Plus Heart Disease Has a New Enemy", "4 Biotech Stocks With Big Catalysts in September", "Here's Why Alexion Pharmaceuticals Dropped 11% in August", "Here's Why The Medicines Company Stock Soared Again on Tuesday", "SPY, BRK.B, NFLX, AMGN: ETF Inflow Alert", "3 Top Biotech Stocks to Buy Right Now", "4 Biotech Stocks to Buy That Are on the Move", "Better Buy: Amgen vs. Celgene", "Celgene's $13.4 Billion Deal With Amgen Is a Win-Win-Win", "5 Top Stock Trades for Tuesday: NFLX, AMGN, ACB, BMY", "Celgene News: CELG Stock Jumps on Sale of Otezla to Amgen", "Should Amgen Finally Buy Alexion Pharmaceuticals?", "3 Reasons Why Amgen Could Actually Acquire Alexion", "ALXN & Takeover Rumors, AMGN's JASMINE Blooms, CLSD Sees The Writing On The Wall", "SPDR S&P 500 ETF Trust Experiences Big Outflow", "What Happened in the Stock Market Today", "Is Amgen a Buy?", "Notable ETF Outflow Detected - SPYG, AVGO, AMGN, ADP", "Wednesday\u2019s Vital Data: Amgen, American Airlines and Apple", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 14, 2019", "Noteworthy Monday Option Activity: APA, STT, AMGN", "Nasdaq 100 Movers: MELI, AMGN", "Ex-Dividend Reminder: Teleflex, Amgen and U.S. Physical Therapy", "Arrowhead Pharmaceuticals: Buy at the High?", "Sandoz To Appeal U.S. Court Ruling In Biosimilar Erelzi U.S. Patent Case", "AMGN Named A Top Socially Responsible Dividend Stock", "5 'Strong Buy' Dividend Stocks With High Upside", "9 Catalysts That Will Drive Chinese Biotech Stocks Much Higher", "Daily Dividend Report: DK, SPNS, SBR, TG, AMGN", "3 Lung Cancer Stocks That Could Soar in September", "iShares U.S. Healthcare ETF Experiences Big Outflow", "S&P 500 Movers: NKTR, AMGN", "Health Care Sector Update for 07/31/2019: NUVA,AMGN,ACRS", "Are Amgen and Gilead Sciences Better Buys After Second-Quarter Earnings?", "Amgen Inc (AMGN) Q2 2019 Earnings Call Transcript", "Amgen Manages to Tread Water for Another Quarter", "Amgen Inc. Q2 adjusted earnings Beat Estimates", "Amgen Q2 19 Earnings Conference Call At 5:30 PM ET", "AMGN September 6th Options Begin Trading", "Health Care Sector Update for 07/31/2019: DMPI,NUVA,AMGN,ACRS", "Health Care Sector Update for 07/31/2019: NUVA,AMGN,ACRS", "Are Amgen and Gilead Sciences Better Buys After Second-Quarter Earnings?", "The Implied Analyst 12-Month Target For EQWL", "ACWI, BABA, KO, AMGN: ETF Inflow Alert", "AMGN August 30th Options Begin Trading", "What Happened in the Stock Market Today", "The 10 Biggest Healthcare Stocks", "10 Biggest Cancer-Fighting Stocks", "Here's Why Coherus BioSciences Is Falling Today", "The Health Care Select Sector SPDR Fund Experiences Big Outflow", "Why Amgen is a Top 25 Dividend Giant (AMGN)", "Here's Why Amgen Stock Gained 10% in June", "How to Invest in Biotech Stocks", "Noteworthy Monday Option Activity: AMP, AVGO, AMGN", "3 Top Biotech Stocks to Buy Right Now", "Notable Monday Option Activity: STZ, CHGG, AMGN", "3 Cancer-Treatment Stocks to Buy", "Here's Why Dova Pharmaceuticals Stock Jumped Higher Today", "XLV, AMGN, LLY, SYK: ETF Outflow Alert", "The 10 Biggest Biotech Stocks", "Notable Wednesday Option Activity: UNH, RHT, AMGN", "3 Large-Cap Biotech Stocks to Buy for Massive Gains", "IWF, ACN, COST, AMGN: Large Inflows Detected at ETF", "Where Will Cara Therapeutics Be in 5 Years?", "3 Cancer-Treatment Stocks to Buy", "SSO, MDT, IBM, AMGN: Large Outflows Detected at ETF", "Health Care Sector Update for 06/07/2019: CRSP,VRTX,LJPC,MRTX,AMGN", "5 Healthcare Stocks to Pick Up From the Wreckage", "5 Reasons Pfizer Sat on a Potential New Alzheimer's Drug", "3 Cancer Stocks Given a Lift by Amgen", "Better Buy: Biogen vs. Amgen", "3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise Deal", "Amgen Reports Positive Data From AMG 510 Early Phase 1 Study - Quick Facts", "Notable Friday Option Activity: TMUS, AMGN, ARR", "SSO, AMZN, AMGN, LIN: Large Outflows Detected at ETF", "Ranking the Top 10 Stock Buybacks of Last Year", "2 Healthcare Stocks That Doubled Investors' Money in 2019", "3 Charts Every Amgen Investor Needs to See", "Interesting AMGN Put And Call Options For July 5th", "Here's Why Mirati Therapeutics Is Jumping Today", "Amgen Offers To Buy Nuevolution For SEK 32.50/shr In Cash - Quick Facts", "Who Had the Better Quarter: Gilead Sciences or Amgen?", "Health Care Sector Update for 05/16/2019: BLUE,MRTX,AGIO,EDAP,AMGN", "Here's Why Mirati Therapeutics Is Surging Today", "Notable Thursday Option Activity: AGN, DAL, AMGN", "3 Stocks With Big News Coming at ASCO 2019", "Health Care Sector Update for 05/10/2019: JNJ, PFE, ABT, MRK, AMGN, GENE, PIRS, TGTX", "IBB, CELG, GILD, AMGN: ETF Inflow Alert", "Why Are Investors Passing on Teva Pharmaceutical Industries?", "June 14th Options Now Available For Amgen (AMGN)", "5 Top Stock Trades for Thursday: CVS, TWLO, EL, AMGN", "Nasdaq 100 Movers: AMGN, AAPL", "Amgen Inc (AMGN) Q1 2019 Earnings Call Transcript", "Amgen Reports an Unusual Slide Backward", "Amgen Earnings: AMGN Stock Dips Slightly Despite Q1 EPS, Sales Beat", "Notable Wednesday Option Activity: EZPW, AMGN, ETSY", "Why Are Investors Passing on Teva Pharmaceutical Industries?", "June 14th Options Now Available For Amgen (AMGN)", "4 More Healthcare Earnings Reports to Watch This Week", "Noteworthy Friday Option Activity: SAIA, COTY, AMGN", "Notable ETF Outflow Detected - IYH, ABBV, AMGN, MDT", "Pfizer Stock Suffers From an Underappreciated Drugs Pipeline", "Amgen is Oversold", "Amgen Updates Earnings Guidance - Quick Facts", "Why Amgen Stock Could Break Out to New Highs", "Radius Health (RDUS) Rallies 33.4% YTD on Robust Tymlos Sales", "Amgen sets $21,900 annual price for new Evenity bone drug", "Better Buy: Amgen vs. Gilead Sciences", "ProShares UltraPro S&P500 Experiences Big Outflow", "FDA Approves Amgen's Osteoporosis Drug Evenity", "Here's Why Novartis Is Sliding Today", "3 Big Stock Charts for Thursday: Citrix Systems, Goldman Sachs Group and Amgen", "5 Stocks in the Age of Miracles", "Amgen's postmenopausal osteoporosis drug gets FDA greenlight", "Amgen's postmenopausal osteoporosis drug gets FDA approval", "Here's Why Novartis Is Sliding Today", "Amgen (AMGN) Shares Cross 3% Yield Mark", "Amgen (AMGN) Shares Cross 3% Yield Mark", "Why Amgen's Giving Novartis a Headache", "Why Amgen Can Deliver Medical and Financial Miracles", "Novartis & Amgen in Legal Dispute Over Migraine Drug Aimovig", "Novartis sues Amgen over migraine treatment Aimovig", "Pfizer's New Lung Cancer Drug Vizimpro Gets EU Approval", "Novartis Resubmits BLA to FDA for Biosimilar of Neulasta", "Noteworthy ETF Inflows: VYM, PFE, IBM, AMGN", "Noteworthy ETF Inflows: VYM, PFE, IBM, AMGN", "BMO\u2019s Got A Point About Teva Stock, But Are Investors Willing To Listen?", "Why Amgen's Giving Novartis a Headache", "Novartis & Amgen in Legal Dispute Over Migraine Drug Aimovig", "The Zacks Analyst Blog Highlights: Apple, Amgen, United Technologies, Travelers and Xilinx", "AbbVie's Psoriasis Drug Skyrizi Gets First Approval in Japan", "Top Research Reports for Apple, Amgen & United Technologies", "QUAL, MO, AMGN, MCO: Large Inflows Detected at ETF", "May 3rd Options Now Available For Amgen (AMGN)", "Biogen Stock Fell Too Far on Unfortunate News", "BMO\u2019s Got A Point About Teva Stock, But Are Investors Willing To Listen?", "Spectrum Pharma (SPPI) Withdraws Rolontis BLA, Shares Down", "Amarin's Vascepa cuts occurrence of serious heart problems 30 pct", "Regeneron, Sanofi Get EC Nod for Label Expansion of Praluent", "Better Buy: Amgen vs. Gilead Sciences", "iShares Edge MSCI USA Quality Factor ETF Experiences Big Inflow", "Roche Gets Approval for Label Expansion of MabThera in Europe", "Roche Receives EC Approval for Label Expansion of Hemlibra", "Here's Why Cytokinetics Stock Jumped Today", "Pfizer's Herceptin Biosimilar Trazimera Gets FDA Approval", "Roche's (RHHBY) Tecentriq Gets FDA Approval for Breast Cancer", "Is Amgen (AMGN) a Profitable Pick ForValue Investors Now?", "AMGN Named 'Top Dividend Stock of the Nasdaq 100' at Dividend Channel With 3.2% Yield", "Better Buy: Amgen vs. Biogen", "Daily Dividend Report: MTN, AMT, AMAT, BMY, AMGN", "RSI Alert: Amgen Now Oversold", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for March 14, 2019", "Ligand Sells Promacta Rights for $827M, Updates '19 View", "3 Big Pharmas Trying to Pop the Rebate Bubble", "U.S. FDA chief tough on e-cigs steps down in surprise resignation", "U.S. FDA chief tough on e-cigarettes steps down abruptly", "US STOCKS-Wall St sinks for 3rd day as healthcare, energy slump", "Wall St sinks for 3rd day as healthcare, energy slump", "Wall St falls for 3rd day as healthcare, energy slump", "Lilly's Emgality Gets FDA Priority Review for Cluster Headache", "Wall Street eyes third day of losses as healthcare sector weighs", "US STOCKS-Wall Street eyes third day of losses as healthcare sector weighs", "Merck Gets CHMP Nod for Six-Week Dosing Option of Keytruda", "U.S. FDA chief Gottlieb resigns", "U.S. FDA chief Gottlieb resigning", "iShares Russell 1000 Growth ETF Experiences Big Inflow", "AbbVie Gets CHMP Nod for Psoriasis Candidate Risankizumab", "US STOCKS-Wall St falls for 3rd day as healthcare, energy slump", "Radius (RDUS) Posts Narrower Q4 Loss on Robust Tymlos Sales", "Sanofi/Regeneron Disagree With Jury Verdict in Amgen's Favor", "Notable Tuesday Option Activity: BAC, AMGN, TZOO", "Roche (RHHBY) to Acquire Spark Therapeutics for $4.8 Billion", "Sanofi, Regeneron lose U.S. patent challenge to Amgen cholesterol drug", "Better Buy: Amgen vs. Celgene", "Amgen Starts Phase III Enrollment for Heart Failure Drug", "Spectrum (SPPI) Misses Earnings Estimates in Q4, Tops Sales", "Merck Gets Priority Review for Keytruda in Third-Line SCLC", "AMGN April 5th Options Begin Trading", "AbbVie's RA Candidate Upadacitinib Gets FDA Priority Review", "Merck's Keytruda Fails to Meet Endpoint in Liver Cancer Study", "Top Analyst Reports for Walmart, Amgen and Honda", "Roche's (RHHBY) BLA for Lymphoma Drug Gets Priority Review", "Merck Gets Priority Review for Keytruda Combo in Kidney Cancer", "The Zacks Analyst Blog Highlights: Walmart, Amgen, Honda, TransCanada and TransUnion", "Teva (TEVA) Q4 Earnings Miss,'19 View Weak, Shares Down", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 14, 2019", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for February 14, 2019", "Key Takeaways from Eli Lilly's (LLY) Q4 Earnings Report", "Merck's Keytruda Gets FDA Priority Review for Head/Neck Cancer", "AbbVie Buys Rights to Novel Immunotherapy for Multiple Myeloma", "Sanofi/Regeneron Cut Price of PCSK9 Inhibitor Praluent by 60%", "Is Amgen a Buy?", "Teva (TEVA) Q4 Earnings Miss,'19 View Weak, Shares Down", "Here's Why Coherus BioSciences Rose 48.7% in January", "Ligand (LGND) Beats on Q4 Earnings & Sales, Raises '19 View", "5 Reasons Eli Lilly Investors Look Can Look Past Lartruvo's Failure", "Lilly (LLY) Lags Q4 Earnings, Lowers 2019 View, Stock Down", "Amgen a Top Socially Responsible Dividend Stock With 3.1% Yield (AMGN)", "Facing crackdown in Canada, drugmakers offered billions in price cuts", "IWV, PEP, ABBV, AMGN: ETF Outflow Alert", "After Hours Most Active for Feb 5, 2019 : BRX, SNAP, ET, S, ECA, M, CZR, MSFT, KURA, EA, AMGN, URBN", "Teva Gains Positive CHMP Opinion for Migraine Drug Ajovy", "Pfizer's (PFE) New Lung Cancer Drug Vizimpro Gets CHMP Nod", "A War on High Drug Prices Could Boost Biosimilars", "Notable ETF Inflow Detected - XLV, AMGN, ABBV, LLY", "Optum to cover Amgen, Eli Lilly migraine drugs, exclude Teva", "Merck's Keytruda tops $2 billion in quarterly sales, shares rise", "Roche Submits sBLA to FDA for Label Expansion of Kadcyla", "Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance", "Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva", "Novartis (NVS) Q4 Earnings Miss Estimates, Revenues Up Y/Y", "Amgen, Inc (AMGN) Q4 2018 Earnings Conference Call Transcript", "Nasdaq 100 Movers: AMGN, AMD", "Amgen (AMGN) Q4 Earnings Beat Estimates, 2019 Guidance Tepid", "Pfizer (PFE) Q4 Earnings Beat, 2019 View Tepid, Stock Dips", "Merck quarterly profit beats estimates on Keytruda strength", "Amgen Q4 18 Earnings Conference Call At 5:00 PM ET", "Amgen 2019 forecast falls short of expectations, shares dip", "Amgen quarterly profit tops Street view, 2019 forecast falls short", "After-Hours Earnings Report for January 29, 2019 : AAPL, AMGN, CNI, SYK, ILMN, EBAY, EQR, AMD, BXP, ALGN, TSS, KLAC", "Amgen (AMGN) to Report Q4 Earnings: What's in the Cards?", "Notable Monday Option Activity: GPRE, YUMC, AMGN", "AbbVie (ABBV) Misses on Q4 Earnings & Revenues, Shares Down", "Amgen Leaves Investors With Mixed Emotions", "Health Care Sector Update for 01/25/2019: CHRS,AMGN,RMD,AZN,IDXG,ABBV", "See Which Of The Latest 13F Filers Holds Amgen", "CVS to cover migraine drugs from Teva, Lilly; excludes Amgen", "Pfizer (PFE) to Report Q4 Earnings: What's in the Cards?", "The Zacks Analyst Blog Highlights: Celgene, Regeneron Pharmaceuticals, Amgen, Alnylam Pharmaceuticals and bluebird bio", "iShares U.S. Healthcare ETF Experiences Big Inflow", "Is a Surprise in the Cards for Novartis (NVS) in Q4 Earnings?", "Amgen/Allergan's Rituxan Biosimilar Meets Goal in Phase III", "Health Care Sector Update for 01/25/2019: CHRS,AMGN,RMD,AZN,IDXG,ABBV", "See Which Of The Latest 13F Filers Holds Amgen", "What's in Store for Bristol-Myers (BMY) in Q4 Earnings?", "Biogen (BIIB) Q4 Earnings Coming Up: What's in the Cards?", "Which Big Pharma Stocks Lose Most in a War on Drug Price Hikes?", "Amgen (AMGN) Gains But Lags Market: What You Should Know", "Amgen's Postmenopausal Osteoporosis Drug Gets FDA Panel Nod", "Biotech Stock Roundup: Amgen, Vertex Get EC Nod for Label Expansion of Drugs", "Amgen's postmenopausal osteoporosis drug wins FDA panel backing", "3 of the Top Big Pharma Stocks to Buy Now", "What's in Store for Merck in 2019 After a Solid Run in '18?", "Here's Why You Should Invest in Illumina (ILMN) Stock Now", "Amgen's Osteoporosis Candidate Evenity Gets Approval in Japan", "Noteworthy ETF Outflows: XLV, MRK, ABT, AMGN", "U.S. Supreme Court rejects Amgen over cholesterol medication patent fight", "Notable ETF Outflow Detected - IBB, AMGN, ILMN, REGN", "U.S. top court rejects Amgen over cholesterol medication patent fight", "Better Buy: Gilead Sciences vs. Amgen", "Here's Why bluebird bio Shares Got Knocked Down 19.3% in December", "Merck Buys NASH Candidate, Keytruda Wins 5 Approvals in Japan", "Teva Pharmaceutical Posting Strong Gain After Resolving Dispute With Amgen", "Spectrum Pharma Fully Enrolls 1St Cohort in Poziotinib Study", "Will Pfizer's (PFE) Stock Keep Up the Momentum in 2019?", "Amgen a Top 25 Dividend Giant With 2.97% Yield (AMGN)", "Teva (TEVA) Ends Dispute with Amgen Over Generic Sensipar", "3 Pharma Stocks Revving for Growth", "Teva, Amgen end dispute over generic Cinacalcet HCl tablets", "Teva, Amgen Settle Dispute Over Teva's Generic Cinacalet HCl Product", "Forget GlaxoSmithKline, Eli Lilly Is a Better Big Pharma Stock", "Will AbbVie (ABBV) Shares Regain Lost Momentum in 2019?", "Spectrum Pharma Files BLA for Neutropenia Candidate Rolontis", "Amgen (AMGN) Stock Moves -1.52%: What You Should Know", "AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV", "Amgen (AMGN) Stock Moves -1%: What You Should Know", "Merck's sBLA for Keytruda in Lung Cancer Gets Extended Review", "AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib", "Allergan Drops, Stops Textured Breast Implant Sales in Europe", "Merck's Keytruda Gets FDA Approval for Rare Skin Cancer", "The Zacks Analyst Blog Highlights: Amgen, Aduro, Vertex, Evofem and Incyte", "QUAL, MA, MO, AMGN: Large Inflows Detected at ETF", "AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV", "Amgen (AMGN) Stock Moves -1%: What You Should Know", "Merck's sBLA for Keytruda in Lung Cancer Gets Extended Review", "Amgen And Molecular Partners Collaborate In Immuno-Oncology", "iShares MSCI World ETF Experiences Big Inflow", "Merck's Keytruda Gets EU Nod as Adjuvant Therapy for Melanoma", "Teva Reports Positive Top-Line Data for Migraine Candidate", "3 Top Healthcare Stocks to Buy in December", "Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know", "Pfizer's (PFE) Biosimilar of Avastin Gets Positive CHMP Nod", "Better Buy: Biogen vs. Amgen", "5 Biotech Stocks Set to Bounce Back in '19 After a Rough Ride", "Amgen (AMGN) Shares Cross 3% Yield Mark", "Gilead Sciences a Top Socially Responsible Dividend Stock With 3.4% Yield (GILD)", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for December 13, 2018", "Biotech Stocks Made Big Progress Toward Preventing Heart Attacks in 2018", "Why Arrowhead Pharmaceuticals Surged 11% Higher Today", "Health Care Sector Update for 12/11/2018: ENTX, AMGN, ITCI, NVS, JNJ, PFE, MRK, ABT", "Wall Street Heads For Higher Open as China's Trade Concessions Trigger Risk Rally", "Health Care Sector Update for 12/11/2018: OPRX,ITCI,ENTX,AMGN,RARX", "Health Care Sector Update for 12/11/2018: ITCI,ENTX,AMGN,RARX", "iShares Nasdaq Biotechnology ETF Experiences Big Inflow", "Amgen (AMGN) Continues to Reward Shareholders, Ups Dividend", "Amgen (AMGN) Gains But Lags Market: What You Should Know", "Noteworthy Friday Option Activity: KODK, AMGN, NYT", "Can Celgene and bluebird bio Survive a Two-Pronged Attack?", "Amgen's BiTE Immunotherapies Show Promise in Early Studies", "AbbVie Settles With Pfizer for Humira Biosimilar in U.S.", "FDA Committee to Review Amgen's (AMGN) Osteoporosis Candidate", "Amgen Reaches Analyst Target Price", "Monday's ETF Movers: XBI, XLV", "Daily Dividend Report: AMGN, AES, ERIE, VTR, MRVL", "3 Big Stock Charts for Wednesday: Delta Air Lines, Amgen and Mondelez International", "Novartis (NVS) Receives EC Approval for Neulasta Biosimilar", "Noteworthy Wednesday Option Activity: AMGN, V, KO", "5 Biotech Stocks to Scoop Up for Big Dividends", "Notable ETF Inflow Detected - SPYG, ABT, BKNG, AMGN", "4 Reasons Why Lilly is Up More Than 30% This Year So Far", "Roche, AbbVie Get FDA Approval for Venclexta Label Expansion", "Amgen (AMGN) Gains As Market Dips: What You Should Know", "Is Amgen (AMGN) a Great Stock for Value Investors?", "Amgen's Blincyto Gets Positive CHMP Opinion for Line Extension", "Drug Pricing Resurfaces, Pfizer to Raise Cost of 41 Drugs", "Amgen (AMGN) Gains As Market Dips: What You Should Know", "Noteworthy ETF Outflows: SPYG, AMGN, TMO, LLY", "Lilly Offers Updates on Progress of Headache Disorder Drugs", "Merck's Keytruda Improves Survival in Esophageal Cancer Study", "Biotech Stock Roundup: GILD's Drug Wins Nod in China, Arena Up On Licensing Deal", "Roche's Tecentriq Gets Priority Review for Breast Cancer", "Ex-Dividend Reminder: Aqua America, Amgen and Jones Lang LaSalle", "Merck's (MRK) Keytruda Gets FDA Approval for Liver Cancer", "Amgen (AMGN) Stock Moves -0.83%: What You Should Know", "Better Buy: Amgen Inc. vs. Pfizer Inc.", "6 Pharmaceutical Stocks to Buy After the Midterms", "Spectrum (SPPI) Earnings and Sales Beat Estimates in Q3", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 15, 2018", "Roche's Tecentriq Gets Priority Review for Breast Cancer", "Ex-Dividend Reminder: Aqua America, Amgen and Jones Lang LaSalle", "Amgen (AMGN) Counts on New Drugs Amid Rising Biosimilar Woes", "3 Cancer Stocks to Watch in December", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for November 08, 2018", "The Zacks Analyst Blog Highlights: Amgen, Intercontinental Exchange, TOTAL S.A., Royal Dutch Shell and Williams", "5 Top Stocks to Make the Most of a Divided Congress", "Ligand (LGND) Beats on Q3 Earnings & Revenues, Raises View", "Election Day 2018: Here Are the Winners & Losers", "Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know", "3 Top Biotech Stocks With P/Es Below 14", "Drug Stocks to Post Earnings on Nov 5: MYL, NBIX, RARE, TARO", "Teva (TEVA) Q3 Earnings Beat, 2018 EPS View Up, Shares Rise", "Radius Health (RDUS) Posts Narrower-Than-Expected Q3 Loss", "Notable Friday Option Activity: AAL, AMGN, QCOM", "7 Healthcare Stocks Soaring on Election Results", "Biotech ETFs in Focus on String of Q3 Earnings Beat", "Amgen (AMGN) Beats on Earnings & Sales in Q3, Raises View", "The Zacks Analyst Blog Highlights: Facebook, Amgen and MGM Resorts International", "Community Health's (CYH) Q3 Loss Widens, Admissions Drop", "Pfizer (PFE) Beats on Q3 Earnings, Meets Sales, Narrows View", "Amgen Inc (AMGN) Q3 2018 Earnings Conference Call Transcript", "Aging Blockbusters Send Amgen Inc.'s Bottom Line Lower", "The Zacks Analyst Blog Highlights: Gilead Sciences, Amgen, Vertex Pharmaceuticals, Celgene and Regeneron Pharmaceuticals", "Amgen (AMGN) Q3 Earnings and Revenues Beat Estimates", "Earnings Reaction History: Amgen Inc., 40.0% Follow-Through Indicator, 2.1% Sensitive", "After-Hours Earnings Report for October 30, 2018 : FB, AMGN, TMUS, BIDU, PSA, APC, EA, EBAY, CXO, OKE, EIX, VRSK", "AMGN Crosses Above Key Moving Average Level", "iShares Russell 1000 Growth ETF Experiences Big Inflow", "The Zacks Analyst Blog Highlights: Allergan, Regeneron Pharmaceuticals, Amgen, Alnylam Pharmaceuticals and AMAG Pharmaceuticals", "This Big Pharma Bet Isn't Paying Off Yet -- and It's Costing You", "Facebook Beats Q3 Estimates, Swings to Positive; Plus AMGN, MGM", "What's in the Cards for Glaxo (GSK) This Earnings Season?", "Anthem (ANTM) Q3 Earnings: What's in Store for the Stock?", "Why Amgen (AMGN) Might Surprise This Earnings Season", "5 Drug/Biotech Stocks Likely to Beat Estimates in Q3 Earnings", "What's in the Cards for HCA Healthcare (HCA) in Q3 Earnings?", "Pfizer (PFE) to Report Q3 Earnings: What's in the Cards?", "Can Amgen (AMGN) Keep the Earnings Streak Alive in Q3?", "Amgen is Oversold", "What's in the Cards for Glaxo (GSK) This Earnings Season?", "Anthem (ANTM) Q3 Earnings: What's in Store for the Stock?", "Why Amgen (AMGN) Might Surprise This Earnings Season", "Is a Beat in the Cards for Allergan (AGN) in Q3 Earnings?", "Incyte (INCY) to Report Q3 Earnings: What's in the Cards?", "Notable Wednesday Option Activity: AMTD, LAD, AMGN", "Bristol-Myers (BMY) Beats on Q3 Earnings, Raises EPS View", "Amgen (AMGN) Q3 Earnings Preview: What to Look Out For", "4 High Dividend Stocks to Grow Profits", "What's in Store for Celgene Corp. (CELG) Q3 Earnings?", "Is a Beat in Store for Vertex (VRTX) This Earnings Season?", "What's in Store for Anika Therapeutics (ANIK) in Q3 Earnings?", "Will Gilead (GILD) HIV Sales Offset HCV Sales Decline in Q3?", "Alexion (ALXN) to Report Q3 Earnings: What's in the Cards?", "Daily Dividend Report: AMGN, MET, MCO, AMP, NEM", "Better Buy: Biogen Inc. vs. Amgen Inc.", "3 Dividend Stocks for Income", "Notable ETF Inflow Detected - SPYG, INTC, CMCSA, AMGN", "AMGN or ILMN: Which Is the Better Value Stock Right Now?", "Amgen (AMGN) Dips More Than Broader Markets: What You Should Know", "Biogen (BIIB) Q3 Earnings Coming Up: What's in the Cards?", "Health Care Sector Update for 10/17/2018: TEVA,ESRX,AMGN,NVW,LLY,VTVT,KDMN,FMS", "Novartis (NVS) Q3 Earnings In Line, Revenues Beat Estimates", "Better Buy: Biogen Inc. vs. Amgen Inc.", "3 Dividend Stocks for Income", "AbbVie Settles With Novartis to Delay Humira Biosimilar in US", "Health Care Sector Update for 10/12/2018: APHB, TRVN, NVO, AMGN, MRK, ABT, PFE, JNJ", "Notable Friday Option Activity: WDC, AMGN, AXS", "J&J (JNJ) to Set the Ball Rolling for Pharma Q3 Earnings", "Validea Warren Buffett Strategy Daily Upgrade Report - 10/11/2018", "4 Strong Stocks to Buy That Double As Big Takeover Targets", "Thursday's ETF with Unusual Volume: PBE", "Here's Why bluebird bio Dropped 13.3% in September", "Roche (RHHBY) Presents Encouraging Data on MS Drug Ocrevus", "Bausch's Bryhali Gets Tentative FDA Nod for Plaque Psoriasis", "Kala Pharmaceuticals (KALA) Catches Eye: Stock Jumps 7.4%", "FDA Sets Action Date for Recro's Pain Management Candidate", "10 S&P 500 Stocks to Buy for the Long-Term", "Validea Peter Lynch Strategy Daily Upgrade Report - 10/11/2018", "Is Arrowhead Pharmaceuticals, Inc. a Buy on the Dip?", "Roche's Hemlibra Receives FDA Approval for Label Expansion", "Roche (RHHBY) Presents Encouraging Data on SMA Drug Risdiplam", "Amgen Gets FDA Nod for Once-Weekly Regimen of Kyprolis Combo", "Biotech Stock Roundup: ALXN on Acquisition Spree, FDA Nod for REGN, AMGN Drugs", "The Zacks Analyst Blog Highlights: Chevron, Amgen, Thermo Fisher, Estee Lauder and Delta Air Lines", "Dr. Reddy's Sells Antibiotic Production Hub to UAE Drugmaker", "5 Reasons Why Investors Should Bet on Merck (MRK) Stock", "5 Breakout Stocks to Buy", "Eli Lilly (LLY) Gets FDA Nod for Migraine Drug Emgality", "November 9th Options Now Available For Amgen (AMGN)", "Amarin's Stock Soars as Fish Oil Drug Lowers Heart Risks", "3 Drugmakers Not Pleased With Amarin's Fish Oil Triumph", "Lilly's Migraine Drug Emgality Wins Positive CHMP Opinion", "Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again", "Is Amgen (AMGN) Stock Outpacing Its Medical Peers This Year?", "Pfizer's Pneumococcal Vaccine Gets Breakthrough Therapy Status", "Is iShares Nasdaq Biotechnology ETF a Buy?", "IWB, PG, WMT, AMGN: ETF Inflow Alert", "7 Best Biotech Stocks for Investors Who Hate Risk", "AbbVie Faces California Insurance Department Suit for Humira", "AstraZeneca's Fasenra Long-Term Asthma Study Data Positive", "Notable Wednesday Option Activity: PLAY, AMGN, CRR", "Mylan's Biosimilar of Neulasta Gets Positive CHMP Opinion", "The Zacks Analyst Blog Highlights: UnitedHealth, Adobe, Amgen, UPS and Bayer", "Top Research Reports for UnitedHealth, Adobe & Amgen", "Teva's (TEVA) Migraine Drug Ajovy Receives FDA Approval", "Allergan Frown Lines Study Passes Test on Higher Botox Dose", "Validea's Top Five Healthcare Stocks Based On Martin Zweig - 9/16/2018", "Is Now a Good Time to Buy Amgen?", "Why bluebird and Celgene Should Worry About Amgen's Latest Clinical Victory", "Does Ajovy's Approval Make Teva a Pain-Free Stock to Buy?", "Merck Gets Priority Review for Yet Another Keytruda sBLA", "Why Amgen Will Likely Be a Boring Dividend Stock Over the Next Few Years", "Regeneron/Sanofi's sBLA for Praluent to be Reviewed by FDA", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 13, 2018", "3 Small Biotech Stocks That Almost Doubled in Past Month", "Merck's Keytruda Combo Gets Nod for Lung Cancer in Europe", "3 Top Dividend Stocks to Buy Right Now", "Is Amgen (AMGN) a Great Stock for Value Investors?", "Noteworthy Tuesday Option Activity: AMGN, RLGY, GRUB", "Noteworthy ETF Inflows: IWF, NVDA, AMGN, MO", "AstraZeneca's Asthma Drug Gets Breakthrough Therapy Status", "Pfizer's Skin Disease Drug Gets Breakthrough Therapy Status", "The Zacks Analyst Blog Highlights: Amgen, Puma Biotechnology, MannKind, United Therapeutics and Vertex Pharmaceuticals", "Merck's Keytruda Gets Priority Review for Rare Skin Cancer", "Biotech Stock Roundup: AMGN, PBYI Get EC Nod for Their Drugs, MNKD Soars", "Amgen Reaches Analyst Target Price", "Better Buy: Amgen Inc. vs. Gilead Sciences, Inc.", "Noteworthy ETF Outflows: IWF, NVDA, AMGN, MO", "Biotech Stock Roundup: GILD Gets EC Nod for Yescarta, AMGN Submits Kyprolis sNDA", "Pfizer Stock Up This Year So Far: What's Going in its Favor?", "Amgen Files for Once-Weekly Regimen for Myeloma Drug Kyprolis", "5 Reasons Why You Should Add Lilly Stock to Your Portfolio", "Why Is Amgen (AMGN) Up 1.3% Since Last Earnings Report?", "Noteworthy Tuesday Option Activity: GM, AXP, AMGN", "Better Buy: Amgen Inc. vs. Gilead Sciences, Inc.", "SPDR Portfolio Total Stock Market ETF Experiences Big Inflow", "Trade of the Day: Amgen Is a Strong Stock in a Giddy Industry", "Is Amgen Inc. a Buy?", "5 Drug Stocks to Buy While the Pharma Sector Is on Sale", "Merck Gets FDA Nod for Keytruda Lung Cancer Label Expansion", "Roche (RHHBY) Gets FDA Approval for Cobas EFGR Mutation Test", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 16, 2018", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for August 16, 2018", "Noteworthy Wednesday Option Activity: AMGN, TRN, AEO", "Allergan's (AGN) Stock Up 4.2% Since Q2 Earnings: Here's Why", "Top Research Reports: UnitedHealth, PepsiCo, Amgen & More", "Here's Why Merck (MRK) Stock is Up Since Q2 Earnings Release", "Ex-Dividend Reminder: Amgen, Allergan and South State", "Amgen Stock Up This Year So Far: Will the Rally Continue?", "3 \u201cStrong Buy\u201d Stocks for the Week", "Spectrum (SPPI) Earnings and Sales Miss Estimates in Q2", "Why Amgen is a Top Socially Responsible Dividend Stock (AMGN)", "5 Companies Making Giant Buybacks", "Better Buy: Gilead Sciences, Inc. vs. Amgen Inc.", "Radius (RDUS) Q2 Loss Narrower Than Expected, Tymlos Sales Up", "Ligand (LGND) Beats on Q2 Earnings & Revenues, Raises View", "Here's Why Lilly (LLY) Stock is Up 15% Since Q2 Earnings", "3 Healthcare Stocks to Buy for the Sector Rebound", "Two Pharma Giants Successfully Navigate a Challenging Climate", "Is a Beat in Store for Radius Health (RDUS) in Q2 Earnings?", "Noteworthy Thursday Option Activity: SYNA, AMGN, IPI", "Biotech Stock Roundup: Celgene, Amgen, Vertex Impress in Q2, Gilead's CEO to Exit", "Daily Dividend Report: ARCC, LFUS, VNOM, MAIN, AAPL, AMGN, SYK", "Pfizer (PFE) Beats on Q2 Earnings & Sales, Ups Profit View", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "3 Healthcare Stocks to Buy for the Sector Rebound", "Two Pharma Giants Successfully Navigate a Challenging Climate", "Amgen Inc.'s Young Lineup Offsets Enbrel Losses With Style", "Earnings Reaction History: Amgen Inc., 45.5% Follow-Through Indicator, 2.2% Sensitive", "After-Hours Earnings Report for July 26, 2018 : AMZN, INTC, AMGN, SBUX, EA, AFL, EW, LRCX, FTV, DFS, DLR, RSG", "Merck's Keytruda Improves Survival in Head/Neck Cancer Study", "Will Pfizer (PFE) Keep the Earnings Streak Alive in Q2?", "iShares Nasdaq Biotechnology ETF Experiences Big Inflow", "Amgen (AMGN) to Report Q2 Earnings: Will it Beat Again?", "AbbVie's Stock Is a Bargain After Falling 8% Last Week", "Noteworthy ETF Outflows: IBB, BIIB, GILD, AMGN", "Biogen (BIIB) to Report Q2 Earnings: What's in the Cards?", "Can Eli Lilly (LLY) Keep the Earnings Streak Alive in Q2?", "AbbVie Settles With Mylan to Delay Humira Biosimilar in U.S.", "Biotech Stock Roundup: AMGN Resubmits Evenity BLA, Advaxis Soars, Regulatory Updates", "Is a Beat in Store for Keryx (KERX) This Earnings Season?", "Roche's Flu Drug Meets Primary Endpoint in Phase III Study", "Pfizer's Xtandi Gets FDA Nod for Expanded Patient Population", "Is a Surprise in the Cards for Novartis in Q2 Earnings?", "Pacira Focused on Exparel Development Amid Competition", "Better Buy: Biogen Inc. vs. Amgen", "Better Buy: Amgen Inc. vs. Johnson & Johnson", "Is the Options Market Predicting a Spike in Amgen (AMGN) Stock?", "Novartis Q2 Earnings Miss, Sales Top on Cosentyx, Entresto", "Amgen Resubmits BLA to FDA for Osteoporosis Candidate Evenity", "August 31st Options Now Available For Amgen (AMGN)", "Merck's Keytruda Gets FDA's Priority Review for Liver Cancer", "Noteworthy ETF Inflows: IBB, GILD, AMGN, BIIB", "3 Huge Biotech Winners in 2018 (So Far)", "Moving Average Crossover Alert: Amgen (AMGN)", "Amgen Reaches Analyst Target Price", "2 Overlooked Biotech Stocks to Buy Now", "Amgen Resubmits BLA to FDA for Osteoporosis Candidate Evenity", "August 31st Options Now Available For Amgen (AMGN)", "Why Biotech Stocks Rallied on Biogen's Alzheimer's Test", "Here's Why AbbVie Stock is Good for Your Portfolio's Health", "Biotech Stock Roundup: GILD's Positive CHMP Nod, Regulatory Updates & More", "Biotech Stock Outlook: Short-Term Pricing Pain to Prevail", "IBB, GILD, AMGN, BIIB: Large Outflows Detected at ETF", "Why Amgen is a Top 25 Dividend Giant (AMGN)", "Should Value Investors Consider Amgen (AMGN) Stock Now?", "4 Drug and Biotech Stocks Awaiting FDA Decisions in July", "4 Drug and Biotech Stocks Awaiting FDA Decisions in July", "Better Buy: Amgen Inc. vs. Pfizer Inc.", "4 Biotech Stocks to Bet on in the Second Half of 2018", "5 Cheap Large Cap Stocks to Buy Now", "Mylan, Lupin Collaborate for the Proposed Biosimilar Enbrel", "Merck's Keytruda Gets Priority Review in Difficult Lung Cancer", "Should Value Investors Consider Amgen (AMGN) Stock Now?", "4 Drug and Biotech Stocks Awaiting FDA Decisions in July", "Merck's Keytruda Under FDA Review for Advanced Melanoma", "Top Stock Reports for Facebook, Amgen & Abbott", "Amgen's Repatha Reduces Bad Cholestrol in Type II Diabetes", "Roche's (RHHBY) Study on Tecentriq for Lung Cancer Positive", "Amgen Announces Top-Line Data From Remicade Biosimilar Study", "Merck (MRK) Stock Up So Far This Year on Keytruda Strength", "XLV, ABBV, AMGN, MDT: ETF Outflow Alert", "Amgen Gets EU Nod to Add Survival Data on Blincyto's Label", "Biotech Stock Roundup: SRPT & SLDB Soar on Positive Data, ANIK & ZIOP Crash", "Teva to Discontinue a Fremanezumab Study on Cluster Headache", "10 Top Stock Picks From Wall Street's Best Analysts", "Noteworthy Friday Option Activity: NKE, APC, AMGN", "Long-Term Investors Take Note -- These 5 Big Pharma Companies Have the Best Pipelines", "Allergan (AGN) Presents Positive Data on Glaucoma Candidate", "Merck's Keytruda Gets FDA Nod for 2nd Lymphoma Indication", "Roche's (RHHBY) Avastin Gets Label Expansion Approval by FDA", "Notable ETF Inflow Detected - XLV, ABBV, AMGN, MDT", "Merck's (MRK) Keytruda Gets FDA Approval for Cervical Cancer", "Biotech Stock Roundup: AXON Soars, Amgen Drugs Get FDA, EC Nod", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for June 14, 2018", "Roche Announces Positive Data on Gazyva and MS Drug Ocrevus", "Allergan's Second Anti-CGRP Drug Positive in Mid-Stage Study", "Amgen Gets FDA Nod to Add ASPIRE Data on Kyprolis Label", "Amgen's (AMGN) Prolia Gets Label Expansion Approval in Europe", "JAK Inhibitors' Prospects Strong: 4 Stocks Ruling the Space", "Roche Rituxan Label Expanded by FDA for Pemphigus Vulgaris", "Biotech Stock Roundup: Regeneron, Celgene, Amgen Impress at ASCO", "Merck Presents Positive Melanoma Data on Keytruda at ASCO", "Humira's Sales Will Decline -- and It's Fantastic News for AbbVie", "Mylan (MYL) Gets FDA Approval for Biosimilar of Neulasta", "Watch Out Amgen, Here Comes Mylan", "Eli Lilly's Olumiant Gets FDA Nod for Rheumatoid Arthritis", "Merck's (MRK) Keytruda Lung Cancer Data in Focus at ASCO", "Biogen Inc Stock Got an Upgrade, but Should You Listen?", "Novartis Announces Positive Data on Kisqali and Tasigna", "Is Amgen Inc. (AMGN) a Buy?", "Health Care Select Sector SPDR Fund Experiences Big Inflow", "Notable Friday Option Activity: TRIP, MAR, AMGN", "Trade of the Day: Amgen, Inc. Clears a Breakout Hurdle", "Biotech ETFs Are the Best Way to Play the Recovering Sector", "July 6th Options Now Available For Amgen (AMGN)", "Why Is Amgen (AMGN) Up 3.7% Since Its Last Earnings Report?", "Merck's Keytruda Shows Survival Benefit in Squamous NSCLC", "3 Top Biosimilars that Will Lift Pfizer Inc. Stock Even More", "3 Reasons Gilead Sciences Is a Better Value Stock Than Amgen", "FDA Confirms September Action Date for Teva's Migraine Drug", "Novartis Gets Approval for Remicade Biosimilar in Europe", "Allergan Stock Down Since Q1 Earnings Report: Here's Why", "Noteworthy ETF Inflows: DGRO, AMGN, MDT, BMY", "Biotech Stock Roundup: FDA Gives Nod to Amgen's Drugs, EU Approves Exelixis' Cabometyx", "Amgen Breaks Above 200-Day Moving Average - Bullish for AMGN", "Amgen's Label Expansion Application for Prolia Gets FDA Nod", "Is This Little Biotech the Best Migraine Stock to Buy Now?", "Migraine Space in Focus as AMGN/NVS' Aimovig Gets FDA Nod", "Roche (RHHBY) Announces Positive Data on Hemophilia Drug", "Intraday Update: Small Caps Keep the Faith, Blue Chips Blue in the Face", "Amgen's Migraine Drug Aimovig Gets FDA Approval, Shares Up", "Health Care Sector Update for 05/18/2018: AMRX,VLRX,AMGN,NVS,AZN", "Health Care Sector Update for 05/18/2018: VLRX,AMGN,NVS,AZN", "XLV, MRK, AMGN, GILD: ETF Inflow Alert", "Company News For May 21, 2018", "Why Spectrum Pharmaceuticals, Inc. Is Up Big Today", "Pfizer Gets FDA Nod for Amgen, J&J's Anemia Drug Biosimilar", "Eli Lilly's Cluster Headache Candidate Succeeds in Phase III", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 16, 2018", "Better Buy: Amgen Inc. vs. Biogen Inc.", "Ex-Dividend Reminder: Eli Lilly, Amgen and Simon Property Group", "Noteworthy Monday Option Activity: XRX, ALGN, AMGN", "Amgen's (AMGN) Repatha Gains EU Nod to Include Outcomes Data", "Trump Announces Plan to Reign In Drug Prices and Pharma Stocks Rally.", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for May 11, 2018", "Ligand (LGND) Beats on Q1 Earnings & Revenues, Keeps View", "VYM, VZ, MRK, AMGN: Large Inflows Detected at ETF", "7 \"Strong Buy\" Dividend Stocks That Should Rip Higher", "What's in Store for Radius Health (RDUS) in Q1 Earnings?", "Are These Disappointing Drugs Back on Track to Billions?", "Radius Health (RDUS) Incurs Narrower-Than-Expected Q1 Loss", "The Zacks Analyst Blog Highlights: Apple, ExxonMobil, Citigroup and Amgen", "This Clinical-Stage Biotech's Tackling a Huge Health Issue, but It Has to Overcome Pessimistic Investors First", "Top Analyst Reports for Apple, ExxonMobil, Citigroup & Amgen", "Biotech Stock Roundup: ALXN, VRTX Post Solid Results, GILD Disappoints in Q1", "XLV, MRK, AMGN, GILD: Large Outflows Detected at ETF", "Nasdaq 100 Movers: STX, SWKS", "Pfizer (PFE) Stock Falls on Q1 Sales Miss, Earnings Beat", "Spectrum (SPPI) Earnings and Sales Beat Estimates in Q1", "Roche (RHHBY) Q1 Earnings: Ocrevus, Perjeta Drive Sales Beat", "Company News for Apr 26, 2018", "Amgen (AMGN) Earnings Beat Estimates in Q1, Revenues Up Y/Y", "Morning Movers: Boeing Booms, Wynn Loses", "Biotech Stock Roundup: PRTA Down, AMGN Revises View, BIIB Misses on Sales", "Notable Wednesday Option Activity: AMGN, AXP, FTR", "What's in the Cards for BioMarin (BMRN) in Q1 Earnings?", "Amgen (AMGN) Shares Cross 3% Yield Mark", "Better Buy: Amgen Inc. vs. Celgene", "Amgen, Inc. (AMGN) Beats Q1 Estimates, Posts Weak F18 Guidance", "After-Hours Earnings Report for April 24, 2018 : AMGN, TXN, CB, COF, ILMN, EW, EQR, WYNN, BXP, MKL, TSS, PKG", "Eli Lilly And Co Produced a Monstrous Q1 Beat, But Is It Enough?", "Drug/Biotech Stock Q1 Earnings Due on Apr 24: LLY, BIIB, AMGN", "Mylan NV Still Undervalued Despite Unveiling of New Products", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "Is a Beat in Store for Vertex (VRTX) This Earnings Season?", "What's in Store for Biogen (BIIB) This Earnings Season?", "J&J, Novartis' Q1 Earnings Impress: Will Others Follow Suit?", "3 Stocks You Can Safely Own Until 2030", "Mylan NV Could Be Closer to a Breakout Than Most Traders Realize", "Big Biotech ETF Can Bounce Back", "Amgen's Aimovig Reduces Episodic Migraine in 30% Patients", "7 Retirement Stocks for the Coming Correction", "Amgen (AMGN) to Report Q1 Earnings: Is a Beat in the Cards?", "What's in Store for Novartis (NVS) This Earnings Season?", "XLV, PFE, MRK, AMGN: ETF Inflow Alert", "J&J (JNJ) to Begin Pharma Q1 Earnings: What's in Store?", "Mylan Fujifilm Kyowa Team Up to Market Humira Biosimilar", "Merck's Keytruda Offers Survival Benefit in Lung Cancer Study", "4 Drug/Biotech Stocks to Buy Ahead of World Health Day", "Novartis Announces Data on Cardiovascular Drug Entresto", "Roche Hemophilia Drug Gets Breakthrough Therapy Designation", "Biotech Stock Roundup: EDGE Falls, ALKS Down, FDA OK's AMGN Drug Label Expansion", "Rigel (RIGL) Sinks on Failure of Mid-Stage Study on Lead Drug", "Morning Movers: Tesla---and the Markets---Are Back on Solid Ground", "Amgen's (AMGN) Xgeva Gets EU Approval for Expanded Label", "Better Dividend Stock to Buy: AbbVie Inc. vs. Pfizer Inc.", "Amgen's Blincyto Gets FDA Nod for Minimum Residual Disease", "Peek Under The Hood: RSP Has 14% Upside", "Lilly's Cyramza Shows Survival Benefit in Liver Cancer Study", "The Zacks Analyst Blog Highlights: Verona, Squibb, Protagonist and Amgen", "Biotech Stock Roundup: PTGX Down, VRNA Up, AMGN's Repatha Gets Positive Opinion", "Results Renew Optimism for Esperion Therapeutics", "5 Biotech Stocks With Amazing Pipelines", "Amgen's Repatha Gains CHMP Nod to Include Outcomes Data", "Novartis Gets Positive CHMP Opinion on Biosimilar Remicade", "Merck, Eisai Get Japanese Nod for Lenvima Label Expansion", "Better Buy: Biogen Inc. vs. Amgen Inc.", "The Zacks Analyst Blog Highlights: Verona, Squibb, Protagonist and Amgen", "Radius Health Down on Negative CHMP Opinion for Lead Drug", "The Zacks Analyst Blog Highlights: Amgen, FedEx, Thermo Fisher, Sherwin-Williams and Ameriprise", "Stemline Therapeutics Inc Stock Investors Are Betting, Not Investing", "Roche's (RHHBY) Lucentis 0.3 mg PFS Receives FDA Approval", "Notable Two Hundred Day Moving Average Cross - AMGN", "Better Buy: Amgen Inc. vs. Gilead Sciences, Inc.", "iShares Core High Dividend ETF Experiences Big Outflow", "Despite Struggles Celgene Corporation Stock Is Still A Buy", "3 Top Biotech Stocks to Buy Right Now", "5 Must-See Quotes From AbbVie's Management", "Merck's Keytruda Gets Priority Review for Cervical Cancer", "IBB, AMGN, GILD, REGN: ETF Outflow Alert", "Is Amgen Inc. (AMGN) a Great Stock for Value Investors?", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for March 15, 2018", "Radius Health Announces Positive Data on Lead Drug Tymlos", "The Amgen, Inc. Stock Spring Is About to Pop", "Amgen Stock Split History", "Regeneron Takes Aim at Amgen and Esperion Therapeutics", "Regeneron and Sanofi Announce Positive Data on Praluent", "Why Coherus Biosciences Is Skyrocketing Today", "Merck to Pay $300M Upfront to Co-Develop Eisai's Cancer Drug", "Daily Dividend Report: GD, CL, MTN, HMN, PM, AMGN, DVN", "Bull of the Day: Regeneron (REGN)", "Wednesday\u2019s Vital Data: Alibaba Group Holding Ltd (BABA), Amgen Inc. (AMGN) and Advanced Micro Devices, Inc. (AMD)", "Why Esperion Therapeutics' Shares Fell Despite Its Good News", "Noteworthy ETF Outflows: IWB, AMGN, GILD, UTX", "3 Top Biotech Stocks to Buy in March", "Notable Tuesday Option Activity: AMGN, NFLX, AMZN", "Interesting AMGN Put And Call Options For May 18th", "10 Companies Making Huge Stock Buybacks in 2018", "Spectrum (SPPI) Q4 Loss Widens Y/Y, Sales Miss, Stock Falls", "After Hours Most Active for Mar 2, 2018 : F, FE, ORCL, BAC, TEVA, AMGN, FTR, QCOM, GE, QQQ, MSFT, CSX", "Amgen (AMGN) Gets CHMP Nod to Expand EU Label of Neulasta", "Biotech ETFs Head to Head: XBI vs. IBB.", "Notable Thursday Option Activity: AMGN, KFY, TAST", "Biotech Stock Round Up: Celgene Suffers Setback, Gilead Teams Up with Sangamo", "3 Reasons AbbVie Inc. Stock Could Keep Soaring in 2018", "3 Top Pharma Stocks With Dividend Yields Over 3%", "Radius (RDUS) Q4 Loss Wider Than Expected on Higher Expenses", "IUSG, MCD, ABT, AMGN: ETF Inflow Alert", "Health Care Sector Update for 02/23/2018: BLCM, PFE, PBYI, AMGN, 4507:JP", "Health Care Sector Update for 02/23/2018: AMGN,PBYI,BLCM,PFE", "Ligand (LGND) Q4 Earnings & Revenues Top, 2018 View Solid", "Is Amgen Inc. a Buy?", "The Zacks Analyst Blog Highlights: Amgen, TOTAL, Marriott, PG&E and Vertex", "Notable Wednesday Option Activity: DDD, ALGN, AMGN", "Radius Health (RDUS) to Disappoint Investors in Q4 Earnings?", "Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 2/18/2018", "Roche (RHHBY) to Acquire Flatiron Health for $1.9 Billion", "AbbVie Hikes Dividend by 35%, Launches $10B Buyback Plan", "VYM, GE, MCD, AMGN: Large Inflows Detected at ETF", "Did AbbVie, Inc. Just Become the Most Shareholder-Friendly Stock in America?", "3 Tough Questions for Amgen", "Can ImmunoGen's Key Ovarian Cancer Candidate Drive Growth?", "Novartis Psoriasis Drug Cosentyx Positive in SCALP Study", "Roche's Rituxan Gets Priority Review for Label Expansion", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 14, 2018", "3 Dividend Stocks for In-the-Know Investors", "Is Agenus Inc. a Buy?", "Trade of the Day: Amgen, Inc. Remains a Promising Biotechnology Play", "Ex-Dividend Reminder: Amgen, Primerica and Monmouth Real Estate Investment", "Better Buy: Amgen Inc. vs. Celgene", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for February 15, 2018", "Novartis' Cosentyx Label Expanded to Include Scalp Psoriasis", "Spectrum Pharma's Rolontis Positive in Pivotal Cancer Study", "Roche Reports Positive Data From Tecentriq-Avastin Study", "Amgen Breaks Below 200-Day Moving Average - Notable for AMGN", "Noteworthy Tuesday Option Activity: WYN, AMGN, MON", "Amgen Q4 Earnings Results: 2 Things to Hate and 2 Things to Like", "Amgen (AMGN) Q4 Earnings & Sales Lag, 2018 Sales View Soft", "Forget Amgen -- Cara Therapeutics, Inc. Is a Better Growth Stock", "Amgen Topples After Fourth-Quarter Sales, Earnings Lag", "Validea John Neff Strategy Daily Upgrade Report - 2/1/2018", "Earnings Reaction History: Amgen Inc., 40.0% Follow-Through Indicator, 2.3% Sensitive", "After-Hours Earnings Report for February 1, 2018 : AAPL, AMZN, GOOGL, V, AMGN, EW, MSI, EMN, FBHS, XL, CPT, AIV", "Amgen Gets CHMP Nod to Add ENDEAVOR Data on Kyprolis Label", "Why Earnings Season Could Be Great for Amgen (AMGN)", "VTV, GE, AMGN, ABT: ETF Inflow Alert", "Roche (RHHBY) Posts Solid 2017 Sales on Tecentriq & Alecensa", "Roche Gets Breakthrough Therapy Designation For ASD Drug", "Meredith (MDP) Hikes Dividend 4.8% Just Ahead of Q2 Earnings", "AMGN Named 'Top Dividend Stock of the Nasdaq 100' at Dividend Channel With 2.7% Yield", "AMGN October 19th Options Begin Trading", "Will Amgen (AMGN) Benefit From Growth Drugs in Q4 Earnings?", "Novartis' Lutathera Gets FDA Approval for Pancreatic Tumors", "Roche Hemophilia Drug Hemlibra Gets Positive CHMP Opinion", "Pfizer (PFE) Stock Falls Despite Q4 Earnings & Sales Beat", "Here's Why AbbVie's Stock Is Skyrocketing 12.6% Today", "5 Biotech and Pharmaceutical Stocks Going Bonkers", "Why Amgen is a Top Socially Responsible Dividend Stock (AMGN)", "Novartis (NVS) Q4 Earnings & Sales Top on Cosentyx, Entresto", "Amgen's Migraine Drug Hits Primary Endpoint in Phase IIIb", "Amgen Reaches Analyst Target Price", "Why Dividend Investors Want to Own AbbVie in 2018", "Novartis Announces Positive Results on Migraine Candidate", "Stocks Up, As Shutdown Vote Looms; Halliburton Breaks Out", "Merck Reports Positive Phase III Liver Cancer Data on Keytruda", "What's in the Cards for Novartis (NVS) This Earnings Season?", "The Zacks Analyst Blog Highlights: UnitedHealth, Amgen, United Technologies, CSX and General Dynamics", "The Ideal Stock Evaluation System?", "Noteworthy ETF Outflows: IWB, AMGN, GILD, ABT", "Biotech M&A Off to a Strong Start in 2018: More Deals to Follow?", "Novartis Announces Positive Results on Migraine Candidate", "Here's Why Nektar Stock Skyrocketed Almost 500% in a Year", "The Zacks Analyst Blog Highlights: Johnson & Johnson, AbbVie, Amgen, Novo-Nordisk and Zoetis", "Amgen Gets FDA Nod to Add ENDEAVOR Data on Kyprolis Label", "Can These 4 Large-Cap Drug Stocks Deliver an Encore in '18?", "Best ETFs for 2018: The SPDR S&P Biotech ETF (XBI) Will Continue to Rock", "What to Expect From Amgen, Inc. in 2018", "Will 2018 Be Amgen Inc.'s Best Year Yet?", "5 Big Biotech Stocks To Buy In 2018", "Will Amgen (AMGN) Continue to Tread Growth Path This Year?", "Novartis (NVS) Announces Acceptance of Humira BLA by the FDA", "How This Biotech Stock Could Top Bigger Rivals In Preventing Migraines", "XLV, MRK, AMGN, GILD: ETF Outflow Alert", "The Zacks Analyst Blog Highlights: Celgene, Amgen, Exelixis, Alexion and Vertex", "Biotech Stock Roundup: Juno Surges on Acquisition Rumor, Concert Down on Patent News", "Will 2018 Be Amgen Inc.'s Best Year Yet?", "AstraZeneca's Asthma Drug Benralizumab Gets Approval in EU", "Here's What AbbVie's Management Just Said About Its Future", "Here's Why Arrowhead Pharmaceuticals Inc. Is Up Today", "Apple, Microsoft May Get Big Tax Break \u2014 For Having Unusual Calendars", "June 2019 Options Now Available For Amgen (AMGN)", "Novartis Starts Trial on Psoriasis Drug Cosentyx Biosoimilar", "Merck's Keytruda on a Roll: Can it Retain the Spark in 2018?", "Jeff Sessions is Taking Some Steam Out of the Marijuana Stocks Rally", "Better Stock: AbbVie Inc (ABBV) vs. Johnson & Johnson (JNJ)", "Notable Wednesday Option Activity: MLM, WTW, AMGN", "Amgen Announces Acceptance of MAA for Evenity in Europe", "Merck's (MRK) Keytruda Succeeds in High-Risk Melanoma Study", "5 Things Amgen's CEO Just Said That Investors Need to Know", "Is AbbVie Stock Still A Strong Buy?", "Humana Extends Contract With Tivity Health, Spurs Healthcare", "2 Top Dividend Stocks to Buy in 2018", "3 Big Biotech Stocks to Buy in January", "Key Biosimilar Approvals in 2017: Progress Report", "ImmunoGen Starts Phase I Study on Leukemia Candidate IMGN632", "XLV, AMGN, GILD, LLY: Large Outflows Detected at ETF", "Can AbbVie (ABBV) Stock Keep the Momentum Alive in 2018?", "3 Large-Cap Pharma Stocks to Watch Out for This New Year", "Amgen's (AMGN) Xgeva Gets FDA Approval for Multiple Myeloma", "Why These 2 Biotechs Could Outperform Amid 'Hyper-Competition'", "The One Safe Way to Get a 55.8% Dividend Yield", "Another Reason 2018 Might Not Be A Banner Year For Biotech Mergers", "iShares Russell 1000 Value ETF Experiences Big Inflow", "Here's How AbbVie Inc. Crushed It in 2017", "Why is Nektar (NKTR) Stock Up More Than 350% This Year?", "Spectrum Pharma Dismisses CEO, Makes Leadership Changes", "3 Biotech Stocks to Buy in January", "Why These 2 Biotechs Could Outperform Amid 'Hyper-Competition'", "The One Safe Way to Get a 55.8% Dividend Yield", "Another Reason 2018 Might Not Be A Banner Year For Biotech Mergers", "iShares Russell 1000 Value ETF Experiences Big Inflow", "Here's How AbbVie Inc. Crushed It in 2017", "Pfizer's Arthritis Drug Gets FDA Nod for Label Expansion", "The 5 Best-Selling Drugs of 2017", "AMGN Dividend Yield Pushes Past 3%", "Daily Dividend Report: AMGN, BEN, WDFC, O, XRAY", "Amgen: Even Biotech Stocks Boost Their Dividends", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for December 14, 2017", "Here's Why Everyone's So Excited About bluebird bio", "Roche/AbbVie Report Positive Phase III Results on Venclexta", "Jim Simons: Pioneer Quant Manager", "How the 10 Top-Yielding Nasdaq Dividend Stocks Can Boost Your Portfolio", "Roche Reports Positive Data from Tecentriq Combination Study", "Here's Why Radius Health Is Rising Today", "Sanofi Begins Combo Studies on Multiple Myeloma Candidate", "IWD, PM, MDT, AMGN: Large Inflows Detected at ETF", "AbbVie/J&J's Imbruvica Succeeds in Combo Study with Rituxan", "Biotech Stock Roundup: FDA Nod for Amgen PCSK9 Inhibitor, Revance Up on RT002 Data", "Roche's Avastin Gets Full FDA Approval for Brain Cancer", "3 Stocks in Focus as Biotech M&A Hopes for 2018 Rise", "Mylan Up on FDA Approval & Amazon's Rumored Pharmacy Interest", "Amgen's PCSK9 Inhibitor Gets FDA Nod for Stroke Prevention", "How Biotechs, Drugmakers Would Fare Under The Senate's Tax Bill", "Amgen, Regeneron Prep For Battle In 2018 Over Cholesterol Drugs", "Why Amgen Could Have An Edge Over These Rivals In Preventing Migraines", "AbbVie Stock Up More Than 30% So Far in 2H17: Here's Why", "5 Biotech and Pharma Stocks with FDA Catalysts this December", "AbbVie Psoriasis Candidate Succeeds in 4th Phase III Study", "Why Medicines Co. Is Tumbling Despite $270 Million Deal", "Bullish Two Hundred Day Moving Average Cross - AMGN", "iShares Russell 1000 Value ETF Experiences Big Inflow", "Biotech Stock Roundup: Regeneron Down on Eylea Data, Biogen-Alkermes in MS Deal", "Will New Drug Approvals Boost Novartis (NVS) Portfolio?", "Nektar (NKTR) Stock Up More than 300% This Year: Here's Why", "J&J Seeks Darzalex's Label Expansion in First-Line Setting", "Noteworthy Thursday Option Activity: HCA, AMGN, FFIV", "Why Medicines Co. Is Tumbling Despite $270 Million Deal", "Amgen (AMGN) Unveils Auto Injector Device for Enbrel in US", "Noteworthy ETF Inflows: DGRO, MRK, WMT, AMGN", "Marco Investment Management Llc Buys DowDuPont Inc, Apple Inc, JPMorgan Chase, Sells E.I. ...", "AstraZeneca's (AZN) Asthma Drug Benralizumab Approved by FDA", "Two Sigma Advisers, Llc Buys DowDuPont Inc, Pfizer Inc, Caterpillar Inc, Sells E.I. ...", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 16, 2017", "Bet on Biogen Inc for Easy Profits Into the New Year", "Biotech Stock Roundup: Dynavax Vaccine Gets FDA Nod, Loxo Inks Deal with Bayer", "Amgen is Oversold", "Ex-Dividend Reminder: U.S. Physical Therapy, Allergan and Amgen", "Novartis (NVS) Arm's Biosimilars Study Results Encourage", "Amgen Gets Positive CHMP Opinion to Expand Nplate's Label", "Ligand (LGND) Q3 Earnings & Revenues Top, 2017 View Raised", "XLV, MRK, ABBV, AMGN: ETF Outflow Alert", "Sum Up The Parts: XLV Could Be Worth $90", "Here's Why Insulet Corporation's Investors Are Pumped", "7 Stocks Primed to Deliver 12% Annual Returns, Forever", "Radius Health (RDUS) Earnings Miss in Q3, Tymlos in Focus", "Sanofi (SNY) Q3 Earnings In Line, Sales Lag, Diabetes Weak", "Looking For Great Stocks? First Use A Checklist To Identify Great Bases", "IWD, MRK, WMT, AMGN: ETF Inflow Alert", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for November 09, 2017", "Pfizer (PFE) Beats on Q3 Earnings, Raises 2017 EPS View", "Pfizer Inc. Stock Is Boring, and That\u2019s Perfect", "AMGN Named 'Top Dividend Stock of the Nasdaq 100' at Dividend Channel With 2.6% Yield", "The Zacks Analyst Blog Highlights: Amgen, Comcast, McDonald's, Waste Management and BB&T", "A Me-Too Push By Biopharma Is Crowding the Psoriasis Market", "AbbVie (ABBV) Q3 Earnings Top, Revenues In Line, View Up", "BioMarin (BMRN) Q3 Loss Narrows, Profit Guidance Raised", "Biotech Stock Roundup: Celgene, Amgen, Gilead Hit by Q3 Results, Vertex Beats on All Fronts", "AbbVie: The Dividend Does It?", "3 Value Stocks at 52-Week Highs Still Worth Buying", "Argyle Capital Management Inc. Buys DowDuPont Inc, W.W. Grainger Inc, CVS Health Corp, Sells E. ...", "Buy the Dip in Amgen, Inc. While Wall Street Fears It", "Amgen (AMGN) Q3 Earnings Top, Sales Decline Y/Y, Stock Falls", "Bristol-Myers: More Bad Medicine for the Market", "Key Predictions for Q3 Earnings Reports of ABBV, MRK", "Will Radius Health (RDUS) Disappoint This Earnings Season?", "Trade of the Day: Amgen, Inc. Nears a Buy Point Again", "3 Stocks to Watch on Thursday: Amgen, Inc. (AMGN), Buffalo Wild Wings (BWLD) and Las Vegas Sands Corp. (LVS)", "What's Behind Amgen's Q3 Revenue Decline", "Three Biotech Firms Top Third-Quarter Views \u2014 But Only One Pops", "Earnings Reaction History: Amgen Inc., 54.5% Follow-Through Indicator, 2.8% Sensitive", "After-Hours Earnings Report for October 25, 2017 : AMGN, SU, LVS, NXPI, VRTX, PSA, AFL, DLR, NOW, WCN, ABX, ORLY", "Notable Wednesday Option Activity: AMGN, LUV, TRIP", "Futures Trending Higher as Earnings Give Hope, ECB Extends Asset Purchase Program", "Biogen (BIIB) Tops Q3 Earnings & Sales, Spinraza Sales Up", "IWD, MRK, WMT, AMGN: ETF Inflow Alert", "Novartis (NVS) Q3 Earnings & Sales Top on New Drugs Strength", "Drug/Biotech Stocks Q3 Earnings on Oct 25: AMGN, GSK, VRTX", "Better Buy: Gilead Sciences, Inc. vs. Amgen", "Boeing, Grubhub, Nike, Glaxo, Amgen, Visa Lead Investing Action Plan", "Health Care Sector Update for 10/23/2017: JNJ, PFE, ABT, MRK, AMGN, TIG, AZN", "Daily Dividend Report: BAC, WFC, AMGN, MPC, TXT, MET", "10 More Retirement Stocks to Buy and Hold for the Rest of Your Life", "What's in the Cards for Amgen (AMGN) this Earnings Season?", "Catch This Falling Knife \u2014 Go Long Celgene Corporation", "Oakbrook Investments Llc Buys Starbucks Corp, Biogen Inc, DowDuPont Inc, Sells The Western ...", "Teva Submits BLA to FDA for Migraine Candidate Fremanezumab", "Merriman Wealth Management, LLC Buys Vanguard S&P 500, PowerShares FTSE RAFI US 1500 ...", "3 Top Stocks Billionaires Love", "IBD's No. 1 Group Under Pressure; These 6 Key Earnings Loom; S&P 500 Futures", "What's in the Cards for Novartis (NVS) This Earnings Season?", "How Allergan's 'Public Relations Backlash' Deepened This Week", "Zacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen", "ImmunoGen to Push Leukemia Candidate into Phase I Trial", "Noteworthy ETF Inflows: IWD, WMT, AMGN, SLB", "Celgene Blood Cancer Treatment: Just The Tip Of Its Disruptive Science?", "Trump Likely To Sign Executive Order On Drug Pricing 'Any Day'", "2 Great Stocks For Retirees", "Better Buy: AbbVie Inc. vs. Merck", "Why 2017 Could Be This Stock's Best Year Yet", "Dubuque Bank & Trust Co Buys Heartland Financial USA Inc, Vanguard Total Stock Market, ...", "3 Stocks for Baby Boomers to Reach Their Goals", "Mylan Gets Complete Response Letter For Biosimilar Neulasta", "Biotech Stock Roundup: Amgen's Imlygic Data Promising, Regeneron Scores Win in PCSK9 Lawsuit", "How Safe Is AbbVie's Dividend?", "Edmp, Inc. Buys Tanger Factory Outlet Centers Inc, CVS Health Corp, Penske Automotive Group ...", "Amgen Label Expansion Application for Prolia Accepted by FDA", "Amgen Wins Reprieve on Its 2nd-Best-Selling Drug", "Forget Teva (TEVA), Buy These 5 Drug Stocks Instead", "Cancer Space Last Week Update: Pipeline Expansion in Focus", "3 Best Healthcare Dividend Aristocrat Stocks You Can Buy Right Now", "AbbVie's Fast Becoming a Top Stock to Buy Now", "3 Blockbuster Drugs That Still Cost More Than They Should", "Dow's Merck Bails On Cholesterol Drug, Prodding Shares Down", "Notable ETF Inflow Detected - IWD, MRK, WMT, AMGN", "Health Care Sector Update for 10/06/2017: JNJ, PFE, ABT, MRK, AMGN, KDMN", "Regeneron and Sanofi Get Favorable Ruling Against Amgen", "Everything Is Going Right for AbbVie: Is It the Best Biotech Stock to Buy Right Now?", "3 Top Stocks Wall Street Insiders Love", "Marshwinds Advisory Co Buys DowDuPont Inc, BHP Billiton, Enbridge Inc, Sells E.I. ...", "Why Regeneron's Patent Win Is Worse For Amgen Than You Think", "This Dirt-Cheap Biotech Stock Is a Bargain to Buy", "AbbVie (ABBV) Stock Up Almost 17% in One Month: Here's Why", "3 Big Pharma Stocks Set to Succeed", "Stocks With Rising Relative Strength: Amgen", "Amgen Enters Into an Immuno-Oncology Partnership With CytomX", "Wall Street's Winning Streak Pauses; Private Sector Hiring Slows", "Health Care Sector Update for 10/04/2017: CTMX,AMGN,MYL,TEVA,RIGL", "Biotech Stock Roundup: Endocyte Shoots up on Deal, Amgen-AbbVie Settle Humira Litigation", "Regeneron Pops After Judge Tosses Ban On Amgen-Rivaling Med", "Health Care Sector Update for 10/04/2017: SBBP,CTMX,AMGN,CLSN", "Amgen, CytomX Join in Immuno-Oncology Collaboration", "Health Care Sector Update for 10/04/2017: RIGL,CTMX,AMGN,CLSN", "Midday Update: U.S. Stocks Turn Positive After Tillerson Denies Plans to Resign", "CytomX Breaks Out On Mash-Up With Amgen In Immuno-Oncology", "3 Top-Ranked Big Biotech Stocks to Buy Now", "Why Shares in AbbVie Soared 18% in September", "Close Update: Wall Street Extends Winning Streak With New Record Highs", "Notable Tuesday Option Activity: AMGN, AMD, PAYX", "Why This Biotech Suffered A 2-Day Headache On Rare-Disease Trial", "AbbVie Patent Deal Staves Off Amgen Competition, But Others Lurk", "AbbVie Stock Upgraded: What You Need to Know", "AbbVie: Better Late Than Never", "Radius (RDUS) Enrols First Patient in Breast Cancer Study", "How Good Is AbbVie's Humira Deal With Amgen?", "3 Dividend Stocks Should Thrive in a Recession", "AbbVie, Amgen Resolve Humira Patent Dispute", "Sanofi Rides on Genzyme & Vaccines Unit, Diabetes Sales Weak", "Why BlackBerry, AbbVie, and bluebird bio Jumped Today", "Biotechs Beating The Market, But Are They In Buy Range?", "Biotech Stocks To Watch And Pharma Industry News", "Why Amgen's Drug Win Sent AbbVie Stock Into The Stratosphere", "Noteworthy ETF Inflows: FVD, BMS, AMGN, CMI", "How Will Trump\u2019s Proposed Tax Reform Impact Drug Companies?", "Biotech Stock Roundup: Amgen Reiterates 2017 Outlook, Intercept Hit by Ocaliva Safety Issues", "Merck's Keytruda Gets FDA Nod for Advanced Gastric Cancer", "Pfizer Sues J&J, Accuses it of Preventing Inflectra Uptake", "Noteworthy Thursday Option Activity: AMGN, FFIV, EBIX", "4 Sell-Ranked Biotech Stocks with Falling Estimates to Avoid", "Biotech Stock Roundup: FDA Nod for First Cancer Biosimilar, HALO up on Deals, Raised Outlook", "Novartis Poised to Grow on Oncology Portfolio & Biosimilars", "Trade of the Day: Amgen, Inc. (AMGN) Stock Has Plenty More Upside", "Is Amgen (AMGN) a Great Stock for Value Investors?", "Novartis Announces Positive Data on Urticaria Drug Xolair", "3 Great Income Stocks That Could Double Their Dividends", "SPDR S&P Biotech (ETF) (XBI): The Quick Guide to XBI", "Amgen/Allergan's Avastin Biosimilar Secures FDA Approval", "3 Reasons Why Gilead Sciences Stock Is a Buy Now", "Top Research Reports for Philip Morris, Amgen & Union Pacific", "iShares Russell 1000 Value ETF Experiences Big Inflow", "Biosimilar 2017 Progress Report: Stocks in Focus", "Noteworthy Thursday Option Activity: AMGN, RCL, CVX", "4 Biotech Stocks for the Long-Term", "Amgen Reaches Analyst Target Price", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 14, 2017", "5 Compelling Reasons Why AbbVie's Dividend Will Keep on Growing", "Novartis' BLA for Biosimilar of Rituxan Accepted by the FDA", "A Biosimilar Cure for Sky-High Cancer Drug Prices", "Biosimilar 2017 Progress Report: Stocks in Focus", "5 Things Regeneron's CEO Said as the Biotech Stock Sank", "3 Things Amgen Inc.'s Management Just Said That You'll Want to Know", "Interesting AMGN Put And Call Options For January 2020", "TQQQ, AMGN, KHC, PCLN: ETF Outflow Alert", "Amgen/AstraZeneca Asthma Candidate Tezepelumab Shows Promise", "AstraZeneca's COPD Candidate Duaklir Reports Positive Data", "Supercharge Your Portfolio With Amgen, Inc. (AMGN) Stock", "Merck's (MRK) Keytruda Gets EU Approval for Bladder Cancer", "Ligand (LGND) Diabetes Candidate Positive in Phase II Study", "Biotech Stock Roundup: Cellectis Down on Clinical Hold, Insmed Soars on Positive Data", "The Only 2 Biotech Stocks With a Higher Dividend Yield Than the S&P 500", "Key FDA Regulatory Events to Watch Out for in Sep 2017", "Amgen Gets EU Nod to Expand Hyperparathyroidism Drug Label", "Noteworthy ETF Outflows: TQQQ, AMGN, KHC, PCLN", "Noteworthy Thursday Option Activity: AMGN, CVX, CMCSA", "Merck's (MRK) Keytruda Gets EU Approval for Bladder Cancer", "Amgen Presents New Repatha Analysis from FOURIER Study", "3 Dividend Stocks That Thrive in Market Crashes", "3 Reasons to Be Cautious on Vertex Pharmaceuticals Incorporated (VRTX) Stock", "Why I Love AbbVie Inc.", "Is the System Rigged Against Biosimilars?", "The Smart Money Likes These 5 Stocks", "Amgen (AMGN) Down 6.4% Since Earnings Report: Can It Rebound?", "Can Sanofi (SNY) Sustain the Solid 1H Momentum in 2H17?", "ProShares UltraPro QQQ Experiences Big Inflow", "3 Reasons AbbVie Is a Better Dividend Stock Than Gilead Sciences", "Biotech Stock Roundup: EU Label Expansion for Alexion, BIIB Facing Drug Price Probe", "4 Biotech Stocks to Add to your Portfolio Post Q2 Earnings", "What Will Drive Regeneron Pharmaceuticals' Growth Higher From Here?", "Biogen's Humira Biosimilar Imraldi Gets Approval in EU", "The Netherlands Is Taking Aim at One of America's Fastest-Growing Sectors", "Add Up The Parts: PWV Could Be Worth $39", "Amgen in Collaboration With Humana for Patients' Benefit", "Noteworthy ETF Inflows: TQQQ, GOOG, AMGN, BIIB", "Chiron Investment Management, LLC Buys iShares iBoxx $ Investment Grade Corporate Bond, Gilead ...", "Can Ligand's Captisol Deals Boost Growth in the Long Run?", "Are Amgen's New Drugs Doing Well Enough to Drive Sales?", "3 Large-Cap Biotech Stocks to Scrape From the Selloff", "The Netherlands Is Taking Aim at One of America's Fastest-Growing Sectors", "Add Up The Parts: PWV Could Be Worth $39", "Amgen in Collaboration With Humana for Patients' Benefit", "Noteworthy ETF Inflows: TQQQ, GOOG, AMGN, BIIB", "Graham Disciple Charles Brandes' 5 Largest 2nd Quarter New Buys", "Here's Why Coherus Biosciences Rose as Much as 22.2% Today", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for August 16, 2017", "XLV, UNH, MRK, AMGN: ETF Inflow Alert", "Ray Gerald L & Associates Ltd Buys Norfolk Southern Corp, Splunk Inc, ONEOK Inc, Sells ...", "Here's Why Array BioPharma Inc. Fell 13.7% in July", "Radius (RDUS) Q2 Loss Wider than Expected on Higher Expenses", "Allergan (AGN) Q2 Earnings & Sales Top, Restasis Sales Down", "Health Care Sector Update for 08/03/2017: JNJ, PFE, ABT, MRK, AMGN, REGN, TEVA", "Pfizer (PFE) Surpasses Q2 Earnings Estimates, Misses Sales", "Ligand (LGND) Q2 Earnings & Revenues Top, 2017 View Raised", "Sanofi (SNY) Q2 Earnings In Line, Sales Lag,'17 View Raised", "Daily Dividend Report: K, CBOE, HTA, AMGN, SYY", "Health Care Sector Update for 07/28/2017: JNJ, PFE, ABT, MRK, AMGN, ABBV, NUVA", "Eliot Finkel Investment Counsel, LLC Buys Extra Space Storage Inc, Bank of Nova Scotia, Chevron ...", "See Which Of The Latest 13F Filers Holds Amgen", "Company News for July 27, 2017", "Arthur M. Cohen & Associates, Llc Buys Brookfield Infrastructure Partners LP, Fortive Corp, ...", "Noteworthy ETF Outflows: XLV, AMGN, AET, ANTM", "AMGN Named A Top Socially Responsible Dividend Stock", "Argyle Capital Management Inc. Buys DXC Technology Co, CVS Health Corp, C.R. ...", "Like Facebook Inc (FB) Stock? Protect Yourself Anyway.", "Nvidia Corporation (NVDA) Stock Isn\u2019t as Attractive as the Company", "Amgen, Inc. (AMGN) Stock Is a Trade for Ailing Portfolios", "Amgen (AMGN) Stock Falls Despite Q2 Earnings & Sales Beat", "2 Incredibly Cheap Dividend Stocks", "Validea Martin Zweig Strategy Daily Upgrade Report - 7/27/2017", "Earnings Reaction History: Amgen Inc., 54.5% Follow-Through Indicator, 3.1% Sensitive", "Biogen (BIIB) Tops Q2 Earnings & Sales, Spinraza Sales Up", "After-Hours Earnings Report for July 25, 2017 : T, AMGN, TXN, CB, CNI, ESRX, EQR, AMP, WCN, WYNN, AMD, TSS", "Noteworthy Tuesday Option Activity: AMGN, NEM, JPM", "3 Large-Cap Biotech Stocks to Buy Now", "Big Pharma Q2 Earnings Releases on Jul 25: LLY, BIIB, AMGN", "3 Stocks That Are Absurdly Cheap Right Now", "Biotech Stock Roundup: Amgen, Biogen Top Q2 Estimates, Update on Incyte RA Drug", "Amgen (AMGN) to Report Q2 Earnings: What's in the Cards?", "3 Dividend Stocks That Thrive in Market Crashes", "Oakbrook Investments Llc Buys Schlumberger, JPMorgan Chase, Visa Inc, Sells W.W. ...", "Biotech Stock Roundup: Vertex Boosted by CF Data, FDA Nod for Gilead, Puma Drugs", "3 Dividend Stocks That Thrive in Both Bull and Bear Markets", "Ligand Signs Agreement with Amgen, Grants Rights to Captisol", "Novartis Tops Q2 Earnings, Sandoz Faces Pricing Pressure", "XLV, UNH, MRK, AMGN: Large Outflows Detected at ETF", "Amgen (AMGN) to Report Q2 Earnings: What's in the Cards?", "Wells Fargo & Co (WFC) Stock Slumps Following Solid Q2 Earnings Report", "Can Novartis (NVS) Spring a Surprise This Earnings Season?", "Trade of the Day: Amgen, Inc. (AMGN) Stock Is a Standout", "Notable Friday Option Activity: REGN, DDD, AMGN", "Amgen Applies to Have Kyprolis' Label Updated", "Why Did Radius Health (RDUS) Stock Plummet Today?", "Mylan's Biosimilar Herceptin Gets FDA Advisory Committee Nod", "Edmp, Inc. Buys Penske Automotive Group Inc, Ventas Inc, STORE Capital Corp, Sells Alphabet ...", "Can ImmunoGen's Lead Pipeline Cancer Candidate Boost Growth?", "Amgen Gets FDA Nod to Broaden Leukemia Drug Blincyto's Label", "Biotech Stock Roundup: Arena Shoots Up on Study Data, CELG Inks Immuno-Oncology Deal", "3 Dividend Stocks in Healthcare", "Health Care Select Sector SPDR Fund Experiences Big Inflow", "Novartis' Cosentyx Superior to Stelara in Psoriasis Study", "Here's What's Behind Amgen, Inc.'s 10.2% Gain in June", "Country Club Trust Company, n.a. Buys iShares MSCI EAFE, Macquarie Infrastructure Corp, Royal ...", "Are Medicines Company's Key Drugs Set for Growth in 2017?", "3 Dividend Stocks You May Be Overlooking", "Better Buy: Amgen Inc. vs. Celgene Corporation", "Merck Falls as FDA Puts Hold on 3 Keytruda Myeloma Studies", "Amgen, Inc. (AMGN) Stock Is the Cure for Ailing Portfolios", "XLV, UNH, MRK, AMGN: Large Inflows Detected at ETF", "Biotech Stock Roundup: Cara Plunges on Study Data, Regulatory Updates & More", "Pfizer's (PFE) Leukemia Candidate Receives Approval in EU", "Key FDA Events to Watch Out for in Jul 2017", "10 Biotech Stocks With Game-Changing Dates in Q3", "3 Charts That Show Why to Buy Gilead Sciences Stock Now", "Teva's (TEVA) Filing for Biosimilar Rituxan Accepted by FDA", "3 Best Fidelity Funds to Finish 2017", "Dova Pharmaceuticals Targets a 9-Figure Opportunity, but Should You Buy Its IPO?", "Alder's Shares Dip Despite Positive Migraine Trial Results", "Novartis' Erelzi, Biosimilar of Enbrel Approved In Europe", "AbbVie Has the Most Valuable Late-Stage Pipeline -- But Is Its Stock a Buy?", "Health Care Select Sector SPDR Fund Experiences Big Inflow", "Amgen Gets Positive CHMP Opinion for Mimpara Label Expansion", "Roche's (RHHBY) Combination Cancer Remedy Wins FDA Approval", "Amgen's Colorectal Cancer Drug Gets FDA Nod to Expand Label", "Merck's Keytruda on a Roll: Can it Retain the Momentum?", "If Esperion Wants to Market the Next Big Cholesterol Drug, It Will Take Strategy", "Novartis Migraine Drug Accepted, AMD Positive in Phase III", "Small Cancer Biotech Space in Focus, 3 Stocks Up 100% & More", "Biotech Stock Roundup: Clovis Soars on Rubraca Data, Seattle Hit by Study Halt", "Ligand Gets Milestone Payment on Partner Drug FDA Approval", "5 Biotech Stocks That Are Roaring Back to Life", "Allergan Continues to Focus on Acquisitions and Branded Unit", "Merck's Keytruda on a Roll: Can it Retain the Momentum?", "3 Dividend Stocks for Long-Term Investors", "Noteworthy Tuesday Option Activity: RHT, CTSH, AMGN", "Health Care Select Sector SPDR Fund Experiences Big Inflow", "AbbVie (ABBV) Stock Hits 52-Week High: More Room to Run?", "3 Most Wildly Overvalued Stocks in Biotech (At Least on Paper)", "AbbVie Stock Just Hit a 52-Week High: Here's Why It Should Go Even Higher", "Amgen's Xgeva Myeloma Label Expansion sBLA Accepted by FDA", "2 Incredibly Cheap Biotech Stocks", "3 Biotech Trades to Diversify Your Portfolio", "3 Stocks That Could Double Your Money", "Is Amgen (AMGN) a Great Stock for Value Investors?", "Nektar (NKTR) Stock Rallied Almost 50% This Year: Here's Why", "Will These Cutting-Edge Cancer Killers Reignite The Biotech Rally?", "Biotech Stock Roundup: Management Changes at Biogen, Alexion, GILD Files HIV Drug", "The Supreme Court Just Made a Big Opportunity for Biosimilars Even Bigger", "Novartis (NVS) Announced Positive Data on Psoriasis Cosentyx", "Why Is ImmunoGen (IMGN) Stock Up 131% This Year?", "Coherus Stock Plummets as FDA Rejects Neulasta Biosimilar", "Merck Stalls Enrolment in Two Myeloma Studies of Keytruda", "Amgen's Multiple Myeloma Drug Receives NICE Recommendation", "Health Care Sector Update for 06/13/2017: JNJ, PFE, ABT, MRK, AMGN, CHRS, IMNP", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for June 14, 2017", "3 Dividend Stocks for Astute Investors", "Sanofi/Regeneron's Praluent Cuts Bad Cholesterol in Studies", "Health Care Sector Update for 06/12/2017: HYH,GTXI,CHRS,AMGN", "Health Care Sector Update for 06/12/2017: TROV,AZN,GTXI,CHRS,AMGN", "BIB, CELG, AMGN, INCY: ETF Inflow Alert", "AbbVie (ABBV) Announced Positive Phase III RA Candidate Data", "Teva Migraine Candidate Succeeds in Second Phase III Study", "Allergan to Buy Keller Funnel, Boost Plastic Surgery Unit", "Why Coherus Biosciences Stock Is Getting Hammered Today", "Sanofi/Regeneron's Praluent Cuts Bad Cholesterol in Studies", "Health Care Sector Update for 06/12/2017: HYH,GTXI,CHRS,AMGN", "3 Value Stocks Perfect for Retirement", "Amgen Files for Repatha in the U.S., EU for Expanded Use", "Amgen (AMGN) Presents Positive Clinical Data on Cancer Drugs", "Noteworthy Monday Option Activity: AMGN, WYN, MNK", "Noteworthy ETF Outflows: XLV, MDT, AMGN, CELG", "Health Care Sector Update for 06/08/2017: JNJ, PRE, ABT, MRK, AMGN, CHRS, TVTY, AXN", "The 5 Best Dividend Stocks in Cholesterol Drugs", "Amgen (AMGN) Down 4.5% Since Earnings Report: Can It Rebound?", "3 Dividend Stocks That Thrive in Market Crashes", "Pfizer's Epogen Biosimilar Gets Positive FDA Committee Vote", "3 Top Dividend Stocks in Generic Drugs", "The Zacks Analyst Blog Highlights: Regeneron, Amgen and Celgene", "Radius Health Osteoporosis Drug Positive in Phase III Study", "How Regeneron Pharmaceuticals, Inc. Makes Most of Its Money", "Biotech Stock Roundup: FDA Nod for Regeneron RA Drug, Amgen Hit by Study Data", "3 Reasons Gilead Sciences, Inc. Is a Better Dividend Stock Than Amgen, Inc.", "This Stock Turned $1,000 Into $1.53 Million in Less Than 33 Years", "Insider Buying: The Evidence", "Edward Owens Buys Abbott Labs, Sells Allergan, Amgen, Aetna", "3 Big Stock Charts for Monday: Bristol-Myers Squibb Co (BMY), Pfizer Inc. (PFE) and Amgen, Inc. (AMGN)", "Amgen is Oversold", "Merck's (MRK) Keytruda Gets FDA Nod for Solid Tumor Cancers", "Amgen, Inc. (AMGN) Stock Dips on Osteoporosis Drug Disappointment", "Notable ETF Outflow Detected - SSO, MRK, MCD, AMGN", "Nasdaq 100 Movers: AMGN, WYNN", "Is the Snap Inc (SNAP) Stock Bounce for Real?", "Why Apple Inc. (AAPL) Stock Is Vulnerable Right Now", "Amgen Evenity Approval Derailed on Cardiovascular Side Effect", "The 3 Best Dividend Stocks in Arthritis Medication", "Noteworthy Monday Option Activity: AMGN, AFL, NOG", "These 3 Biotech Stocks Have Ballooned in 2017, but Will They Pop?", "3 Stocks to Watch on Monday: Amgen, Inc. (AMGN), Lockheed Martin Corporation (LMT) and Ford Motor Company (F)", "Hbk Investments L P Buys NXP Semiconductors NV, SPDR S&P 500, Amgen Inc, Sells St Jude ...", "Astrazeneca (AZN) Gets Positive CHMP Opinion for Brodalumab", "Amgen (AMGN) Shares Cross 3% Yield Mark", "Health Care Sector Update for 05/22/2017: RDUS,AMGN,EYEG,VRX,BSTG", "Here's Why Radius Health Gained as Much as 20.2% Today", "Starbucks Corporation (SBUX) Stock Is Waking Up. Drink Up!", "Merck's (MRK) Keytruda Gets FDA Nod for Two New Indications", "Implied FMK Analyst Target Price: $32", "Market Tailwind Has Lifted This Top Fidelity Mutual Fund Manager's Portfolio", "What's Your Flavor? Don't Worry, There's An ETF For That", "AbbVie Down on Humira Patent Loss: Is More Damage in Store?", "Salesforce.com, Inc. (CRM) Stock Roars Into Earnings", "Amgen, Inc. (AMGN) Stock Has the Cure for Boring Portfolios", "Amgen (AMGN) Submits BLA to FDA for Migraine Drug Erenumab", "Health Care Sector Update for 05/16/2017: MNKD,AKBA,FMS,ETRM", "3 Best Dividend Stocks in Biotech", "The Zacks Analyst Blog Highlights: J.C. Penney, Amazon, Verizon, Citigroup and Amgen", "Lilly's Migraine Drug Phase III Trials Meet Primary Endpoint", "Better Buy: Gilead Sciences, Inc. vs. Amgen Inc.", "Is Regeneron Pharmaceuticals Stock Still a Buy After Its Big Bounce?", "Noteworthy ETF Inflows: XLV, MRK, UNH, AMGN", "Celgene's (CELG) Revlimid Looks Solid on Label Expansion", "Ex-Dividend Reminder: Consolidated Edison, Amgen and Simon Property Group", "Bellevue Group AG Buys Align Technology Inc, Anthem Inc, Walgreens Boots Alliance Inc, Sells ...", "Notable Two Hundred Day Moving Average Cross - AMGN", "Ligand Pharmaceuticals (LGND) Q1 Earnings Miss Estimates", "Notable Wednesday Option Activity: WFM, INGN, AMGN", "Mylan (MYL) Beats on Q1 Earnings, Revenues Miss Estimates", "Allergan (AGN) Beats Q1 Earnings Estimates, Ups 2017 View", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 15, 2017", "XLV, UNH, AMGN, MDT: ETF Inflow Alert", "Biotech Stock Roundup: Amgen, Gilead, Celgene Q1 Earnings, Sunesis Down on Vosaroxin Update", "9 Brand-Name Companies That Provide at Least a 5% 401(k) Match", "5 Things AbbVie Management Just Said That You'll Want to Know", "Pfizer (PFE) Q1 Earnings Beat, Sales Lag, 2017 View Intact", "Radius Health (RDUS) Posts Wider Q1 Loss, Tymlos Approved", "Is Regeneron (Finally) Getting Back on Track?", "Better Buy: Amgen Inc. vs. Johnson & Johnson", "Sanofi (SNY) Q1 Earnings Top, Sales Rise Y/Y, Shares Up", "These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016", "Amgen (AMGN) Q1 Earnings Top, Sales Miss, Shares Decline", "Starbucks Corporation (SBUX) Should Dip After Earnings, And That\u2019s OK", "Amgen's Q1 Results Highlight the Need for an Acquisition", "Will Amazon.com, Inc. (AMZN) Stock Hit $950? It\u2019s Not a Given.", "3 Stocks to Watch on Thursday: Nokia Oyj (ADR) (NOK), Amgen, Inc. (AMGN) and PayPal Holdings Inc (PYPL)", "Amgen: The Bear Case From a Bull", "Sanofi (SNY) Q1 Earnings Top, Sales Rise Y/Y, Shares Up", "These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016", "Amgen (AMGN) Q1 Earnings Top, Sales Miss, Shares Decline", "Better Buy: Amgen Inc. vs. Biogen", "5 Fantastic Earnings Charts", "After-Hours Earnings Report for April 26, 2017 : AMGN, PYPL, SU, LVS, PSA, EQIX, AVB, FISV, ORLY, EFX, WCN, NOW", "Earnings Reaction History: Amgen Inc., 60.0% Follow-Through Indicator, 3.2% Sensitive", "The 3 Best Long-Term Dividend Stocks To Buy Now (AMGN,HON, CVS)", "What's in Store for Merck (MRK) this Earnings Season?", "Pfizer (PFE) Q1 Earnings: Will it Pull Off a Surprise?", "SSO, MRK, UNH, AMGN: Large Outflows Detected at ETF", "Better Buy: Amgen Inc. vs. Biogen", "Notable Tuesday Option Activity: WDC, THO, AMGN", "Novartis Tops Q1 Earnings: Cosentyx, Entresto Boost Sales", "What Options Traders Expect from Amgen, Inc. (AMGN) Earnings", "Biogen (BIIB) Q1 Earnings & Sales Top, Spinraza Sales Strong", "Better Buy: Amgen Inc. vs. Pfizer", "Celgene (CELG) to Post Q1 Earnings: What's in the Cards?", "Read This Before You Buy Biotech Stocks", "Amgen (AMGN) to Report Q1 Earnings: Will it Beat Again?", "Alexion (ALXN) Q1 Earnings: Can the Stock Pull a Surprise?", "Universal Health (UHS) Q1 Earnings: What's in the Cards?", "Eli Lilly (LLY) to Report Q1 Earnings: What's in the Cards?", "What's in Store for Agenus (AGEN) this Earnings Season?", "What's in Store for Biogen (BIIB) this Earnings Season?", "What's in the Cards for Centene (CNC) this Earnings Season?", "XLV, AMGN, MDT, LLY: Large Inflows Detected at ETF", "The Zacks Analyst Blog Highlights: Alphabet, Amgen, Lowe's, Bristol-Myers and Priceline", "5 Major Drug Stocks Likely to Beat Q1 Earnings Estimates", "AbbVie Inc.: The Bear Case From a Bull", "Mylan Down on FDA Warning Letter to Manufacturing Facility", "Novartis (NVS) Q1 Earnings: Will the Stock Disappoint?", "ANTH's (ANTH) Blisibimod Completes Dosing in Phase III Study", "Country Club Trust Company, n.a. Buys WisdomTree Europe Hedged Equity Fund, Vanguard ...", "The 3 Top Dividend Stocks in the Healthcare Sector", "3 Big Drugmakers Most Likely to Buy Incyte", "10 Reasons Amgen Could Be the World's Most Perfect Stock", "3 Big Biotech Stocks With Big-Time Catalysts", "Analysts Release New Health Care Stock Ratings", "Amgen's Offering a Money Back Guarantee for Repatha. Will It Be Enough?", "3 Top Big Pharma Stocks to Buy Now", "Analysts Anticipate 10% Gains Ahead For XLV", "This Is Why Radius Health Inc. Tumbled 8.6% in March", "Amgen Files for Xgeva Label Expansion, To Include Myeloma", "Biotech Stock Roundup: Acorda Down on Court Ruling, Patent Challenge for CELG Drug", "Why Is Amgen (AMGN) Up 12.9% Since the Last Earnings Report?", "Rosenbaum Jay D. Buys Salesforce.com, Newell Brands, General Dynamics, Sells Walt Disney Co, ...", "Notable ETF Outflow Detected - DGRO, MRK, AMGN, WMT", "3 Top Big Pharma Stocks to Buy Now", "Healthcare Winners and Losers Following the AHCA's Failure", "Better Buy: Celgene Corporation vs. Amgen Inc.", "Could Pfizer Buy Esperion Therapeutics?", "Mylan Receives CRL for Generic Advair Diskus From the FDA", "FDA Grants Amgen Priority Review for Blincyto sBLA", "What's Next for Amgen's Repatha?", "The 3 Best Cholesterol Drug Stocks to Buy in 2017", "Notable ETF Outflow Detected - XLV, MRK, UNH, AMGN", "Biotech Stock Roundup: Regeneron, Tesaro Drugs Approved, Vertex Scores Big in Study", "3 Drugmakers With Boatloads of Cash to Spend", "Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in Europe", "3 Big Stock Charts for Tuesday: Alphabet Inc (GOOGL), Amgen, Inc. (AMGN) and United Parcel Service, Inc. (UPS)", "Biotech ETFs Defy Trump Tweets To Rally, But What Can Send Them Higher?", "Amgen's Leukemia Drug Accepted for Priority Review by FDA", "Merck's Ketruda Gets Positive CHMP Opinion for Lymphoma", "5 Stocks With Ridiculously Fast-Growing Dividends", "Amgen's Humira Biosimilar Approved in Europe", "Amgen's (AMGN) Humira Biosimilar Receives Approval in EU", "Pfizer's Immunotherapy for Skin Cancer Gets FDA Approval", "The Zacks Analyst Blog Highlights: Berkshire Hathaway, Amgen, Walgreens Boots Alliance, General Electric and Carnival", "Why You're Smart to Buy Jazz Pharmaceuticals plc", "J&J (JNJ) Anaemia Drug Marketing Label Expanded in Europe", "Health ETF Wobbles As Vote On Bill To Replace ObamaCare Nears; Gold Gains", "Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen", "Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results", "Notable ETF Outflow Detected - XLV, UNH, AMGN, MDT", "3 Biotech Stocks That Are Broker Favorites", "Biotech Bull Making a Comeback", "Amgen (AMGN): Repatha Outcomes Data Disappoint, Shares Drop", "How This Company Is Taking on Amgen", "Health ETF Wobbles As Vote On Bill To Replace ObamaCare Nears; Gold Gains", "Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen", "Amgen, Inc. (AMGN) Offers Money-Back Guarantee to Heart Attack Victims on Repatha", "Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher", "Privacy Revamp Makes Facebook Inc (FB) Stock Even More Attractive", "Amgen, Inc. (AMGN) Stock Crashed. Here\u2019s How to Trade It.", "Why Biotech Stock Gilead (GILD) Could Be a Value Trap", "Stock Market News for March 17, 2017", "What are Sanofi's (SNY) Strengths and Challenges in 2017?", "Market Close Report: NASDAQ trading volume joins the top ten ranking for the year. NASDAQ Composite Index closes at 5,901", "Why Amgen, AmTrust Financial Services, and BRF Slumped Today", "Here's Why Amgen, The Medicines Company, and Esperion Therapeutics Are All Tanking Today", "Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in China", "Nasdaq 100 Movers: AMGN, ADBE", "Biotech Stock Roundup: Amgen's Data on Repatha, Catalyst Soars on Firdapse Data", "Merck's (MRK) Keytruda Gets FDA Nod for Lymphoma Indication", "Amgen's Repatha Meets Primary Endpoint in Phase III Study", "Noteworthy Tuesday Option Activity: AMGN, ROK, ORCL", "Noteworthy ETF Inflows: XLV, AMGN, MDT, ABBV", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for March 14, 2017", "The 19 Best-Selling Prescription Drugs of All-Time", "Does Amgen Offer a Great Value Buying Opportunity Right Now?", "Why Amgen (AMGN) Stock Rallied After Q4 Earnings Release?", "After Hours Most Active for Mar 10, 2017 : DISH, GE, LLTC, FNB, INTC, QQQ, GM, AGN, V, BAC, ABCO, AMGN", "AbbVie Stock Upgraded: What You Need to Know", "AbbVie at the Cowen Healthcare Conference: 4 Things You'll Want to Know", "Daily Dividend Report: PBA, PLCE, AMGN, SPLS, VGR", "J2 Global, eHealth, Pfizer, Amgen and Mylan highlighted as Zacks Bull and Bear of the Day", "Novartis (NVS) Reports Positive Data on Biosimilar Humira", "Which Biotech Is the Best Dividend Stock?", "Why Amgen (AMGN) Stock Rallied After Q4 Earnings Release?", "After Hours Most Active for Mar 10, 2017 : DISH, GE, LLTC, FNB, INTC, QQQ, GM, AGN, V, BAC, ABCO, AMGN", "Here's Why Amgen Stock Rose 10.5% in February", "Mylan (MYL) Beats on Q4 Earnings, Stock Up on Strong View", "Why Perrigo Company plc Stock Crashed on Tuesday", "Biotech Stock Roundup: Kite Soars on CAR-T Data, EXEL in Immuno-Oncology Deals", "Here's Why Esperion Therapeutics Inc Stock Popped Today", "3 Biotech Stocks You Don't Have to Babysit", "Amgen Dividend History: What's Ahead for the Biotech Pioneer?", "3 Ways to Play This Biotech Stocks Dip", "Numeric Investors Llc Buys Gilead Sciences, Microsoft, Baxter International, Sells Facebook, ...", "3 Stocks You Don't Have to Babysit", "Ligand (LGND) Q4 Earnings Down Y/Y, Revenues Miss Estimates", "Notable Friday Option Activity: CELG, AMGN, LMT", "Better Cloud Growth Stock: Twilio Inc. vs. Veeva Systems", "Zacks Industry Outlook Highlights: Johnson & Johnson, Pfizer, Glaxo, Amgen's and Lilly", "Noteworthy ETF Inflows: TQQQ, AMGN, KHC, CHTR", "The Zacks Analyst Blog Highlights: Amgen, Procter & Gamble, Bank of America, Netflix and Honda", "Heart-Thumping, Game-Changing Ways We're Treating Cardiovascular Disease", "Who Could Buy Bristol-Myers Squibb?", "Study Reveals PCSK9 Drugs Can Save Heart Disease Patients", "Valeant's (VRX) Plaque Psoriasis Drug Approved in the U.S.", "Pfizer's Xeljanz Combo Comparable to AbbVie's Humira", "Should I Buy Procter & Gamble Co (PG) Stock? 3 Pros, 3 Cons", "Noteworthy ETF Inflows: TQQQ, AMGN, KHC, CHTR", "The Zacks Analyst Blog Highlights: Amgen, Procter & Gamble, Bank of America, Netflix and Honda", "Heart-Thumping, Game-Changing Ways We're Treating Cardiovascular Disease", "Who Could Buy Bristol-Myers Squibb?", "Study Reveals PCSK9 Drugs Can Save Heart Disease Patients", "Want to Get In on Biotech? Check Out These 3 Stocks", "Amgen Looking to Broaden Leukemia Drug Blincyto's Label", "Mylan's Proposed Biosimailar for Cancer Under Review in U.S.", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for February 15, 2017", "Daniel Loeb Picks Up Rate-Sensitive Financials, Drops Pharma", "Noteworthy Monday Option Activity: AMGN, AMBA, AXON", "PRIMECAP Management Buys AstraZeneca PLC, Alkermes PLC, Whirlpool, Sells Union Pacific, ...", "Hunter Associates inc. Buys Pfizer, Procter & Gamble Co, R.R. ...", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 13, 2017", "3 Beaten-Down Stocks Ready to Bounce Back", "Vanguard Growth ETF Experiences Big Inflow", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for February 15, 2017", "Sanofi (SNY) Q4 Earnings In Line; Can Sell Praulent for Now", "Why Coherus Biosciences Is Falling Today", "Allergan (AGN) Tops Q4 Earnings; 2017 Sales View Upbeat", "Amgen's Secondary Hyperparathyroidism Drug Approved in U.S.", "Better Buy: Amgen Inc. vs. Celgene", "Biotech Stock Roundup: Amgen, Gilead Report 4Q Results, ARIAD Seeks EU Nod for Brigatinib", "Van Strum & Towne Inc. Buys Charles Schwab, Bank of Americaoration, 3M Co, Sells Eaton ...", "Sapphire Star Partners LP Buys Cirrus Logic, Cracker Barrel Old Country Store, Vascular ...", "VUG, AMGN, MMM, ABBV: Large Inflows Detected at ETF", "Company News for February 06, 2017", "Merck???s Keytruda Gets Priority Review for Bladder Cancer", "Trump's Plan to Lower Drug Costs Is a Fairy Tale", "Nasdaq 100 Movers: AMZN, AMGN", "3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), GoPro Inc (GPRO) and Visa Inc (V)", "Regeneron (REGN) Q4 Earnings: Will the Stock Disappoint?", "Amgen (AMGN) Q4 Earnings Top; Repatha Positive in CV Study", "Why Morgan Stanley, Amgen, and Tableau Software Jumped Today", "Market Close Report: Historical high reached as NASDAQ Composite Index closes at 5,666.77.", "Why The Medicines Company Rocketed Higher Today", "Why Esperion Therapeutics, Inc. Is Soaring Today", "Health Care Sector Update for 02/03/2017: CBM,CERU,IDXG", "Biotech Stock Roundup: Celgene, Biogen, ABBV Post Q4 Results, Catabasis Falls on DMD Data", "Are Options Traders Betting on a Big Move in Amgen (AMGN) Stock?", "Amgen (AMGN) Q4 Earnings Top; Repatha Positive in CV Study", "Why Morgan Stanley, Amgen, and Tableau Software Jumped Today", "Drug Stocks to Report Q4 Earnings on Feb 2: MRK & AMGN", "Should You Sell Amgen (AMGN) Before Earnings?", "These 3 Biotech Stocks Are Ridiculously Cheap", "Merck Keytruda Gets EU Approval for First-Line Lung Cancer", "Mallinckrodt (MNK) Earnings This Quarter: Stock to Disappoint?", "After-Hours Earnings Report for February 2, 2017 : AMZN, V, AMGN, HIG, ESS, MSI, CMG, MTD, KIM, HBI, CSC, OTEX", "Amgen, Inc. (AMGN) Q4 Earnings Preview", "The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals", "Drug Stocks to Report Q4 Earnings on Feb 2: MRK & AMGN", "Amgen Wins Favorable CHMP Opinion for Humira Biosimilar", "United Bank Buys Fortis, Sells ITC Holdings, Revance Therapeutics, T. Rowe Price Group", "Amgen, Inc.: Capture Stronger Upside in AMGN Stock", "Stock Market News for January 27, 2017", "Pfizer (PFE) Q4 Earnings Lag, Sales Top; '17 Sales View Soft", "4 FDA Decisions to Watch Out for in Feb 2017", "Stock Market Roundup Jan. 31: Nasdaq Rebounds Amid Trump Biotech Meeting", "Biogen (BIIB) Q4 Earnings Top Estimates; '17 Sales View Soft", "Novartis (NVS) Beats Q4 Earnings, Might Spin-Off Alcon", "3 Biotech Stocks to Buy and Hold Stress-Free", "Noteworthy ETF Inflows: VUG, AMGN, MMM, ABBV", "Health Care Sector Update for 01/27/2017: AMGN", "Why the Amgen, Inc. (AMGN) Patent Case Is So Important", "4 Top Biotech Mutual Funds for 2017", "5 Biotech Stocks You'll Want to Watch in the 1st Quarter", "Value Investing 2017: 3 Stocks to Put on Your Radar", "Better Buy: Amgen Inc. vs. Celgene Corporation", "Donald Trump Just Leveled Drug Companies With These 4 Words", "Coherus Offers Positive Phase III Data on Humira Biosimilar", "Can Amgen (AMGN) Be a Top Choice for Value Investors?", "Apple Inc. (AAPL) Stock Cuts Production, But It May Not Be Time to Run", "Should You Buy Amgen Inc. (AMGN) Stock? 3 Pros, 3 Cons", "SPDR S&P Biotech (ETF) (XBI): Get on Board the Biotech Train!", "Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short", "Notable Wednesday Option Activity: BIIB, MRK, AMGN", "Stock Market News for January 10, 2017", "Amgen Inks Multiple Deals, Offers Update on Repatha Lawsuit", "3 Cheap Value Stocks to Buy Today", "Rosenbaum Jay D. Buys Comcast Corp, Lowe's Companies Inc, The Travelers Companies Inc, Sells ...", "Why Amgen's Stock Slumped in 2016", "Notable ETF Outflow Detected - TQQQ, AMGN, KHC, GILD", "Pfizer's Humira Biosimilar Meets Primary Endpoint in Study (Revised)", "Why Biotech Titans Are Clashing Over Cholesterol", "Midday Update: Stocks Regain Upward Momentum After Mixed Jobs Report", "AMGN Crosses Above Key Moving Average Level", "Kite Pharma Inks Deals for CAR T Cell Drug in Japan, China", "S&P 500 Movers: REGN, AMGN", "3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), Gap Inc (GPS) and PriceSmart, Inc. (PSMT)", "Health Care Sector Update for 01/06/2017: MDCO, SNY, REGN, JNJ, PFE, ABT, MRK, AMGN", "Stock Futures Turn Positive on Gains in Hourly Earnings", "Pfizer's Humira Biosimilar Meets Primary Endpoint in Study", "Amgen's Repatha Wins Over Sanofi & Regeneron's Praluent", "Why Regeneron Pharmaceuticals, Sears Holdings, and Shake Shack Slumped Today", "Nasdaq 100 Movers: REGN, AMGN", "S&P 500 Movers: REGN, AMGN", "3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), Gap Inc (GPS) and PriceSmart, Inc. (PSMT)", "Biotech Stock Roundup: Inotek Plunges on Pipeline Setback, Kite Files IND for Study Initiation", "Kite Pharma (KITE) to Move Cancer Candidate into Phase I", "Health Care Sector Update for 01/04/2017: SNY,AMGN,REGN,CBAY,AGRX", "Noteworthy Tuesday Option Activity: M, APA, AMGN", "Biotech Stocks: What to Watch in 2017", "Close Update: Labor Market Report Powers S&P 500 and Nasdaq to Record Highs", "The Zacks Analyst Blog Highlights: Comcast, Amgen, General Mills, Target and Ford", "These 3 Dividend Stocks Are Ridiculously Cheap", "6 Dividend Stocks Increasing Payouts \u2014 AMGN CVS MCO FITB BXP CHH", "3 Big Pharma Stocks With the Fastest-Growing Dividends", "Ligand (LGND) Signs Licensing Deals with Ono and Novartis", "Noteworthy ETF Outflows: TQQQ, AMGN, KHC, GILD", "2 Healthcare Stocks With Better Dividends Than HCP, Inc.", "OEF, V, IBM, AMGN: Large Outflows Detected at ETF", "3 Big Stock Charts for Tuesday: Darden Restaurants, Inc. (DRI), Amgen, Inc. (AMGN) and Caterpillar Inc. (CAT)", "Amgen Files for Approval of Osteoporosis Drug in Japan", "Great News: Clinical Trial Success Rates Are Up for the First Time in More Than a Decade", "Merck Keytruda Gets CHMP Nod for First-Line Lung Cancer", "3 Small Biotech Stocks That Big Biotechs Like", "Daily Dividend Report: AMGN, FITB, MCO, WOR, WDR", "Is This Gilead Sciences' Biggest Mistake in 2016?", "Pfizer: FDA Approves Eczema Ointment; Xtandi Fails Study", "5 Fairly Valued Dividend Growth Stocks In The Healthcare Sector", "Big Pharma Face Off: Is Merck More Attractive than J&J?", "XLV, AMGN, ABBV, GILD: ETF Outflow Alert", "3 Top Biotech Stocks to Buy on Sale", "Better Buy: Gilead Sciences Inc. vs. Amgen Inc.", "Stock Exchange: Do Emotions And Symbolism Affect Technical Analysis?", "Is This Gilead Sciences' Biggest Mistake in 2016?", "Pfizer: FDA Approves Eczema Ointment; Xtandi Fails Study", "Amgen, Inc. (AMGN) Stock Might Be on Santa\u2019s Buy List", "Better Buy: Amgen Inc. vs. Biogen", "Biogen Inc (BIIB) Stock Trade Showcases the \u2018Art of the Steal\u2019", "Stock Market News for December 08, 2016", "Biotech Stock Roundup: Actelion Remains in M&A Spotlight, ASH Data in Focus", "Harvard Bioscience's Recent Acquisitions Make A Difference, Initiate With Buy Rating", "YieldBoost Amgen To 4.7% Using Options", "Monday\u2019s Vital Data: Bank of America Corp (BAC), Apple Inc. (AAPL) and Seadrill Ltd (SDRL)", "Amgen, Inc. (AMGN) Stock Might Be on Santa\u2019s Buy List", "Better Buy: Amgen Inc. vs. Biogen", "Biogen Inc (BIIB) Stock Trade Showcases the \u2018Art of the Steal\u2019", "Stock Market News for December 08, 2016", "Pfizer/Merck KGaA: Priority Review for Cancer Drug Avelumab", "Better Buy: Amgen Inc. vs. Pfizer", "3 Top Dividend Stocks to Buy in 2017", "Merck: Keytruda's Priority Review for New Cancer Indication", "J&J Immunotherapy Darzalex OK'd for Label Expansion by FDA", "5 Biotech Stocks George Soros Is Buying", "Novartis (NVS) Reports Favorable Data on Enbrel Biosimilar", "The Zacks Analyst Blog Highlights: Amgen, Cisco, NextEra Energy, AbbVie and eBay", "Novartis/Amgen Migraine Drug Positive in Phase III Study", "Biotech Stock Roundup: Actelion Soars on Acquisition Talks, Another Clinical Hold for Juno", "Aegerion's Juxtapid Gets Pricing Authorization in Japan", "Top Research Reports for Cisco, Amgen & NextEra Energy", "Amgen's Migraine Drug Hits Primary Endpoint in STRIVE Study", "3 Stocks to Watch on Wednesday: Amgen, Inc. (AMGN), Cisco Systems, Inc. (CSCO) and NetApp Inc. (NTAP)", "3 Beaten-Down Biotech Stocks to Buy for Huge Gains", "Amgen Files for Avastin Biosimilar; Repatha Data Positive", "Biotech Stock Roundup: Biotech Stocks Soar on Election Results, Gilead HBV Drug Approved", "Regeneron/Sanofi's Praluent CV Outcomes Study to Continue", "3 Biotech ETFs for Decades of Big Returns", "How To Invest During The Trump Presidency", "Amgen Presents Osteoporosis Data; Parsabiv Approved in EU", "Fidelity Healthcare Fund: 5 Things You Should Know", "3 Drugmakers That Probably Have Lower Tax Rates Than You Do", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 14, 2016", "Drug Stocks' Q3 Earnings to Watch on Nov 14: ARGS, AST", "Is Immunotherapy the Next Hot Industry for Biotech Stock Investors?", "Kite Pharma Q3 Loss Betters Estimate; KTE-C19 On Track", "5 Top Biotech Stocks to Buy on Trump Victory", "Peek Into Drug Stocks' Q3 Earnings on Nov 11: XBIT & REPH", "Biotech Stock Roundup: Ionis Soars on Spinraza Data, Regeneron's Q3 Results Mixed", "Better Buy: Amgen Inc. vs. Johnson & Johnson", "IYH, UNH, AMGN, ABBV: ETF Outflow Alert", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for November 09, 2016", "Stock Exchange: Is Post-Election Technical Analysis Useful?", "Biotech ETFs Slumping on Q3 Results", "Zacks Industry Outlook Highlights: Amgen, Vertex, Valeant Pharmaceuticals International, Mylan N.V. and Gilead Sciences", "SPXT's Underlying Holdings Imply 14% Gain Potential", "2 Reasons Why the iShares NASDAQ Biotechnology Index (ETF) Tumbled 11% in October", "Is AbbVie's Dividend Worth the Risk?", "Zacks Industry Outlook Highlights: Mylan, Lilly, Pfizer, Novartis and Amgen", "Why AbbVie Shares Tumbled 11.6% in October", "Why Amgen Inc. Shares Nose-Dived 15.4% in October", "Allergan (AGN) Lags Q3 Earnings, Cuts View, Ups Buyback", "$10 Billion Flop: Is Amgen Stock Still a Buy?", "Pfizer's Surprising News Upends the Market for Next-Gen Cholesterol Busters", "Pfizer (PFE) Q3 Earnings Lag; Cuts View, Sheds Bococizumab", "Drug Stocks to Watch for Earnings on Nov 2; AGN, ZTS & More", "3 Things You Really Need to Know About Pfizer's Q3 Results", "Genetic Stocks to Watch for Earnings on Nov 1: GILD & More", "Biotech Stock Roundup: Amgen Down on Enbrel Sales, Regeneron's Sarilumab Faces Delay", "Amgen, Inc. (AMGN) Stock Sinks Despite Q3 Earnings Beat", "Nasdaq 100 Movers: AMGN, SRCL", "Amgen (AMGN) Q3 Earnings & Sales Top; Enbrel Hurts Stock", "Why Amgen, McKesson, and Stonemor Partners Slumped Today", "Market Close Report: NASDAQ Composite index closes at 5,190.10 down -25.87 points", "5 Things Amgen Inc.'s Management Wants You to Know", "Here's Why Amgen (AMGN) Stock Slid Over 10% Today", "Will This Trend Cost Biotech Stock Investors Lots of Money?", "Amgen, Inc. (AMGN) Stock Sinks Despite Q3 Earnings Beat", "Nasdaq 100 Movers: AMGN, SRCL", "After-Hours Earnings Report for October 27, 2016 : AMZN, GOOGL, AMGN, BIDU, SYK, MCK, AFL, LNKD, RSG, EXPE, HIG, PFG", "Biotech Stock Roundup: Clinical Holds Hit Inovio & Aduro, Vertex Q3 Results Miss Estimates", "Gilead Sciences (GILD) Q3 Earnings: Stock to Disappoint?", "Can Prothena (PRTA) Pull a Surprise This Earnings Season?", "Biogen (BIIB) Beats on Q3 Earnings; Tecfidera Propels Sales", "Amgen, Inc. Tumbles 11% as Pricing Concerns Mount for Lead Drug Enbrel", "Novartis (NVS) Tops Q3 Earnings, Misses Sales Estimates", "Merck Keytruda Gets FDA Approval for First-Line Lung Cancer", "3 Key Questions for Amgen Inc. in Q3", "Agenus (AGEN): What's Ahead for the Stock in Q3 Earnings?", "Can AbbVie (ABBV) Sustain Earnings Beat Trend in Q3?", "Noteworthy Monday Option Activity: AMGN, CEMP, RDUS", "Health Care Sector Update for 10/24/2016: AAC,UNIS,INO", "Is a Surprise Coming for Amgen (AMGN) This Earnings Season?", "Amgen's (AMGN) Xgeva Meets Endpoint in Phase III Study", "The Zacks Analyst Blog Highlights: Pfizer, Novartis AG, Amgen, Merck and Momenta Pharmaceuticals", "GlaxoSmithKline (GSK) Q3 Earnings: What's in the Cards?", "Bristol-Myers Squibb (BMY) Q3 Earnings: What's in Store?", "Best And Worst Biotech ETFs Of 2016 Tell A Tale About This Industry", "7 Drug Stocks to Consider as Biosimilars Pick Up Pace", "Can Biogen (BIIB) Keep the Earnings Streak Alive in Q3?", "Will Amgen (AMGN) Sustain its Earnings Beat Trend in Q3?", "Novartis (NVS) Q3 Earnings: Stock to Beat Estimates Again?", "Celgene (CELG) Q3 Earnings: What's in Store for the Stock?", "Can Eli Lilly (LLY) Pull a Surprise this Earnings Season?", "Can Merck (MRK) Keep the Earnings Streak Alive in Q3?", "3 Stocks to Supplement Your Social Security Benefits", "Pfizer to Launch Remicade Biosimilar in U.S. in November", "What's in Store for BioMarin (BMRN) This Earnings Season?", "Health Care Select Sector SPDR Fund Experiences Big Inflow", "J&J (JNJ) Likely to Beat Earnings Estimates in Q3 Again", "Abbott Labs (ABT) Q3 Earnings: What's Ahead for the Stock?", "Stock Market News for October 12, 2016", "Better Buy: Regeneron Pharmaceuticals, Inc. vs. Roche Holding AG", "Teva Acquires Rights to Oncology Biosimilar Candidates", "3 Top Biotech Stocks to Buy Right Now", "Daily Dividend Report: AMGN, LLY, WY, HSY, VMC, UNM", "Pfizer to Sell Hospira Infusion Unit to ICU Medical for $1B", "3 Ways Rockwell Medical Inc. Could Turn Things Around", "XLV, AMGN, MDT, ABBV: ETF Outflow Alert", "Amgen Announces Publication of Blincyto Phase I/II Data", "3 Top Biotech Stocks to Buy in October", "Marketplace Roundtable: The State Of Biotech", "3 Healthcare Stocks That Could Raise Their Dividends", "6 Healthcare Stocks Investors Can't Miss in Q3 Earnings", "Is It Too Late to Get In on This Millionaire-Maker Stock?", "Allergan Focus on Brands, Biosimilar Products & Acquisitions", "Why Arrowhead Pharmaceuticals Stock Spiked Today", "Mid-Morning Market Update: Markets Edge Lower; PepsiCo Beats Q3 Expectations", "Health Care Sector Update for 09/29/2016: ARWR,AMGN,AEGR,ITCI", "3 Reasons Not to Lose Faith in Amgen, Inc. (AMGN)", "Momenta to Regain Rights to Humira Biosimilar from Shire", "Amgen (AMGN) Migraine Drug Hits Phase III Primary Endpoint", "Amgen's Multiple Myeloma Drug Kyprolis Fails in Phase III", "XLV, AMGN, MDT, GILD: ETF Inflow Alert", "Nasdaq 100 Movers: GILD, NCLH", "Amgen/UCB's BLA for Osteoporosis Drug Accepted in the U.S.", "Biosimilars in Limelight on FDA Approval of Amgen Drug", "Here's Why Ligand Pharmaceuticals Inc Is Plunging Today", "Amgen's Biosimilar of Abbvie's Humira Gets FDA Approval", "Biotech Stock Roundup: Amgen's Kyprolis Disappoints, Array Up on Cancer Data", "Amgen (AMGN) Repatha Meets Endpoints in Phase III Study", "Stock Market News for September 21, 2016", "Trade of the Day: iShares Nasdaq Biotechnology Index (ETF) (IBB) Is Turning Things Around", "Biotech ETF At Best Level Since January; Are You Braced For Bumps?", "Know Before You Buy These 85 Blue Chips", "Amgen (AMGN) Parsabiv Gets Positive CHMP Opinion in EU", "Is This New Market the Biggest Investment Idea of the Decade?", "As Humira Alternative Gets FDA Approval, Is Abbvie in Trouble?", "Novartis Reports Positive Phase II Data on Migraine Drug", "SPDR S&P Biotech (ETF) (XBI): The Bears Got Nothin\u2019 on Biotech Stocks", "Stock Market News for September 15, 2016", "Third Avenue Fund Comments on Amgen", "The Zacks Analyst Blog Highlights: Spectrum Pharmaceuticals, Amgen, AbbVie and Vertex Pharmaceuticals", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 14, 2016", "S&P 500 Movers: AAL, PRGO", "IWF, V, PEP, AMGN: ETF Outflow Alert", "Noteworthy Monday Option Activity: AMGN, ULTA, AIG", "Two Things You Must Understand About Biotech Investing", "The Biotech ETF With The Unusual Investment Strategy", "Market Treaded Water In August As Investors Shifted To Growth Stocks -- Before Switching Back", "Merck's Lung Cancer Drug Keytruda Under Priority Review", "3 Attractive Income Stocks Whose Dividends Could Double", "Biotech Stock Roundup: CoLucid Soars on Migraine Data, Dynavax Drug FDA Panel Meeting Cancelled", "3 Drug Stocks That Could Benefit from Key FDA Events in Sep 2016", "Biotech Stock Roundup: Gilead in Patent Infringement Lawsuit, Enbrel Biosimilar Approved", "Why Cytokinetics, Inc. Got Hammered Today", "The Medicines Co. Offers Update on Dyslipidemia Programs", "Novartis (NVS) Gets FDA Nod for Biosimilar Version of Enbrel", "Amgen (AMGN) Reports Positive Data on Prolia and Repatha", "Noteworthy ETF Outflows: TQQQ, AMGN, KHC, GILD", "Regeneron/Sanofi Present Positive Phase III Praluent Data", "Amgen Gets FDA Approval for Label Expansion of Blincyto", "Amgen Gets CRL for Secondary Hyperparathyroidism Drug", "Health Care Sector Update for 08/25/2016: AMGN,PVCT", "Commit To Purchase Amgen At $135, Earn 5.5% Using Options", "J&J (JNJ) Seeks EU Approval for Darzalex's Expanded Use", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for August 25, 2016", "Noteworthy Monday Option Activity: DVAX, AMGN, NDSN", "3 Reasons Medivation Is the Juiciest Target in Biotech", "These Next-Generation Cholesterol Drugs Could Raise U.S. Healthcare Costs by $119 Billion a Year", "Cytokinetics' Amyotrophic Lateral Sclerosis Study Enrolled", "The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen", "Better Buy: Amgen Inc. vs. Biogen", "Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data", "Another Endorsement for Biotech ETFs", "3 Stocks to Watch on Tuesday: Twilio Inc (TWLO), Hain Celestial Group Inc (HAIN) and Wal-Mart Stores, Inc. (WMT)", "Amgen, Inc (AMGN) \u2013 Amgen Stock Is a Powerhouse", "3 Cheap Dividend Stocks You Can Buy Right Now", "Prices for These 4 Top-Selling Prescription Drugs Have More Than Doubled Since 2010", "Prices for These 4 Top-Selling Prescription Drugs Have More Than Doubled Since 2010", "Martin Whitman's Third Avenue Management Purchases 8 Stocks", "The Zacks Analyst Blog Highlights: Regeneron, BioMarin, AbbVie, Amgen and Biogen", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 15, 2016", "4 Reasons Amgen, Inc. Shareholders Netted a 13% Gain in July", "Biotech Stock Roundup: Earnings in Focus, AbbVie Takes Steps to Block Humira Copycat", "7 Battered Biotech Stocks to Buy", "Kite Pharma (KITE) Q2 Loss Wider but Focus is on KTE-C19", "Notable ETF Outflow Detected - DGRO, ABBV, AMGN, UPS", "Kite (KITE) Q2 Earnings: What's in Store for the Stock?", "Finding Value In The S&P 500: 9 Healthcare Dividend Growth Stocks: Part 1", "Why Advaxis, Inc. Shares Are Soaring 11% Again Today", "IBB: Significantly Overbought - Sharp Declines Imminent", "Mid-Day Market Update: Dow Drops Over 100 Points; Avon Shares Surge Following Earnings Beat", "Stock Market News for August 09, 2016", "2 Biotech Funds Leading Nascent Bull Market: Which Is Right For You?", "Mid-Afternoon Market Update: Crude Oil Down 1.5%; RetailMeNot Shares Gain On Strong Results", "Which Of The Latest 13F Filers Holds Amgen?", "QQQ ETF Posts 52-Week High; Energy Stocks Sag As Oil Drops To $40", "Noteworthy ETF Outflows: BIB, AMGN, CELG, BIIB", "UCB (UCBJF) Posts 1H16 Results, Reaffirms 2016 Guidance", "Company News for July 29, 2016", "Close Update: Stocks Pressured by Earnings, Worries About Economy", "The Zacks Analyst Blog Highlights: Facebook, Amgen, Whole Foods and Groupon", "The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Amgen and Celgene", "Amgen (AMGN) Tops Q2 Earnings & Revenues, Raises View", "2 Large Cap Drug Stocks to Watch for Earnings: ABBV & MRK", "Facebook (FB) Owns Q2 Earnings on Huge Beat, Plus GRPN, GPRO and More", "Biotech Stock Roundup: Biogen Q2 Results Impress, Gilead HCV Franchise Under Pressure", "After-Hours Earnings Report for July 27, 2016 : FB, AMGN, MCK, PSA, SU, NXPI, ORLY, PXD, ABX, VRTX, MAR, O", "AMGN Named A Top Socially Responsible Dividend Stock", "The Zacks Analyst Blog Highlights: Facebook, Amgen, Whole Foods and Groupon", "AbbVie (ABBV) Q2 Earnings: Will the Stock Pull a Surprise?", "Alexion (ALXN) Q2 Earnings: Stock Likely to Disappoint", "One Biotech Plays Red Light, Green Light With the FDA", "Merck (MRK) Q2 Earnings: Will the Stock Pull a Surprise?", "ARIAD (ARIA) to Report Q2 Earnings: Will the Stock Surprise?", "Bristol-Myers (BMY): Stock to Beat Earnings Again in Q2", "Earnings Reaction History: Amgen Inc., 63.6% Follow-Through Indicator, 2.7% Sensitive", "Outerwall Inc: What the Buyout Means for OUTR Stock", "Amgen, Inc.: AMGN Stock May Be Prepping for a Surge", "Zacks Industry Outlook Highlights: Bristol-Myers, Pfizer, Sanofi, Amgen and Biogen", "Glaxo (GSK) Q2 Earnings: Can the Stock Pull a Surprise?", "Vertex (VRTX) to Report Q2 Earnings: Is a Surprise in Store?", "Amgen (AMGN) May Beat Q2 Earnings: Will the Stock Gain?", "Biotech Earnings Battle: Gilead (GILD) vs. Amgen (AMGN)", "Celgene (CELG) Q2 Earnings: Can the Stock Pull a Surprise?", "Outerwall Inc: What the Buyout Means for OUTR Stock", "Amgen, Inc.: AMGN Stock May Be Prepping for a Surge", "Zacks Industry Outlook Highlights: Bristol-Myers, Pfizer, Sanofi, Amgen and Biogen", "Glaxo (GSK) Q2 Earnings: Can the Stock Pull a Surprise?", "Vertex (VRTX) to Report Q2 Earnings: Is a Surprise in Store?", "Amgen (AMGN) May Beat Q2 Earnings: Will the Stock Gain?", "Biotech Earnings Battle: Gilead (GILD) vs. Amgen (AMGN)", "Daily Dividend Report: AMGN, NLSN, MAC, CF, EE, WWD", "Implied MOAT Analyst Target Price: $38", "3 Drug Stocks to Report Earnings on Jul 19: JNJ, NVS, NEOG", "Valeant's (VRX) Brodalumab BLA Up for Review in the U.S.", "3 Biotech Stocks for Conservative Investors", "4 Rock-Solid, Cheap Biotech Stocks", "5 Figures to Look For When Johnson & Johnson Reports Its Second-Quarter Results", "Novartis' Enbrel Biosimilar Gets FDA Panel Recommendation", "Noteworthy ETF Outflows: SSO, AMGN, MCD, CVS", "The Zacks Analyst Blog Highlights: Juno, Amgen, AbbVie, Gilead and CytRx", "Here's Why Regeneron Pharmaceuticals, Inc. Dropped Another 12% in June", "Biotech Stock Roundup: Juno In and Out of Clinical Hold, Amgen Biosimilar Gets Panel Backing", "Amgen's Repatha Gains FDA Approval for New Dosing Option", "Instant Analysis: Amgen's Latest Approval Raises the Bar Yet Again on Regeneron Pharmaceuticals Inc and Sanofi SA (ADR)", "Amgen Humira Biosimilar Briefing Documents Look Good", "Noteworthy ETF Outflows: IWF, GOOGL, GOOG, AMGN", "Amgen and Daiichi Sankyo Team Up for Biosimilars in Japan", "Amgen's Kyprolis Gains Approval in EU for Label Expansion", "Should Davita's (DVA) Stock Be in Your Portfolio Now?", "AstraZeneca Skin Drug, Tralokinumab, Rights Licensed to LEO", "5 Dividend Growth Stocks to Excel in Any Market Condition", "3 Top Healthcare Stocks to Buy Now", "3 Healthcare Stocks That Could Raise their Dividends", "Amgen (AMGN) Shares Cross Above 200 DMA", "Zacks.com featured highlights: Wal-Mart Stores, Home Depot, Amgen, United Parcel Service and Intel", "Amgen's Kyprolis Gains Approval in EU for Label Expansion", "Should Davita's (DVA) Stock Be in Your Portfolio Now?", "AstraZeneca Skin Drug, Tralokinumab, Rights Licensed to LEO", "5 Dividend Growth Stocks to Excel in Any Market Condition", "3 Biotech Stocks to Buy in the Wake of the Brexit Vote", "The iShares NASDAQ Biotechnology Index (IBB): Biotech Stocks Are Pushing for Recovery", "Pfizer's PCSK9 Inhibitor Tops Two Additional Phase III Studies", "The 3 Most Important Data Releases and FDA Decisions in the Second Half of 2016", "IXJ, AMGN, AGN, CELG: Large Inflows Detected at ETF", "2 Biotech Stocks That Could Raise Their Dividends -- and 1 That Won't", "Amgen's Biosimilar of AbbVie's Humira to Face FDA Panel", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for June 14, 2016", "Tricking the Common Cold Into Destroying Cancer", "Notable ETF Outflow Detected - PJP, AGN, AMGN, LLY", "How This Former Market Darling Became an Undervalued Stock", "Biotech Stock Roundup: Biogen Slips on MS Results, ASCO Data in Focus", "IBB: The iShares NASDAQ Biotechnology Index (ETF) Is Still a Buy", "Why Kite Pharma Shares Vaulted 10.7% Higher in May", "Better Dividend Stock: Pfizer vs. Amgen", "The New $17 Billion Market You've Probably Never Heard of (and 3 Stocks Poised to Profit)", "3 Biotechs Expecting Market-Moving Trial Results Soon", "SSO, AMGN, CVS, ABBV: Large Outflows Detected at ETF", "Novartis (NVS) Announces Positive Results on Migraine Drug", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for June 02, 2016", "Merck, AbbVie & Amgen Drugs a Step Closer to EU Approval", "3 Growth Stocks to Buy in June", "Interested in Medivation? Take a Number!", "YieldBoost AMGN To 6.4% Using Options", "Amgen (AMGN) Shares Cross Above 200 DMA", "Billionaires Lightened Their Load on These 3 Widely-Held Stocks in Q1", "Regeneron Reports Interim Data on Cholesterol Lowering Drug", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for June 02, 2016", "Merck, AbbVie & Amgen Drugs a Step Closer to EU Approval", "Thinking About Buying Gold? Think Again", "Drug Stocks Reporting Earnings on May 17: AXON & FWP", "The Math Shows EUSA Can Go To $48", "Biotech Stock Roundup: Medivation Buyout Rumors Continue, NewLink Plunges on Late-Stage Data", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 13, 2016", "Here's What Pfizer's Telling Us About Biotech M&A", "XLV, UNH, GILD, AMGN: ETF Outflow Alert", "Biotech Stock Roundup: Pfizer to Buy Anacor for $5.2B, Pipeline Setbacks for Aduro, Trevena", "Thinking About Buying Gold? Think Again", "Kite Pharma (KITE) Posts Narrower-than-Expected Loss in Q1", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for May 11, 2016", "Drug Stocks Reporting on May 10: XON, ARIA, CPRX & More", "Drug Stocks' Earnings Previews: FGEN, IRWD, ENTA, FLML", "Bristol-Myers/AbbVie Empliciti Gets Approved in the EU", "The Zacks Analyst Blog Highlights: Amgen, Gilead, Celgene, Medivation and Biogen", "AMGN Makes Notable Cross Below Critical Moving Average", "Kite (KITE) to Report Q1 Earnings: Will the Stock Disappoint?", "Health Care Select Sector SPDR Fund Experiences Big Inflow", "Biotech Stock Roundup: Amgen Impresses, Gilead Disappoints in Q1, Biogen to Spin Off Hemophilia", "Biotech Stocks Earnings Preview: REGN, LGND, ECYT & More", "Regeneron Pharmaceuticals Inc Has a Lot to Prove on May 5", "Biotech Stocks Reporting on May 9: INCY, HZNP, JUNO & More", "The Zacks Analyst Blog Highlights: Amgen, Johnson & Johnson, Pfizer, Mylan and Mallinckrodt", "Aside From 1 Eyesore, Amgen Delivers Another Solid Quarter", "Biotech ETFs Sink on Mixed Q1 Results", "Trade of the Day: IBB Breaking Down", "Amgen, Inc. (AMGN) Earnings Prove It Should Be in Your Portfolio", "3 Drug Stocks Reporting Early Next Week: PFE, MYL, MNK", "Amgen (AMGN) Tops Q1 Earnings & Revenues, Ups View", "Insulet Pumps Out 69% Revenue Growth in Q1, Reaffirms 2016 Guidance", "Q1 Earnings Reports Continue the Deluge: AMZN, GILD, AMGN", "Amgen (AMGN) Beats Q1 Earnings Estimates, Raises 2016 Outlook", "Celgene Corporation Short-Term, Long-Term Guidance Up. Medium-Term? Not So Much", "Earnings Reaction History: Amgen Inc., 70.0% Follow-Through Indicator, 2.8% Sensitive", "After-Hours Earnings Report for April 28, 2016 : AMZN, GILD, AMGN, BIDU, HIG, RSG, EXPE, ESS, BMRN, LNKD, SWKS, DLR", "FVD, LMBS: Big ETF Inflows", "See Which Of The Latest 13F Filers Holds Amgen", "3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), Gilead Sciences, Inc. (GILD) and TiVo, Inc. (TIVO)", "Aegerion (AEGR): Can the Stock Surprise in Q1 Earnings?", "Aerie (AERI): Can the Stock Pull a Surprise in Q1 Earnings?", "Biotech Stock Gilead (GILD) Likely to Beat in Q1 Earnings", "Health Care Select Sector SPDR Fund Experiences Big Inflow", "Celgene (CELG) Q1 Earnings: What's in Store for the Stock?", "Centene (CNC) Q1 Earnings: Surprise in Store for Stock?", "Aetna (AET) Q1 Earnings: Is a Surprise in Store for Stock?", "4 Biotech Stocks Reporting on Apr 28: AMGN, GILD, ALXN, CELG", "Anthem (ANTM): Stock Poised to Beat on Q1 Earnings", "Amgen (AMGN) May Beat Q1 Earnings: Will the Stock Gain?", "What to Expect from Hubbell (HUBB) This Earnings Season?", "5 Biotech Stocks to Bet on This Earnings Season", "3 Data Points That Will Likely Define Amgen's First-Quarter Report on April 28", "Does Biotech\u2019s Recent Bounce Have Legs?", "Bristol-Myers (BMY) Q1 Earnings: Can the Stock Surprise?", "BioMarin (BMRN) Q1 Earnings: Stock Likely to Beat Estimates", "AbbVie (ABBV) Likely to Beat on Q1 Earnings: Stock to Gain?", "Glaxo (GSK) Q1 Earnings: What's in Store for the Stock?", "Will Currency & Competition Hurt Lilly's (LLY) Q1 Earnings?", "Amgen's (AMGN) Phase III Study Results on Nplate Published", "20 Reasons to Buy Amgen and Never Sell", "Health Care Sector Update for 04/20/2016: CARA, AMGN, MRK, ABT, PFE, JNJ, STJ", "Biotech Stock Roundup: Medivation Buyout Rumors Resurface, Synta Up on Merger Deal", "Vertex (VRTX) to Report Q1 Earnings: Is a Surprise in Store?", "AbbVie (ABBV) Likely to Beat on Q1 Earnings: Stock to Gain?", "Health Care Sector Update for 04/18/2016: MDVN, BIIB, AMGN, MRK, ABT, PFE, JNJ", "Will MS Franchise Sales Boost Biogen's (BIIB) 1Q Earnings?", "Health Care Sector Update for 04/15/2016: AMGN, MRK, ABT, PFE, JNJ, VRX, MRNS", "Surprising Analyst 12-Month Target For IWL", "Will Perrigo (PRGO) Surprise Earnings Estimates in Q1?", "IWF, AMGN, UNH, MA: Large Outflows Detected at ETF", "Health Care Sector Update for 04/19/2016: SCMP, AMGN, MRK, ABT, PFE, JNJ", "Trade of the Day: Pounce on AMGN Stock on a Pullback", "Health Care Sector Update for 04/13/2016: OCLS, PSTI, AMGN, MRK, ABT, PFE, JNJ", "3 Biotech Takeover Targets That Could Get Bought Soon", "Health Care Sector Update for 04/12/2016: AMGN, MRK, ABT, PFE, JNJ, CLVS, CBRP", "Shares of Regeneron Pharmaceuticals, Inc. Struggled in March -- Here's Why", "Novartis Binocrit's Subcutaneous Formula Gets EC Approval", "Notable ETF Outflow Detected - IWB, GILD, AMGN, SBUX", "Health Care Sector Update for 04/14/2016: AMGN, MRK, ABT, PFE, JNJ, ABBV, ENTA, SNTA", "7 Healthcare Stocks to Buy for Your Retirement", "Forget Regeneron Pharmaceuticals, Inc.: These 2 Stocks Are Better Buys", "This Amgen News Could Be a Game-Changer in its Fight Against Sanofi and Regeneron Pharmaceuticals", "Amgen Breaks Above 200-Day Moving Average - Bullish for AMGN", "3 Biotech Stocks on the Verge of an Overdue Run (AMGN, GILD, REGN)", "Better Buy: Regeneron Pharmaceuticals, Inc. vs. Amgen", "Pfizer's PCSK9 Inhibitor Positive in Second Phase III Study", "Pfizer's (PFE) Biosimilar of Remicade Receives FDA Approval", "Post Conference Get-Together", "4 Best Biotech Stocks of the First Quarter of 2016", "Is Celator Pharmaceuticals, Inc. a Stock Worth Buying?", "Better Buy: Amgen Inc. vs. Celgene Corp.", "Community Banks Can Be the 'Teddy Bears' to Shield Against Market", "Why Fitbit Inc (FIT), Medivation Inc (MDVN) and Tesla Motors Inc (TSLA) Are 3 of Today\u2019s Best Stocks", "Health Care Sector Update for 03/31/2016: MDVN,AZN,GILD,AMGN,SNY,GNVA,LIFE", "This Could Be the Next Big Pharma Buyout", "Opko Health Inc.: FDA Denial Won\u2019t Kill OPK", "3 Biotech Stocks You Don't Have to Babysit", "Noteworthy ETF Outflows: SPY, JNJ, UNH, AMGN", "Last Week's Best Healthcare ETF", "The Zacks Analyst Blog Highlights: Gilead, Amgen, Regeneron, Ionis and Biogen", "4 Surging Stocks Brokers Love in the Healthcare Sector", "9 Things You Need to Know About Biosimilar Drugs", "3 Biotech Stocks That Make the Grade for Investors", "Gilead & Biogen's Patent Woes, Amgen Scores Win in Patent Litigation", "J&J, Roche Tie Up to Study Dual Immunotherapy Combination", "Stock Market News for March 22, 2012", "Gilead and 4 Other Buy Stocks in the Biotech Industry", "Biogen Inc. vs. Amgen: Which Big Biotech Is the Smarter Buy Today?", "Forget CVS Health Corp.: Here Are 2 Better Dividend Stocks", "UCB and Amgen Report Positive Data on Osteoporosis Drug", "Regeneron/Sanofi Report Positive Phase III Data on Praluent", "Amgen, Inc.: AMGN Stock Looking to Break Out", "Kite Collaborates with Roche for Immunotherapy Cocktail", "How Risky Is Opko Health Inc. Stock?", "Zacks Industry Outlook Highlights: Valeant, Pfizer, Amgen and Biogen", "Amgen Wins PCSK9 Lawsuit, Sanofi and Regeneron to Appeal", "Why Investors Should Sell These Biotech Stocks & Buy Gilead Instead", "Biotech Investing Guide: 3 Stocks to Buy and 3 to Avoid", "This Big Biotech ETF Faces a Key Technical Test", "Amgen, Inc.: AMGN Stock Looking to Break Out", "AbbVie's Boehringer Deal to Boost Immunology Pipeline", "What's in Store for TrovaGene (TROV) in Q4 Earnings?", "The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Gilead Sciences, Biogen, Amgen and Regeneron Pharmaceuticals", "Eli Lilly's Ixekizumab Positive in Plaque Psoriasis Studies", "What Does Trump's Healthcare Plan Mean for Investors?", "3 Reasons Novartis Stock Could Rise", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for March 14, 2016", "The Zacks Analyst Blog Highlights: Gilead, Amgen, Baxalta, PTC Therapeutics and Cara Therapeutics", "Amgen Seeks FDA Approval for Blincyto's Label Expansion", "Biotech Stock Roundup: Gilead HIV Drug Approved, Baxalta in Immuno-Oncology Deal", "Kite Pharma Q4 Loss Wider but Focus Remains on KTE-C19", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for March 02, 2016", "Did Amgen's Experimental Osteoporosis Drug Just Whiff at the Plate?", "The Zacks Analyst Blog Highlights: Catalyst Pharma, PTC Therapeutics, Radius Health, Amgen and Celgene", "Daily Dividend Report: GD, AVGO, AMGN, PXD, HES, HRB", "Biotech Stock Roundup: PTCT Plunges on \"RTF\" from FDA, Radius Shoots Up on Amgen Data", "The Zacks Analyst Blog Highlights: Amgen, CVR Refining, Essex Property Trust, Avalonbay Communities and Willis Towers Watson", "5 Must-See Comments From Amgen's Top Executives", "Amgen & UCB's Romosozumab Positive in Late-Stage Study", "Health Care Sector Update for 02/22/2016: UNIS,AMGN,TRVN,CMRX", "Midday Update: Oil Lifts Dow to Seven-Week High, Energy Stocks Lead Broad-Based Rally for Markets", "Why Radius Health Inc. is Screaming Higher Today", "Kite (KITE) to Report 4Q Earnings: What's in Store?", "AstraZeneca Zurampic Gets EU Nod, Brilique Label Expanded", "Better Buy: Gilead Sciences Inc. vs. Amgen Inc.", "IWV, ORCL, AMGN, CVS: Large Outflows Detected at ETF", "Can Biotech Stocks Bounce Back?", "New Strong Buy Stocks for February 18th", "AstraZeneca Cancer Drug Gets Breakthrough Therapy Status", "Health Care Sector Update for 02/16/2016: AMGN, CPHR", "5 Beaten Down Stocks with Strong Dividend Yields", "Amgen's Aranesp Meets Primary Endpoint in Phase III Study", "Gilead Sciences Wants to Make Being a Shareholder Worth It", "Novartis Filing for Neulasta Biosimilar Accepted in the EU", "This FDA Panel Decision Just Changed the Game", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 11, 2016", "Pfizer's Biosimilar of Remicade Recommended for Approval", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for February 10, 2016", "Novartis Acquires Rights to Biosimilar of Remicade from Pfizer", "Ligand Pharmaceuticals (LGND): Q4 Earnings Preview", "Biogen Inc. Takes Aim at Johnson & Johnson", "Amgen's Blincyto and Repatha Positive in Phase III Studies", "Will 2016 Be Amgen Inc.'s Best Year Yet?", "Noteworthy ETF Outflows: IUSG, AMGN, UNP, RAI", "Why NantKwest Shares Fell 41% in January", "Company News for February 01, 2016", "Biotech ETFs Slide as Stocks Report Mixed Q4 Results", "Biotech Billionaire Launches His Most Auspicious Project Yet", "Where to Invest Money in 2016: 7 Great Ideas", "AbbVie: There Ain't No Stinkin' Biosimilar Threat", "Amgen's Q4 Crushed Estimates and Answered 3 Important Questions in the Process", "The Zacks Analyst Blog Highlights: Amazon.com, Microsoft, Visa, Skyworks Solutions and Amgen", "Amgen Tops on Q4 Earnings & Revenues, Ups 2016 Outlook", "Biotech ETF (IBB) Hits New 52-Week Low", "3 Biotech Stocks You Don't Have to Babysit", "Q4 Pedal to the Metal: AMZN, MSFT, V & More", "Amgen (AMGN) Beats Q4 Earnings, Revenue Estimates", "Celgene Corporation Looks Forward", "Earnings Reaction History: Amgen Inc., 70.0% Follow-Through Indicator, 3.2% Sensitive", "After-Hours Earnings Report for January 28, 2016 : MSFT, AMZN, V, AMGN, EA, SWKS, WDC, KLAC, EMN, CPT, FLEX, N", "3 Key Numbers to Monitor When Amgen Reports Fourth-Quarter Results", "Amgen's Biosimilar of AbbVie's Humira under FDA Review", "Top Biotechs for 2016", "Q4 Pedal to the Metal: AMZN, MSFT, V & More", "Amgen (AMGN) Beats Q4 Earnings, Revenue Estimates", "Celgene Corporation Looks Forward", "Amgen Presents Encouraging Phase III Data on Vectibix", "Novartis (NVS) to Report Q4 Earnings: Will It Disappoint?", "Last Week's Best Healthcare ETF", "Amgen Kyprolis' Label Expanded, Repatha Approved in Japan", "3 Healthcare Stocks You Don't Have to Babysit", "The Weekly Play: Sell Calls on This Sector (IBB)", "Biotech Stock Roundup: Sarepta Plunges on Briefing Documents, Acorda to Buy Biotie", "3 Slides That Perfectly Sum Up Where AbbVie Is Headed Next", "Biogen's (BIIB) Biosimilar of Amgen's Enbrel Gets EU Nod", "The Best Healthcare ETF of the Week", "AbbVie's Management Just Made Some Pretty Bold Predictions", "7 Battered Biotech Stocks: Bargains or Busts?", "5 Burning Questions We Want Answered When Johnson & Johnson Reports Its Q4 Results", "5 Slides That Tell You Everything You Need to Know About Amgen", "3 Stocks with Better Dividends Than CVS Health Corporation", "Coherus Biosciences and Baxalta Take Aim at Amgen and Pfizer", "4 Great Retirement Stocks to Buy in 2016", "Agree To Buy Amgen At $95, Earn 5.7% Using Options", "The Zacks Analyst Blog Highlights: AbbVie, Amgen, Ligand Pharmaceuticals, Revance Therapeutics and Exelixis", "Stocks, Mutual Funds Rose In Q4 Despite Dec. Woes", "Was Celgene Corporation's Bad News Really That Bad?", "IUSG, AMGN, UNH, CELG: Large Outflows Detected at ETF", "Biotech Stock Roundup: MannKind Tanks on Deal Termination, Speedy Review for Gilead Drug", "DoctoRx Positions For 2016: My No. 1 Risk Factor Is The Flood Of Money Into Biotech", "Why Amgen is a Top 25 Dividend Giant (AMGN)", "Midday Update: Stocks Unravel on Global Growth Concerns; Mid-East Tensions, Soft U. S. Data Also Weigh on Markets", "Mid-Morning Market Update: Markets Open Lower; Tesla Motors Delivers 17,400 Vehicles in Fourth Quarter", "Stock Futures Fall as Chinese Manufacturing Slows, Mid-East Tensions Escalate", "5 Biotech Stocks That Doubled in 2015", "IUSG, AMGN, UNH, CELG: Large Outflows Detected at ETF", "What Does 2016 Hold for Biotech Stocks?", "Alan Fournier Sells GM, Buys Molson Coors Brewing", "The Biggest Healthcare Headlines of 2015", "Will 2016 Be Johnson & Johnson's Best Year Yet?", "Will Amgen Inc. Raise Its Dividend in 2016?", "AMGN Named A Top Socially Responsible Dividend Stock", "Health Care Sector Update for 01/04/2016: AMAG,UNIS,MYMX", "Tuesday's ETF Movers: VPL, ECON", "Notable ETF Outflow Detected - IWB, AMGN, MA, ABBV", "Celgene Corporation's Best Drug in 2015", "Enzon Pharmaceuticals, Inc. (ENZN) Ex-Dividend Date Scheduled for December 30, 2015", "What Happened in Biotech in 2015?", "The Worst Regeneron Pharmaceuticals, Inc. Headlines in 2015", "Biotech Industry Could Offer Early Profit in 2016", "Ligand (LGND) Upgraded to Buy, Perfect for Your Portfolio", "Biotech Stock Roundup: KaloBios Removes CEO Shkreli, Actelion PAH Drug Approved", "Pfizer Inc.'s Biggest Disappointment in 2015", "Baxalta/Momenta's Humira Biosimilar Meets Trial Objective", "9 Great Dividend-Paying Stocks for 2016", "Why Aegerion Pharmaceuticals' Stock Bolted Higher Today", "5 Can't-Miss Drug Approvals of 2015", "Stock Market News for December 17, 2015", "The Zacks Analyst Blog Highlights: Actelion, Amgen, Gilead, AbbVie and BioMarin", "The Best Amgen Inc. Headlines in 2015", "The Zacks Analyst Blog Highlights: Amgen, ARIAD, Clovis Oncology, Regeneron and Akebia Therapeutics", "4 Top Dividend Plays To Help Cure Stock Price Blues", "Big Biotech Amgen Facing Pivotal Year In 2016", "Instant Analysis: Amgen Cranks Dividend 27% Higher", "Biotech Stock Roundup: Amgen Hikes First Quarter Dividend, ARIAD Lowers Iclusig Outlook", "Amgen Returns More to Shareholders, Hikes Dividend by 27%", "Company News for December 17, 2015", "Amgen (AMGN) Shares Cross Above 200 DMA", "Did CVS Health Just Make a Huge Mistake?", "Amgen Regains Rights to Prolia, Xgeva & Vectibix from Glaxo", "The Best Johnson & Johnson Headlines in 2015", "Why Akebia Therapeutics Shares Soared 10% Today", "Top FDA Drug Approvals in 2015: High Cholesterol", "IBB, AMGN, REGN, BIIB: Large Outflows Detected at ETF", "Daily Dividend Report: AMGN, CVS, BEN, MCO, USB, GIS, SRE, O", "Merck and Eli Lilly Expand Immuno-Oncology Collaboration", "3 Attractive Income Stocks Whose Dividends Could Double", "Aegerion Pharmaceuticals Lost a Third of Its Value in November: Time to Buy?", "Novartis??? Biosimilar for Pfizer???s Enbrel Accepted in the EU", "Health Care Sector Update for 12/09/2015: CHRS,AMGN,AEZS,AEZ.TO", "The Top 3 Drug Approvals of 2015", "Amgen Seeks Kyprolis Label Expansion, Inks Deals with Merck", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for December 14, 2015", "Health Care Sector Update for 12/04/2015: PTLA, GALE, AMGN", "PowerShares Dynamic Pharmaceuticals Portfolio Experiences Big Inflow", "The Zacks Analyst Blog Highlights: Repros Therapeutics, AbbVie, Amgen, XOMA and Gilead", "Foamix Pharmaceuticals Ltd Hopes to Profit From Eli Lilly's and Amgen's Side Effect", "Stock Market News for December 02, 2015", "Biotech Stock Roundup: Repros Tanks on CRL, AbbVie Multiple Myeloma Drug Approved", "Stock Market News for December 04, 2015", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for December 02, 2015", "Amgen Inc. Takes Aim at AbbVie Inc.", "What Healthcare Dividend Stock Is Best?", "The Zacks Analyst Blog Highlights: BioMarin, Amgen, Vertex, Gilead, Biogen and Repros", "Amgen Seeks FDA Approval for First Biosimilar of Humira", "Biotech Stock Roundup: KaloBios Soars as Shkreli Steps In, FDA Panel Not Convinced about BioMarin Drug", "Johnson & Johnson's Latest FDA Approval Could Spell Problems for Amgen", "CVS Health Plays Favorites with New Cholesterol Drugs", "Amgen's Repatha Gets Preferred Position on CVS Formularies", "IYH, AMGN, CELG, LLY: ETF Outflow Alert", "Relevance of Portfolio Holdings: 3 Concentrated Funds to Buy & Sell", "5 Things Amgen, Inc. Wants You to Know", "The Best Healthcare ETF of the Week", "Better Dividend Stock: Amgen or AstraZeneca PLC?", "Amgen's Multiple Myeloma Drug Kyprolis Gains EU Approval", "Healthcare's Greatest Dividend Stocks", "Novartis: FDA Accepts BLA for Biosimilar Version of Neulasta", "3 Biotech Stocks You Don't Have to Babysit", "AMGN Crosses Above Key Moving Average Level", "PRIMECAP Sells Stake in Technology Company", "These 2 Companies Could Revolutionize Heart Disease Prevention", "A Bounty of Data Pushes Amgen Higher by 14% in October", "IBB, REGN, AMGN, CELG: ETF Outflow Alert", "Amgen's Repatha Is Too Bloody Pricey for the U.K.", "4 Observations You May Have Overlooked in Celgene's Q3 Earnings Report", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 12, 2015", "5 Biotech Stocks with Good Growth Prospects", "Why Aegerion Pharmaceuticals Is Crashing Today", "Kite (KITE) to Report 3Q Earnings: What's in Store?", "7 Cash-Rich Stocks to Buy Now", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for November 10, 2015", "Kite Pharma (KITE) Posts Narrower Than Expected Loss in 3Q", "What Does 2016 Hold for This Closely-Watched Biotech ETF?", "Insulet Delivers Healthy Q3 Revenue Growth; Stock Pumps Up 14%", "Biotech Sees Better-than-Expected Earnings: ETFs in Focus", "Gilead and 2 Biotech Picks Value Investors Will Love", "Amgen (AMGN) Shares Cross 2% Yield Mark", "IBB, CELG, REGN, AMGN: Large Inflows Detected at ETF", "The Zacks Analyst Blog Highlights: AbbVie, Amgen, Dyax, Repros and Gilead", "Health Care Sector Update for 11/09/2015: KPTI, AMGN", "What Awaits Ligand Pharmaceuticals (LGND) in Q3 Earnings?", "Celgene Corporation Mixed Bag of Earnings", "Biotech Stock Roundup: AbbVie's Humira Remains Strong, Shire to Buy Dyax", "What to Expect From Celgene Corporation's Earnings Report", "4 Questions to Ask Ahead of Celgene's Q3 Report", "10 Stocks with 10% Plus Gains in October", "Amgen Clobbers Estimates in Q3 Thanks to New Drug Growth, but 1 Portfolio Segment Clearly Disappoint", "Focus on Health Care Savings: 5 Generic Drug Stocks to Buy", "Amgen Ups 2015 Outlook with Q3 Earnings & Revenue Beat", "United Therapeutics Beats on Q3 Earnings, Revenues", "Agenus Q3 Loss Wider than Expected, Pipeline in Focus", "Biotech Stock Roundup: Biogen Tops Estimates, FDA Approves Alexion's Strensiq", "Amgen (AMGN) Stock Climbing on Q3 Earnings and Revenue Beat", "Earnings Reaction History: Amgen Inc., 80.0% Follow-Through Indicator, 3.1% Sensitive", "After-Hours Earnings Report for October 28, 2015 : AMGN, PSA, SU, VRTX, WMB, ORLY, NXPI, MAR, WPZ, EQIX, LNC, TSO", "Noteworthy ETF Inflows: IBB, AMGN, CELG, REGN", "Midday Update: Stocks Slump as Economic Data Disappoints, Oil Drops, FOMC Looms", "Bristol-Myers Beats on Q3 Earnings, Guidance Encouraging", "Aegerion (AEGR) Q3 Earnings Preview: What's in the Cards?", "Spectrum (SPPI) Initiates Phase III on Apaziquone Under SPA", "BioDelivery/Endo Up on FDA Approval of Pain Drug Belbuca", "Amgen Breaks Above 200-Day Moving Average - Bullish for AMGN", "5 Things Amgen Investors Want to Know When It Reports Its Q3 Results", "Novartis (NVS) Misses on Q3 Earnings, Maintains 2015 View", "Midday Update: Stocks Slump as Economic Data Disappoints, Oil Drops, FOMC Looms", "Bristol-Myers Beats on Q3 Earnings, Guidance Encouraging", "Acorda Up on Q3 Earnings & Revenue Beat, Ampyra in Focus", "Spectrum Pharmaceuticals' Evomela Gets CRL in the U.S.", "Foamix Starts Patient Enrollment in Phase II Study on FMX103", "Battle Royale: Amgen Inc. vs. Biogen Inc.", "Exelixis Starts Cometriq Rolling NDA Filing for Kidney Cancer", "Will Express Scripts (ESRX) Surprise Q3 Earnings Estimates?", "Relypsa's Hyperkalemia Drug Veltassa Approved in the U.S.", "Stock Market News for October 22, 2015", "The Zacks Analyst Blog Highlights: Altria, Nike, Apple, Amgen and Home Depot", "Biogen Tops Q3 Earnings, Announces Job Cuts, Ups View", "IVV, PFE, UNH, AMGN: Large Inflows Detected at ETF", "Stock Market News for October 21, 2015", "Illumina Tops Q3 Earnings, Meets Revenues; '15 View Cut", "eBay's (EBAY) 1st Earnings without PayPal: What's in Store? (revised)", "Kite (KITE) KTE-C19 Endorsed for EU Orphan Status Yet Again", "Stock Market News for October 20, 2015", "Texas Instruments (TXN) Q3 Earnings: What to Expect?", "Eli Lilly's Failure Is a Success for These Companies", "Will Tecfidera Slowdown Hit Biogen (BIIB) Earnings in Q3?", "Is Lilly (LLY) Poised to Beat Earnings Expectations in Q3?", "Zafgen Continues to Fall; Partial Clinical Hold on Beloranib", "Go Back to the Future with These 5 Market Crushing Stocks", "Will Currency Hit Abbott Laboratories (ABT) in Q3 Earnings?", "Will Hubbell (HUB-B) Disappoint Earnings Estimates in Q3?", "The 5 Best Bargains in the Stock Market", "3 Blue-Chip Biotech Stocks Worth Buying for the Long Haul", "CMS Hikes Medicare Rate for Genomic's Breast Cancer Test (Revised)", "Cellectis S.A. (CLLS) Jumps: Stock Adds 7.6% in Session", "The FDA Turns Pfizer Away, but Few Are Surprised", "What's in Store for Morningstar (MORN) in Q3 Earnings?", "Medicare Initiates Coverage on Genomic Prostate Cancer Test", "5 Immunotherapy Stocks to Watch for Treating Cancer", "What to Expect from Lam Research's (LRCX) Q1 Earnings?", "eBay's (EBAY) 1st Earnings without PayPal: What's in Store?", "Will Nielsen's (NLSN) Earnings Disappoint Estimates in Q3?", "Daily Dividend Report: AMGN, WBA, UTX, CAT, AON, WY, CF", "Breaking Down Biotech's Bloodbath: Which Companies to Buy", "Will Nielsen's (NLSN) Earnings Disappoint Estimates in Q3?", "Zafgen Reports Patient Death in Late-Stage Beloranib Study", "Stock Market News for October 14, 2015", "Vital Therapies (VTL) Looks Good: Stock Jumps 12.2%", "5 Stocks Searching for a Cancer Cure Right Now", "Theravance (TBPH) Advances TD-0714, Submits IND to FDA", "IYH, PFE, UNH, AMGN: ETF Inflow Alert", "Hooker Furniture, Yum! Brands, Amgen and Astra Zeneca highlighted as Zacks Bull and Bear of the Day", "BioDelivery's Bunavail Supply Hit by Specification Issues", "Alimera Sciences (ALIM) in Focus: Stock Rises 12.3%", "Lilly (LLY) Halts CETP Inhibitor Development, Shares Tumble", "Celgene (CELG) Posts Encouraging One-Year Data on Otezla", "Alexion (ALXN) Presents Positive 5-Year Data on Strensiq", "CMS Hikes Medicare Rate for Genomic's Breast Cancer Test", "New Strong Buy Stocks for October 12th", "Will Currency Play Spoilsport with J&J's (JNJ) Q3 Earnings?", "Osiris Therapeutics, Inc. (OSIR) Ex-Dividend Date Scheduled for October 14, 2015", "Amgen Was Clobbered in September -- Here's Why", "Stock Market News for October 08, 2015", "The Zacks Analyst Blog Highlights: Amgen, Regeneron, Acorda, Amicus and AbbVie", "3 Pharma Stocks With Big Margins of Safety", "Cholesterol Busters Will Be Cheaper but Remain Top Sellers", "Stock Market News for October 07, 2015", "The Zacks Analyst Blog Highlights: CVS Health, Amgen, Eli Lilly, AbbVie and Teva Pharmaceutical", "Winners and Losers of Eli Lilly's CETP Drug Failure", "Amgen Was Clobbered in September -- Here's Why", "Stock Market News for October 08, 2015", "Infinity (INFI) Updates on Duvelisib and IPI-549 on R&D Day", "4 Pharma Stocks Gaining from High Pricing Power", "Who Wins and Loses with the TPP?", "Merck's (MRK) All-Oral Ribavirin-Free HCV Data Published", "Amgen Turning the Tables on 'Generic' Competition", "Express Scripts Includes Praluent and Repatha in Formulary", "The Medicines Co. Ties Up with SymBio for Ionsys in Japan", "3 Rock-Solid Dividend Stocks You Can Buy Right Now", "Amgen Is In Novartis' Crosshair", "Health Care Sector Update for 10/02/2015: CHRS,AMGN,XNPT,FOLD", "Can You Guess Which Surprising Company Is Trying to Become a Cardiovascular Drug Giant?", "Stock Market News for October 01, 2015", "Baxalta, Momenta Begin Pivotal Study on Biosimilar of Humira", "The Zacks Analyst Blog Highlights: Express Scripts, AbbVie, Amgen, Anika Therapeutics and PDL BioPharma", "Esperion Plunges on FDA Advice for Cardiovascular Study", "Ligand, SAGE Captisol Partnership to Also Include SAGE-689", "Clovis' Rociletinib under Review in U.S., EU for Lung Cancer", "Buy 3 Compelling Biotech Stocks at Bargain Prices", "The Zacks Analyst Blog Highlights: Fitbit, Hain Celestial Group, Nautilus and Amgen", "4 Fit & Healthy Stocks to Love on World Heart Day", "Pfizer Raises 2015 Outlook on Hospira Acquisition, Shares Up", "Regeneron/Sanofi's PCSK9 Inhibitor Praluent Approved in EU", "The Price War for New Cholesterol Drugs Is Heating Up", "IYH, PFE, UNH, AMGN: Large Inflows Detected at ETF", "Stock Market News for September 25, 2015", "Health Care Sector Update for 09/25/2015: NAVB, BIIB, AMGN", "Amgen Becomes Oversold", "The Zacks Analyst Blog Highlights: Juno, Amgen, Gilead, Intra-Cellular and TRACONThe Zacks Analyst Blog Highlights: Juno, Amgen, Gilead, Intra-Cellular and TRACON", "Stock Market News for September 28, 2015", "Amgen Gets a Step Closer to a Multibillion-Dollar Market", "Amgen, Allergan's Biosimilar of Avastin Tops Phase III Study", "Biotech Stock Roundup: Clinton's Tweet Shakes Biotech Stocks, Amgen In Pipeline-Boosting Deals", "Amgen's Billion-Dollar Cholesterol-Curbing Bet", "5 Biotech Stocks Hit Hard by Hillary Clinton's Tweet", "Amgen's Kyprolis Label Expansion Under Priority Review", "3 Stocks Battling Heart Disease: 2 to Buy, 1 to Sell", "Will the FDA Approve All 3 of These Cancer Drugs in October?", "Amgen Gets a Step Closer to a Multibillion-Dollar Market", "Amgen, Allergan's Biosimilar of Avastin Tops Phase III Study", "Biotech Stock Roundup: Clinton's Tweet Shakes Biotech Stocks, Amgen In Pipeline-Boosting Deals", "Which Biotech Blue-Chip Stock Is the Best Buy?", "Amgen Seeks FDA Approval for Repatha's New Dosing Option", "Will Kite (KITE) Get Orphan Status Again in EU for KTE-C19?", "These 3 Numbers Say Amgen Inc. Is Cheap", "Yellen Doesn't Raise Rates: 4 Biotech Stocks to Buy", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 14, 2015", "Better Buy: Amgen, Inc or Regeneron Pharmaceuticals Inc?", "The Zacks Analyst Blog Highlights: Amgen, Tetraphase, Geron, Alexion and ACADIA", "Biotech Stock Roundup: Biosimilar Competition for Amgen, Tetraphase Hit By Disappointing Data", "Attention Biotech Investors: Biosimilars Are Finally Here!", "You Don't Have to Wait for the Next Big Thing in Biotech -- It's Already Here", "Biotech Blue-Chip Amgen Took a Drubbing Last Month -- Here's Why", "Noteworthy ETF Outflows: PJP, MDCO, AMGN, AGN", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 14, 2015", "Notable ETF Outflow Detected - XLV, GILD, AGN, AMGN", "Amgen's Next-Generation Cholesterol Drug Is Approved, but Pricing Is a Huge Concern", "Biotech Stock Roundup: Amgen in the News, ARIAD a Takeover Target?", "Amgen, Novartis Team Up; Bone Drug Positive in Phase III", "Regeneron and Sanofi Present Encouraging Praluent Data", "PCSK9 Drugs Are Here (and Way Over There)", "Amgen Inc.'s FDA Approval Holds Blockbuster Potential", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for September 02, 2015", "A Word of Advice for Amgen: Objects in the Mirror Are Closer Than They Appear", "Alnylam Presents Positive Data on PCSK9 Synthesis Inhibitor", "Amgen's PCSK9 Inhibitor, Repatha, Approved in the U.S.", "The Zacks Analyst Blog Highlights: Vital Therapies, Amgen, BioMarin, Acorda and Macrocure", "Biotech Stock Roundup: Acorda Gains on Patent Issues, Vital Crushed by Liver Data", "AstraZeneca Strikes Deal with Valeant for Psoriasis Drug", "Amgen Inc.'s FDA Approval Holds Blockbuster Potential", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for September 02, 2015", "A Word of Advice for Amgen: Objects in the Mirror Are Closer Than They Appear", "Alnylam Presents Positive Data on PCSK9 Synthesis Inhibitor", "Is Esperion's Good News Actually Bad?", "Kite Pharma Provides Update, Death Not Related to KTE-C19", "iShares U.S. Healthcare ETF Experiences Big Inflow", "XLV, GILD, AGN, AMGN: Large Outflows Detected at ETF", "Why Eli Lilly (LLY) was a Bright Spot in the Market on Thursday", "Notable Two Hundred Day Moving Average Cross - AMGN", "This Is a Concern That Amgen Investors Shouldn't Take Lightly", "Biotech Stock Roundup: Kite Addresses Patient Death Concerns, Omeros Soars on Data", "Is Esperion's Good News Actually Bad?", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for August 13, 2015", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 13, 2015", "Better Dividend Stock: Gilead Sciences Inc. vs. Amgen Inc.", "Is CVS Health's Anti-Tobacco Strategy Paying Off?", "Health Care Select Sector SPDR Fund Experiences Big Inflow", "Will Kite Pharma (KITE) Miss Earnings Estimates Yet Again? - Analyst Blog", "The Zacks Analyst Blog Highlights: Amgen, Vertex, Regeneron, Baxalta and VIVUS - Press Releases", "3 Reasons Behind Amgen's 15% Gain in July", "Aegerion's Loss Narrower than Expected, View Maintained - Analyst Blog", "Biotech Stock Roundup: Baxalta Rejects Shire Bid, Amgen's Beat & Raise Quarter - Analyst Blog", "Kite Pharma 2Q Loss Wider Than Expected, Pipeline in Focus - Analyst Blog", "Mixed Biotech Earnings put These ETFs in Focus - ETF News And Commentary", "Will Ligand Pharmaceuticals (LGND) Beat Earnings in Q2? - Analyst Blog", "Nasdaq 100 Movers: WFM, AMGN", "Amgen Beats on Q2 Earnings & Revenues, Raises Outlook - Analyst Blog", "Amgen Crushes Wall Street's Expectations in Q2, But This Figure Is a Bit Worrisome", "FBT, AMGN, TECH, NKTR: ETF Inflow Alert", "The Zacks Analyst Blog Highlights: Biogen, AbbVie, Regeneron, Amgen and XOMA - Press Releases", "What Company Will Be Fastest Growing Big-Cap Biotech?", "Even With Recent Declines, Investors Still Love Biotech ETFs", "After-Hours Earnings Report for July 30, 2015 : AMGN, BRCM, LNKD, EA, EIX, ESS, HBI, UHS, EXPE, WU, MTD, DLR", "Earnings Reaction History: Amgen Inc., 70.0% Follow-Through Indicator, 2.9% Sensitive", "Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst Blog", "Merck Tops on Q2 Earnings & Revenues, Revises Outlook - Analyst Blog", "Nasdaq 100 Movers: BIDU, AMGN", "Will Amgen (AMGN) Keep the Earnings Streak Alive in 2Q? - Analyst Blog", "Key Takeaways from Amgen's (AMGN) Q2 Earnings Report - Stocks in the News", "Even With Recent Declines, Investors Still Love Biotech ETFs", "After-Hours Earnings Report for July 30, 2015 : AMGN, BRCM, LNKD, EA, EIX, ESS, HBI, UHS, EXPE, WU, MTD, DLR", "Regeneron Pharmaceuticals and Sanofi Grab a Blockbuster FDA Approval", "A Big Day For Biotech And It's Not Going So Well", "Shire's (SHPG) Q2 Earnings Lag Estimates, 2015 View Raised - Analyst Blog", "AMGN Dividend Yield Pushes Past 2%", "Forget Biogen, Buy These Promising Biotech Stocks Instead - Analyst Blog", "Biotech Stock Roundup: Amgen PCSK9 Inhibitor First to Gain Approval, Exelixis Up on Positive Data - Analyst Blog", "2015\u2019s Top 6 Big Pharma Headlines Thus Far", "Amgen's Repatha Gains EU Nod; First PCSK9 Drug Approved - Analyst Blog", "Amgen Inc. Grabs a Potential Blockbuster Approval", "QLD, ALXN, AAL, AMGN: ETF Outflow Alert", "Amgen Popular Amongst Latest 13F Filers", "Will Abbott Laboratories (ABT) Miss Earnings This Season? - Analyst Blog", "The Zacks Analyst Blog Highlights: Amgen, Exelixis, Regeneron, Five Prime Therapeutics and AbbVie - Press Releases", "Biotech Stock Roundup: Amgen PCSK9 Inhibitor First to Gain Approval, Exelixis Up on Positive Data - Analyst Blog", "2015\u2019s Top 6 Big Pharma Headlines Thus Far", "Noteworthy Wednesday Option Activity: CAT, CSX, AMGN", "Amgen Breaks Above 200-Day Moving Average - Bullish for AMGN", "Stock Market News for July 14, 2015 - Market News", "iShares Russell 1000 ETF Experiences Big Inflow", "$1.5 Trillion Reasons to Invest in These Companies", "Amgen Reports Positive Data on Leukemia Drug Blincyto - Analyst Blog", "Health Care Sector Update for 07/09/2015: MYL, REGN, AZN", "Amgen's Single Most Important FDA Decision of 2015 Is Nearly Here", "Allergan Buys Rights to Merck's Migraine Drugs for $250M - Analyst Blog", "Are Biotechs In A Bubble?", "Nasdaq 100 Movers: BIDU, AAL", "2 Dividend Stocks to Buy in a Market Crash", "IBB, CELG, AMGN, REGN: Large Inflows Detected at ETF", "Regeneron and Sanofi Report Positive Data on Praluent - Analyst Blog", "Stock Market News for June 30, 2015 - Market News", "Amgen Among 3 Medical Giants With Healthy Payouts", "The Zacks Analyst Blog Highlights: BioMarin, Vical, Epizyme, Amgen and Medicines Co - Press Releases", "Biotech Stock Roundup: BioMarin Jumps on Dwarfism Data, Vical Plunges on Vaccine Data - Analyst Blog", "Stock Market News for June 23, 2015 - Market News", "Kite Pharma and Bluebird Tie Up for HPV Cancer Targets - Analyst Blog", "ProShares Releases 2 New Leveraged Biotech ETFs", "Stock Market News for July 01, 2015 - Market News", "Stock Market News for June 30, 2015 - Market News", "Nasdaq Composite's New High Built On Solid Growth", "Biotech ETFs Hit New 2015 Highs", "5 Healthcare Stocks for Dividend Lovers", "Stock Market News for June 15, 2015 - Market News", "3 Big Healthcare Trends Wall Street Is Overlooking", "Amgen Presents Interim Data on Migraine Drug AMG 334 - Analyst Blog", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for June 12, 2015", "Merck (MRK) Presents Multiple Biosimilar and Diabetes Data - Analyst Blog", "Why Drugmaker AbbVie Can Power Past Patent Expiration", "Biotech Stock Roundup: FDA Panel Recommends Regeneron's Praluent, SAGE Gains on Data - Analyst Blog", "Stock Market News for June 10, 2015 - Market News", "Regeneron/Sanofi's Praluent Gets Positive FDA Panel Vote - Analyst Blog", "Amgen Breaks Below 200-Day Moving Average - Notable for AMGN", "3 Things AbbVie Inc.'s Management Wants You to Know", "Regeneron/Sanofi's PCSK9 Drug Praluent Set for FDA Panel - Analyst Blog", "Cholesterol Drugs: 3 Stocks to Watch This Week", "These 3 Ultra-Rare Diseases Are Utterly Terrifying", "Biotech Stock Roundup: ImmunoGen Soars on ASCO Data, Amgen Collaborates with Roche - Analyst Blog", "VUG, ORCL, AMGN, ACT: ETF Outflow Alert", "Merck's Keytruda under Priority Review for Lung Cancer - Analyst Blog", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for June 03, 2015", "Amgen's Repatha Briefing Document Gives Mixed Review - Analyst Blog", "Regeneron/Sanofi's PCSK9 Drug Praluent Set for FDA Panel - Analyst Blog", "Cholesterol Drugs: 3 Stocks to Watch This Week", "Investing for Beginners: How to Start in Biotech", "Amgen Inc: Why You Shouldn't Count Chickens Before They Hatch", "PRIMECAP Sells Portions of Its Top Two Stakes", "Actavis to Continue Selling Namenda IR under Court Ruling - Analyst Blog", "VUG, ORCL, AMGN, ACT: ETF Inflow Alert", "Roche Collaborates with Amgen for Immuno-Oncology - Analyst Blog", "AstraZeneca, Amgen End Psoriasis Drug Brodalumab Deal - Analyst Blog", "Healthcare Investment Opportunities for the Long Term", "Health Care Sector Update for 05/22/2015: SRPT, AMGN, MRK", "Stock Market News for May 21, 2015 - Market News", "J&J (JNJ) to File for More than 10 New Products by 2019 - Analyst Blog", "Forget MannKind Stock's Price: Here's What You Need to Focus on Instead", "Amgen's PCSK9 Inhibitor a Step Closer to EU Approval - Analyst Blog", "The Best Business Model in Biotech", "2 Stocks With Jaw-Dropping Growth Potential", "XLV, PFE, ACT, AMGN: ETF Inflow Alert", "Amgen Announces Positive Results on Migraine Candidate - Analyst Blog", "Will Kite Pharma (KITE) Miss Earnings Estimates Yet Again? - Analyst Blog", "The \"Best of Breed\" Dividend Stocks", "5 Largest Markets for Pharmaceuticals", "Stock Market News for May 19, 2015 - Market News", "Kite Pharma Narrows Q1 Loss, Misses Estimates; Gives View - Analyst Blog", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 12, 2015", "The Best And Worst ETFs Of The Week Amid Biotech Rebound", "Regeneron Earnings Shine, but All Eyes Are on the Pipeline", "Will Ligand Pharmaceuticals (LGND) Miss on Q1 Earnings? - Analyst Blog", "Beyond Pharma: 3 Healthcare Choices - Analyst Blog", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for May 13, 2015", "Biotech's Blue Chip Stocks", "The Zacks Analyst Blog Highlights: Amgen, Celladon, Kite Pharma, Pharmacyclics and Vertex Pharmaceuticals - Press Releases", "The Zacks Analyst Blog Highlights: Amgen, Celladon, Biogen, Celgene and Gilead - Press Releases", "Express Scripts Issues Upbeat Outlook Despite Shifting Competitive Landscape", "3 Stable Large-Cap Biotech Stocks to Buy Now - Analyst Blog", "The Zacks Analyst Blog Highlights: Celladon, Amgen, Biogen and Alnylam Pharmaceuticals - Press Releases", "Celldex 1Q Loss Narrower-Than-Expected, Pipeline in Focus - Analyst Blog", "Acorda Posts 1Q Loss, Ampyra Generic Challenges in Focus - Analyst Blog", "Biotech's Blue Chip Stocks", "The Zacks Analyst Blog Highlights: Amgen, Celladon, Kite Pharma, Pharmacyclics and Vertex Pharmaceuticals - Press Releases", "Stock Market News for April 28, 2015 - Market News", "Pfizer Beats on Q1 Earnings, Cuts View on Currency Woes - Analyst Blog", "5 Biotech Stocks to Avoid After Monday's Slump - Analyst Blog", "The Internet of Things is About to Solve Biotech's Oldest Problem", "Biotech Bubble Bursting? 3 Stocks I Want to Buy", "Merck (MRK) Beats on Q1 Earnings & Revenues, Ups View - Analyst Blog", "Nasdaq Joins The Record High Club", "Illumina's Earnings Set Positive Tone for Biotech", "Is Amgen Inc.'s Dividend Sustainable?", "The Zacks Analyst Blog Highlights: Amgen, Medicines, Athersys and Alnylam - Press Releases", "Amgen, Inc. Earnings: 4 Things You Probably Overlooked", "Actelion (ALIOF) Beats Q1 Earnings & Revenue Expectations - Analyst Blog", "Amgen Beats on Q1 Earnings & Revenues, Ups Earnings View - Analyst Blog", "Are Biosimilars the Next Big Thing in Biotech?", "Alnylam Reports Positive Patisiran Results, Shares Up - Analyst Blog", "Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys - Analyst Blog", "Earnings Reaction History: Amgen Inc., 80.0% Follow-Through Indicator, 3.3% Sensitive", "Everything Investors Should Know about Amgen Q1 Earnings - Stocks in the News", "After-Hours Earnings Report for April 21, 2015 : AMGN, YHOO, ACE, SYK, YUM, ILMN, DFS, BRCM, CMG, ISRG, VMW, URI", "Oncolytics' Reolysin Gets One More Orphan Drug Status - Analyst Blog", "TrovaGene's (TROV) PCM Data Impresses, Shares Rally - Analyst Blog", "Pfizer's Cancer Drug Meets First Primary Endpoint in Phase III - Analyst Blog", "Will Abbott Labs (ABT) Disappoint on Earnings This Quarter? - Analyst Blog", "The 3 Best Stocks for Investing in Cholesterol Drugs", "Biotech Investors Shouldn't Miss These Stocks This Earnings - Earnings ESP", "Amgen Gets FDA Nod for Chronic Heart Failure Drug Corlanor - Analyst Blog", "3 Biotech Stocks Under $10 with Amazing Growth Prospects - Analyst Blog", "3 Biotech Stocks That May Disappear Before 2020", "Biogen Reports New Data from Acute Optic Neuritis Study - Analyst Blog", "Will Amgen (AMGN) Keep Earnings Streak Alive in 1Q? - Analyst Blog", "Biotech Stock Roundup: Favorable Briefing Documents for MDCO's Kengreal, Alexion Soliris Label Update - Analyst Blog", "J&J Beats on Q1 Earnings, Cuts View on Currency Woes - Analyst Blog", "Alnylam Reports Publication of New Data on Hemophilia Drug - Analyst Blog", "AVEO Upgraded to Strong Buy, Add to Your Portfolio - Analyst Blog", "ARCA biopharma Gains on Fast Track Status for Gencaro - Analyst Blog", "Amgen Upgraded to Strong Buy, Perfect for Your Portfolio - Analyst Blog", "10 Largest Companies by Market Cap in Biotech", "Bayer to Expand Copanlisib Program by Three New Studies - Analyst Blog", "Biotech Stock Roundup: Favorable Briefing Documents for MDCO's Kengreal, Alexion Soliris Label Update - Analyst Blog", "Oncolytics' Reolysin Filed for Gastric Cancer Orphan Status - Analyst Blog", "Halozyme to Advance PEGPH20 Following FDA Meet - Analyst Blog", "Biotech Stock Roundup: Alkermes Drug Fares Well, Targacept Slides on Deal Termination - Analyst Blog", "Could Celgene Corporation Muscle Its Way Past Amgen Inc.?", "Can This Pharma Go From Good to Great?", "Why Smart Money Loves This Biotech Stock", "How Amgen Could Side-Step The Sting of Patent Expiration", "The Zacks Analyst Blog Highlights: Horizon Pharma, Hyperion Therapeutics, Conatus, Amgen and Biogen - Press Releases", "Biotech Stock Roundup: Horizon to Buy Hyperion, Conatus Up on Liver Disease Data - Analyst Blog", "Why Coherus BioSciences Inc. Shares Burst Today", "Amgen's Kyprolis Gets FDA Priority Review for Expanded Use - Analyst Blog", "ProShares Ultra QQQ Experiences Big Outflow", "Hospira Presents Data on Retacrit, an Epogen Biosimilar - Analyst Blog", "5 Freakishly Expensive Cancer Drugs", "The Safest Biotech Bet on the Market", "3 Top Stocks for Obamacare Lovers", "Investors Might Want To Stay Away From This Biotech ETF", "The Zacks Analyst Blog Highlights: Biogen, Prothena, Vertex, Gilead and Amgen - Press Releases", "Amgen (AMGN) Shares Cross 2% Yield Mark", "Biotech Stock Roundup: Biogen Soars on Alzheimer's Data, Gilead HCV Drugs Label Update - Analyst Blog", "Ligand Pharmaceuticals: Biotech's Jack Of All Trades", "Why ImmunoGen Inc. is Soaring Higher Today", "Could These Experimental Drugs Eclipse Harvoni's Historic Launch?", "CELG Stock - Here's Why Celgene Is Worth Snapping Up", "Biotechnology: One of the Last Great Growth Frontiers for Retail Investors", "Amgen Seeks Approval for PCSK9 Inhibitor Repatha in Japan - Analyst Blog", "Dividend Stocks: 2 to Avoid, 1 to Buy", "Drug Spending Is Soaring: 3 Takeaways You Can't Miss", "Notable ETF Inflow Detected - XLV, AMGN, BIIB, CELG", "The Zacks Analyst Blog Highlights: Amgen, Regeneron, Nektar, ACADIA and Pharmacyclics - Press Releases", "This Market Could Grow 6250% in 10 Years", "Regeneron Hits a 52-Week High on Positive Praluent Data - Analyst Blog", "Biotech Stock Roundup: Amgen & Regeneron Shine at ACC, Nektar Drug Disappoints - Analyst Blog", "Zacks Industry Outlook Highlights: Orexigen, MannKind, Amgen, Medivation and Express Scripts - Press Releases", "Esperion Soars on Positive Phase IIb Data on ETC-1002 - Analyst Blog", "Where Is Radius Health Now?", "Zacks Investment Ideas feature highlights: Biogen, Amgen, SPDR S&P Biotech ETF, BioShares Biotechnology Clinical Trials Fund and ProShares Ultra Nasdaq Biotechnology ETF - Press Releases", "Regeneron/Sanofi's PCSK9 Drug Praluent Data Published - Analyst Blog", "Can This Biotech Stock Go from Good to Great?", "Should Gilead Sciences Inc.\u2019s Slowing Growth Concern Investors?", "3 Biotech ETFs Crushing the Market in 2015 - ETF News And Commentary", "Akebia Completes Enrolment in Phase II Renal Anemia Study - Analyst Blog", "Notable ETF Inflow Detected - IWB, QCOM, CVS, AMGN", "Why AbbVie Inc.'s $21 Billion Deal Had To Happen", "3 Cheap Dividend Stocks You Can Buy Right Now", "2 Tiny Biotechs That Could Have Blockbuster Opportunity", "Amgen Presents Encouraging PCSK9 Inhibitor Repatha Data - Analyst Blog", "Daily Dividend Report: GD, TYC, AMGN, DVN, PXD, HES, HRB", "Amgen-Celimmune Tie Up for Autoimmune Disorder Drug - Analyst Blog", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for March 03, 2015", "Amgen's Kyprolis Fares Better than Velcade in Study - Analyst Blog", "Amgen's Kyprolis Under EU Review - Analyst Blog", "Noteworthy ETF Inflows: IYH, MRK, GILD, AMGN", "Amgen Reports Encouraging Late-Stage Data on AMG 416 - Analyst Blog", "Weekly Market Wrap: March 6, 2015", "Billionaire George Soros Just Bought These 3 Stocks: Should You?", "Pssst... Pfizer Just Told Investors That This is the Next Big Thing", "3 Biotech Stocks for Short-Term, Bullish Trades", "$20 Billion Market: What\u2019s the Best Stock to Buy?", "iShares S&P 500 Growth ETF Experiences Big Outflow", "Stock Market News for February 18, 2015 - Market News", "Why Cytokinetics Inc. Shares Soared Today", "The Nasdaq-100 Turns 30: Tracking Innovation in Large Cap Growth", "1 Sentence That Tells You Everything You Need to Know About Each of These 10 Big Pharma Earnings Rep", "Forget Gilead Sciences: Here Are 3 Better Biotech Stocks", "Amgen's Skin Cancer Drug to Face FDA Advisory Panel - Analyst Blog", "Will Kite Pharma (KITE) Disappoint this Earnings Season? - Analyst Blog", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for February 11, 2015", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 10, 2015", "3 All-or-Nothing Biotech Stocks We're Closely Watching", "Why Shares of Cytokinetics Incorporated Skyrocketed", "Fantastic News: A Revolutionary New Breast Cancer Drug Is on the Way", "Which Biotech Stock Should Pfizer, Inc. Buy?", "Amgen director buys 3,000 shares", "Gilead, Amgen Q4 Earnings & Weak Outlook Affect Biotech ETFs - ETF News And Commentary", "bluebird bio's Thalassemia Drug Gets Breakthrough Status - Analyst Blog", "Biotech Stock Roundup: Biogen Impresses with 4Q Results, Gilead & AbbVie HCV Drugs in Focus - Analyst Blog", "Merck (MRK) Beats on Q4 Earnings but Guidance Falls Short - Analyst Blog", "3 Medical Advancements You May Be Missing Out On", "5 Things Amgen, Inc.'s Management Wants You to Know", "IYH, GILD, AMGN, ABBV: ETF Outflow Alert", "3 Companies with Better Dividends Than Johnson & Johnson", "Can Biotech Duplicate Its 2014 Performance, or Is It Time to Jump Ship?", "Can You Guess What Legal Drug Outsells the NFL?", "3 Biotech Giants That Shouldn't Pay a Dividend", "Big Pharma: An Up-Close Look at One Key Player", "Amgen Reveals Positive Results on Biosimilar Candidate - Analyst Blog", "Pfizer Beats on Q4 Earnings, Guides Below Expectations - Analyst Blog", "Amgen, Inc. Earnings: 1 Sentence That Tells You Everything You Need to Know", "Earnings Reaction History: Amgen Inc., 77.8% Follow-Through Indicator, 3.4% Sensitive", "After-Hours Earnings Report for January 27, 2015 : AAPL, T, AMGN, CNI, YHOO, ACE, SYK, ILMN, WDC, EA, VMW, JNPR", "IYH, AMGN, ABBV, CELG: Large Inflows Detected at ETF", "TrovaGene Partners with Leading Cancer Research Institutes - Analyst Blog", "These 3 Pharmaceutical Companies Control Roughly Half of All Cancer Drug Sales", "Amgen Beats on Q4 Earnings & Revenues, Maintains Outlook - Analyst Blog", "Will Amgen (AMGN) Keep the Earnings Streak Alive in 4Q? - Analyst Blog", "Medivation and Astellas Report TERRAIN Data on Xtandi - Analyst Blog", "UCB's New Epilepsy Drug Under Review in the U.S., EU - Analyst Blog", "Curis Up on Immuno-Oncology Agreement with Aurigene - Analyst Blog", "BioMarin to Raise Funds to Finance Prosensa Acquisition - Analyst Blog", "Novartis' Psoriasis Drug Cosentyx Gets FDA Approval - Analyst Blog", "Keryx to Raise $110 Million Through Issuance of Shares - Analyst Blog", "These 3 Dividend Stocks Could Crush the Market in 2015", "Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinical Hold Lifted - Analyst Blog", "Bristol-Myers Makes Leadership Changes, Names New CEO - Analyst Blog", "Hospira's Plum 36O Infusion System Gets FDA Clearance - Analyst Blog", "Alnylam to Raise $450 Million Through Issuance of Shares - Analyst Blog", "J&J Beats on Q4 Earnings, Revenues Hit by Currency - Analyst Blog", "Can AbbVie Inc. Overcome Humira\u2019s Looming Patent Expiration?", "Novartis' Cosentyx Approved in Europe for Plaque Psoriasis - Analyst Blog", "Affymetrix Hits 52-Week High on Strong Top-Line Growth - Analyst Blog", "Sanofi and Boehringer Ingelheim Ink Strategic Deal - Analyst Blog", "AbbVie Gains EU Approval for Hepatitis C Virus Treatment - Analyst Blog", "How to Invest in an Aging America", "These Stocks' Dividends Could Soar in 2015", "Vanguard Growth ETF Experiences Big Inflow", "Hospira Submits Retacrit Regulatory Application to the FDA - Analyst Blog", "ZIOPHARM, Intrexon Ink CAR T Deal with MD Anderson - Analyst Blog", "Supernus Downgraded as Lead Drugs Face Patent Challenges - Analyst Blog", "Bull of the Day: Amgen (AMGN) - Bull of the Day", "AstraZeneca Announces Encouraging Data from Brilinta Study - Analyst Blog", "7 Things Amgen Corporation's CEO Wants You to Know", "3 Stocks to Buy When the Market Crashes", "Amgen Maintains 2015 View, Expects Several Drug Launches - Analyst Blog", "Biotech Stock Roundup: Shire to Acquire NPSP, Celgene & Pharmacyclics Give Strong Outlook - Analyst Blog", "Illumina Partners Lockheed Martin for Genomics Solutions - Analyst Blog", "Amgen (AMGN) Reveals Mixed Results from Vectibix Studies - Analyst Blog", "Biogen to Acquire Convergence, Expand Pain Pipeline - Analyst Blog", "Aegerion Reveals Preliminary 2014 Results and 2015 Outlook - Analyst Blog", "Regeneron/Sanofi Seek PCSK9 Drug Praluent Approval in EU - Analyst Blog", "Emergent BioSolutions Provides Preliminary 2014 Results - Analyst Blog", "Conatus Announced Results from Emricasan Studies - Analyst Blog", "AMAG Provides 2014 Preliminary Results & 2015 Guidance - Analyst Blog", "Vertex Pharmaceuticals' Kalydeco Remains in Focus in 2015 - Analyst Blog", "Perrigo/Ferrara Candy Ink Supply Deal for Gummy Products - Analyst Blog", "UCB Initiates Phase III Psoriasis Study on Cimzia with Dermira - Analyst Blog", "3 Pharma Stocks That Soared Past Pfizer in 2014 - Analyst Blog", "Novartis' Biosimilar of Neupogen Gets Favorable Opinion - Analyst Blog", "XLV, AMGN, ABBV, BMY: ETF Outflow Alert", "3 Tech Giants Quietly Investing in Synthetic Biology", "Enzon Pharmaceuticals, Inc. (ENZN) Ex-Dividend Date Scheduled for January 08, 2015", "Nasdaq 100 Movers: NXPI, BIIB", "Can You Guess the Most Common Reason People Visit the Doctor?", "Kite Pharma Up on Amgen Cancer Immunotherapy Tie-Up - Analyst Blog", "Prospects For 2014's Best and Worst Performing Sectors", "Amgen Upgraded to Strong Buy; is it in Your Portfolio? - Analyst Blog", "Tekmira Jumped Following Update on its Oncology Candidate - Analyst Blog", "iShares Russell 1000 ETF Experiences Big Inflow", "Teva's Granix Label Expanded to Include Self-Administration - Analyst Blog", "Synthetic Biologics Unveils Top-Line Safety Data on SYN-004 - Analyst Blog", "Company News for January 06, 2015 - Corporate Summary", "Can-Fite Enrols First Patient for a Liver Cancer Study - Analyst Blog", "Stock Market News for December 26, 2014 - Market News", "After Gilead Sciences, Is it Time to Sell Biotech Stocks? - Analyst Blog", "3 Pharma Giants Growing Significantly Faster Than GlaxoSmithKline PLC", "BioLineRx Out-Licences Skin Lesion Treatment Candidate - Analyst Blog", "BioCryst Rises on Positive Ebola Candidate Results - Analyst Blog", "Amgen Named A Top Socially Responsible Dividend Stock", "Kite Pharma Files IND for Non-Hodgkin Lymphoma Drug - Analyst Blog", "Can-Fite Enrols First Patient for a Liver Cancer Study - Analyst Blog", "Gilead Falls on AbbVie and Express Scripts Deal: 3 Biotech ETFs to Watch - ETF News And Commentary", "Achillion Gains on Positive Results from its HCV Candidates - Analyst Blog", "Medivation Licenses CureTech's Cancer Drug Pidilizumab - Analyst Blog", "Amgen (AMGN) Shares Cross 2% Yield Mark", "iShares Russell 1000 Growth ETF Experiences Big Inflow", "Buying These 3 Stocks Is Like Making a Bet in a Burning House", "Cytokinetics Rises After Extending Astellas Agreement - Analyst Blog", "Endo/BioDelivery File Regulatory Application for Pain Drug - Analyst Blog", "Gilead Falls on AbbVie and Express Scripts Deal: 3 Biotech ETFs to Watch - ETF News And Commentary", "Celgene Gets Positive CHMP Recommendation for Revlimid - Analyst Blog", "Why Is George Soros Buying This Beaten Down Biotech Stock?", "Seattle Genetics Initiates Phase Ib Study on Leukemia Drug - Analyst Blog", "Weekly Market Wrap: December 19, 2014", "Agenus Jumps on Positive Data from Shingles Candidate - Analyst Blog", "Orexigen's Obesity Drug Mysimba Gets CHMP Nod - Analyst Blog", "Novartis Successfully Expands Signifor Label in the U.S. - Analyst Blog", "Alkermes Starts Phase I Study on Schizophrenia Candidate - Analyst Blog", "Acorda's Ampyra in Phase III for Post-Stroke Walking Deficit - Analyst Blog", "Is Illumina (ILMN) Worth Adding to Your Portfolio? - Analyst Blog", "OPKO Up on Announcing Global Partnership with Pfizer - Analyst Blog", "Novartis AG and Amgen Inc. Take Aim at Johnson & Johnson", "Halozyme Up on Collaboration and Licensing Deal with J&J - Analyst Blog", "Alnylam Provides Pipeline Update, Growth Strategy - Analyst Blog", "Jazz Pharmaceuticals Starts Defibrotide Rolling NDA Filing - Analyst Blog", "Puma Biotechnology Reveals Positive Interim PB272 Data - Analyst Blog", "Can These Top Dividend-Paying Stocks Soar in 2015?", "Can Pfizer\u2019s Cholesterol Drug Catch Up To The Competition?", "bluebird bio (BLUE) Soars on Data from LentiGlobin Study - Analyst Blog", "Mylan Among First to Launch Generic Celebrex - Analyst Blog", "Alexion's Soliris Receives Orphan Drug Status in Japan - Analyst Blog", "Biotech Stock Roundup: Cubist to be Acquired by Merck, Bluebird Shoots Up on ASH Data - Analyst Blog", "3 Reasons Amgen, Inc. Could Soar in 2015", "Dynavax & AstraZeneca Alter Agreement for Asthma Product - Analyst Blog", "Alnylam Reports Positive Initial Phase I Data on ALN-AT3 - Analyst Blog", "Pharmacyclics Presents Imbruvica Data at the ASH Meeting - Analyst Blog", "Amgen Successfully Expands Xgeva Label in the U.S. - Analyst Blog", "Novartis Reports Encouraging Data on Biosimilar of Neupogen - Analyst Blog", "AbbVie Reveals Phase II Data on Blood Cancer Drug at ASH (Revised) - Analyst Blog", "Biotech Stock Roundup: Cubist to be Acquired by Merck, Bluebird Shoots Up on ASH Data - Analyst Blog", "3 Reasons Amgen, Inc. Could Soar in 2015", "Dynavax & AstraZeneca Alter Agreement for Asthma Product - Analyst Blog", "Alnylam Reports Positive Initial Phase I Data on ALN-AT3 - Analyst Blog", "AbbVie Reveals Phase II Data on Blood Cancer Drug at ASH - Analyst Blog", "3 Top Large-Cap Biotech Stocks for 2015", "Bayer Files Hemophilia A Drug Marketing Application in EU - Analyst Blog", "3 Biotech Companies That Are Making Incredibly Smart Moves", "Regeneron at 52-Week High on Eylea Priority Review Status - Analyst Blog", "Why Biotech Stocks Don't Pay Dividends", "Amgen's Blincyto Gets FDA Nod, Carries Boxed Warning - Analyst Blog", "ADMA Biologics' RI-002 Positive in Phase III Study - Analyst Blog", "Synageva Completes BLA Submission for Sebelipase Alfa - Analyst Blog", "Oncolytics Files for Orphan Drug Designation for Reolysin - Analyst Blog", "Biogen Up on Encouraging Interim Data on Alzheimer's Drug - Analyst Blog", "IWB, C, AMGN, ABBV: ETF Inflow Alert", "Pharmacyclics, J&J Seek Imbruvica Label Expansion in EU - Analyst Blog", "A Look At 3 Overbought ETFs", "5 Things Amgen, Inc.'s Management Wants You to Know", "Dynavax Regains TLR 7/9 Inhibitor DV1179 Rights from Glaxo - Analyst Blog", "Celgene Hits 52-Week High on Positive CHMP Opinion - Analyst Blog", "Alexion's Soliris Gets Final Positive NICE Recommendation - Analyst Blog", "Should Gilead Sciences, Inc. Pay a Dividend?", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for December 03, 2014", "AstraZeneca/Amgen's Brodalumab Excels in Psoriasis Study - Analyst Blog", "Alexion's (ALXN) Soliris Gets Orphan Drug Status in Japan - Analyst Blog", "Amgen Ends Gastric Cancer Drug Studies on Safety Review - Analyst Blog", "Gilead Sciences Inc. Just Paid $125 Million for Something It Can't Use for a Year", "Novartis' Psoriasis Drug Cosentyx Backed for EU Approval - Analyst Blog", "Amgen and AbbVie Strengthen Manufacturing Facilities in Asia - Analyst Blog", "Regeneron & Sanofi Present Positive Data on PCSK9 Drug - Analyst Blog", "Health Care Sector Update for 11/26/2014: ARWR, AMGN, AZN", "Biotech: And Yet We've Just Begun...", "3 Stocks to Buy With Your Bull Market Profits", "AstraZeneca/Amgen's Brodalumab Positive in Psoriasis Trial - Analyst Blog", "Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy - Analyst Blog", "Pandering Your Wealth Away", "NPS Pharmaceuticals Incurs Wider Q3 Loss, Revenues Miss - Analyst Blog", "Noteworthy ETF Inflows: IWF, AMGN, ABBV, MMM", "Notable ETF Outflow Detected - IWF, SLB, AMZN, AMGN", "Why Aegerion Pharmaceuticals, Inc. Stock Collapsed in October", "ETF Outlook: First Trust Amex Biotech Index Fund ETF (FBT)", "Amgen Held By Latest 13F Filers", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for November 06, 2014", "Alnylam Pharmaceuticals, Inc. Has This Ratio Right", "5 Things Celgene Corporation's Management Wants You to Know", "Why Amgen, Inc. Stock Surged 15% in October", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 10, 2014", "Aegerion Q3 Loss Wider than Expected, 2014 View Lowered - Analyst Blog", "Noteworthy ETF Inflows: IWF, AMGN, UNP, MA", "Buy These Top Ranked ETFs on Solid Biotech Stock Earnings - ETF News And Commentary", "Stock Market News for October 29, 2014 - Market News", "Pfizer Inc.'s Earnings: Emerging Market Growth and Patent Expirations Square Off", "Amgen Up on Strategic Initiatives and 2015 Guidance - Analyst Blog", "Ligand Pharmaceuticals' Shares Fall on Q3 Earnings Miss - Analyst Blog", "3 Dividend Stocks Better Than Pfizer, Inc.", "Amgen Beats on Q3 Earnings & Revenues, Ups View Again - Analyst Blog", "Pfizer Beats Earnings, But Lacks Year-over-Year EPS Growth - Stocks in the News", "A safe route into the biotech sector", "Amgen, Inc. Earnings: Restructuring Efforts Are Beginning to Pay Off", "After-Hours Earnings Report for October 27, 2014 : AMGN, TMUS, GGP, AVB, HIG, UHS, XL, MAS, AGNC, PCL, DDR, BRX", "3 Money-Making Biotech Stocks That Could Go Higher", "Will Amgen (AMGN) Disappoint in the Q3 Earnings Season? - Analyst Blog", "Amgen Beats Earnings Estimates, What's Next for AMGN? - Stocks in the News", "Novartis' Secukinumab Receives Favorable FDA Panel Vote - Analyst Blog", "Daniel Loeb Comments on Amgen Inc", "Biotech Stock Roundup: AbbVie Calls off Shire Acquisition, Will Amgen Consider Breakup? - Analyst Blog", "Celgene Corporation's Earnings Preview: Pay Attention to New Kids", "Drug ETFs Attractive Buys On Pullback", "Amgen Gains as Third Point Suggests Split - Analyst Blog", "5 Best Biotech Stocks to Buy Now", "Notable ETF Inflow Detected - VTI, PM, WMT, AMGN", "Novartis' Secukinumab Receives Favorable FDA Panel Vote - Analyst Blog", "Biotech Stock Roundup: Gilead Nabs FDA Nod for Combo HCV Drug, Auxilium Accepts Endo Offer - Analyst Blog", "A Quick Look at Amgen, Inc.'s Drug Development Pipeline", "Where Will Celgene Corporation Stock Be a Year From Now?", "3 Dividend Stocks to Buy If the Market Crashes", "Can Dividend Stock GlaxoSmithKline plc Bounce Back?", "Amgen Sues Sanofi and Regeneron over PCSK9 Candidate - Analyst Blog", "Amgen's Blinatumomab Gets Priority Review in the U.S. - Analyst Blog", "3 Companies With the Best Retirement Plans", "Nasdaq 100 Movers: NXPI, CTSH", "Amgen, Inc. Gives AbbVie Inc the Highest Form of Flattery", "Amgen Up on Positive Phase III Data on Psoriasis Biosimilar - Analyst Blog", "Amgen's Data on Evolocumab Published in The Lancet - Analyst Blog", "ETF Outlook: Health Care Select Sector SPDR ETF (XLV)", "Novartis Releases Data on Secukinumab for Plaque Psoriasis - Analyst Blog", "XLV, AMGN, BMY, BIIB: ETF Inflow Alert", "Should Pfizer Inc. Buy This Surprisingly Competitive Biotech Stock?", "Atara Biotherapeutics refiles terms for $75 million IPO", "Better Dividend Stock: Amgen, Inc. or AbbVie Inc.?", "Stock of the Week: Amgen Inc. (AMGN)", "The Next Blue-Chip Stocks: Biogen Idec", "Ligand Earns Milestone Payment on EU Approval of Noxafil - Analyst Blog", "Illumina Pads Gene Sequencing Lead With Pharma Deals", "Celldex (CLDX) Up on Pilot Study Initiation on CDX-301 - Analyst Blog", "ETF Outlook: S&P Health Care Select SPDR ETF (XLV)", "Zacks Rank #1 Additions for Thursday - Tale of the Tape", "Seattle Genetics' Adcetris Positive in Durability Analysis - Analyst Blog", "BioMarin (BMRN) Faces Threat of Genericization for Kuvan - Analyst Blog", "Acorda Skyrockets on $525M Civitas Therapeutics Deal - Analyst Blog", "Gilead Scores with TAF-based HIV Regimen, Shares Up - Analyst Blog", "Notable ETF Inflow Detected - XLV, JNJ, AMGN, BMY", "3 Top Dividend Growth Stocks to Buy in October", "Celgene's Otezla Label Expanded to Include Plaque Psoriasis - Analyst Blog", "Zacks Rank #1 Additions for Tuesday - Tale of the Tape", "Amgen Files Blinatumomab Marketing Application in U.S. - Analyst Blog", "Bayer/Regeneron Successfully Expand Eylea Label in Japan - Analyst Blog", "Auxilium Pharmaceuticals Favors QLT Deal Over Endo Bid - Analyst Blog", "Glaxo Fined Roughly $484M in China Bribery Probe - Analyst Blog", "Inovio/GeneOne Life Science Collaborate for Ebola Vaccine - Analyst Blog", "XLV, JNJ, AMGN, BMY: ETF Inflow Alert", "VIVUS and Auxilium Announce Stendra Label Expansion - Analyst Blog", "3 Biotechs Investors Should Watch", "Sanofi & MyoKardia Ink Deal to Develop Cardiomyopathies - Analyst Blog", "3 Hot Ways to Play the Biotechnology Bonanza", "Merck Posts Positive Data on Osteoporosis Drug Odanacatib - Analyst Blog", "UCB-Amgen Reveals Positive Data on Romosozumab for PMO - Analyst Blog", "Flexion Continues to Fall Post Clinical Hold on FX006 - Analyst Blog", "Synthetic Biologics' SYN-005 Gets Orphan Drug Designation - Analyst Blog", "Is Illumina (ILMN) a Buy on Solid Q2, Strategic Road Map? - Analyst Blog", "Amarin Plunges after the FDA Denies Vascepa SPA Appeal - Analyst Blog", "Biogen Reports Positive Two-Year Data on MS Drug Plegridy - Analyst Blog", "Health Care Select Sector SPDR Fund Experiences Big Inflow", "Why I'd Avoid Pfizer Inc. Stock Despite the Dividend", "Medivation-Astellas' Xtandi's Label Expanded by FDA - Analyst Blog", "Why Amgen Inc.'s Stock Is up 23% in 2014", "Synthetic Biologics' SYN-005 Gets Orphan Drug Designation - Analyst Blog", "Is Illumina (ILMN) a Buy on Solid Q2, Strategic Road Map? - Analyst Blog", "Amarin Plunges after the FDA Denies Vascepa SPA Appeal - Analyst Blog", "Biogen Reports Positive Two-Year Data on MS Drug Plegridy - Analyst Blog", "Health Care Select Sector SPDR Fund Experiences Big Inflow", "Why I'd Avoid Pfizer Inc. Stock Despite the Dividend", "3 Reasons Sanofi's Stock Could Fall", "Medivation Eyes Blockbuster As Cancer Drug Gets An OK", "Amgen Seeks EU Approval for PCSK9 Inhibitor Evolocumab - Analyst Blog", "Exelixis Slumps 55% on Disappointing Cabozantinib Results - Analyst Blog", "Biotech Stock Roundup: United Therapeutics Up on Court Ruling, Amgen Files PCSK9 Inhibitor - Analyst Blog", "Is It Time to Buy Amgen, Inc.'s Stock?", "Sanofi Reports Positive Phase III Data on Dengue Vaccine - Analyst Blog", "Arena Pharmaceuticals' APD811 Gets Orphan Drug Status - Analyst Blog", "3 Reasons Eli Lilly & Co.'s Stock Could Rise", "Noteworthy ETF Inflows: VUG, FB, AMGN, MCD", "Great Cholesterol Drug Data From Regeneron Pharmaceuticals Inc. and Sanofi SA, but Read the Fine Pri", "United Therapeutics Soars on Remodulin Patent Case Win - Analyst Blog", "Regeneron/Sanofi Presents Encouraging Alirocumab Data - Analyst Blog", "Pfizer's C. Difficile Vaccine Gets Fast Track Status - Analyst Blog", "Amgen Submits Regulatory Application for PCSK9 Inhibitor - Analyst Blog", "OncoMed's Vantictumab Studies' Partial Clinical Hold Lifted - Analyst Blog", "Intellipharmaceutics' Oxycodone Program to Prevent Overdose - Analyst Blog", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for September 03, 2014", "Nasdaq 100 Movers: VIP, VRTX", "Amgen's Chronic Heart Failure Drug Gets Priority Review - Analyst Blog", "Aegerion Resolves FDA's Warning on Juxtapid, Lifts Overhang - Analyst Blog", "MediciNova Rises on FDA's Nod on MN-166 Study Initiation - Analyst Blog", "BioTime's AST-OPC1 Cleared by FDA for Phase I/IIa Study - Analyst Blog", "Repros Reports Encouraging Late-Stage Data on Androxal - Analyst Blog", "VUG, FB, AMGN, AXP: ETF Inflow Alert", "Isis Pharmaceuticals Starts Phase III Study on ISIS-APOCIIIRx - Analyst Blog", "7 Things Regeneron Pharmaceuticals Inc.'s Management Wants You to Know", "3 Reasons Amgen Inc.'s Stock Could Fall", "3 Reasons Celgene Corporation's Stock Could Fall", "Kite Pharma Drug Fares Well in Non-Hodgkin's Lymphoma Study - Analyst Blog", "HCP Boasts Of 29 Years Of Dividend Increases", "Regado Slumps on Permanent Termination of Revolixys Study - Analyst Blog", "VIVUS Acquires Certain Topamax Related Patents from J&J - Analyst Blog", "Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog", "7 Things Regeneron Pharmaceuticals Inc.'s Management Wants You to Know", "3 Reasons Amgen Inc.'s Stock Could Fall", "3 Reasons Celgene Corporation's Stock Could Fall", "Kite Pharma Drug Fares Well in Non-Hodgkin's Lymphoma Study - Analyst Blog", "Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Analyst Blog", "3 Reasons Gilead Science, Inc.\u2019s Stock Could Rise", "Healthcare Enjoys Growth Trends: 3 Medical Stocks to Buy - Analyst Blog", "Zacks Rank #1 Additions for Monday - Tale of the Tape", "Amgen (AMGN) Reports Encouraging Top-Line Data on AMG 416 - Analyst Blog", "Techne Corporation (TECH) Ex-Dividend Date Scheduled for August 19, 2014", "3 Reasons Amgen, Inc.'s Stock Could Rise", "Ligand Up on Multi-Program Captisol Deal with Avion Pharma - Analyst Blog", "Nasdaq 100 Movers: NTAP, MNST", "Amgen's FOCUS Study on Multiple Myeloma Drug Kyprolis Fails - Analyst Blog", "Thursday's ETF Movers: BBH, GXC", "Noteworthy ETF Outflows: IYH, AMGN, BIIB, CELG", "IYH, JNJ, PFE, AMGN: ETF Inflow Alert", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 12, 2014", "5 Things Amgen, Inc.'s Management Wants You to Know", "NPS Pharma Reports Earnings in Q2 on Strong Gattex Sales - Analyst Blog", "Ligand Gains on Q2 Earnings Beat, Increases Guidance - Analyst Blog", "Biotech Stock Roundup: Amgen Plans Job Cuts, Regeneron's Eylea Continues to Impress - Analyst Blog", "Why Amgen, Inc.\u2019s Kyprolis FOCUS Failure Is a Big Deal", "S&P Down 3% - What's on Sale? - Ahead of Wall Street", "Sector Update: Health Care", "Sector Update: Health-care Shares Flat in Pre-Market Trading; Amgen Up 3% on Positive Kyprolis Data", "Celebrating 20 Years of The Motley Fool Online", "Midday Update: GDP Spooks Wall Street On Fears of Less Accommodative Fed", "Strong Q2 Growth Unnerves Wall Street On Rate Hike Concerns", "Nasdaq 100 Movers: GRMN, REGN", "Amgen's Multiple Myeloma Drug Kyprolis Succeeds - Analyst Blog", "Closing Update: Stocks Shave Post-GDP Loss as Fed Lessens Rate-Hike Fears", "After-Hours Earnings Report for July 29, 2014 : AXP, AMGN, APC, ESRX, AFL, EQR, AMP, VRTX, MAR, BXP, FISV, NEM", "Will Amgen (AMGN) Disappoint This Earnings Season? - Analyst Blog", "Daily Dividend Report: K, WWE, AMGN, ETR, AVY, RBC", "Bayer/Amgen's Nexavar Does Not Show Resilience in Study - Analyst Blog", "Biotech Stock Roundup: AbbVie's Tax Inversion, Amgen Drug Scores in Phase 3 - Analyst Blog", "Notable ETF Inflow Detected - IWB, AMGN, UNH, BMY", "Amgen Beats on Q2 Earnings & Revs, Ups View & Plans Job Cuts - Analyst Blog", "Amgen's AMG 416 Succeeds in Phase III, Shares Up - Analyst Blog", "Anthera Acquires Sollpura from Eli Lilly - Analyst Blog", "Astellas Up on Pipeline Update, Oncology in Focus - Analyst Blog", "Cytokinetics Up on Positive Tirasemtiv Data - Analyst Blog", "Novartis' Phase III Results on Secukinumab Published - Analyst Blog", "Biotech Stock Roundup: Regado Plunges on Study Update, Jazz Gains on Product Acquisition Deal - Analyst Blog", "Alexion Pharma Looks To Life Beyond Its Blockbuster", "Astellas Up on Pipeline Update, Oncology in Focus (revised) - Analyst Blog", "BIND Therapeutics Ends Oncology Deal with Amgen - Analyst Blog", "Sector Update: Healthcare Stocks Slightly Higher; BIND Therapeutics Drops Partnership with Amgen on Cancer Treatment", "Sector Update: Healthcare", "Amgen Gets Breakthrough Therapy Status for Leukemia Drug - Analyst Blog", "Bayer Inks Hemophilia Deal with Dimension Therapeutics - Analyst Blog", "XLV, AMGN, BMY, UNH: Large Outflows Detected at ETF", "Muscle-loss biotech Atara Biotherapeutics files for a $50 million IPO", "Dow Hits 17,000 On Jobs Report; Walgreen Same-Store-Sales Surge 7.5%", "Sector Update: Healthcare", "Amgen-AstraZeneca Psoriatic Arthritis Drug Shows Improvement - Analyst Blog", "XLV, AMGN, BMY, UNH: Large Inflows Detected at ETF", "Stock Market News for June 05, 2014 - Market News", "Amgen Takes Over #44 Spot From Union Pacific", "The Health Care Sector May Have More Room To Run", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for June 03, 2014", "Sector Update: Healthcare Shares Flat Pre-Market; Geron Gets Partial Clinical Hold Lifted", "Isis Shines, PTC Therapeutics Soars - Analyst Blog", "Qiagen's therascreen KRAS Gets FDA Nod - Analyst Blog", "Notable ETF Outflow Detected - XLV, MRK, AMGN, BMY", "Sector Update: Healthcare Stocks Higher Pre-Market; Durata Sinks 11% After Strong Rally", "Sector Update: Healthcare", "Amgen's Vectibix Label Expanded - Analyst Blog", "Nasdaq 100 Movers: GILD, VIP", "Bayer and Orion Ink Oncology Deal - Analyst Blog", "Biotech Stock Roundup: Medivation Gains on Xtandi Strength, Amgen Scores in Late-Stage Study - Analyst Blog", "Amgen-AstraZeneca Psoriasis Drug Scores - Analyst Blog", "Wider-Than-expected Loss at NPS Pharma, Shares Down - Analyst Blog", "Techne Corporation (TECH) Ex-Dividend Date Scheduled for May 07, 2014", "3 Biotech Beats this Earnings Season - Earnings ESP", "Noteworthy ETF Outflows: SPY, FB, CVS, AMGN", "Biotech Stock Roundup: Gilead's Sovaldi Shines, Biogen & Alexion Up Outlook - Analyst Blog", "Stock Market News for May 23, 2014 - Market News", "Stock Market News for April 28, 2014 - Market News", "Drugs That Disappointed Investors In 2013: Infinity's IPI-145", "Edwards Lifesciences Q1 Earnings Top, Revs Miss - Analyst Blog", "Stock Market News for April 24, 2014 - Market News", "Earnings from Gilead and Amgen Put These ETFs in Focus - ETF News And Commentary", "Emergent's BioThrax Gets Orphan Drug Status - Analyst Blog", "OncoGenex Gains Fast Track Status for Custirsen - Analyst Blog", "Stock Market News for April 30, 2014 - Market News", "Nasdaq 100 Movers: ISRG, GILD", "Noteworthy ETF Outflows: PJP, LLY, MRK, AMGN", "Amgen's Q1 Earnings Decline Y/Y - Analyst Blog", "5 Stocks to Lose Post-Earnings - Analyst Blog", "Centene (CNC) Soars: Stock Adds 12.2% in Session - Tale of the Tape", "Sector Update: Healthcare Shares Flat in Pre-Market; Biogen up on Q1 Results, FY 2014 Guidance", "Sector Update: Healthcare", "ResMed Posts In-line Earnings but Misses on Revs - Analyst Blog", "Epizyme Up on Milestone Payment from Glaxo - Analyst Blog", "Encouraging Results from Pfizer's Xeljanz - Analyst Blog", "Economic News, Earnings Fuel Modest Losses in US Stocks", "Illumina Posts Better-than-Expected Q1 Earnings, Guides Up - Analyst Blog", "Stock Market News for April 22, 2014 - Market News", "Sarepta Soars on Eteplirsen Submission Plans - Analyst Blog", "After-Hours Earnings Report for April 22, 2014 : T, GILD, AMGN, CNI, YUM, DFS, ILMN, ISRG, VMW, FTI, JNPR, BCR", "#PreMarket Primer: Wednesday, April 23: Data From China Takes Some Pressure Off Beijing", "Week Ahead Market Report: April 21, 2014", "Narrower-than-Expected Loss at Cepheid, View Tweaked - Analyst Blog", "Emergent BioSolutions Gains on Trial News - Analyst Blog", "Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog", "Dynavax Starts Phase III Study on Heplisav-B - Analyst Blog", "Noteworthy ETF Inflows: XLV, JNJ, AMGN, BMY", "Ambit Biosciences Slumps: AMBI Falls 13.0% in Session - Tale of the Tape", "Will Amgen (AMGN) Miss This Earnings Season? - Analyst Blog", "Encouraging Results from Lexicon Candidate - Analyst Blog", "FDA Nod for Merck's Grastek - Analyst Blog", "Alimera/pSivida Seek FDA Approval for Iluvien - Analyst Blog", "Another Earnings Beat from J&J, View Up - Analyst Blog", "Gilead Bucks Biotech Trend Thanks to Sovaldi News - Analyst Blog", "Stock Market News for April 14, 2014 - Market News", "Pipeline Progress at Coronado Biosciences - Analyst Blog", "Repros Completes Enrollment for Androxal Study - Analyst Blog", "Positive Data on Biogen/Sobi's Eloctate - Analyst Blog", "Encouraging Data from Bristol-Myers - Analyst Blog", "Stock Market News for April 11, 2014 - Market News", "Encouraging Results on Gilead's Sovaldi - Analyst Blog", "Qiagen Expands Personalized Healthcare Pipeline - Analyst Blog", "Stock Market News for April 10, 2014 - Market News", "3 Top-Ranked Biotech Stocks on the Rebound - Analyst Blog", "Positive Results on Intercept Pharma's OCA - Analyst Blog", "Amgen Breaks Below 200-Day Moving Average - Notable for AMGN", "Gilead Announces Encouraging Sovaldi Data - Analyst Blog", "Positive Trial Data Lifts Alkermes - Analyst Blog", "Oncolytics Reports Additional Data on Reolysin - Analyst Blog", "Halozyme Falls on Phase II Study Halt - Analyst Blog", "Zacks Rank #1 Additions for Tuesday - Tale of the Tape", "Sanofi to File for Lemtrada Approval Again - Analyst Blog", "Halozyme Study Under Clinical Hold - Analyst Blog", "Encouraging Pre-Clinical Data from Celldex - Analyst Blog", "Intercept Pharma Prices 1M Share Offering, Shares Down - Analyst Blog", "Stock Market News for April 07, 2014 - Market News", "Momentum Slide to Continue for Netflix, Facebook? - Analyst Blog", "Amgen's Oncology Candidate Disappoints - Analyst Blog", "Stock Market News for April 04, 2014 - Market News", "Zacks Rank #1 Additions for Friday - Tale of the Tape", "Update on Merck's MK-3475 - Analyst Blog", "Noteworthy ETF Inflows: IBB, AMGN, BIIB, ALXN", "Stock Market News for April 01, 2014 - Market News", "Bull of the Day: Amgen (AMGN) - Bull of the Day", "Sector Update: Healthcare", "Healthcare Stocks Helping Pace Market Rally; Amgen Climbs on FDA Approval for New Cholesterol Drug", "Aegerion Pharmaceuticals' Viability Threatened As Regulatory, Legal And Market Forces Close In", "Nasdaq 100 Movers: WYNN, GRMN", "Glaxo and Amgen Terminate Agreement - Analyst Blog", "Retrophin (RTRX) Catches Eye: Stock Moves 7.9% Higher - Tale of the Tape", "Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews", "Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook", "Update on Celgene's Product Portfolio - Analyst Blog", "Stock Market News for March 25, 2014 - Market News", "Zacks Rank #1 Additions for Tuesday - Tale of the Tape", "Japan Approves Medivation/Astellas' Xtandi - Analyst Blog", "IBB, BIIB, AMGN, REGN: ETF Outflow Alert", "Are Biotech Stocks Oversold? - Analyst Blog", "Coverage Initiated on Illumina - Analyst Blog", "3 ETFs Tumble Most on Biotech Sell-off - ETF News And Commentary", "Stock Market News for March 19, 2014 - Market News", "Biotech Stock Roundup: Biogen Up for S&P100, Geron Plunges on Clinical Hold - Analyst Blog", "Amgen Scores Again with PCSK9 Inhibitor - Analyst Blog", "Stock Market News for March 14, 2014 - Market News", "Stock Market News for March 24, 2014 - Market News", "Biotech Stock Roundup: Amgen, Regeneron Slide on PCSK9 Inhibitor Concerns - Analyst Blog", "Zacks Rank #1 Additions for Wednesday - Tale of the Tape", "Bayer/Amgen's Nexavar Fails in Late-Stage Study - Analyst Blog", "Phase I Data on Rexahn's Supinoxin - Analyst Blog", "Chelsea Therapeutics Posts Wider Q4 Loss - Analyst Blog", "Stock Market News for March 11, 2014 - Market News", "Sector Update: Healthcare Shares Mixed Pre-Market; Synta Jumps 4% on Q4 Results", "Bright Outlook at Ligand - Analyst Blog", "IBB, BIIB, AMGN, REGN: ETF Outflow Alert", "Monday's ETF Movers: XLV, GXC", "Stock Market News for March 07, 2014 - Market News", "Pipeline Progress at Alkermes - Analyst Blog", "Profit from Orphan Drugs: 3 Choices (Revised) - Analyst Blog", "Bull of the Day: Quintiles (Q) - Bull of the Day", "Profit from Orphan Drugs: 3 Choices - Analyst Blog", "Sector Update: Healthcares", "Are These Biotechs Part of Your Portfolio? - Analyst Blog", "Amgen Takes Over #39 Spot From McDonald's", "Biogen Keeps Momentum Going With MS Drug Tecfidera", "Noteworthy ETF Inflows: IBB, BIIB, GILD, AMGN", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for March 03, 2014", "Amgen Becomes #192 Most Shorted S&P 500 Component, Replacing American Tower", "Enter Biosimilars: 3 Stock Picks - Analyst Blog", "Myriad Genetics Up on Prolaris Data; Aims Reimbursement - Analyst Blog", "NPS Pharma Swings to Earnings on Strong Revenues - Analyst Blog", "Illumina Expands in China - Analyst Blog", "Stock Market News for February 12, 2014 - Market News", "IBB, GILD, BIIB, AMGN: Large Inflows Detected at ETF", "Stock Market News for February 11, 2014 - Market News", "Healthcare Stocks Ahead More Than 1% as a Group; Agilent, Amgen Teaming Up on New Diagnostic Equipment", "Sector Update: Healthcare", "Bayer Progresses with Stivarga - Analyst Blog", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 11, 2014", "Ex-Dividend Reminder: Entergy, TECO Energy and Amgen", "Merck Misses on Earnings by a Penny - Analyst Blog", "Guidance Update From Actavis - Analyst Blog", "3 Reasons For Biotech Stock Advance To Continue", "Another Strong Earnings Beat from Amgen - Analyst Blog", "After-Hours Earnings Report for January 28, 2014 : T, AMGN, YHOO, ACE, ILMN, BXP, VMW, EA, RKT, AJG, TSS, WRB", "Cytokinetics Rises on Q4 Earnings Beat - Analyst Blog", "Drugmaker Merck Tries To Jump-Start Slow Growth", "Illumina, LabCorp Ink Multi-Year Deal - Analyst Blog", "Illumina Shares Hit 52-Week High - Analyst Blog", "Sector Update: Healthcare Shares Mixe Pre-Market; UnitedHealth Down 2% on Q4 Results", "Sector Update: Healthcare", "Illumina, Amgen Ally for Diagnostic Test - Analyst Blog", "Will Amgen (AMGN) Miss This Earnings Season? - Analyst Blog", "Stock Market News for January 10, 2014 - Corporate Summary", "Biotech Stock Roundup: Amgen Data Looks Good, CANF Tumbles - Industry Outlook", "Positive Data on Amgen's Romosozumab - Analyst Blog", "Sector Update: Healthcare Shares Mixed Pre-Market; Amgen Reports Positive Results From Phase 2 Trial", "Sector Update: Healthcare", "Amgen Inc. (AMGN): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report", "Healthcare Stocks Posting Narrow Gains; Illumina Spikes on Collaboration With Amgen on Cancer Test", "Pipeline Progress at Novartis - Analyst Blog", "Setback for Vertex Pharma - Analyst Blog", "In Insider Trading, Icahn Boosts Stake in Nuance, and Frost Buys More Shares of Opko", "Are Biotech ETFs Back on Track? - ETF News And Commentary", "Losing My Religion: How I Unlearned Efficient Markets Folly", "Orphan Drug Status for CNAT's Emricasan - Analyst Blog", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for December 03, 2013", "Enzon Pharmaceuticals, Inc. (ENZN) Ex-Dividend Date Scheduled for December 24, 2013", "Pipeline Progress at Novartis - Analyst Blog", "Setback for Vertex Pharma - Analyst Blog", "In Insider Trading, Icahn Boosts Stake in Nuance, and Frost Buys More Shares of Opko", "Data on Amgen's Pipeline Candidates - Analyst Blog", "Stock Market News for November 21, 2013 - Market News", "Dendreon (DNDN) in Focus: Stock Moves 9.7% Higher - Tale of the Tape", "A safe way to win with biotech growth", "Techne Corporation (TECH) Ex-Dividend Date Scheduled for November 07, 2013", "Top Ranked Biotech ETF in Focus: BBH - ETF News And Commentary", "Another Earnings and Rev Beat from Amgen - Analyst Blog", "Inside Biotech ETFs: Can the Run Continue? - ETF News And Commentary", "Stock Downgrades: Should Nokia Shareholders Jump Out of Windows?", "Stocks Gaining on Bullish Earnings, Benign Employment", "New Stock Coverage: Texas Instruments Is Messing With Us", "Roche's Gazyva Approved in the U.S. - Analyst Blog", "Techne Corporation (TECH) Ex-Dividend Date Scheduled for November 07, 2013", "Crush the S&P 500 With This Innovative ETF", "Mixed Data on Pfizer's Xeljanz - Analyst Blog", "Biotech ETFs Plummeting (XBI, IBB, BBH)", "Encouraging Data on Novartis' Secukinumab - Analyst Blog", "Adobe, Amgen Case Studies: Why Do We Fear Buying Retraces?", "Market Shrugs Off Weaker Than Expected Jobs Report, Stock Inch Higher Into Open", "United Therapeutics Aims For A Cardiovascular Drug OK", "After-Hours Earnings Report for October 22, 2013 : AMGN, CNI, ACE, BRCM, FTI, ALTR, JNPR, BCR, CREE, TSS, RHI, WCN", "Sector Update: Healthcare Shares Lower; CytRx Corporation up 14% Pre-Market on Preliminary Phase 2 Results", "Biotech Alexion: A Giant In The Tiny Orphan Market", "Amgen/Cytokinetics Drug Misses Primary Endpoint - Analyst Blog", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for September 03, 2013", "PRIMECAP Trims Top Biotechs and More", "Bayer's Nexavar Holds Promise - Analyst Blog", "Sangamo to Buy Ceregene - Analyst Blog", "AstraZeneca to Acquire Amplimmune - Analyst Blog", "Company News for August 27, 2013 - Corporate Summary", "Stock Upgrades: Hugh Grant Eyes Hollywood Ending at Monsanto Company", "Amgen to Acquire Onyx Pharma - Analyst Blog", "Taper Coming Despite Weak Data? - Ahead of Wall Street", "Bull of the Day: Biogen Idec (BIIB) - Bull of the Day", "Pre-Market Primer: Amgen, Inc. to Acquire Onyx Pharmaceuticals; Durable Goods Order Plunge", "Sector Update: Healthcare", "These ETFs House The Next Biotech Takeover Targets", "Market Close Report: NASDAQ Composite index closes at 3,657.57 down -.22 points", "Dow, S&P 500 Erase Friday's Momentum on Lackluster Data", "Healthcare Stocks End in the Red; Prana Gains on Speculation of Future Drug-Trial Success", "Sector Update: Healthcare", "August 26: Will Taper Happen Despite Discouraging Data? - Economic Highlights", "Healthcare Stocks Mostly Higher; Response Genetics Hits 52 Week Highs On Pathwork Deal; ONXX and AMGN In The News", "Sector Update: Healthcare", "Pound For Pound, Are Biotechs Still Worth Their Salt?", "Healthcare Stocks Still Higher Near Closing Bell; Regado Biosciences Jumps Nearly 20% in Market Debut", "Sector Update: Healthcare", "Neutral on Onyx Pharma - Analyst Blog", "Healthcare Stocks Slightly Higher This Afternoon; Cytokinetics Advances After New Data Find ALS Drug Well-Tolerated", "Cytokinetics: Previewing The Release Of Data From The ATOMIC-AHF Trial Of Omecamtiv Mecarbil", "Amgen's Onyx Acquisition Could be Delayed - Analyst Blog", "Sector Update: Healthcare Shares Lower Pre-Bell; Onyx Pharmaceuticals Down 6% on Stalled Takeover Talks", "Sector Update: Healthcare", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 14, 2013", "Techne Corporation (TECH) Ex-Dividend Date Scheduled for August 14, 2013", "NPS Pharma Reports Loss but Gattex Encourages - Analyst Blog", "Market Close Report: NASDAQ Composite index closes at 3,669.12 up 15.11 points", "Sector Update: Healthcare", "Market Close Report: NASDAQ Composite index closes at 3,654.01 down -11.76 points", "Buyback ETF Defies Logic", "Benzinga Market Primer: Thursday, August 1: Futures Up On Europe and Asia", "Amgen Beats on Earnings & Revs in Q2 - Analyst Blog", "Benzinga Market Primer: Wednesday, July 31: Futures Higher Heading Into FOMC Decision", "Earnings Decline Again at Merck - Analyst Blog", "Pharma & Biotech Stock Outlook - July/Aug 2013 - Industry Outlook", "Cytokinetics: A Preview Of Key Upcoming Clinical Trial Results", "After-Hours Earnings Report for July 30, 2013 : AMGN, AFL, EQR, SYMC, BXP, FISV, OKE, VRSK, KIM, OKS, TRMB, GNW", "Will Amgen (AMGN) Beat Earnings? - Analyst Blog", "Will Merck (MRK) Beat Earnings This Quarter? - Analyst Blog", "Will Pfizer (PFE) Beat Earnings? - Analyst Blog", "Huge Earnings Beat from Biogen; Outlook Up Again - Analyst Blog", "Amgen - Servier Ink Deal - Analyst Blog", "Positive Data for Novartis' Candidate - Analyst Blog", "Pharma & Biotech Stock Outlook - July/Aug 2013 - Zacks Analyst Interviews", "Priority Review for Roche Candidate - Analyst Blog", "Onyx Pharma Turns Down Amgen offer - Analyst Blog", "Stock Market News for July 1, 2013 - Market News", "Benzinga Market Primer: Monday, July 1", "Global Manufacturing Indexes Are Better Across the Board", "Stocks Kick Off the Third Quarter with Modest Gains", "Biotech ETFs Surge as Onyx Rejects Amgen Offer - ETF News And Commentary", "Estarylla Lot Recalled by Novartis' Sandoz - Analyst Blog", "Novartis' Sandoz Progresses with Biosimilars - Analyst Blog", "Amgen Xgeva Label Expanded - Analyst Blog", "Apremilast Data Presented by Celgene - Analyst Blog", "Amgen's Oncology Drug Meets Primary Endpoint - Analyst Blog", "3 Impressive Biotech ETFs Crushing the Market - ETF News And Commentary", "Pipeline Progress at Roche - Analyst Blog", "Enzon Pharmaceuticals, Inc. (ENZN) Ex-Dividend Date Scheduled for June 05, 2013", "A Look Ahead: This Week's ETFs to Watch", "CHMP Positive on Teva's Lonquex - Analyst Blog", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for June 03, 2013", "Market Close Report: NASDAQ Composite index closes at 3,455.91 down -35.39 points", "Amgen-Astellas Collaborate - Analyst Blog", "Amgen, Inc. (AMGN): Today's Most Compelling Stock Buy", "Stock Market News for May 22, 2013 - Market News", "Market Close Report: NASDAQ Composite index closes at 3,496.43 down -2.54 points", "Stock Market News for June 3, 2013 - Market News", "Stock Market News for May 14, 2013 - Market News", "Amgen to Set Up JV in China - Analyst Blog", "Stock Market News for May 13, 2013 - Market News", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 14, 2013", "Q1 Revenue In-Line. Amgen Deal Is Encouraging - Analyst Blog", "S&P Highlights Biotech ETFs", "Amgen, Inc. (AMGN): Today's Most Compelling Stock Buy", "Sanofi/REGN Commence Enrollment - Analyst Blog", "Stock Market News for May 14, 2013 - Market News", "Amgen to Set Up JV in China - Analyst Blog", "Stock Market News for May 13, 2013 - Market News", "Is the Biotech Sector Still a Market Leader? - Real Time Insight", "Stocks Market News for April 25, 2013 - Market News", "Stock Upgrades: Yesterday's Mutiny Provides Bounty for P&G Shareholders", "Tax Benefit Boosts Amgen Earnings - Analyst Blog", "X Factor: 5 Stocks Reaching Their Ex-Dividend Date on May 14", "Market Close Report: NASDAQ Composite index closes at 3,269.65 up .32 points", "Minyanville's T3 Morning Market Call: Bulls and Bears Both Have Valid Arguments", "Benzinga Market Primer: Tuesday, April 23", "After-Hours Earnings Report for April 23, 2013 : AAPL, T, AMGN, NSC, BRCM, FTI, EW, JNPR, BCR, SLG, RE, OII", "Will Amgen Beat Earnings? - Analyst Blog", "Vertex News Lifts Biotech ETFs", "Stock Market News for April 19, 2013 - Market News", "Benzinga Market Primer: Wednesday, April 24", "ETF Showdown: A Pharma Fight", "Under The Hood: An Unheralded Biotech ETF", "Tech, Biotech ETFs Lead Market's Jump To New Highs", "Three Market-Based ETFs Trouncing SPY", "Spectrum Progresses with SPI-2012 - Analyst Blog", "Cytokinetics Begins CK-2127107 Study - Analyst Blog", "Stock Market News for April 3, 2013 - Market News", "Weekly Preview: Earnings Season Continues, Apple In Focus", "AstraZeneca Discusses Strategy - Analyst Blog", "Biotech Breakout Boosting ETFs", "This Dead Money Sector is Leading the S&P This Year", "Moving Averages Indicate These Sector ETFs Could be Stretched", "Markets Close Out Losing Week on Up Note", "Positive Data on Amgen Candidate - Analyst Blog", "Stock Market News for March 13, 2013 - Market News", "Stock Market News for March 28, 2013 - Market News", "Stock Market News for March 4, 2013 - Market News", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for March 01, 2013", "Setback for Amgen - Analyst Blog", "Market Close Report: NASDAQ Composite index closes at 3,116.25 down -45.57 points", "Merck Signs Biosimilars Deal - Analyst Blog", "AstraZeneca Inks Deal - Analyst Blog", "After Hours Most Active for Feb 14, 2013 : QQQ, C, AMGN, FCH, DELL, CSCO, CBS, QLIK, NWSA, BAC, BP, GE", "Aegerion Incurs Wider Loss - Analyst Blog", "UCB, Amgen Discontinue Study - Analyst Blog", "Techne Corporation (TECH) Ex-Dividend Date Scheduled for February 13, 2013", "After Hours Most Active for Feb 11, 2013 : BAC, FB, GILD, UAL, TTWO, FE, WFR, AMGN, TLM, ATVI, KORS, SQNM", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 11, 2013", "Actavis Provides 2013 Guidance - Analyst Blog", "Safest Way to Play Biotech - Cook`s Kitchen", "Amgen Misses on EPS, Guides Above - Analyst Blog", "Amgen Provides Long-Term Update - Analyst Blog", "After Hours Most Active for Jan 24, 2013 : MSFT, QQQ, AMGN, NOK, SBUX, PFE, MRK, BAC, HIG, NWSA, KO, INTC", "Amgen gives early payday to the bulls", "After-Hours Earnings Report for January 23, 2013 : AAPL, AMGN, SYK, CCI, SYMC, SNDK, WDC, ALTR, NE, VAR, FFIV, LRCX", "Earnings Preview: Amgen - Analyst Blog", "Trius: Why Last Friday's Equity Offering Is Good For The Stock", "After Hours Most Active for Jan 18, 2013 : LLTC, BAC, AMGN, BML^Q, O, QQQ, JNJ, PBI, LXP, DELL, INTC, ATVI", "Management Expands at AstraZeneca - Analyst Blog", "ETF Talk: Here Is to Your Healthcare", "After Hours Most Active for Jan 16, 2013 : QQQ, EBAY, SWY, BAC, GM, AMGN, PPG, MSFT, MT, DELL, INTC, CBS", "After Hours Most Active for Jan 15, 2013 : QQQ, DELL, MTU, TSM, BAC, HCA, WFC, SKM, MSFT, AMGN, YHOO, CSCO", "Amgen's Dividend Policy Has Ignited Their Stock", "After Hours Most Active for Jan 10, 2013 : LO, DRE, SIRI, BAC, AMGN, MT, EMC, HUN, QQQ, CSCO, INTC, APOL", "Biogen Submits Hemophilia B BLA - Analyst Blog", "BioMimetic's Pipeline Progresses - Analyst Blog", "Zacks #1 Rank Additions for Wednesday - Tale of the Tape", "Canadian Approval for BMY's Drug - Analyst Blog", "Positive Data on Actelion Candidate - Analyst Blog", "Zacks #1 Rank Additions for Monday - Tale of the Tape", "Amgen to Increase Dividend; Share Buy Backs (AMGN)", "Market Wrap-Up for Dec.14 (BBY, AAPL, AMGN, DE, MRO, more)", "Dividend-Payer Amgen Is Hitting New Highs Again", "Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)", "Bear of the Day: Align Technology (ALGN) - Bear of the Day", "Zacks #1 Rank Additions for Friday - Tale of the Tape", "Zacks #1 Rank Additions for Tuesday - Tale of the Tape", "Zacks #1 Rank Additions for Friday - Tale of the Tape", "Enzon Pharmaceuticals, Inc. (ENZN) Ex-Dividend Date Scheduled for December 06, 2012", "Zacks #1 Rank Additions for Tuesday - Tale of the Tape", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for December 05, 2012", "Abbott's Humira's Label Expanded - Analyst Blog", "The Best Pharma Stock to Profit from the 'Patent Cliff'", "These ETFs Are Awash in 2013 Takeover Targets", "AZN's Forxiga Gets EU Approval - Analyst Blog", "Celgene's Apremilast Encourages - Analyst Blog", "Weekly Top Insider Sells: DHR, MSFT, GOOG, and AMGN", "Out of the Red and into the Black: John McCamant on Investment in Blood Cancer Companies", "Generic Erosion Hurts AstraZeneca - Analyst Blog", "Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)", "Beat and Raise Quarter for Amgen - Analyst Blog", "Biotech ETFs: A Fiscal Cliff Safe Haven? - ETF News And Commentary", "S&P Likes a Trio of Biotech ETFs", "After-Hours Earnings Report for October 23, 2012 : AMGN, ACE, AFL, NSC, BRCM, BXP, VMW, ALTR, FTI, CHRW, JNPR, BCR", "Deutsche Bank Upgrades Amgen to \u201cBuy\u201d; Sees Strong Growth, Upside, and Higher Dividends Ahead (AMGN)", "Deutsche Bank Upgrades Amgen to a \u201cBuy\u201d (AMGN)", "It's Time to Sell These 4 Surging Stocks", "After Hours Most Active for Oct 18, 2012 : CX, MSFT, QQQ, SIRI, S, GEN, VOD, MMR, MRVL, AMGN, NOK, AMD", "Stock Market News for October 17, 2012 - Market News", "Amgen Reports Increased Profit; Beats Analysts Expectations (AMGN)", "Brian Rogers' Highest Sells: Kimberly-Clark, Pinnacle West Capital and Amgen Inc.", "Abbott Reports Encouraging HCV Data - Analyst Blog", "Short Interest Swings in Biotech Stocks (BIIB, CELG, GILD)", "AstraZeneca Licenses Ardelyx's Drugs - Analyst Blog", "New Indication for Abbott's Humira - Analyst Blog", "52-Week High Companies: AMGN, CBE, FISV, NEWS, ACE", "Novartis Progresses with AIN457 - Analyst Blog", "This Drug Market Could Expand 80-Fold by 2020", "Another Approval for Amgen's Prolia - Analyst Blog", "Celgene's Drug Pipeline News Soothes Investor Worries", "Weekly Top Insider Sells: COF, GOOG, AMGN, CRM and FIS", "Amgen Bounces Back On Strong 2012 Performance", "After Hours Most Active for Sep 13, 2012 : AEO, BAC, NOK, ORI, C, QQQ, SPLS, SIRI, DHI, AMGN, HBAN, INTC", "Robert Baird Cuts Amgen to \u201cNeutral\u201d; Recent Rally Overdone? (AMGN)", "Amgen Upgraded to \u201cBuy\u201d at UBS; Clinical Data Looking Up? (AMGN)", "Brean Murray Starts Coverage on Amgen as a \u201cBuy\u201d; Long-Term Pipeline Looking Good (AMGN)", "Another Approval for Amgen's Prolia - Analyst Blog", "Celgene's Drug Pipeline News Soothes Investor Worries", "Weekly Top Insider Sells: COF, GOOG, AMGN, CRM and FIS", "Amgen Doing Fine Despite Challenges", "Takeda Halts GAMMA Study in Japan - Analyst Blog", "Pipeline Setback at Amgen - Analyst Blog", "5 Familiar Stocks to Sell (or Short)! - Investment Ideas", "Pipeline Progress at CELG, Shares Up - Analyst Blog", "Amgen Beats, Raises Guidance - Analyst Blog", "Biotechs In Motion As New Drug Pipeline Brims", "After-Hours Earnings Report for July 26, 2012 : AMZN, AMGN, ARBA, ATR, AFSI, APKT, BJRI, AMKR, ABAX, BAS, BBNK, AGYS", "Suggestions For Summer Reading For Growth Investors", "Good News for Celgene's Pipeline - Analyst Blog", "Better Investors: Men or Women?", "Merck Osteoporosis Candidate Scores - Analyst Blog", "Top-Performing Funds Latch On To Biotech And Discount Retail Stocks", "After Hours Most Active for Jul 11, 2012 : LSI, FCX, PSEC, PHM, BAC, FB, ACC, WM, QCOM, AMGN, ACWI, SBAC", "Merck KGaA's Erbitux Disappoints - Analyst Blog", "FDA Label Expansion for Erbitux - Analyst Blog", "Amgen Acquires KAI - Analyst Blog", "DaVita to Settle Epogen Lawsuit - Analyst Blog", "Amgen's Sensipar Disappoints - Analyst Blog", "Dr. Reddy's & Merck Serono Team Up - Analyst Blog", "New Highs, New Lows, Yield Greed", "After Hours Most Active for Jul 11, 2012 : LSI, FCX, PSEC, PHM, BAC, FB, ACC, WM, QCOM, AMGN, ACWI, SBAC", "Merck KGaA's Erbitux Disappoints - Analyst Blog", "FDA Label Expansion for Erbitux - Analyst Blog", "Amgen Acquires KAI - Analyst Blog", "DaVita to Settle Epogen Lawsuit - Analyst Blog", "Amgen's Sensipar Disappoints - Analyst Blog", "Amgen Q1 Profit and Revenue Beat Expectations (AMGN)", "Abbott Presents Data on Humira - Analyst Blog", "Earnings Preview: Amgen - Analyst Blog", "Earnings Preview: Abbott Labs - Analyst Blog", "The Zacks Analyst Blog Highlights: The Goldman Sachs Group, Lloyd's, Bank of America, JPMorgan Chase and Amgen - Press Releases", "Amgen Reaches for KAI Pharma - Analyst Blog", "Amgen-AstraZeneca Team Up - Analyst Blog", "Amgen Psoriasis Candidate Impresses - Analyst Blog", "Positive Data on Lilly Psoriasis Drug - Analyst Blog", "Dow Takes Back 13,000, But Can't Reclaim Key Trendline Support", "Encouraging Data on Amgen Candidate - Analyst Blog", "DaVita Downgraded to Neutral - Analyst Blog", "Hospira Back to Neutral - Analyst Blog", "Amgen a Step Closer to Micromet - Analyst Blog", "DaVita Outperforms, Affirms Outlook - Analyst Blog", "Earnings Preview: DaVita Inc. - Analyst Blog", "Amgen, Inc. (AMGN) - Bull of the Day", "The Zacks Analyst Blog Highlights: Amgen, Sanofi, Regeneron, Alnylam and Coach - Press Releases", "3 Biotechnology Stocks for Short-Term Traders", "Amgen Upped to Outperform - Analyst Blog", "Market Wrap-Up for Feb.6 (HAS, SYY, HUM, PNC, DIS, more)", "How Many Stocks Should You Own? - Investment Ideas", "Zacks #1 Rank Additions for Tuesday - Tale of the Tape", "Five ETFs that started 2012 strong", "Amgen Misses; 2012 Outlook Strong - Analyst Blog", "Zacks Bull and Bear of the Day Highlights: Amgen, Montpelier Re Holdings, Cisco Systems, Illumina and Roche Holdings - Press Releases", "Watson Buys Ascent Pharmahealth - Analyst Blog", "Market Wrap-Up for Jan.23 (HAL, PG, PRU, BLK, COP, more)", "Biosimilars: The Next Big Thing - Analyst Blog", "Hospira Upped to Neutral - Analyst Blog", "FDA Panel to Review Amgen's Xgeva - Analyst Blog", "Amgen\u2019s Price Target Raised at Citigroup (AMGN)", "Zacks #1 Rank Additions for Friday - Tale of the Tape", "DaVita Upgraded to Outperform - Analyst Blog", "Zacks #1 Rank Additions for Tuesday - Tale of the Tape", "Micromet's Blinatumomub Data at ASH - Analyst Blog", "Zacks #1 Rank Additions for Friday - Tale of the Tape", "Micromet Stays Neutral - Analyst Blog", "Zacks #1 Rank Additions for Wednesday - Tale of the Tape", "Mid-Day Update: Stocks Sitting Higher as Europe Hope Rises; ISM Services Index Falls", "Amgen Corporation - Value", "Watson-Amgen to Develop Biosimilars - Analyst Blog", "Zacks #1 Rank Additions for Friday - Tale of the Tape", "Largest option buying in equities so far", "The Zacks Analyst Blog Highlights: Alleghany, TransAtlantic, Tyson Foods, Tech Data and Amgen - Press Releases", "EU Label Expansion for Amgen Drug - Analyst Blog", "Investing With The House", "3 Cheap Stocks with a Shrinking Share Count", "Largest option buying in equities so far", "Micromet Begins New Trial - Analyst Blog", "Pfizer Poised to Introduce Blockbuster Arthritis Pill", "Amgen Started as an \u201cOutperform\u201d at BMO Capital; Valuation Call (AMGN)", "Hearty Profits: Companies Racing to Develop the Next Big Cholesterol Drug", "Want to be a Venture Capitalist? Invest in these 2 Stocks", "Opening View: Debt Vote Cancelled, Stocks Spiral Lower", "Healthcare Takeovers Targets: Express Scripts Buys Medco", "Overlook this Sector and It Could Cost You", "Mid-Day Update: Stocks Give Up Gains at Session's Half; Europe Worries Linger", "Mid-Day Update: Stocks Down, Housing, Industrial Production, Earnings Weigh", "3 HOLDRS ETFs With Low Fees and Low Valuations", "7 Ailing Health Care Stocks to Sell", "Stocks Higher Ahead Next Week's Earnings; Economic Data Supports", "Mid-Day Update: Stocks Firmer Following Data Deluge, Corporate Earnings", "10 Health Care Stocks That Have Flatlined", "Mid-Day Update: Stocks Manage Another Rally; Investors Eye Positive Employment Data", "US Indexes Lower as Industrial Production, Housing Data Weighs; HP Guidance Disappoints", "Stocks Broadly Higher; Libyan Crisis Eases; Japan G-7 Aid Reassures Investors", "Mid-Day Update: Stocks Shooting Higher; Investor Attention Turns Back to Libya", "Companies Lend a Helping Hand", "How To Play Biotech With ETFs", "Do Mergers Mean Billions for Biotech?", "Did You Know.....", "Undervalued Biotech Stock to Buy for 2011", "US Indexes Higher at Session's Half Despite Crude Prices Bubbling Higher, Disappointing Durable Goods Data", "Stocks Skid at Mid-Day; Investors Seek Direction Ahead of Fed, GDP Numbers", "Mid-Day Update: Bearish Sentiment Sends Major Indexes Broadly Lower", "Amgen, Celgene and Novartis in the Fight Against Pancreatic Cancer", "5 Things That Drive Biotech ETFs", "Using ETFs to Mimic Mutual Fund Ideas", "Option Activity Alert: Amgen, Inc. and Dendreon Corporation", "10 Stocks That Should Pay a Dividend, but Don\u2019t (GOOG, AAPL, BRK.A, AMZN, more)", "Opening View: DJIA Futures Edge Higher Ahead of FOMC", "11 Famous Health Care Stocks to Sell", "Betting on long-term upside in Amgen (NASDAQ:AMGN)", "Affymax fate may be decided today", "Sidewinder Update: Amgen (NASDAQ: AMGN)", "11 Health Care Stocks to Sell"], "Elapsed Time": ["10 HOURS AGO", "2 DAYS AGO", "2 DAYS AGO", "2 DAYS AGO", "3 DAYS AGO", "JUN 19, 2020", "JUN 18, 2020", "JUN 16, 2020", "10 HOURS AGO", "JUN 15, 2020", "JUN 12, 2020", "JUN 12, 2020", "JUN 11, 2020", "JUN 10, 2020", "JUN 8, 2020", "JUN 4, 2020", "JUN 16, 2020", "JUN 2, 2020", "MAY 28, 2020", "MAY 27, 2020", "MAY 26, 2020", "MAY 24, 2020", "MAY 19, 2020", "MAY 18, 2020", "JUN 3, 2020", "MAY 17, 2020", "MAY 15, 2020", "MAY 13, 2020", "MAY 13, 2020", "MAY 13, 2020", "MAY 11, 2020", "MAY 11, 2020", "MAY 17, 2020", "MAY 8, 2020", "MAY 6, 2020", "MAY 6, 2020", "MAY 5, 2020", "MAY 5, 2020", "MAY 1, 2020", "MAY 1, 2020", "MAY 11, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 28, 2020", "APR 28, 2020", "APR 27, 2020", "APR 30, 2020", "APR 23, 2020", "APR 23, 2020", "APR 22, 2020", "APR 20, 2020", "APR 19, 2020", "APR 17, 2020", "APR 17, 2020", "APR 26, 2020", "APR 23, 2020", "APR 23, 2020", "APR 22, 2020", "APR 20, 2020", "APR 7, 2020", "APR 4, 2020", "APR 2, 2020", "APR 17, 2020", "APR 2, 2020", "MAR 31, 2020", "MAR 31, 2020", "MAR 30, 2020", "MAR 30, 2020", "MAR 27, 2020", "MAR 26, 2020", "APR 2, 2020", "MAR 25, 2020", "MAR 20, 2020", "MAR 17, 2020", "MAR 16, 2020", "MAR 15, 2020", "MAR 12, 2020", "MAR 11, 2020", "MAR 26, 2020", "MAR 5, 2020", "MAR 5, 2020", "MAR 4, 2020", "MAR 4, 2020", "MAR 4, 2020", "MAR 3, 2020", "MAR 3, 2020", "MAR 9, 2020", "FEB 27, 2020", "FEB 27, 2020", "FEB 27, 2020", "FEB 27, 2020", "FEB 26, 2020", "FEB 25, 2020", "FEB 24, 2020", "FEB 28, 2020", "FEB 21, 2020", "FEB 21, 2020", "FEB 21, 2020", "FEB 19, 2020", "FEB 13, 2020", "FEB 13, 2020", "FEB 13, 2020", "FEB 21, 2020", "FEB 8, 2020", "FEB 7, 2020", "FEB 6, 2020", "FEB 6, 2020", "FEB 5, 2020", "FEB 5, 2020", "FEB 4, 2020", "FEB 10, 2020", "FEB 2, 2020", "FEB 2, 2020", "JAN 31, 2020", "JAN 31, 2020", "JAN 31, 2020", "JAN 31, 2020", "JAN 31, 2020", "FEB 4, 2020", "JAN 31, 2020", "JAN 30, 2020", "JAN 30, 2020", "JAN 30, 2020", "JAN 30, 2020", "JAN 30, 2020", "JAN 29, 2020", "JAN 31, 2020", "JAN 26, 2020", "JAN 25, 2020", "JAN 24, 2020", "JAN 24, 2020", "JAN 23, 2020", "JAN 19, 2020", "JAN 19, 2020", "JAN 28, 2020", "JAN 16, 2020", "JAN 14, 2020", "JAN 13, 2020", "JAN 13, 2020", "JAN 10, 2020", "JAN 9, 2020", "JAN 7, 2020", "JAN 17, 2020", "JAN 6, 2020", "JAN 2, 2020", "JAN 2, 2020", "JAN 2, 2020", "JAN 2, 2020", "JAN 2, 2020", "JAN 1, 2020", "JAN 6, 2020", "JAN 6, 2020", "DEC 30, 2019", "DEC 28, 2019", "DEC 27, 2019", "DEC 24, 2019", "DEC 22, 2019", "DEC 31, 2019", "DEC 19, 2019", "DEC 19, 2019", "DEC 18, 2019", "DEC 17, 2019", "DEC 16, 2019", "DEC 16, 2019", "DEC 16, 2019", "DEC 21, 2019", "DEC 13, 2019", "DEC 12, 2019", "DEC 12, 2019", "DEC 12, 2019", "DEC 12, 2019", "DEC 11, 2019", "DEC 11, 2019", "DEC 15, 2019", "DEC 9, 2019", "DEC 9, 2019", "DEC 9, 2019", "DEC 8, 2019", "DEC 7, 2019", "DEC 6, 2019", "DEC 6, 2019", "DEC 10, 2019", "DEC 9, 2019", "DEC 9, 2019", "DEC 2, 2019", "DEC 2, 2019", "DEC 1, 2019", "NOV 29, 2019", "NOV 27, 2019", "DEC 6, 2019", "NOV 26, 2019", "NOV 25, 2019", "NOV 25, 2019", "NOV 25, 2019", "NOV 25, 2019", "NOV 24, 2019", "NOV 24, 2019", "NOV 27, 2019", "NOV 26, 2019", "NOV 25, 2019", "NOV 25, 2019", "NOV 21, 2019", "NOV 21, 2019", "NOV 20, 2019", "NOV 20, 2019", "NOV 22, 2019", "NOV 19, 2019", "NOV 19, 2019", "NOV 18, 2019", "NOV 18, 2019", "NOV 16, 2019", "NOV 14, 2019", "NOV 13, 2019", "NOV 20, 2019", "NOV 11, 2019", "NOV 11, 2019", "NOV 9, 2019", "NOV 7, 2019", "NOV 7, 2019", "NOV 6, 2019", "NOV 6, 2019", "NOV 12, 2019", "NOV 4, 2019", "NOV 2, 2019", "NOV 1, 2019", "NOV 1, 2019", "NOV 1, 2019", "NOV 1, 2019", "NOV 1, 2019", "NOV 5, 2019", "OCT 31, 2019", "OCT 31, 2019", "OCT 31, 2019", "OCT 31, 2019", "OCT 30, 2019", "OCT 29, 2019", "OCT 29, 2019", "OCT 31, 2019", "OCT 29, 2019", "OCT 29, 2019", "OCT 29, 2019", "OCT 26, 2019", "OCT 24, 2019", "OCT 23, 2019", "OCT 23, 2019", "OCT 29, 2019", "OCT 29, 2019", "OCT 18, 2019", "OCT 18, 2019", "OCT 11, 2019", "OCT 7, 2019", "OCT 7, 2019", "OCT 4, 2019", "OCT 23, 2019", "OCT 3, 2019", "OCT 2, 2019", "OCT 1, 2019", "OCT 1, 2019", "SEP 28, 2019", "SEP 27, 2019", "SEP 27, 2019", "OCT 3, 2019", "SEP 26, 2019", "SEP 26, 2019", "SEP 20, 2019", "SEP 18, 2019", "SEP 17, 2019", "SEP 17, 2019", "SEP 16, 2019", "SEP 27, 2019", "SEP 13, 2019", "SEP 12, 2019", "SEP 11, 2019", "SEP 11, 2019", "SEP 11, 2019", "SEP 10, 2019", "SEP 10, 2019", "SEP 15, 2019", "SEP 9, 2019", "SEP 9, 2019", "SEP 9, 2019", "SEP 9, 2019", "SEP 9, 2019", "SEP 8, 2019", "SEP 8, 2019", "SEP 9, 2019", "SEP 6, 2019", "SEP 5, 2019", "SEP 5, 2019", "SEP 3, 2019", "AUG 30, 2019", "AUG 28, 2019", "AUG 27, 2019", "SEP 8, 2019", "AUG 26, 2019", "AUG 26, 2019", "AUG 26, 2019", "AUG 25, 2019", "AUG 24, 2019", "AUG 23, 2019", "AUG 22, 2019", "AUG 26, 2019", "AUG 18, 2019", "AUG 14, 2019", "AUG 14, 2019", "AUG 13, 2019", "AUG 12, 2019", "AUG 12, 2019", "AUG 12, 2019", "AUG 21, 2019", "AUG 11, 2019", "AUG 7, 2019", "AUG 6, 2019", "AUG 5, 2019", "AUG 5, 2019", "AUG 4, 2019", "AUG 2, 2019", "AUG 12, 2019", "JUL 31, 2019", "JUL 31, 2019", "JUL 31, 2019", "JUL 30, 2019", "JUL 30, 2019", "JUL 30, 2019", "JUL 29, 2019", "JUL 31, 2019", "JUL 31, 2019", "JUL 31, 2019", "JUL 22, 2019", "JUL 17, 2019", "JUL 15, 2019", "JUL 12, 2019", "JUL 10, 2019", "JUL 27, 2019", "JUL 8, 2019", "JUL 8, 2019", "JUL 8, 2019", "JUL 6, 2019", "JUL 1, 2019", "JUL 1, 2019", "JUN 30, 2019", "JUL 8, 2019", "JUN 29, 2019", "JUN 27, 2019", "JUN 27, 2019", "JUN 25, 2019", "JUN 19, 2019", "JUN 19, 2019", "JUN 18, 2019", "JUN 29, 2019", "JUN 29, 2019", "JUN 10, 2019", "JUN 7, 2019", "JUN 6, 2019", "JUN 6, 2019", "JUN 4, 2019", "JUN 3, 2019", "JUN 18, 2019", "JUN 3, 2019", "MAY 31, 2019", "MAY 31, 2019", "MAY 30, 2019", "MAY 28, 2019", "MAY 26, 2019", "MAY 23, 2019", "JUN 3, 2019", "MAY 21, 2019", "MAY 17, 2019", "MAY 16, 2019", "MAY 16, 2019", "MAY 16, 2019", "MAY 15, 2019", "MAY 10, 2019", "MAY 23, 2019", "MAY 5, 2019", "MAY 2, 2019", "MAY 1, 2019", "MAY 1, 2019", "APR 30, 2019", "APR 30, 2019", "APR 30, 2019", "MAY 8, 2019", "MAY 5, 2019", "MAY 2, 2019", "APR 29, 2019", "APR 26, 2019", "APR 22, 2019", "APR 22, 2019", "APR 18, 2019", "APR 30, 2019", "APR 16, 2019", "APR 16, 2019", "APR 15, 2019", "APR 13, 2019", "APR 10, 2019", "APR 9, 2019", "APR 9, 2019", "APR 18, 2019", "APR 9, 2019", "APR 9, 2019", "APR 9, 2019", "APR 9, 2019", "APR 8, 2019", "APR 8, 2019", "APR 7, 2019", "APR 9, 2019", "APR 5, 2019", "APR 4, 2019", "APR 4, 2019", "APR 4, 2019", "APR 2, 2019", "APR 2, 2019", "APR 1, 2019", "APR 7, 2019", "APR 5, 2019", "MAR 27, 2019", "MAR 26, 2019", "MAR 26, 2019", "MAR 25, 2019", "MAR 25, 2019", "MAR 22, 2019", "APR 1, 2019", "MAR 18, 2019", "MAR 18, 2019", "MAR 18, 2019", "MAR 17, 2019", "MAR 15, 2019", "MAR 15, 2019", "MAR 14, 2019", "MAR 20, 2019", "MAR 12, 2019", "MAR 12, 2019", "MAR 11, 2019", "MAR 11, 2019", "MAR 10, 2019", "MAR 8, 2019", "MAR 7, 2019", "MAR 13, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 5, 2019", "MAR 5, 2019", "MAR 5, 2019", "MAR 4, 2019", "MAR 4, 2019", "MAR 6, 2019", "MAR 1, 2019", "FEB 26, 2019", "FEB 26, 2019", "FEB 25, 2019", "FEB 25, 2019", "FEB 24, 2019", "FEB 22, 2019", "MAR 1, 2019", "FEB 21, 2019", "FEB 21, 2019", "FEB 20, 2019", "FEB 20, 2019", "FEB 20, 2019", "FEB 19, 2019", "FEB 18, 2019", "FEB 21, 2019", "FEB 14, 2019", "FEB 13, 2019", "FEB 13, 2019", "FEB 13, 2019", "FEB 12, 2019", "FEB 12, 2019", "FEB 12, 2019", "FEB 17, 2019", "FEB 14, 2019", "FEB 11, 2019", "FEB 8, 2019", "FEB 7, 2019", "FEB 6, 2019", "FEB 6, 2019", "FEB 6, 2019", "FEB 11, 2019", "FEB 5, 2019", "FEB 4, 2019", "FEB 4, 2019", "FEB 3, 2019", "FEB 1, 2019", "FEB 1, 2019", "FEB 1, 2019", "FEB 5, 2019", "FEB 1, 2019", "FEB 1, 2019", "JAN 31, 2019", "JAN 30, 2019", "JAN 30, 2019", "JAN 30, 2019", "JAN 29, 2019", "FEB 1, 2019", "JAN 29, 2019", "JAN 29, 2019", "JAN 29, 2019", "JAN 29, 2019", "JAN 28, 2019", "JAN 28, 2019", "JAN 25, 2019", "JAN 29, 2019", "JAN 25, 2019", "JAN 25, 2019", "JAN 25, 2019", "JAN 24, 2019", "JAN 24, 2019", "JAN 24, 2019", "JAN 24, 2019", "JAN 25, 2019", "JAN 25, 2019", "JAN 21, 2019", "JAN 21, 2019", "JAN 21, 2019", "JAN 20, 2019", "JAN 18, 2019", "JAN 17, 2019", "JAN 23, 2019", "JAN 16, 2019", "JAN 15, 2019", "JAN 14, 2019", "JAN 14, 2019", "JAN 9, 2019", "JAN 7, 2019", "JAN 7, 2019", "JAN 16, 2019", "JAN 7, 2019", "JAN 6, 2019", "JAN 4, 2019", "JAN 4, 2019", "JAN 3, 2019", "JAN 3, 2019", "JAN 3, 2019", "JAN 7, 2019", "JAN 3, 2019", "JAN 2, 2019", "JAN 2, 2019", "JAN 2, 2019", "DEC 29, 2018", "DEC 28, 2018", "DEC 28, 2018", "JAN 3, 2019", "DEC 27, 2018", "DEC 24, 2018", "DEC 21, 2018", "DEC 21, 2018", "DEC 20, 2018", "DEC 20, 2018", "DEC 20, 2018", "DEC 27, 2018", "DEC 27, 2018", "DEC 24, 2018", "DEC 21, 2018", "DEC 18, 2018", "DEC 18, 2018", "DEC 18, 2018", "DEC 18, 2018", "DEC 20, 2018", "DEC 18, 2018", "DEC 17, 2018", "DEC 15, 2018", "DEC 14, 2018", "DEC 14, 2018", "DEC 13, 2018", "DEC 12, 2018", "DEC 18, 2018", "DEC 12, 2018", "DEC 11, 2018", "DEC 11, 2018", "DEC 11, 2018", "DEC 11, 2018", "DEC 10, 2018", "DEC 10, 2018", "DEC 12, 2018", "DEC 7, 2018", "DEC 5, 2018", "DEC 4, 2018", "DEC 3, 2018", "DEC 3, 2018", "DEC 3, 2018", "DEC 3, 2018", "DEC 10, 2018", "NOV 28, 2018", "NOV 28, 2018", "NOV 28, 2018", "NOV 27, 2018", "NOV 26, 2018", "NOV 26, 2018", "NOV 22, 2018", "NOV 29, 2018", "NOV 19, 2018", "NOV 19, 2018", "NOV 19, 2018", "NOV 19, 2018", "NOV 16, 2018", "NOV 15, 2018", "NOV 15, 2018", "NOV 21, 2018", "NOV 14, 2018", "NOV 13, 2018", "NOV 12, 2018", "NOV 12, 2018", "NOV 11, 2018", "NOV 9, 2018", "NOV 9, 2018", "NOV 14, 2018", "NOV 14, 2018", "NOV 7, 2018", "NOV 7, 2018", "NOV 7, 2018", "NOV 7, 2018", "NOV 7, 2018", "NOV 7, 2018", "NOV 9, 2018", "NOV 6, 2018", "NOV 5, 2018", "NOV 3, 2018", "NOV 2, 2018", "NOV 2, 2018", "NOV 2, 2018", "NOV 2, 2018", "NOV 7, 2018", "NOV 1, 2018", "OCT 31, 2018", "OCT 31, 2018", "OCT 30, 2018", "OCT 30, 2018", "OCT 30, 2018", "OCT 30, 2018", "NOV 1, 2018", "OCT 30, 2018", "OCT 30, 2018", "OCT 30, 2018", "OCT 29, 2018", "OCT 29, 2018", "OCT 29, 2018", "OCT 28, 2018", "OCT 30, 2018", "OCT 26, 2018", "OCT 26, 2018", "OCT 26, 2018", "OCT 26, 2018", "OCT 26, 2018", "OCT 25, 2018", "OCT 25, 2018", "OCT 26, 2018", "OCT 26, 2018", "OCT 26, 2018", "OCT 26, 2018", "OCT 24, 2018", "OCT 24, 2018", "OCT 24, 2018", "OCT 25, 2018", "OCT 23, 2018", "OCT 23, 2018", "OCT 23, 2018", "OCT 22, 2018", "OCT 22, 2018", "OCT 22, 2018", "OCT 22, 2018", "OCT 24, 2018", "OCT 21, 2018", "OCT 20, 2018", "OCT 19, 2018", "OCT 19, 2018", "OCT 19, 2018", "OCT 19, 2018", "OCT 17, 2018", "OCT 22, 2018", "OCT 21, 2018", "OCT 20, 2018", "OCT 12, 2018", "OCT 12, 2018", "OCT 12, 2018", "OCT 11, 2018", "OCT 11, 2018", "OCT 16, 2018", "OCT 11, 2018", "OCT 11, 2018", "OCT 10, 2018", "OCT 9, 2018", "OCT 9, 2018", "OCT 9, 2018", "OCT 9, 2018", "OCT 11, 2018", "OCT 8, 2018", "OCT 5, 2018", "OCT 4, 2018", "OCT 3, 2018", "OCT 3, 2018", "OCT 3, 2018", "OCT 2, 2018", "OCT 8, 2018", "SEP 28, 2018", "SEP 28, 2018", "SEP 27, 2018", "SEP 27, 2018", "SEP 26, 2018", "SEP 24, 2018", "SEP 24, 2018", "OCT 1, 2018", "SEP 21, 2018", "SEP 21, 2018", "SEP 20, 2018", "SEP 20, 2018", "SEP 19, 2018", "SEP 19, 2018", "SEP 19, 2018", "SEP 24, 2018", "SEP 18, 2018", "SEP 17, 2018", "SEP 17, 2018", "SEP 17, 2018", "SEP 16, 2018", "SEP 15, 2018", "SEP 14, 2018", "SEP 18, 2018", "SEP 13, 2018", "SEP 13, 2018", "SEP 12, 2018", "SEP 12, 2018", "SEP 11, 2018", "SEP 11, 2018", "SEP 11, 2018", "SEP 14, 2018", "SEP 11, 2018", "SEP 10, 2018", "SEP 7, 2018", "SEP 6, 2018", "SEP 6, 2018", "SEP 5, 2018", "SEP 5, 2018", "SEP 11, 2018", "SEP 2, 2018", "AUG 31, 2018", "AUG 29, 2018", "AUG 29, 2018", "AUG 28, 2018", "AUG 27, 2018", "AUG 27, 2018", "SEP 4, 2018", "SEP 2, 2018", "AUG 23, 2018", "AUG 23, 2018", "AUG 22, 2018", "AUG 22, 2018", "AUG 21, 2018", "AUG 24, 2018", "AUG 15, 2018", "AUG 15, 2018", "AUG 15, 2018", "AUG 14, 2018", "AUG 14, 2018", "AUG 14, 2018", "AUG 14, 2018", "AUG 20, 2018", "AUG 13, 2018", "AUG 10, 2018", "AUG 9, 2018", "AUG 8, 2018", "AUG 8, 2018", "AUG 7, 2018", "AUG 7, 2018", "AUG 13, 2018", "AUG 6, 2018", "AUG 3, 2018", "AUG 2, 2018", "AUG 2, 2018", "AUG 1, 2018", "AUG 1, 2018", "JUL 31, 2018", "AUG 6, 2018", "AUG 6, 2018", "AUG 3, 2018", "JUL 26, 2018", "JUL 26, 2018", "JUL 26, 2018", "JUL 25, 2018", "JUL 25, 2018", "JUL 27, 2018", "JUL 23, 2018", "JUL 23, 2018", "JUL 19, 2018", "JUL 19, 2018", "JUL 19, 2018", "JUL 18, 2018", "JUL 18, 2018", "JUL 24, 2018", "JUL 17, 2018", "JUL 16, 2018", "JUL 16, 2018", "JUL 16, 2018", "JUL 15, 2018", "JUL 13, 2018", "JUL 13, 2018", "JUL 18, 2018", "JUL 13, 2018", "JUL 12, 2018", "JUL 12, 2018", "JUL 11, 2018", "JUL 11, 2018", "JUL 10, 2018", "JUL 10, 2018", "JUL 13, 2018", "JUL 13, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 5, 2018", "JUL 5, 2018", "JUL 5, 2018", "JUL 3, 2018", "JUL 9, 2018", "JUL 2, 2018", "JUL 2, 2018", "JUL 2, 2018", "JUL 1, 2018", "JUN 29, 2018", "JUN 28, 2018", "JUN 28, 2018", "JUL 3, 2018", "JUL 2, 2018", "JUL 2, 2018", "JUN 26, 2018", "JUN 26, 2018", "JUN 25, 2018", "JUN 25, 2018", "JUN 28, 2018", "JUN 22, 2018", "JUN 21, 2018", "JUN 20, 2018", "JUN 20, 2018", "JUN 18, 2018", "JUN 18, 2018", "JUN 15, 2018", "JUN 24, 2018", "JUN 14, 2018", "JUN 14, 2018", "JUN 14, 2018", "JUN 13, 2018", "JUN 13, 2018", "JUN 13, 2018", "JUN 13, 2018", "JUN 15, 2018", "JUN 12, 2018", "JUN 12, 2018", "JUN 11, 2018", "JUN 11, 2018", "JUN 8, 2018", "JUN 6, 2018", "JUN 5, 2018", "JUN 13, 2018", "JUN 5, 2018", "JUN 5, 2018", "JUN 4, 2018", "JUN 4, 2018", "JUN 4, 2018", "JUN 4, 2018", "JUN 3, 2018", "JUN 5, 2018", "JUN 1, 2018", "MAY 31, 2018", "MAY 30, 2018", "MAY 24, 2018", "MAY 24, 2018", "MAY 24, 2018", "MAY 24, 2018", "JUN 3, 2018", "MAY 24, 2018", "MAY 24, 2018", "MAY 23, 2018", "MAY 23, 2018", "MAY 23, 2018", "MAY 22, 2018", "MAY 22, 2018", "MAY 24, 2018", "MAY 21, 2018", "MAY 21, 2018", "MAY 18, 2018", "MAY 18, 2018", "MAY 18, 2018", "MAY 18, 2018", "MAY 17, 2018", "MAY 21, 2018", "MAY 17, 2018", "MAY 16, 2018", "MAY 16, 2018", "MAY 15, 2018", "MAY 15, 2018", "MAY 14, 2018", "MAY 14, 2018", "MAY 17, 2018", "MAY 11, 2018", "MAY 10, 2018", "MAY 9, 2018", "MAY 9, 2018", "MAY 9, 2018", "MAY 7, 2018", "MAY 5, 2018", "MAY 11, 2018", "MAY 4, 2018", "MAY 4, 2018", "MAY 3, 2018", "MAY 2, 2018", "MAY 1, 2018", "MAY 1, 2018", "MAY 1, 2018", "MAY 4, 2018", "APR 27, 2018", "APR 26, 2018", "APR 25, 2018", "APR 25, 2018", "APR 25, 2018", "APR 25, 2018", "APR 24, 2018", "APR 30, 2018", "APR 24, 2018", "APR 24, 2018", "APR 24, 2018", "APR 24, 2018", "APR 23, 2018", "APR 23, 2018", "APR 20, 2018", "APR 24, 2018", "APR 20, 2018", "APR 20, 2018", "APR 20, 2018", "APR 19, 2018", "APR 18, 2018", "APR 18, 2018", "APR 18, 2018", "APR 20, 2018", "APR 17, 2018", "APR 12, 2018", "APR 12, 2018", "APR 12, 2018", "APR 10, 2018", "APR 6, 2018", "APR 5, 2018", "APR 18, 2018", "APR 4, 2018", "APR 4, 2018", "APR 3, 2018", "APR 3, 2018", "APR 3, 2018", "APR 2, 2018", "MAR 30, 2018", "APR 5, 2018", "MAR 29, 2018", "MAR 28, 2018", "MAR 27, 2018", "MAR 27, 2018", "MAR 26, 2018", "MAR 26, 2018", "MAR 26, 2018", "MAR 30, 2018", "MAR 23, 2018", "MAR 23, 2018", "MAR 23, 2018", "MAR 23, 2018", "MAR 22, 2018", "MAR 22, 2018", "MAR 21, 2018", "MAR 23, 2018", "MAR 19, 2018", "MAR 19, 2018", "MAR 16, 2018", "MAR 14, 2018", "MAR 14, 2018", "MAR 14, 2018", "MAR 14, 2018", "MAR 19, 2018", "MAR 13, 2018", "MAR 13, 2018", "MAR 12, 2018", "MAR 12, 2018", "MAR 9, 2018", "MAR 8, 2018", "MAR 8, 2018", "MAR 14, 2018", "MAR 7, 2018", "MAR 7, 2018", "MAR 6, 2018", "MAR 6, 2018", "MAR 6, 2018", "MAR 5, 2018", "MAR 5, 2018", "MAR 7, 2018", "MAR 2, 2018", "MAR 1, 2018", "MAR 1, 2018", "MAR 1, 2018", "FEB 28, 2018", "FEB 27, 2018", "FEB 27, 2018", "MAR 2, 2018", "FEB 23, 2018", "FEB 23, 2018", "FEB 23, 2018", "FEB 22, 2018", "FEB 21, 2018", "FEB 21, 2018", "FEB 21, 2018", "FEB 26, 2018", "FEB 18, 2018", "FEB 16, 2018", "FEB 16, 2018", "FEB 15, 2018", "FEB 15, 2018", "FEB 15, 2018", "FEB 14, 2018", "FEB 20, 2018", "FEB 14, 2018", "FEB 13, 2018", "FEB 13, 2018", "FEB 13, 2018", "FEB 13, 2018", "FEB 12, 2018", "FEB 11, 2018", "FEB 14, 2018", "FEB 8, 2018", "FEB 6, 2018", "FEB 6, 2018", "FEB 6, 2018", "FEB 6, 2018", "FEB 3, 2018", "FEB 2, 2018", "FEB 9, 2018", "FEB 1, 2018", "FEB 1, 2018", "FEB 1, 2018", "FEB 1, 2018", "JAN 31, 2018", "JAN 31, 2018", "JAN 30, 2018", "FEB 1, 2018", "JAN 30, 2018", "JAN 30, 2018", "JAN 30, 2018", "JAN 29, 2018", "JAN 29, 2018", "JAN 29, 2018", "JAN 29, 2018", "JAN 30, 2018", "JAN 26, 2018", "JAN 26, 2018", "JAN 24, 2018", "JAN 24, 2018", "JAN 23, 2018", "JAN 23, 2018", "JAN 28, 2018", "JAN 23, 2018", "JAN 22, 2018", "JAN 22, 2018", "JAN 22, 2018", "JAN 22, 2018", "JAN 22, 2018", "JAN 22, 2018", "JAN 23, 2018", "JAN 23, 2018", "JAN 19, 2018", "JAN 19, 2018", "JAN 18, 2018", "JAN 18, 2018", "JAN 17, 2018", "JAN 21, 2018", "JAN 17, 2018", "JAN 17, 2018", "JAN 16, 2018", "JAN 16, 2018", "JAN 16, 2018", "JAN 12, 2018", "JAN 12, 2018", "JAN 17, 2018", "JAN 17, 2018", "JAN 11, 2018", "JAN 11, 2018", "JAN 11, 2018", "JAN 11, 2018", "JAN 10, 2018", "JAN 10, 2018", "JAN 12, 2018", "JAN 11, 2018", "JAN 10, 2018", "JAN 10, 2018", "JAN 9, 2018", "JAN 9, 2018", "JAN 9, 2018", "JAN 9, 2018", "JAN 10, 2018", "JAN 7, 2018", "JAN 6, 2018", "JAN 5, 2018", "JAN 5, 2018", "JAN 4, 2018", "JAN 4, 2018", "JAN 4, 2018", "JAN 8, 2018", "JAN 2, 2018", "DEC 29, 2017", "DEC 27, 2017", "DEC 27, 2017", "DEC 23, 2017", "DEC 22, 2017", "DEC 18, 2017", "JAN 3, 2018", "JAN 2, 2018", "DEC 29, 2017", "DEC 27, 2017", "DEC 27, 2017", "DEC 23, 2017", "DEC 15, 2017", "DEC 18, 2017", "DEC 14, 2017", "DEC 13, 2017", "DEC 13, 2017", "DEC 13, 2017", "DEC 13, 2017", "DEC 13, 2017", "DEC 12, 2017", "DEC 14, 2017", "DEC 11, 2017", "DEC 8, 2017", "DEC 8, 2017", "DEC 7, 2017", "DEC 6, 2017", "DEC 6, 2017", "DEC 6, 2017", "DEC 11, 2017", "DEC 4, 2017", "DEC 4, 2017", "DEC 4, 2017", "DEC 4, 2017", "NOV 30, 2017", "NOV 30, 2017", "NOV 30, 2017", "DEC 5, 2017", "NOV 29, 2017", "NOV 29, 2017", "NOV 29, 2017", "NOV 29, 2017", "NOV 24, 2017", "NOV 24, 2017", "NOV 22, 2017", "NOV 30, 2017", "NOV 29, 2017", "NOV 20, 2017", "NOV 17, 2017", "NOV 16, 2017", "NOV 15, 2017", "NOV 15, 2017", "NOV 15, 2017", "NOV 21, 2017", "NOV 15, 2017", "NOV 14, 2017", "NOV 14, 2017", "NOV 14, 2017", "NOV 13, 2017", "NOV 10, 2017", "NOV 9, 2017", "NOV 15, 2017", "NOV 3, 2017", "NOV 3, 2017", "NOV 3, 2017", "NOV 2, 2017", "NOV 2, 2017", "NOV 1, 2017", "NOV 8, 2017", "OCT 31, 2017", "OCT 31, 2017", "OCT 31, 2017", "OCT 30, 2017", "OCT 29, 2017", "OCT 27, 2017", "OCT 27, 2017", "NOV 1, 2017", "OCT 27, 2017", "OCT 27, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 27, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 25, 2017", "OCT 25, 2017", "OCT 25, 2017", "OCT 25, 2017", "OCT 25, 2017", "OCT 26, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 23, 2017", "OCT 25, 2017", "OCT 20, 2017", "OCT 20, 2017", "OCT 20, 2017", "OCT 19, 2017", "OCT 19, 2017", "OCT 19, 2017", "OCT 19, 2017", "OCT 23, 2017", "OCT 18, 2017", "OCT 17, 2017", "OCT 17, 2017", "OCT 17, 2017", "OCT 16, 2017", "OCT 16, 2017", "OCT 16, 2017", "OCT 19, 2017", "OCT 14, 2017", "OCT 13, 2017", "OCT 13, 2017", "OCT 12, 2017", "OCT 11, 2017", "OCT 11, 2017", "OCT 11, 2017", "OCT 16, 2017", "OCT 10, 2017", "OCT 10, 2017", "OCT 9, 2017", "OCT 9, 2017", "OCT 8, 2017", "OCT 8, 2017", "OCT 7, 2017", "OCT 11, 2017", "OCT 6, 2017", "OCT 6, 2017", "OCT 6, 2017", "OCT 6, 2017", "OCT 6, 2017", "OCT 6, 2017", "OCT 6, 2017", "OCT 7, 2017", "OCT 5, 2017", "OCT 5, 2017", "OCT 5, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 5, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 3, 2017", "OCT 3, 2017", "OCT 4, 2017", "OCT 3, 2017", "OCT 3, 2017", "OCT 2, 2017", "OCT 2, 2017", "OCT 2, 2017", "OCT 2, 2017", "SEP 29, 2017", "OCT 3, 2017", "SEP 29, 2017", "SEP 28, 2017", "SEP 28, 2017", "SEP 28, 2017", "SEP 28, 2017", "SEP 28, 2017", "SEP 27, 2017", "SEP 29, 2017", "SEP 26, 2017", "SEP 25, 2017", "SEP 21, 2017", "SEP 21, 2017", "SEP 21, 2017", "SEP 20, 2017", "SEP 20, 2017", "SEP 27, 2017", "SEP 19, 2017", "SEP 18, 2017", "SEP 17, 2017", "SEP 16, 2017", "SEP 15, 2017", "SEP 15, 2017", "SEP 15, 2017", "SEP 19, 2017", "SEP 14, 2017", "SEP 14, 2017", "SEP 13, 2017", "SEP 13, 2017", "SEP 13, 2017", "SEP 13, 2017", "SEP 12, 2017", "SEP 14, 2017", "SEP 12, 2017", "SEP 12, 2017", "SEP 12, 2017", "SEP 11, 2017", "SEP 11, 2017", "SEP 7, 2017", "SEP 7, 2017", "SEP 12, 2017", "SEP 6, 2017", "SEP 6, 2017", "SEP 6, 2017", "SEP 4, 2017", "SEP 4, 2017", "SEP 1, 2017", "SEP 1, 2017", "SEP 7, 2017", "SEP 6, 2017", "AUG 29, 2017", "AUG 29, 2017", "AUG 29, 2017", "AUG 27, 2017", "AUG 26, 2017", "AUG 31, 2017", "AUG 25, 2017", "AUG 24, 2017", "AUG 24, 2017", "AUG 23, 2017", "AUG 23, 2017", "AUG 22, 2017", "AUG 22, 2017", "AUG 25, 2017", "AUG 20, 2017", "AUG 18, 2017", "AUG 18, 2017", "AUG 16, 2017", "AUG 15, 2017", "AUG 15, 2017", "AUG 15, 2017", "AUG 21, 2017", "AUG 20, 2017", "AUG 18, 2017", "AUG 18, 2017", "AUG 16, 2017", "AUG 9, 2017", "AUG 8, 2017", "AUG 15, 2017", "AUG 8, 2017", "AUG 8, 2017", "AUG 7, 2017", "AUG 4, 2017", "AUG 3, 2017", "AUG 3, 2017", "AUG 1, 2017", "AUG 8, 2017", "JUL 31, 2017", "JUL 31, 2017", "JUL 28, 2017", "JUL 28, 2017", "JUL 27, 2017", "JUL 27, 2017", "JUL 27, 2017", "JUL 31, 2017", "JUL 27, 2017", "JUL 26, 2017", "JUL 26, 2017", "JUL 26, 2017", "JUL 26, 2017", "JUL 26, 2017", "JUL 26, 2017", "JUL 27, 2017", "JUL 25, 2017", "JUL 25, 2017", "JUL 25, 2017", "JUL 25, 2017", "JUL 24, 2017", "JUL 24, 2017", "JUL 23, 2017", "JUL 26, 2017", "JUL 21, 2017", "JUL 21, 2017", "JUL 20, 2017", "JUL 19, 2017", "JUL 19, 2017", "JUL 18, 2017", "JUL 18, 2017", "JUL 21, 2017", "JUL 21, 2017", "JUL 14, 2017", "JUL 14, 2017", "JUL 14, 2017", "JUL 14, 2017", "JUL 14, 2017", "JUL 17, 2017", "JUL 17, 2017", "JUL 13, 2017", "JUL 13, 2017", "JUL 12, 2017", "JUL 12, 2017", "JUL 11, 2017", "JUL 13, 2017", "JUL 10, 2017", "JUL 10, 2017", "JUL 10, 2017", "JUL 10, 2017", "JUL 9, 2017", "JUL 8, 2017", "JUL 6, 2017", "JUL 10, 2017", "JUL 5, 2017", "JUL 5, 2017", "JUL 3, 2017", "JUL 3, 2017", "JUL 3, 2017", "JUL 2, 2017", "JUN 30, 2017", "JUL 6, 2017", "JUN 30, 2017", "JUN 28, 2017", "JUN 28, 2017", "JUN 28, 2017", "JUN 27, 2017", "JUN 27, 2017", "JUN 26, 2017", "JUN 30, 2017", "JUN 22, 2017", "JUN 22, 2017", "JUN 21, 2017", "JUN 21, 2017", "JUN 21, 2017", "JUN 21, 2017", "JUN 21, 2017", "JUN 26, 2017", "JUN 22, 2017", "JUN 20, 2017", "JUN 20, 2017", "JUN 19, 2017", "JUN 19, 2017", "JUN 19, 2017", "JUN 18, 2017", "JUN 20, 2017", "JUN 16, 2017", "JUN 16, 2017", "JUN 16, 2017", "JUN 16, 2017", "JUN 16, 2017", "JUN 15, 2017", "JUN 15, 2017", "JUN 17, 2017", "JUN 15, 2017", "JUN 15, 2017", "JUN 13, 2017", "JUN 13, 2017", "JUN 13, 2017", "JUN 13, 2017", "JUN 13, 2017", "JUN 15, 2017", "JUN 12, 2017", "JUN 12, 2017", "JUN 12, 2017", "JUN 9, 2017", "JUN 8, 2017", "JUN 8, 2017", "JUN 8, 2017", "JUN 12, 2017", "JUN 12, 2017", "JUN 6, 2017", "JUN 6, 2017", "JUN 6, 2017", "JUN 5, 2017", "JUN 5, 2017", "MAY 31, 2017", "JUN 8, 2017", "MAY 30, 2017", "MAY 30, 2017", "MAY 27, 2017", "MAY 26, 2017", "MAY 26, 2017", "MAY 25, 2017", "MAY 25, 2017", "MAY 31, 2017", "MAY 24, 2017", "MAY 24, 2017", "MAY 23, 2017", "MAY 23, 2017", "MAY 23, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 24, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 19, 2017", "MAY 19, 2017", "MAY 19, 2017", "MAY 19, 2017", "MAY 18, 2017", "MAY 17, 2017", "MAY 17, 2017", "MAY 19, 2017", "MAY 16, 2017", "MAY 16, 2017", "MAY 15, 2017", "MAY 15, 2017", "MAY 14, 2017", "MAY 12, 2017", "MAY 12, 2017", "MAY 16, 2017", "MAY 11, 2017", "MAY 11, 2017", "MAY 10, 2017", "MAY 10, 2017", "MAY 10, 2017", "MAY 10, 2017", "MAY 9, 2017", "MAY 12, 2017", "MAY 4, 2017", "MAY 3, 2017", "MAY 3, 2017", "MAY 3, 2017", "MAY 2, 2017", "MAY 2, 2017", "APR 29, 2017", "MAY 7, 2017", "APR 28, 2017", "APR 28, 2017", "APR 27, 2017", "APR 27, 2017", "APR 27, 2017", "APR 27, 2017", "APR 27, 2017", "APR 29, 2017", "APR 28, 2017", "APR 28, 2017", "APR 26, 2017", "APR 26, 2017", "APR 26, 2017", "APR 26, 2017", "APR 26, 2017", "APR 26, 2017", "APR 26, 2017", "APR 26, 2017", "APR 26, 2017", "APR 25, 2017", "APR 25, 2017", "APR 25, 2017", "APR 25, 2017", "APR 25, 2017", "APR 24, 2017", "APR 24, 2017", "APR 23, 2017", "APR 21, 2017", "APR 21, 2017", "APR 21, 2017", "APR 20, 2017", "APR 24, 2017", "APR 20, 2017", "APR 20, 2017", "APR 18, 2017", "APR 18, 2017", "APR 17, 2017", "APR 14, 2017", "APR 12, 2017", "APR 20, 2017", "APR 11, 2017", "APR 11, 2017", "APR 11, 2017", "APR 11, 2017", "APR 10, 2017", "APR 8, 2017", "APR 7, 2017", "APR 12, 2017", "APR 6, 2017", "APR 6, 2017", "APR 6, 2017", "APR 5, 2017", "APR 5, 2017", "APR 5, 2017", "APR 5, 2017", "APR 6, 2017", "APR 6, 2017", "APR 2, 2017", "APR 1, 2017", "MAR 31, 2017", "MAR 31, 2017", "MAR 31, 2017", "APR 4, 2017", "MAR 30, 2017", "MAR 29, 2017", "MAR 29, 2017", "MAR 29, 2017", "MAR 28, 2017", "MAR 28, 2017", "MAR 28, 2017", "MAR 30, 2017", "MAR 27, 2017", "MAR 27, 2017", "MAR 27, 2017", "MAR 24, 2017", "MAR 24, 2017", "MAR 24, 2017", "MAR 24, 2017", "MAR 27, 2017", "MAR 22, 2017", "MAR 22, 2017", "MAR 22, 2017", "MAR 21, 2017", "MAR 21, 2017", "MAR 21, 2017", "MAR 20, 2017", "MAR 23, 2017", "MAR 22, 2017", "MAR 22, 2017", "MAR 17, 2017", "MAR 17, 2017", "MAR 17, 2017", "MAR 17, 2017", "MAR 20, 2017", "MAR 17, 2017", "MAR 17, 2017", "MAR 17, 2017", "MAR 17, 2017", "MAR 17, 2017", "MAR 16, 2017", "MAR 17, 2017", "MAR 16, 2017", "MAR 15, 2017", "MAR 14, 2017", "MAR 14, 2017", "MAR 13, 2017", "MAR 13, 2017", "MAR 13, 2017", "MAR 16, 2017", "MAR 10, 2017", "MAR 10, 2017", "MAR 10, 2017", "MAR 9, 2017", "MAR 8, 2017", "MAR 8, 2017", "MAR 7, 2017", "MAR 11, 2017", "MAR 10, 2017", "MAR 3, 2017", "MAR 3, 2017", "MAR 2, 2017", "MAR 1, 2017", "MAR 1, 2017", "MAR 1, 2017", "MAR 7, 2017", "FEB 28, 2017", "FEB 27, 2017", "FEB 27, 2017", "FEB 26, 2017", "FEB 24, 2017", "FEB 24, 2017", "FEB 23, 2017", "FEB 28, 2017", "FEB 22, 2017", "FEB 22, 2017", "FEB 22, 2017", "FEB 22, 2017", "FEB 21, 2017", "FEB 17, 2017", "FEB 17, 2017", "FEB 23, 2017", "FEB 22, 2017", "FEB 22, 2017", "FEB 22, 2017", "FEB 22, 2017", "FEB 21, 2017", "FEB 15, 2017", "FEB 15, 2017", "FEB 17, 2017", "FEB 14, 2017", "FEB 13, 2017", "FEB 13, 2017", "FEB 13, 2017", "FEB 10, 2017", "FEB 10, 2017", "FEB 10, 2017", "FEB 14, 2017", "FEB 14, 2017", "FEB 9, 2017", "FEB 8, 2017", "FEB 8, 2017", "FEB 8, 2017", "FEB 8, 2017", "FEB 8, 2017", "FEB 10, 2017", "FEB 7, 2017", "FEB 6, 2017", "FEB 6, 2017", "FEB 6, 2017", "FEB 5, 2017", "FEB 3, 2017", "FEB 3, 2017", "FEB 8, 2017", "FEB 3, 2017", "FEB 3, 2017", "FEB 3, 2017", "FEB 3, 2017", "FEB 3, 2017", "FEB 3, 2017", "FEB 2, 2017", "FEB 3, 2017", "FEB 3, 2017", "FEB 1, 2017", "FEB 1, 2017", "FEB 1, 2017", "FEB 1, 2017", "FEB 1, 2017", "FEB 1, 2017", "FEB 2, 2017", "FEB 1, 2017", "FEB 1, 2017", "FEB 1, 2017", "JAN 30, 2017", "JAN 30, 2017", "JAN 27, 2017", "JAN 27, 2017", "JAN 31, 2017", "JAN 31, 2017", "JAN 31, 2017", "JAN 26, 2017", "JAN 25, 2017", "JAN 24, 2017", "JAN 19, 2017", "JAN 27, 2017", "JAN 18, 2017", "JAN 18, 2017", "JAN 18, 2017", "JAN 18, 2017", "JAN 17, 2017", "JAN 14, 2017", "JAN 13, 2017", "JAN 19, 2017", "JAN 11, 2017", "JAN 11, 2017", "JAN 11, 2017", "JAN 11, 2017", "JAN 11, 2017", "JAN 10, 2017", "JAN 10, 2017", "JAN 12, 2017", "JAN 10, 2017", "JAN 10, 2017", "JAN 9, 2017", "JAN 9, 2017", "JAN 8, 2017", "JAN 6, 2017", "JAN 6, 2017", "JAN 10, 2017", "JAN 6, 2017", "JAN 6, 2017", "JAN 6, 2017", "JAN 6, 2017", "JAN 6, 2017", "JAN 6, 2017", "JAN 6, 2017", "JAN 6, 2017", "JAN 6, 2017", "JAN 6, 2017", "JAN 4, 2017", "JAN 4, 2017", "JAN 4, 2017", "JAN 3, 2017", "JAN 1, 2017", "JAN 6, 2017", "JAN 5, 2017", "JAN 4, 2017", "DEC 27, 2016", "DEC 25, 2016", "DEC 23, 2016", "DEC 22, 2016", "DEC 31, 2016", "DEC 30, 2016", "DEC 20, 2016", "DEC 20, 2016", "DEC 19, 2016", "DEC 19, 2016", "DEC 18, 2016", "DEC 21, 2016", "DEC 16, 2016", "DEC 15, 2016", "DEC 15, 2016", "DEC 15, 2016", "DEC 14, 2016", "DEC 13, 2016", "DEC 13, 2016", "DEC 16, 2016", "DEC 16, 2016", "DEC 15, 2016", "DEC 12, 2016", "DEC 11, 2016", "DEC 8, 2016", "DEC 8, 2016", "DEC 7, 2016", "DEC 13, 2016", "DEC 12, 2016", "DEC 12, 2016", "DEC 12, 2016", "DEC 11, 2016", "DEC 8, 2016", "DEC 8, 2016", "NOV 30, 2016", "DEC 7, 2016", "NOV 29, 2016", "NOV 29, 2016", "NOV 22, 2016", "NOV 22, 2016", "NOV 21, 2016", "NOV 21, 2016", "NOV 18, 2016", "NOV 30, 2016", "NOV 18, 2016", "NOV 18, 2016", "NOV 17, 2016", "NOV 17, 2016", "NOV 17, 2016", "NOV 16, 2016", "NOV 16, 2016", "NOV 18, 2016", "NOV 15, 2016", "NOV 14, 2016", "NOV 14, 2016", "NOV 14, 2016", "NOV 13, 2016", "NOV 11, 2016", "NOV 11, 2016", "NOV 16, 2016", "NOV 10, 2016", "NOV 10, 2016", "NOV 10, 2016", "NOV 9, 2016", "NOV 8, 2016", "NOV 8, 2016", "NOV 8, 2016", "NOV 11, 2016", "NOV 8, 2016", "NOV 7, 2016", "NOV 7, 2016", "NOV 7, 2016", "NOV 6, 2016", "NOV 4, 2016", "NOV 4, 2016", "NOV 8, 2016", "NOV 2, 2016", "NOV 2, 2016", "NOV 1, 2016", "NOV 1, 2016", "NOV 1, 2016", "NOV 1, 2016", "OCT 31, 2016", "NOV 3, 2016", "OCT 28, 2016", "OCT 28, 2016", "OCT 28, 2016", "OCT 28, 2016", "OCT 28, 2016", "OCT 28, 2016", "OCT 28, 2016", "OCT 30, 2016", "OCT 28, 2016", "OCT 28, 2016", "OCT 27, 2016", "OCT 26, 2016", "OCT 26, 2016", "OCT 26, 2016", "OCT 26, 2016", "OCT 28, 2016", "OCT 25, 2016", "OCT 25, 2016", "OCT 25, 2016", "OCT 24, 2016", "OCT 24, 2016", "OCT 24, 2016", "OCT 24, 2016", "OCT 26, 2016", "OCT 21, 2016", "OCT 21, 2016", "OCT 21, 2016", "OCT 21, 2016", "OCT 21, 2016", "OCT 20, 2016", "OCT 20, 2016", "OCT 21, 2016", "OCT 20, 2016", "OCT 20, 2016", "OCT 19, 2016", "OCT 19, 2016", "OCT 19, 2016", "OCT 18, 2016", "OCT 20, 2016", "OCT 13, 2016", "OCT 13, 2016", "OCT 13, 2016", "OCT 12, 2016", "OCT 12, 2016", "OCT 11, 2016", "OCT 11, 2016", "OCT 17, 2016", "OCT 7, 2016", "OCT 7, 2016", "OCT 5, 2016", "OCT 4, 2016", "OCT 2, 2016", "OCT 1, 2016", "OCT 1, 2016", "OCT 7, 2016", "SEP 30, 2016", "SEP 30, 2016", "SEP 29, 2016", "SEP 29, 2016", "SEP 29, 2016", "SEP 28, 2016", "SEP 28, 2016", "SEP 30, 2016", "SEP 28, 2016", "SEP 27, 2016", "SEP 27, 2016", "SEP 27, 2016", "SEP 27, 2016", "SEP 27, 2016", "SEP 26, 2016", "SEP 28, 2016", "SEP 21, 2016", "SEP 21, 2016", "SEP 21, 2016", "SEP 20, 2016", "SEP 20, 2016", "SEP 19, 2016", "SEP 17, 2016", "SEP 26, 2016", "SEP 16, 2016", "SEP 15, 2016", "SEP 15, 2016", "SEP 14, 2016", "SEP 13, 2016", "SEP 13, 2016", "SEP 12, 2016", "SEP 16, 2016", "SEP 12, 2016", "SEP 11, 2016", "SEP 9, 2016", "SEP 9, 2016", "SEP 8, 2016", "SEP 8, 2016", "SEP 7, 2016", "SEP 12, 2016", "SEP 1, 2016", "SEP 1, 2016", "AUG 31, 2016", "AUG 31, 2016", "AUG 30, 2016", "AUG 29, 2016", "AUG 29, 2016", "SEP 2, 2016", "AUG 25, 2016", "AUG 25, 2016", "AUG 24, 2016", "AUG 24, 2016", "AUG 24, 2016", "AUG 22, 2016", "AUG 21, 2016", "AUG 27, 2016", "AUG 18, 2016", "AUG 18, 2016", "AUG 17, 2016", "AUG 17, 2016", "AUG 16, 2016", "AUG 16, 2016", "AUG 16, 2016", "AUG 19, 2016", "AUG 13, 2016", "AUG 12, 2016", "AUG 12, 2016", "AUG 12, 2016", "AUG 12, 2016", "AUG 11, 2016", "AUG 11, 2016", "AUG 14, 2016", "AUG 9, 2016", "AUG 8, 2016", "AUG 4, 2016", "AUG 4, 2016", "AUG 3, 2016", "AUG 3, 2016", "AUG 2, 2016", "AUG 9, 2016", "AUG 2, 2016", "AUG 2, 2016", "AUG 2, 2016", "AUG 1, 2016", "JUL 29, 2016", "JUL 29, 2016", "JUL 29, 2016", "AUG 2, 2016", "JUL 28, 2016", "JUL 28, 2016", "JUL 28, 2016", "JUL 28, 2016", "JUL 27, 2016", "JUL 27, 2016", "JUL 27, 2016", "JUL 29, 2016", "JUL 26, 2016", "JUL 26, 2016", "JUL 26, 2016", "JUL 26, 2016", "JUL 26, 2016", "JUL 26, 2016", "JUL 25, 2016", "JUL 27, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 20, 2016", "JUL 25, 2016", "JUL 18, 2016", "JUL 18, 2016", "JUL 18, 2016", "JUL 17, 2016", "JUL 16, 2016", "JUL 15, 2016", "JUL 14, 2016", "JUL 19, 2016", "JUL 14, 2016", "JUL 13, 2016", "JUL 13, 2016", "JUL 12, 2016", "JUL 12, 2016", "JUL 11, 2016", "JUL 7, 2016", "JUL 14, 2016", "JUL 6, 2016", "JUL 6, 2016", "JUL 6, 2016", "JUL 6, 2016", "JUL 4, 2016", "JUL 2, 2016", "JUL 1, 2016", "JUL 7, 2016", "JUL 6, 2016", "JUL 6, 2016", "JUL 6, 2016", "JUL 6, 2016", "JUN 24, 2016", "JUN 24, 2016", "JUN 29, 2016", "JUN 23, 2016", "JUN 20, 2016", "JUN 18, 2016", "JUN 14, 2016", "JUN 13, 2016", "JUN 13, 2016", "JUN 10, 2016", "JUN 23, 2016", "JUN 8, 2016", "JUN 7, 2016", "JUN 6, 2016", "JUN 6, 2016", "JUN 4, 2016", "JUN 4, 2016", "JUN 1, 2016", "JUN 9, 2016", "JUN 1, 2016", "MAY 31, 2016", "MAY 28, 2016", "MAY 27, 2016", "MAY 25, 2016", "MAY 25, 2016", "MAY 24, 2016", "JUN 1, 2016", "JUN 1, 2016", "MAY 31, 2016", "MAY 16, 2016", "MAY 16, 2016", "MAY 16, 2016", "MAY 12, 2016", "MAY 12, 2016", "MAY 21, 2016", "MAY 19, 2016", "MAY 19, 2016", "MAY 16, 2016", "MAY 10, 2016", "MAY 10, 2016", "MAY 9, 2016", "MAY 6, 2016", "MAY 12, 2016", "MAY 5, 2016", "MAY 4, 2016", "MAY 4, 2016", "MAY 4, 2016", "MAY 4, 2016", "MAY 3, 2016", "MAY 3, 2016", "MAY 6, 2016", "MAY 2, 2016", "MAY 2, 2016", "MAY 2, 2016", "MAY 2, 2016", "APR 29, 2016", "APR 29, 2016", "APR 29, 2016", "MAY 3, 2016", "APR 28, 2016", "APR 28, 2016", "APR 28, 2016", "APR 28, 2016", "APR 28, 2016", "APR 27, 2016", "APR 27, 2016", "APR 29, 2016", "APR 27, 2016", "APR 27, 2016", "APR 26, 2016", "APR 26, 2016", "APR 25, 2016", "APR 25, 2016", "APR 25, 2016", "APR 27, 2016", "APR 25, 2016", "APR 25, 2016", "APR 25, 2016", "APR 25, 2016", "APR 25, 2016", "APR 23, 2016", "APR 22, 2016", "APR 25, 2016", "APR 22, 2016", "APR 22, 2016", "APR 21, 2016", "APR 20, 2016", "APR 20, 2016", "APR 20, 2016", "APR 20, 2016", "APR 22, 2016", "APR 22, 2016", "APR 18, 2016", "APR 18, 2016", "APR 15, 2016", "APR 15, 2016", "APR 15, 2016", "APR 14, 2016", "APR 19, 2016", "APR 14, 2016", "APR 13, 2016", "APR 13, 2016", "APR 12, 2016", "APR 11, 2016", "APR 11, 2016", "APR 6, 2016", "APR 14, 2016", "APR 6, 2016", "APR 5, 2016", "APR 5, 2016", "APR 4, 2016", "APR 4, 2016", "APR 4, 2016", "APR 4, 2016", "APR 6, 2016", "APR 2, 2016", "APR 1, 2016", "APR 1, 2016", "APR 1, 2016", "APR 1, 2016", "MAR 31, 2016", "MAR 31, 2016", "APR 3, 2016", "MAR 30, 2016", "MAR 29, 2016", "MAR 28, 2016", "MAR 28, 2016", "MAR 28, 2016", "MAR 28, 2016", "MAR 28, 2016", "MAR 30, 2016", "MAR 24, 2016", "MAR 23, 2016", "MAR 22, 2016", "MAR 22, 2016", "MAR 21, 2016", "MAR 21, 2016", "MAR 21, 2016", "MAR 24, 2016", "MAR 18, 2016", "MAR 18, 2016", "MAR 18, 2016", "MAR 17, 2016", "MAR 17, 2016", "MAR 15, 2016", "MAR 11, 2016", "MAR 18, 2016", "MAR 10, 2016", "MAR 8, 2016", "MAR 7, 2016", "MAR 7, 2016", "MAR 7, 2016", "MAR 4, 2016", "MAR 4, 2016", "MAR 11, 2016", "MAR 3, 2016", "MAR 2, 2016", "MAR 2, 2016", "MAR 1, 2016", "MAR 1, 2016", "FEB 29, 2016", "FEB 26, 2016", "MAR 3, 2016", "FEB 25, 2016", "FEB 23, 2016", "FEB 23, 2016", "FEB 23, 2016", "FEB 22, 2016", "FEB 22, 2016", "FEB 22, 2016", "FEB 26, 2016", "FEB 22, 2016", "FEB 21, 2016", "FEB 19, 2016", "FEB 19, 2016", "FEB 18, 2016", "FEB 18, 2016", "FEB 16, 2016", "FEB 22, 2016", "FEB 16, 2016", "FEB 13, 2016", "FEB 12, 2016", "FEB 11, 2016", "FEB 10, 2016", "FEB 10, 2016", "FEB 9, 2016", "FEB 16, 2016", "FEB 8, 2016", "FEB 7, 2016", "FEB 5, 2016", "FEB 3, 2016", "FEB 2, 2016", "FEB 2, 2016", "FEB 1, 2016", "FEB 9, 2016", "JAN 31, 2016", "JAN 30, 2016", "JAN 30, 2016", "JAN 29, 2016", "JAN 29, 2016", "JAN 29, 2016", "JAN 29, 2016", "FEB 1, 2016", "JAN 28, 2016", "JAN 28, 2016", "JAN 28, 2016", "JAN 28, 2016", "JAN 28, 2016", "JAN 27, 2016", "JAN 27, 2016", "JAN 28, 2016", "JAN 28, 2016", "JAN 28, 2016", "JAN 28, 2016", "JAN 25, 2016", "JAN 25, 2016", "JAN 23, 2016", "JAN 22, 2016", "JAN 27, 2016", "JAN 20, 2016", "JAN 20, 2016", "JAN 19, 2016", "JAN 18, 2016", "JAN 17, 2016", "JAN 16, 2016", "JAN 14, 2016", "JAN 21, 2016", "JAN 13, 2016", "JAN 13, 2016", "JAN 12, 2016", "JAN 11, 2016", "JAN 8, 2016", "JAN 8, 2016", "JAN 8, 2016", "JAN 14, 2016", "JAN 7, 2016", "JAN 6, 2016", "JAN 6, 2016", "JAN 5, 2016", "JAN 4, 2016", "JAN 4, 2016", "JAN 4, 2016", "JAN 7, 2016", "JAN 7, 2016", "JAN 3, 2016", "JAN 3, 2016", "JAN 3, 2016", "JAN 1, 2016", "DEC 31, 2015", "DEC 30, 2015", "JAN 4, 2016", "DEC 29, 2015", "DEC 29, 2015", "DEC 29, 2015", "DEC 29, 2015", "DEC 28, 2015", "DEC 26, 2015", "DEC 24, 2015", "DEC 30, 2015", "DEC 23, 2015", "DEC 22, 2015", "DEC 22, 2015", "DEC 21, 2015", "DEC 21, 2015", "DEC 20, 2015", "DEC 17, 2015", "DEC 24, 2015", "DEC 17, 2015", "DEC 17, 2015", "DEC 17, 2015", "DEC 17, 2015", "DEC 17, 2015", "DEC 16, 2015", "DEC 16, 2015", "DEC 17, 2015", "DEC 15, 2015", "DEC 15, 2015", "DEC 15, 2015", "DEC 14, 2015", "DEC 14, 2015", "DEC 12, 2015", "DEC 11, 2015", "DEC 16, 2015", "DEC 11, 2015", "DEC 10, 2015", "DEC 9, 2015", "DEC 9, 2015", "DEC 9, 2015", "DEC 8, 2015", "DEC 7, 2015", "DEC 11, 2015", "DEC 4, 2015", "DEC 3, 2015", "DEC 3, 2015", "DEC 3, 2015", "DEC 2, 2015", "DEC 2, 2015", "DEC 4, 2015", "DEC 1, 2015", "NOV 28, 2015", "NOV 28, 2015", "NOV 27, 2015", "NOV 27, 2015", "NOV 25, 2015", "NOV 25, 2015", "DEC 1, 2015", "NOV 24, 2015", "NOV 23, 2015", "NOV 23, 2015", "NOV 21, 2015", "NOV 20, 2015", "NOV 20, 2015", "NOV 20, 2015", "NOV 24, 2015", "NOV 19, 2015", "NOV 17, 2015", "NOV 17, 2015", "NOV 16, 2015", "NOV 14, 2015", "NOV 13, 2015", "NOV 13, 2015", "NOV 19, 2015", "NOV 12, 2015", "NOV 11, 2015", "NOV 10, 2015", "NOV 10, 2015", "NOV 10, 2015", "NOV 9, 2015", "NOV 9, 2015", "NOV 13, 2015", "NOV 9, 2015", "NOV 7, 2015", "NOV 6, 2015", "NOV 6, 2015", "NOV 6, 2015", "NOV 5, 2015", "NOV 5, 2015", "NOV 9, 2015", "NOV 5, 2015", "NOV 5, 2015", "NOV 4, 2015", "NOV 3, 2015", "NOV 2, 2015", "NOV 2, 2015", "OCT 30, 2015", "NOV 5, 2015", "OCT 29, 2015", "OCT 28, 2015", "OCT 28, 2015", "OCT 28, 2015", "OCT 28, 2015", "OCT 28, 2015", "OCT 28, 2015", "OCT 29, 2015", "OCT 27, 2015", "OCT 27, 2015", "OCT 27, 2015", "OCT 27, 2015", "OCT 27, 2015", "OCT 26, 2015", "OCT 26, 2015", "OCT 28, 2015", "OCT 27, 2015", "OCT 24, 2015", "OCT 23, 2015", "OCT 23, 2015", "OCT 23, 2015", "OCT 23, 2015", "OCT 23, 2015", "OCT 26, 2015", "OCT 23, 2015", "OCT 22, 2015", "OCT 22, 2015", "OCT 21, 2015", "OCT 21, 2015", "OCT 21, 2015", "OCT 21, 2015", "OCT 23, 2015", "OCT 21, 2015", "OCT 20, 2015", "OCT 19, 2015", "OCT 19, 2015", "OCT 19, 2015", "OCT 19, 2015", "OCT 19, 2015", "OCT 21, 2015", "OCT 19, 2015", "OCT 19, 2015", "OCT 18, 2015", "OCT 17, 2015", "OCT 16, 2015", "OCT 16, 2015", "OCT 16, 2015", "OCT 19, 2015", "OCT 16, 2015", "OCT 16, 2015", "OCT 16, 2015", "OCT 16, 2015", "OCT 16, 2015", "OCT 15, 2015", "OCT 15, 2015", "OCT 16, 2015", "OCT 15, 2015", "OCT 14, 2015", "OCT 14, 2015", "OCT 14, 2015", "OCT 14, 2015", "OCT 13, 2015", "OCT 13, 2015", "OCT 15, 2015", "OCT 13, 2015", "OCT 13, 2015", "OCT 13, 2015", "OCT 13, 2015", "OCT 13, 2015", "OCT 12, 2015", "OCT 12, 2015", "OCT 13, 2015", "OCT 9, 2015", "OCT 8, 2015", "OCT 8, 2015", "OCT 8, 2015", "OCT 7, 2015", "OCT 7, 2015", "OCT 7, 2015", "OCT 12, 2015", "OCT 9, 2015", "OCT 8, 2015", "OCT 7, 2015", "OCT 6, 2015", "OCT 6, 2015", "OCT 6, 2015", "OCT 7, 2015", "OCT 7, 2015", "OCT 5, 2015", "OCT 4, 2015", "OCT 2, 2015", "OCT 2, 2015", "OCT 1, 2015", "OCT 1, 2015", "OCT 6, 2015", "SEP 30, 2015", "SEP 30, 2015", "SEP 30, 2015", "SEP 30, 2015", "SEP 29, 2015", "SEP 29, 2015", "SEP 28, 2015", "OCT 1, 2015", "SEP 28, 2015", "SEP 25, 2015", "SEP 25, 2015", "SEP 25, 2015", "SEP 25, 2015", "SEP 25, 2015", "SEP 24, 2015", "SEP 28, 2015", "SEP 24, 2015", "SEP 24, 2015", "SEP 23, 2015", "SEP 23, 2015", "SEP 22, 2015", "SEP 21, 2015", "SEP 20, 2015", "SEP 24, 2015", "SEP 24, 2015", "SEP 24, 2015", "SEP 23, 2015", "SEP 14, 2015", "SEP 14, 2015", "SEP 14, 2015", "SEP 12, 2015", "SEP 18, 2015", "SEP 11, 2015", "SEP 11, 2015", "SEP 10, 2015", "SEP 9, 2015", "SEP 9, 2015", "SEP 6, 2015", "SEP 5, 2015", "SEP 11, 2015", "SEP 11, 2015", "SEP 2, 2015", "SEP 2, 2015", "SEP 2, 2015", "SEP 2, 2015", "SEP 2, 2015", "SEP 4, 2015", "SEP 2, 2015", "SEP 1, 2015", "AUG 31, 2015", "AUG 31, 2015", "AUG 28, 2015", "AUG 27, 2015", "AUG 26, 2015", "SEP 2, 2015", "SEP 2, 2015", "SEP 1, 2015", "AUG 31, 2015", "AUG 19, 2015", "AUG 19, 2015", "AUG 18, 2015", "AUG 17, 2015", "AUG 25, 2015", "AUG 21, 2015", "AUG 21, 2015", "AUG 20, 2015", "AUG 19, 2015", "AUG 12, 2015", "AUG 12, 2015", "AUG 12, 2015", "AUG 17, 2015", "AUG 8, 2015", "AUG 7, 2015", "AUG 7, 2015", "AUG 6, 2015", "AUG 6, 2015", "AUG 6, 2015", "AUG 5, 2015", "AUG 11, 2015", "AUG 4, 2015", "AUG 3, 2015", "JUL 31, 2015", "JUL 31, 2015", "JUL 31, 2015", "JUL 30, 2015", "JUL 30, 2015", "AUG 5, 2015", "JUL 30, 2015", "JUL 30, 2015", "JUL 30, 2015", "JUL 29, 2015", "JUL 28, 2015", "JUL 28, 2015", "JUL 28, 2015", "JUL 30, 2015", "JUL 30, 2015", "JUL 30, 2015", "JUL 27, 2015", "JUL 27, 2015", "JUL 24, 2015", "JUL 24, 2015", "JUL 27, 2015", "JUL 22, 2015", "JUL 22, 2015", "JUL 22, 2015", "JUL 22, 2015", "JUL 21, 2015", "JUL 21, 2015", "JUL 20, 2015", "JUL 23, 2015", "JUL 22, 2015", "JUL 16, 2015", "JUL 15, 2015", "JUL 14, 2015", "JUL 14, 2015", "JUL 13, 2015", "JUL 12, 2015", "JUL 17, 2015", "JUL 9, 2015", "JUL 9, 2015", "JUL 8, 2015", "JUL 7, 2015", "JUL 6, 2015", "JUL 6, 2015", "JUL 2, 2015", "JUL 9, 2015", "JUN 30, 2015", "JUN 30, 2015", "JUN 25, 2015", "JUN 24, 2015", "JUN 23, 2015", "JUN 23, 2015", "JUN 23, 2015", "JUL 1, 2015", "JUN 30, 2015", "JUN 19, 2015", "JUN 18, 2015", "JUN 17, 2015", "JUN 15, 2015", "JUN 14, 2015", "JUN 22, 2015", "JUN 11, 2015", "JUN 11, 2015", "JUN 11, 2015", "JUN 10, 2015", "JUN 10, 2015", "JUN 10, 2015", "JUN 9, 2015", "JUN 11, 2015", "JUN 8, 2015", "JUN 8, 2015", "JUN 7, 2015", "JUN 3, 2015", "JUN 3, 2015", "JUN 2, 2015", "JUN 2, 2015", "JUN 9, 2015", "JUN 8, 2015", "JUN 8, 2015", "MAY 30, 2015", "MAY 30, 2015", "MAY 27, 2015", "MAY 26, 2015", "MAY 26, 2015", "JUN 2, 2015", "MAY 25, 2015", "MAY 23, 2015", "MAY 22, 2015", "MAY 21, 2015", "MAY 21, 2015", "MAY 19, 2015", "MAY 25, 2015", "MAY 25, 2015", "MAY 17, 2015", "MAY 15, 2015", "MAY 15, 2015", "MAY 14, 2015", "MAY 13, 2015", "MAY 12, 2015", "MAY 19, 2015", "MAY 18, 2015", "MAY 11, 2015", "MAY 9, 2015", "MAY 8, 2015", "MAY 7, 2015", "MAY 5, 2015", "MAY 12, 2015", "MAY 4, 2015", "APR 30, 2015", "APR 30, 2015", "APR 29, 2015", "APR 29, 2015", "APR 29, 2015", "APR 29, 2015", "MAY 4, 2015", "MAY 4, 2015", "APR 28, 2015", "APR 28, 2015", "APR 28, 2015", "APR 28, 2015", "APR 27, 2015", "APR 27, 2015", "APR 28, 2015", "APR 24, 2015", "APR 24, 2015", "APR 23, 2015", "APR 23, 2015", "APR 23, 2015", "APR 22, 2015", "APR 22, 2015", "APR 25, 2015", "APR 22, 2015", "APR 22, 2015", "APR 21, 2015", "APR 21, 2015", "APR 21, 2015", "APR 20, 2015", "APR 20, 2015", "APR 22, 2015", "APR 20, 2015", "APR 18, 2015", "APR 17, 2015", "APR 16, 2015", "APR 15, 2015", "APR 15, 2015", "APR 15, 2015", "APR 20, 2015", "APR 15, 2015", "APR 14, 2015", "APR 14, 2015", "APR 14, 2015", "APR 14, 2015", "APR 13, 2015", "APR 11, 2015", "APR 15, 2015", "APR 15, 2015", "APR 9, 2015", "APR 9, 2015", "APR 8, 2015", "APR 6, 2015", "APR 5, 2015", "APR 5, 2015", "APR 11, 2015", "APR 2, 2015", "APR 1, 2015", "APR 1, 2015", "MAR 31, 2015", "MAR 30, 2015", "MAR 30, 2015", "MAR 28, 2015", "APR 4, 2015", "MAR 28, 2015", "MAR 27, 2015", "MAR 26, 2015", "MAR 26, 2015", "MAR 25, 2015", "MAR 25, 2015", "MAR 23, 2015", "MAR 28, 2015", "MAR 23, 2015", "MAR 23, 2015", "MAR 23, 2015", "MAR 21, 2015", "MAR 21, 2015", "MAR 20, 2015", "MAR 19, 2015", "MAR 23, 2015", "MAR 18, 2015", "MAR 18, 2015", "MAR 18, 2015", "MAR 18, 2015", "MAR 17, 2015", "MAR 16, 2015", "MAR 16, 2015", "MAR 19, 2015", "MAR 15, 2015", "MAR 13, 2015", "MAR 12, 2015", "MAR 10, 2015", "MAR 9, 2015", "MAR 8, 2015", "MAR 7, 2015", "MAR 16, 2015", "MAR 5, 2015", "MAR 3, 2015", "MAR 2, 2015", "MAR 2, 2015", "FEB 28, 2015", "FEB 27, 2015", "FEB 26, 2015", "MAR 6, 2015", "FEB 21, 2015", "FEB 21, 2015", "FEB 20, 2015", "FEB 20, 2015", "FEB 18, 2015", "FEB 18, 2015", "FEB 17, 2015", "FEB 23, 2015", "FEB 13, 2015", "FEB 12, 2015", "FEB 12, 2015", "FEB 11, 2015", "FEB 10, 2015", "FEB 9, 2015", "FEB 9, 2015", "FEB 13, 2015", "FEB 8, 2015", "FEB 8, 2015", "FEB 6, 2015", "FEB 6, 2015", "FEB 5, 2015", "FEB 4, 2015", "FEB 4, 2015", "FEB 8, 2015", "FEB 3, 2015", "FEB 3, 2015", "FEB 3, 2015", "FEB 1, 2015", "JAN 31, 2015", "JAN 31, 2015", "JAN 31, 2015", "FEB 4, 2015", "JAN 27, 2015", "JAN 27, 2015", "JAN 27, 2015", "JAN 27, 2015", "JAN 26, 2015", "JAN 26, 2015", "JAN 25, 2015", "JAN 28, 2015", "JAN 23, 2015", "JAN 23, 2015", "JAN 22, 2015", "JAN 22, 2015", "JAN 22, 2015", "JAN 22, 2015", "JAN 22, 2015", "JAN 24, 2015", "JAN 21, 2015", "JAN 21, 2015", "JAN 21, 2015", "JAN 21, 2015", "JAN 20, 2015", "JAN 20, 2015", "JAN 20, 2015", "JAN 21, 2015", "JAN 20, 2015", "JAN 19, 2015", "JAN 18, 2015", "JAN 18, 2015", "JAN 16, 2015", "JAN 16, 2015", "JAN 16, 2015", "JAN 20, 2015", "JAN 16, 2015", "JAN 15, 2015", "JAN 14, 2015", "JAN 14, 2015", "JAN 14, 2015", "JAN 14, 2015", "JAN 13, 2015", "JAN 16, 2015", "JAN 13, 2015", "JAN 13, 2015", "JAN 12, 2015", "JAN 12, 2015", "JAN 12, 2015", "JAN 12, 2015", "JAN 12, 2015", "JAN 13, 2015", "JAN 9, 2015", "JAN 9, 2015", "JAN 8, 2015", "JAN 7, 2015", "JAN 7, 2015", "JAN 7, 2015", "JAN 6, 2015", "JAN 10, 2015", "JAN 6, 2015", "JAN 5, 2015", "JAN 5, 2015", "JAN 2, 2015", "DEC 30, 2014", "DEC 30, 2014", "DEC 29, 2014", "JAN 6, 2015", "DEC 29, 2014", "DEC 26, 2014", "DEC 26, 2014", "DEC 26, 2014", "DEC 26, 2014", "DEC 26, 2014", "DEC 24, 2014", "DEC 29, 2014", "DEC 24, 2014", "DEC 23, 2014", "DEC 23, 2014", "DEC 23, 2014", "DEC 23, 2014", "DEC 22, 2014", "DEC 22, 2014", "DEC 24, 2014", "DEC 24, 2014", "DEC 23, 2014", "DEC 22, 2014", "DEC 21, 2014", "DEC 19, 2014", "DEC 19, 2014", "DEC 19, 2014", "DEC 22, 2014", "DEC 17, 2014", "DEC 16, 2014", "DEC 16, 2014", "DEC 16, 2014", "DEC 16, 2014", "DEC 15, 2014", "DEC 18, 2014", "DEC 15, 2014", "DEC 15, 2014", "DEC 15, 2014", "DEC 13, 2014", "DEC 11, 2014", "DEC 11, 2014", "DEC 11, 2014", "DEC 15, 2014", "DEC 10, 2014", "DEC 9, 2014", "DEC 9, 2014", "DEC 9, 2014", "DEC 9, 2014", "DEC 9, 2014", "DEC 9, 2014", "DEC 10, 2014", "DEC 10, 2014", "DEC 9, 2014", "DEC 9, 2014", "DEC 9, 2014", "DEC 8, 2014", "DEC 6, 2014", "DEC 5, 2014", "DEC 8, 2014", "DEC 4, 2014", "DEC 4, 2014", "DEC 4, 2014", "DEC 4, 2014", "DEC 4, 2014", "DEC 3, 2014", "DEC 3, 2014", "DEC 4, 2014", "DEC 2, 2014", "DEC 2, 2014", "DEC 1, 2014", "DEC 1, 2014", "DEC 1, 2014", "NOV 28, 2014", "NOV 26, 2014", "DEC 2, 2014", "NOV 26, 2014", "NOV 26, 2014", "NOV 25, 2014", "NOV 24, 2014", "NOV 24, 2014", "NOV 21, 2014", "NOV 20, 2014", "NOV 26, 2014", "NOV 14, 2014", "NOV 13, 2014", "NOV 13, 2014", "NOV 12, 2014", "NOV 12, 2014", "NOV 11, 2014", "NOV 7, 2014", "NOV 17, 2014", "NOV 6, 2014", "NOV 6, 2014", "NOV 6, 2014", "NOV 5, 2014", "NOV 5, 2014", "NOV 5, 2014", "NOV 3, 2014", "NOV 7, 2014", "OCT 31, 2014", "OCT 31, 2014", "OCT 30, 2014", "OCT 29, 2014", "OCT 29, 2014", "OCT 29, 2014", "OCT 29, 2014", "NOV 1, 2014", "OCT 28, 2014", "OCT 28, 2014", "OCT 27, 2014", "OCT 27, 2014", "OCT 27, 2014", "OCT 24, 2014", "OCT 24, 2014", "OCT 28, 2014", "OCT 23, 2014", "OCT 22, 2014", "OCT 22, 2014", "OCT 22, 2014", "OCT 22, 2014", "OCT 22, 2014", "OCT 21, 2014", "OCT 23, 2014", "OCT 23, 2014", "OCT 15, 2014", "OCT 15, 2014", "OCT 14, 2014", "OCT 14, 2014", "OCT 14, 2014", "OCT 20, 2014", "OCT 13, 2014", "OCT 12, 2014", "OCT 10, 2014", "OCT 10, 2014", "OCT 9, 2014", "OCT 8, 2014", "OCT 8, 2014", "OCT 13, 2014", "OCT 7, 2014", "OCT 7, 2014", "OCT 7, 2014", "OCT 6, 2014", "OCT 6, 2014", "OCT 4, 2014", "OCT 2, 2014", "OCT 8, 2014", "SEP 26, 2014", "SEP 25, 2014", "SEP 25, 2014", "SEP 25, 2014", "SEP 25, 2014", "SEP 25, 2014", "SEP 25, 2014", "SEP 29, 2014", "SEP 24, 2014", "SEP 24, 2014", "SEP 23, 2014", "SEP 23, 2014", "SEP 23, 2014", "SEP 23, 2014", "SEP 22, 2014", "SEP 25, 2014", "SEP 19, 2014", "SEP 19, 2014", "SEP 19, 2014", "SEP 18, 2014", "SEP 17, 2014", "SEP 17, 2014", "SEP 17, 2014", "SEP 22, 2014", "SEP 16, 2014", "SEP 16, 2014", "SEP 15, 2014", "SEP 12, 2014", "SEP 11, 2014", "SEP 11, 2014", "SEP 11, 2014", "SEP 17, 2014", "SEP 16, 2014", "SEP 16, 2014", "SEP 15, 2014", "SEP 12, 2014", "SEP 11, 2014", "SEP 10, 2014", "SEP 8, 2014", "SEP 11, 2014", "SEP 4, 2014", "SEP 3, 2014", "SEP 3, 2014", "SEP 3, 2014", "SEP 3, 2014", "SEP 3, 2014", "SEP 2, 2014", "SEP 4, 2014", "SEP 2, 2014", "SEP 2, 2014", "SEP 2, 2014", "AUG 29, 2014", "AUG 29, 2014", "AUG 29, 2014", "AUG 29, 2014", "SEP 2, 2014", "AUG 28, 2014", "AUG 28, 2014", "AUG 28, 2014", "AUG 28, 2014", "AUG 28, 2014", "AUG 28, 2014", "AUG 27, 2014", "AUG 29, 2014", "AUG 26, 2014", "AUG 26, 2014", "AUG 26, 2014", "AUG 26, 2014", "AUG 26, 2014", "AUG 26, 2014", "AUG 26, 2014", "AUG 27, 2014", "AUG 26, 2014", "AUG 26, 2014", "AUG 26, 2014", "AUG 22, 2014", "AUG 20, 2014", "AUG 20, 2014", "AUG 20, 2014", "AUG 25, 2014", "AUG 19, 2014", "AUG 18, 2014", "AUG 18, 2014", "AUG 18, 2014", "AUG 15, 2014", "AUG 14, 2014", "AUG 14, 2014", "AUG 19, 2014", "AUG 11, 2014", "AUG 11, 2014", "AUG 11, 2014", "AUG 7, 2014", "AUG 7, 2014", "AUG 6, 2014", "AUG 13, 2014", "AUG 4, 2014", "AUG 4, 2014", "AUG 4, 2014", "AUG 4, 2014", "JUL 30, 2014", "JUL 30, 2014", "JUL 30, 2014", "AUG 5, 2014", "JUL 30, 2014", "JUL 29, 2014", "JUL 28, 2014", "JUL 28, 2014", "JUL 25, 2014", "JUL 23, 2014", "JUL 21, 2014", "JUL 30, 2014", "JUL 21, 2014", "JUL 18, 2014", "JUL 16, 2014", "JUL 14, 2014", "JUL 10, 2014", "JUL 9, 2014", "JUL 8, 2014", "JUL 21, 2014", "JUL 3, 2014", "JUL 3, 2014", "JUL 3, 2014", "JUL 2, 2014", "JUN 25, 2014", "JUN 23, 2014", "JUN 20, 2014", "JUL 3, 2014", "JUN 12, 2014", "JUN 12, 2014", "JUN 5, 2014", "JUN 5, 2014", "JUN 4, 2014", "JUN 3, 2014", "JUN 2, 2014", "JUN 12, 2014", "MAY 28, 2014", "MAY 28, 2014", "MAY 27, 2014", "MAY 27, 2014", "MAY 27, 2014", "MAY 27, 2014", "MAY 23, 2014", "JUN 2, 2014", "MAY 14, 2014", "MAY 12, 2014", "MAY 9, 2014", "MAY 6, 2014", "MAY 1, 2014", "MAY 1, 2014", "APR 30, 2014", "MAY 23, 2014", "APR 28, 2014", "APR 28, 2014", "APR 25, 2014", "APR 24, 2014", "APR 24, 2014", "APR 24, 2014", "APR 24, 2014", "APR 30, 2014", "APR 23, 2014", "APR 23, 2014", "APR 23, 2014", "APR 23, 2014", "APR 23, 2014", "APR 23, 2014", "APR 23, 2014", "APR 24, 2014", "APR 23, 2014", "APR 23, 2014", "APR 23, 2014", "APR 23, 2014", "APR 22, 2014", "APR 22, 2014", "APR 22, 2014", "APR 23, 2014", "APR 21, 2014", "APR 21, 2014", "APR 17, 2014", "APR 16, 2014", "APR 16, 2014", "APR 15, 2014", "APR 15, 2014", "APR 21, 2014", "APR 15, 2014", "APR 15, 2014", "APR 15, 2014", "APR 15, 2014", "APR 14, 2014", "APR 14, 2014", "APR 14, 2014", "APR 15, 2014", "APR 11, 2014", "APR 11, 2014", "APR 11, 2014", "APR 11, 2014", "APR 11, 2014", "APR 10, 2014", "APR 10, 2014", "APR 14, 2014", "APR 10, 2014", "APR 10, 2014", "APR 9, 2014", "APR 9, 2014", "APR 8, 2014", "APR 8, 2014", "APR 8, 2014", "APR 10, 2014", "APR 8, 2014", "APR 8, 2014", "APR 7, 2014", "APR 7, 2014", "APR 7, 2014", "APR 4, 2014", "APR 4, 2014", "APR 8, 2014", "APR 3, 2014", "APR 1, 2014", "MAR 31, 2014", "MAR 31, 2014", "MAR 31, 2014", "MAR 28, 2014", "MAR 27, 2014", "APR 4, 2014", "MAR 26, 2014", "MAR 26, 2014", "MAR 26, 2014", "MAR 25, 2014", "MAR 25, 2014", "MAR 25, 2014", "MAR 25, 2014", "MAR 26, 2014", "MAR 24, 2014", "MAR 24, 2014", "MAR 24, 2014", "MAR 19, 2014", "MAR 19, 2014", "MAR 18, 2014", "MAR 14, 2014", "MAR 24, 2014", "MAR 12, 2014", "MAR 12, 2014", "MAR 12, 2014", "MAR 12, 2014", "MAR 12, 2014", "MAR 11, 2014", "MAR 11, 2014", "MAR 12, 2014", "MAR 10, 2014", "MAR 10, 2014", "MAR 7, 2014", "MAR 7, 2014", "MAR 7, 2014", "MAR 5, 2014", "MAR 5, 2014", "MAR 11, 2014", "MAR 3, 2014", "MAR 3, 2014", "MAR 3, 2014", "FEB 28, 2014", "FEB 28, 2014", "FEB 27, 2014", "FEB 26, 2014", "MAR 4, 2014", "FEB 19, 2014", "FEB 14, 2014", "FEB 12, 2014", "FEB 11, 2014", "FEB 11, 2014", "FEB 11, 2014", "FEB 11, 2014", "FEB 21, 2014", "FEB 10, 2014", "FEB 7, 2014", "FEB 5, 2014", "FEB 3, 2014", "FEB 3, 2014", "JAN 29, 2014", "JAN 28, 2014", "FEB 10, 2014", "JAN 22, 2014", "JAN 22, 2014", "JAN 20, 2014", "JAN 16, 2014", "JAN 16, 2014", "JAN 16, 2014", "JAN 27, 2014", "JAN 10, 2014", "JAN 8, 2014", "JAN 3, 2014", "JAN 2, 2014", "JAN 2, 2014", "DEC 30, 2013", "JAN 16, 2014", "DEC 23, 2013", "DEC 20, 2013", "DEC 19, 2013", "DEC 4, 2013", "DEC 4, 2013", "DEC 3, 2013", "DEC 2, 2013", "DEC 23, 2013", "DEC 23, 2013", "DEC 20, 2013", "DEC 19, 2013", "NOV 21, 2013", "NOV 21, 2013", "NOV 20, 2013", "DEC 2, 2013", "NOV 6, 2013", "OCT 24, 2013", "OCT 23, 2013", "OCT 22, 2013", "OCT 22, 2013", "OCT 22, 2013", "OCT 22, 2013", "NOV 7, 2013", "NOV 6, 2013", "OCT 15, 2013", "OCT 10, 2013", "OCT 8, 2013", "OCT 7, 2013", "OCT 4, 2013", "OCT 22, 2013", "OCT 22, 2013", "SEP 30, 2013", "SEP 30, 2013", "SEP 13, 2013", "SEP 5, 2013", "AUG 30, 2013", "AUG 30, 2013", "OCT 4, 2013", "AUG 27, 2013", "AUG 27, 2013", "AUG 27, 2013", "AUG 27, 2013", "AUG 26, 2013", "AUG 26, 2013", "AUG 28, 2013", "AUG 26, 2013", "AUG 26, 2013", "AUG 26, 2013", "AUG 26, 2013", "AUG 26, 2013", "AUG 26, 2013", "AUG 26, 2013", "AUG 26, 2013", "AUG 26, 2013", "AUG 26, 2013", "AUG 23, 2013", "AUG 22, 2013", "AUG 22, 2013", "AUG 22, 2013", "AUG 22, 2013", "AUG 26, 2013", "AUG 16, 2013", "AUG 15, 2013", "AUG 15, 2013", "AUG 13, 2013", "AUG 13, 2013", "AUG 12, 2013", "AUG 8, 2013", "AUG 22, 2013", "AUG 7, 2013", "AUG 6, 2013", "AUG 1, 2013", "JUL 31, 2013", "JUL 31, 2013", "JUL 30, 2013", "JUL 30, 2013", "AUG 7, 2013", "JUL 30, 2013", "JUL 29, 2013", "JUL 29, 2013", "JUL 29, 2013", "JUL 25, 2013", "JUL 10, 2013", "JUL 9, 2013", "JUL 30, 2013", "JUL 5, 2013", "JUL 1, 2013", "JUL 1, 2013", "JUL 1, 2013", "JUL 1, 2013", "JUL 1, 2013", "JUL 1, 2013", "JUL 8, 2013", "JUN 26, 2013", "JUN 17, 2013", "JUN 14, 2013", "JUN 13, 2013", "JUN 11, 2013", "JUN 10, 2013", "JUN 4, 2013", "JUN 30, 2013", "JUN 3, 2013", "MAY 31, 2013", "MAY 31, 2013", "MAY 29, 2013", "MAY 24, 2013", "MAY 22, 2013", "MAY 20, 2013", "JUN 3, 2013", "MAY 14, 2013", "MAY 14, 2013", "MAY 13, 2013", "MAY 13, 2013", "MAY 10, 2013", "MAY 10, 2013", "MAY 9, 2013", "MAY 15, 2013", "MAY 14, 2013", "MAY 14, 2013", "MAY 1, 2013", "APR 25, 2013", "APR 25, 2013", "APR 25, 2013", "APR 24, 2013", "MAY 7, 2013", "APR 24, 2013", "APR 23, 2013", "APR 23, 2013", "APR 23, 2013", "APR 22, 2013", "APR 19, 2013", "APR 19, 2013", "APR 24, 2013", "APR 11, 2013", "APR 11, 2013", "APR 10, 2013", "APR 10, 2013", "APR 9, 2013", "APR 5, 2013", "APR 3, 2013", "APR 19, 2013", "MAR 28, 2013", "MAR 28, 2013", "MAR 25, 2013", "MAR 25, 2013", "MAR 22, 2013", "MAR 21, 2013", "MAR 13, 2013", "MAR 28, 2013", "MAR 4, 2013", "FEB 27, 2013", "FEB 27, 2013", "FEB 25, 2013", "FEB 21, 2013", "FEB 15, 2013", "FEB 14, 2013", "MAR 7, 2013", "FEB 12, 2013", "FEB 11, 2013", "FEB 11, 2013", "FEB 7, 2013", "JAN 31, 2013", "JAN 25, 2013", "JAN 24, 2013", "FEB 13, 2013", "JAN 24, 2013", "JAN 23, 2013", "JAN 23, 2013", "JAN 22, 2013", "JAN 21, 2013", "JAN 18, 2013", "JAN 17, 2013", "JAN 24, 2013", "JAN 16, 2013", "JAN 15, 2013", "JAN 11, 2013", "JAN 10, 2013", "JAN 8, 2013", "JAN 4, 2013", "DEC 26, 2012", "JAN 16, 2013", "DEC 19, 2012", "DEC 17, 2012", "DEC 14, 2012", "DEC 14, 2012", "DEC 13, 2012", "DEC 12, 2012", "DEC 12, 2012", "DEC 21, 2012", "DEC 11, 2012", "DEC 7, 2012", "DEC 4, 2012", "DEC 4, 2012", "DEC 3, 2012", "NOV 28, 2012", "NOV 26, 2012", "DEC 12, 2012", "NOV 15, 2012", "NOV 15, 2012", "OCT 29, 2012", "OCT 29, 2012", "OCT 26, 2012", "OCT 25, 2012", "OCT 24, 2012", "NOV 16, 2012", "OCT 24, 2012", "OCT 23, 2012", "OCT 23, 2012", "OCT 22, 2012", "OCT 19, 2012", "OCT 18, 2012", "OCT 17, 2012", "OCT 24, 2012", "OCT 17, 2012", "OCT 16, 2012", "OCT 15, 2012", "OCT 9, 2012", "OCT 4, 2012", "OCT 1, 2012", "OCT 1, 2012", "OCT 17, 2012", "SEP 25, 2012", "SEP 19, 2012", "SEP 17, 2012", "SEP 14, 2012", "SEP 13, 2012", "SEP 12, 2012", "SEP 10, 2012", "SEP 27, 2012", "SEP 25, 2012", "SEP 19, 2012", "AUG 29, 2012", "AUG 21, 2012", "AUG 16, 2012", "AUG 13, 2012", "AUG 3, 2012", "SEP 7, 2012", "JUL 27, 2012", "JUL 27, 2012", "JUL 26, 2012", "JUL 23, 2012", "JUL 16, 2012", "JUL 13, 2012", "JUL 13, 2012", "AUG 2, 2012", "JUL 11, 2012", "JUL 10, 2012", "JUL 9, 2012", "JUL 9, 2012", "JUL 6, 2012", "JUN 11, 2012", "JUN 8, 2012", "JUL 12, 2012", "JUL 11, 2012", "JUL 10, 2012", "JUL 9, 2012", "JUL 9, 2012", "JUL 6, 2012", "APR 24, 2012", "APR 24, 2012", "JUN 7, 2012", "APR 19, 2012", "APR 17, 2012", "APR 12, 2012", "APR 11, 2012", "APR 10, 2012", "APR 4, 2012", "APR 2, 2012", "APR 20, 2012", "MAR 27, 2012", "MAR 8, 2012", "FEB 28, 2012", "FEB 22, 2012", "FEB 17, 2012", "FEB 14, 2012", "FEB 9, 2012", "MAR 28, 2012", "FEB 9, 2012", "FEB 8, 2012", "FEB 6, 2012", "FEB 3, 2012", "JAN 31, 2012", "JAN 31, 2012", "JAN 27, 2012", "FEB 9, 2012", "JAN 24, 2012", "JAN 23, 2012", "JAN 13, 2012", "JAN 5, 2012", "DEC 30, 2011", "DEC 27, 2011", "DEC 23, 2011", "JAN 25, 2012", "DEC 20, 2011", "DEC 13, 2011", "DEC 9, 2011", "DEC 8, 2011", "DEC 7, 2011", "DEC 5, 2011", "DEC 5, 2011", "DEC 20, 2011", "DEC 2, 2011", "DEC 1, 2011", "NOV 22, 2011", "NOV 21, 2011", "NOV 21, 2011", "NOV 17, 2011", "NOV 16, 2011", "DEC 5, 2011", "SEP 11, 2011", "SEP 8, 2011", "AUG 30, 2011", "AUG 1, 2011", "JUL 29, 2011", "JUL 22, 2011", "JUL 20, 2011", "NOV 15, 2011", "MAY 17, 2011", "MAY 5, 2011", "APR 27, 2011", "APR 15, 2011", "APR 15, 2011", "APR 13, 2011", "MAR 24, 2011", "MAY 17, 2011", "MAR 18, 2011", "MAR 18, 2011", "MAR 18, 2011", "FEB 18, 2011", "FEB 16, 2011", "FEB 1, 2011", "DEC 17, 2010", "MAR 24, 2011", "OCT 27, 2010", "OCT 27, 2010", "OCT 26, 2010", "OCT 21, 2010", "SEP 13, 2010", "SEP 13, 2010", "AUG 18, 2010", "DEC 14, 2010", "JUL 20, 2010", "JUL 15, 2010", "JUN 21, 2010", "FEB 9, 2010", "AUG 2, 2010"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/molecular-partners-hopes-for-covid-19-rebound-after-eye-drug-failure-2020-06-26", "https://www.nasdaq.com/articles/study-sees-probable-higher-heart-risk-for-new-amgen-osteoporosis-drug-2020-06-24", "https://www.nasdaq.com/articles/qqq-intc-amgn-tmus%3A-etf-inflow-alert-2020-06-24", "https://www.nasdaq.com/articles/amgen-to-present-at-bmo-capital-markets-2020-healthcare-conference-webcast-at-4%3A00-pm-et", "https://www.nasdaq.com/articles/meet-the-pharma-company-that-just-had-a-bigger-ipo-than-modernas-2020-06-23", "https://www.nasdaq.com/articles/why-beyondspring-is-plunging-today-2020-06-19", "https://www.nasdaq.com/articles/is-amgen-stock-a-buy-2020-06-18", "https://www.nasdaq.com/articles/u.s.-appeals-court-rejects-rule-requiring-drug-prices-in-tv-ads-2020-06-16", "https://www.nasdaq.com/articles/molecular-partners-hopes-for-covid-19-rebound-after-eye-drug-failure-2020-06-26", "https://www.nasdaq.com/articles/health-care-sector-update-for-06-15-2020%3A-lly-bysi-bbi-amgn-2020-06-15", "https://www.nasdaq.com/articles/notable-friday-option-activity%3A-w-tif-amgn-2020-06-12", "https://www.nasdaq.com/articles/2-top-small-cap-stocks-to-buy-right-now-2020-06-12", "https://www.nasdaq.com/articles/july-31st-options-now-available-for-amgen-amgn-2020-06-11", "https://www.nasdaq.com/articles/amgen-to-present-at-goldman-sachs-41st-annual-global-healthcare-conference-webcast-at-1%3A20", "https://www.nasdaq.com/articles/noteworthy-etf-outflows%3A-iyh-amgn-mdt-dhr-2020-06-08", "https://www.nasdaq.com/articles/moderna-names-amgen-executive-david-meline-as-cfo-2020-06-04", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-qqq-intc-amgn-tmus-2020-06-16", "https://www.nasdaq.com/articles/amgen-to-present-at-the-jefferies-2020-virtual-healthcare-conference-webcast-at-4%3A00-pm-et", "https://www.nasdaq.com/articles/nasdaq-today%3A-why-alexion-and-workday-stock-are-soaring-2020-05-28", "https://www.nasdaq.com/articles/peek-under-the-hood%3A-ius-has-10-upside-2020-05-27", "https://www.nasdaq.com/articles/is-coherus-biosciences-a-buy-2020-05-26", "https://www.nasdaq.com/articles/is-arrowhead-pharmaceuticals-a-buy-2020-05-24", "https://www.nasdaq.com/articles/vtv-t-ko-amgn%3A-etf-inflow-alert-2020-05-19", "https://www.nasdaq.com/articles/monday-sector-laggards%3A-healthcare-technology-communications-2020-05-18", "https://www.nasdaq.com/articles/3-top-large-cap-stocks-to-buy-in-june-2020-06-03", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-david-dreman-5-17-2020-2020-05-17", "https://www.nasdaq.com/articles/notable-friday-option-activity%3A-amgn-unh-tgt-2020-05-15", "https://www.nasdaq.com/articles/ex-dividend-reminder%3A-amerisourcebergen-amgen-and-sabra-health-care-reit-2020-05-13", "https://www.nasdaq.com/articles/whats-behind-adaptive-biotechnologies-q1-earnings-miss-2020-05-13", "https://www.nasdaq.com/articles/is-now-still-a-good-time-to-buy-amgen-2020-05-13", "https://www.nasdaq.com/articles/heres-why-cytokinetics-is-skyrocketing-24.5-today-2020-05-11", "https://www.nasdaq.com/articles/why-amgen-soared-in-april-2020-05-11", "https://www.nasdaq.com/articles/better-buy%3A-pfizer-vs.-bristol-myers-squibb-2020-05-17", "https://www.nasdaq.com/articles/amgen%3Afda-grants-fast-track-designation-for-omecamtiv-mecarbil-in-heart-failure-2020-05-08", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-gm-axcella-beyond-meat-smiledirect-2020-05-06", "https://www.nasdaq.com/articles/amgen-reports-positive-results-for-otezla-in-phase-3-trial-2020-05-06", "https://www.nasdaq.com/articles/why-akebia-therapeutics-stock-is-crushing-it-today-2020-05-05", "https://www.nasdaq.com/articles/amgen%3A-court-ruling-prevents-cipla-from-making-generic-version-of-kyprolis-2020-05-05", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-tesla-medigus-aemetis-2020-05-01", "https://www.nasdaq.com/articles/amgen-inc-amgn-q1-2020-earnings-call-transcript-2020-05-01", "https://www.nasdaq.com/articles/astrazeneca-completes-recovery-of-global-rights-to-brazikumab-from-allergan-2020-05-11", "https://www.nasdaq.com/articles/amgen-stock-jumps-on-earnings-covid-19-trial-announcement-2020-04-30", "https://www.nasdaq.com/articles/amgen-inc.-q1-adjusted-earnings-beat-estimates-2020-04-30", "https://www.nasdaq.com/articles/heres-why-investors-should-follow-sanofi-and-glaxosmithklines-new-coronavirus", "https://www.nasdaq.com/articles/better-buy%3A-illumina-vs.-adaptive-biotechnologies-2020-04-30", "https://www.nasdaq.com/articles/how-these-15-stock-suggestions-fared-against-the-market-2020-04-28", "https://www.nasdaq.com/articles/iyh-jnj-abt-amgn%3A-etf-inflow-alert-2020-04-28", "https://www.nasdaq.com/articles/heres-why-verastem-oncology-is-tanking-today-2020-04-27", "https://www.nasdaq.com/articles/amgen-studying-otezla-for-coronavirus-q1-results-beat-street-estimates-2020-04-30", "https://www.nasdaq.com/articles/3-dividend-stocks-weathering-the-coronavirus-storm-2020-04-23", "https://www.nasdaq.com/articles/better-buy%3A-amgen-vs.-johnson-johnson-2020-04-23", "https://www.nasdaq.com/articles/artificial-intelligence-and-drug-discovery%3A-the-companies-leading-the-way-2020-04-22", "https://www.nasdaq.com/articles/heres-why-verastem-stock-is-jumping-today-2020-04-20", "https://www.nasdaq.com/articles/3-stocks-im-buying-right-now-2020-04-19", "https://www.nasdaq.com/articles/4-healthcare-stocks-to-buy-for-coronavirus-innovation-2020-04-17", "https://www.nasdaq.com/articles/itot-abt-cost-amgn%3A-etf-outflow-alert-2020-04-17", "https://www.nasdaq.com/articles/3-coronavirus-stocks-to-buy-now-2020-04-26", "https://www.nasdaq.com/articles/3-dividend-stocks-weathering-the-coronavirus-storm-2020-04-23", "https://www.nasdaq.com/articles/better-buy%3A-amgen-vs.-johnson-johnson-2020-04-23", "https://www.nasdaq.com/articles/artificial-intelligence-and-drug-discovery%3A-the-companies-leading-the-way-2020-04-22", "https://www.nasdaq.com/articles/amgn-may-29th-options-begin-trading-2020-04-09", "https://www.nasdaq.com/articles/here-are-all-the-companies-working-on-covid-19-vaccines-treatments-and-testing-2020-04-07", "https://www.nasdaq.com/articles/why-gilead-sciences-is-the-hottest-stock-to-buy-today-2020-04-04", "https://www.nasdaq.com/articles/why-amgen-stock-sailed-through-march-without-a-scratch-2020-04-02", "https://www.nasdaq.com/articles/1-recent-ipo-to-add-to-your-watch-list-2020-04-17", "https://www.nasdaq.com/articles/amgen-adaptive-partner-to-find-neutralizing-antibodies-for-covid-19-2020-04-02", "https://www.nasdaq.com/articles/amgen-purchases-49-of-shares-of-amgen-astellas-biopharma-2020-03-31", "https://www.nasdaq.com/articles/amgen-pauses-some-clinical-trials-to-reduce-coronavirus-transmission-risk-2020-03-31", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-ftcs-pgr-lly-amgn-2020-03-30", "https://www.nasdaq.com/articles/4-reasons-drug-stocks-are-a-buy-right-now-2020-03-30", "https://www.nasdaq.com/articles/why-amgen-is-the-top-dividend-stock-of-the-nasdaq-100-with-3.2-yield-amgn-2020-03-27", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-26-2020%3A-jnj-pfe-abt-mrk-amgn-htgm-rkda-bioc-2020-03-26", "https://www.nasdaq.com/articles/amgen-teams-up-with-adaptive-biotechnologies-to-develop-covid-19-therapy-2020-04-02", "https://www.nasdaq.com/articles/4-reasons-biotech-stocks-are-a-buy-right-now-2020-03-25", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-tqqq-googl-amgn-txn-2020-03-20", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-17-2020%3A-jnj-pfe-abt-mrk-amgn-dbvt-avro-mrna-2020-03-17", "https://www.nasdaq.com/articles/7-biotech-stocks-to-buy-and-hold-in-2020-2020-03-16", "https://www.nasdaq.com/articles/better-buy%3A-biogen-vs.-amgen-2020-03-15", "https://www.nasdaq.com/articles/noteworthy-etf-inflows%3A-tqqq-googl-amgn-txn-2020-03-12", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-11-2020%3A-jnj-pfe-abt-mrk-amgn-sphs-cdmo-kala-2020-03-11", "https://www.nasdaq.com/articles/top-drug-stocks-under-%245-2020-03-26", "https://www.nasdaq.com/articles/daily-dividend-report%3A-gdhesvzamgnpm-2020-03-05", "https://www.nasdaq.com/articles/is-ishares-nasdaq-biotechnology-index-fund-a-buy-2020-03-05", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-04-2020%3A-jnj-pfe-abt-mrk-amgn-mrna-reph-cnc-drrx-2020-03", "https://www.nasdaq.com/articles/proshares-proshares-ultrapro-qqq-experiences-big-inflow-2020-03-04", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-04-2020%3A-jnj-pfe-abt-mrk-amgn-drrx-vvus-vygr-2020-03-04", "https://www.nasdaq.com/articles/thermo-fisher-scientific-to-spend-%2411.5-billion-upgrading-its-dna-testing-game-2020-03-03", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-03-2020%3A-jnj-pfe-abt-mrk-amgn-kmph-omer-gnmk-2020-03-03", "https://www.nasdaq.com/articles/better-buy%3A-amgen-vs.-gilead-sciences-2020-03-09", "https://www.nasdaq.com/articles/fda-approves-biohavens-migraine-treatment-nurtec-odt-2020-02-28", "https://www.nasdaq.com/articles/amgen-breaks-below-200-day-moving-average-notable-for-amgn-2020-02-27", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-27-2020%3A-jnj-pfe-abt-mrk-amgn-tdoc-ormp-lhcg-2020-02-27", "https://www.nasdaq.com/articles/analysts-forecast-11-upside-for-the-holdings-of-ftcs-2020-02-27", "https://www.nasdaq.com/articles/heres-why-karyopharm-therapeutics-has-a-unique-growth-opportunity-2020-02-26", "https://www.nasdaq.com/articles/amgen-is-oversold-2020-02-25", "https://www.nasdaq.com/articles/3-biotech-stocks-that-surged-last-week-2020-02-24", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-to-buy-right-now-2020-02-28", "https://www.nasdaq.com/articles/a-plan-to-use-blockchain-to-stop-counterfeit-drugs-moves-forward-2020-02-21", "https://www.nasdaq.com/articles/investors-scrambled-to-buy-this-biotech-ipo-2020-02-21", "https://www.nasdaq.com/articles/iwb-abt-amgn-lin%3A-large-outflows-detected-at-etf-2020-02-21", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-19-2020%3A-jnj-pfe-abt-mrk-amgn-mreo-amed-ctso-2020-02-19", "https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-zbra-amgn-mmm-2020-02-13", "https://www.nasdaq.com/articles/amgn-april-3rd-options-begin-trading-2020-02-13", "https://www.nasdaq.com/articles/3-biotech-stocks-that-made-early-shareholders-millionaires-2020-02-13", "https://www.nasdaq.com/articles/fda-approves-esperion-therapeutics-new-cholesterol-drug-2020-02-21", "https://www.nasdaq.com/articles/is-amgen-a-stock-to-buy-2020-02-08", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-07-2020%3A-jnj-pfe-abt-mrk-amgn-asrt-zgnx-mygn-2020-02-07", "https://www.nasdaq.com/articles/how-bristol-myers-squibb-trounced-wall-streets-q4-estimates-2020-02-06", "https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-2-6-2020-2020-02-06", "https://www.nasdaq.com/articles/why-amgen-stock-dropped-10.4-in-january-2020-02-05", "https://www.nasdaq.com/articles/pkw-amgn-unp-orcl%3A-etf-inflow-alert-2020-02-05", "https://www.nasdaq.com/articles/teva-pharmaceutical-just-got-a-little-migraine-relief-2020-02-04", "https://www.nasdaq.com/articles/bristol-myers-squibb-stock-is-too-cheap-to-ignore-2020-02-10", "https://www.nasdaq.com/articles/could-guardant-health-be-a-millionaire-maker-stock-2020-02-02", "https://www.nasdaq.com/articles/amgen-is-making-3-big-bets-will-they-pay-off-for-investors-2020-02-02", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-3-yield-mark-2020-01-31", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity%3A-amgn-expe-cvs-2020-01-31", "https://www.nasdaq.com/articles/stock-market-news%3A-amazons-amazing-amgen-falls-short-2020-01-31", "https://www.nasdaq.com/articles/amgens-shares-slip-on-soft-guidance.-time-to-buy-2020-01-31", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-amgn-amzn-2020-01-31", "https://www.nasdaq.com/articles/amgen-a-top-socially-responsible-dividend-stock-with-3.0-yield-amgn-2020-02-04", "https://www.nasdaq.com/articles/amgen-inc-amgn-q4-2019-earnings-call-transcript-2020-01-31", "https://www.nasdaq.com/articles/amgen-revenue-slipped-1-in-the-fourth-quarter-2020-01-31", "https://www.nasdaq.com/articles/amgen-issues-fy20-guidance-quick-facts-2020-01-30", "https://www.nasdaq.com/articles/amgen-inc.-q4-adjusted-earnings-beat-estimates-2020-01-30", "https://www.nasdaq.com/articles/amgen-q4-19-earnings-conference-call-at-5%3A00-pm-et-2020-01-30-0", "https://www.nasdaq.com/articles/amgen-q4-19-earnings-conference-call-at-5%3A00-pm-et-2020-01-30", "https://www.nasdaq.com/articles/why-teva-stock-could-be-the-next-general-electric-stock-2020-01-29", "https://www.nasdaq.com/articles/where-will-cara-therapeutics-be-in-5-years-2020-01-31", "https://www.nasdaq.com/articles/which-big-biotech-has-the-safer-dividend-amgen-or-gilead-sciences-2020-01-26", "https://www.nasdaq.com/articles/is-mylan-stock-a-buy-2020-01-25", "https://www.nasdaq.com/articles/relative-strength-alert-for-amgen-2020-01-24", "https://www.nasdaq.com/articles/better-buy%3A-amgen-vs.-gilead-sciences-2020-01-24", "https://www.nasdaq.com/articles/better-buy%3A-exact-sciences-vs.-qiagen-2020-01-23", "https://www.nasdaq.com/articles/3-attractive-dividend-stocks-whose-dividends-could-double-2020-01-19", "https://www.nasdaq.com/articles/2-biotechs-battling-immune-diseases-2020-01-19", "https://www.nasdaq.com/articles/ishares-core-dividend-growth-etf-experiences-big-inflow-2020-01-28", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity%3A-mos-ppg-amgn-2020-01-16", "https://www.nasdaq.com/articles/health-care-sector-update-for-01-14-2020%3A-jnj-pfe-abt-mrk-amgn-rtix-trxc-mreo-2020-01-14", "https://www.nasdaq.com/articles/novartis-heart-drug-gets-accelerated-review-in-britain-for-high-risk-patients-2020-01-13", "https://www.nasdaq.com/articles/health-care-sector-update-for-01-13-2020%3A-jnj-pfe-abt-mrk-amgn-iova-ocx-nvta-2020-01-13", "https://www.nasdaq.com/articles/health-care-sector-update-for-01-10-2020%3A-jnj-pfe-abt-mrk-amgn-acrs-mrna-ptla-2020-01-10", "https://www.nasdaq.com/articles/noteworthy-etf-outflows%3A-iwb-amgn-lly-qcom-2020-01-09", "https://www.nasdaq.com/articles/these-25-companies-laid-off-workers-in-2019-2020-01-07", "https://www.nasdaq.com/articles/ishares-russell-1000-etf-experiences-big-outflow-2020-01-17", "https://www.nasdaq.com/articles/amgen-a-top-25-dividend-giant-with-2.68-yield-amgn-2020-01-06", "https://www.nasdaq.com/articles/amgn-february-14th-options-begin-trading-2020-01-02", "https://www.nasdaq.com/articles/3-of-the-best-healthcare-stocks-to-buy-in-2020-2020-01-02", "https://www.nasdaq.com/articles/amgen-completes-purchase-of-about-%242.8-bln-of-beigene-shares-2020-01-02", "https://www.nasdaq.com/articles/better-buy%3A-abbott-laboratories-vs.-pfizer-2020-01-02", "https://www.nasdaq.com/articles/health-care-sector-update-for-01-02-2020%3A-jnj-pfe-abt-mrk-amgn-ipha-ontx-aeri-2020-01-02", "https://www.nasdaq.com/articles/breakingviews-a-health-craze-for-2020%3A-chinese-medicine-2020-01-02", "https://www.nasdaq.com/articles/health-care-sector-update-for-01-06-2020%3A-jnj-pfe-abt-mrk-amgn-life-lptx-novn-2020-01-06", "https://www.nasdaq.com/articles/amgen-a-top-25-dividend-giant-with-2.68-yield-amgn-2020-01-06", "https://www.nasdaq.com/articles/the-success-of-vascepa-actually-might-be-a-problem-for-amarin-2019-12-30", "https://www.nasdaq.com/articles/3-biotech-stocks-that-crushed-it-in-2019-2019-12-28", "https://www.nasdaq.com/articles/u.s.-cannabis-stocks-will-make-cheap-smart-buys-in-2020-2019-12-27", "https://www.nasdaq.com/articles/3-blockbuster-cancer-drug-launches-to-watch-in-2020-2019-12-24", "https://www.nasdaq.com/articles/better-buy%3A-amgen-vs.-johnson-johnson-2019-12-22", "https://www.nasdaq.com/articles/vascepas-future-looks-rosy-but-it-could-still-be-fishy-for-amarin-stock-2019-12-31", "https://www.nasdaq.com/articles/fda-nod-for-bhc-third-rituxan-biosim-in-the-offing-cbio-soars-nerv-depressed-2019-12-19", "https://www.nasdaq.com/articles/3-dividend-stocks-that-hiked-their-payouts-by-more-than-100-in-5-years-2019-12-19", "https://www.nasdaq.com/articles/better-buy%3A-vertex-pharmaceuticals-vs.-alexion-pharmaceuticals-2019-12-18", "https://www.nasdaq.com/articles/7-biotech-stocks-to-buy-and-hold-in-2020-2019-12-17", "https://www.nasdaq.com/articles/amarins-vascepa-approval-seems-fishy-for-patients-and-amrn-investors-2019-12-16", "https://www.nasdaq.com/articles/is-amarin-a-%2420-billion-stock-2019-12-16", "https://www.nasdaq.com/articles/bristol-myers-placed-a-big-bet-on-celgenes-pipeline.-will-it-pay-off-for-investors-2019-12", "https://www.nasdaq.com/articles/how-gilead-sciences-is-helping-fund-bristol-myers-squibbs-celgene-acquisition-2019-12-21", "https://www.nasdaq.com/articles/3-reasons-this-biotech-is-a-buy-for-risk-averse-investors-2019-12-13", "https://www.nasdaq.com/articles/daily-dividend-report%3A-amgn-zts-pki-pwr-axp-2019-12-12", "https://www.nasdaq.com/articles/january-2020-options-now-available-for-amgen-amgn-2019-12-12", "https://www.nasdaq.com/articles/heres-why-you-should-own-amgen-stock-in-2020-2019-12-12", "https://www.nasdaq.com/articles/why-bridgebio-pharma-is-currently-trading-at-2x-its-ipo-price-2019-12-12", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-11-2019%3A-jnj-pfe-abt-mrk-amgn-aqst-rckt-mrns-2019-12-11", "https://www.nasdaq.com/articles/is-rigel-pharmaceuticals-stock-a-buy-2019-12-11", "https://www.nasdaq.com/articles/better-buy%3A-gilead-sciences-vs.-amgen-2019-12-15", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-09-2019%3A-jnj-pfe-abt-mrk-amgn-pdli-tgtx-tvty-arql-2019-12", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-09-2019%3A-jnj-pfe-abt-mrk-amgn-arql-thor-mbio-xbit-2019-12", "https://www.nasdaq.com/articles/3-healthcare-stocks-to-buy-before-the-end-of-2019-2019-12-09", "https://www.nasdaq.com/articles/better-buy%3A-biogen-vs.-amgen-2019-12-08", "https://www.nasdaq.com/articles/4-fda-dates-biotech-investors-should-circle-in-december-2019-12-07", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-06-2019%3A-jnj-pfe-abt-mrk-amgn-cyad-sava-cris-2019-12-06", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-06-2019%3A-jnj-pfe-abt-mrk-amgn-cyad-oncy-rckt-sava-2019-12", "https://www.nasdaq.com/articles/amgen%3A-candor-study-supports-combination-of-kyprolis-darzalex-quick-facts-2019-12-10", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-09-2019%3A-jnj-pfe-abt-mrk-amgn-pdli-tgtx-tvty-arql-2019-12", "https://www.nasdaq.com/articles/better-buy%3A-amgen-vs.-pfizer-2019-12-04", "https://www.nasdaq.com/articles/why-novartiss-%249.7-billion-purchase-of-the-medicines-company-is-bad-news-for-amgen-2019-12", "https://www.nasdaq.com/articles/notable-monday-option-activity%3A-m-amgn-ibm-2019-12-02", "https://www.nasdaq.com/articles/biotech-stocks-facing-fda-decision-in-december-2019-2019-12-01", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-29-2019%3A-jnj-pfe-abt-mrk-amgn-canf-regn-azn-2019-11-29", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-27-2019%3A-jnj-pfe-abt-mrk-amgn-arav-tnxp-vrca-2019-11-27", "https://www.nasdaq.com/articles/can-cannabis-2.0-kickstart-marijuana-stocks-2019-12-06", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-26-2019%3A-jnj-pfe-abt-mrk-amgn-ccxi-xfor-snoa-2019-11-26", "https://www.nasdaq.com/articles/a-45-premium%3A-heres-why-the-medicines-company-is-worth-more-to-novartis-than-it-was-to-you", "https://www.nasdaq.com/articles/why-the-medicines-company-stock-is-soaring-today-2019-11-25", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-25-2019%3A-jnj-pfe-abt-mrk-amgn-srne-mdco-nvs-ziop-2019-11", "https://www.nasdaq.com/articles/healthcare-stocks-that-hit-new-highs-mtem-amgn-amed...-2019-11-25", "https://www.nasdaq.com/articles/does-amarin-have-a-dark-horse-suitor-2019-11-24", "https://www.nasdaq.com/articles/why-im-holding-on-to-my-bristol-myers-squibb-shares-now-that-the-celgene-acquisition-has", "https://www.nasdaq.com/articles/why-abbvie-is-a-dividend-growth-stock-thats-too-cheap-to-ignore-2019-11-27", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-26-2019%3A-jnj-pfe-abt-mrk-amgn-ccxi-xfor-snoa-2019-11-26", "https://www.nasdaq.com/articles/a-45-premium%3A-heres-why-the-medicines-company-is-worth-more-to-novartis-than-it-was-to-you", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-to-buy-in-november-2019-11-21", "https://www.nasdaq.com/articles/missed-the-310-rise-of-arrowhead-pharmaceuticals-keep-an-eye-on-this-competitor-2019-11-21", "https://www.nasdaq.com/articles/amgen-boosts-fy19-outlook-after-otezla-acquisition-quick-facts-2019-11-21", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-itot-pg-xom-amgn-2019-11-20", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-20-2019%3A-jnj-pfe-abt-mrk-amgn-alc-bcrx-crsp-2019-11-20", "https://www.nasdaq.com/articles/2-stocks-to-buy-if-youre-worried-about-a-recession-2019-11-22", "https://www.nasdaq.com/articles/heres-why-the-medicines-company-jumped-higher-again-today-2019-11-19", "https://www.nasdaq.com/articles/if-biosimilars-are-struggling-someone-forgot-to-tell-coherus-biosciences-2019-11-19", "https://www.nasdaq.com/articles/heres-why-the-medicines-company-moved-higher-today-2019-11-18", "https://www.nasdaq.com/articles/the-question-is-not-why-amarin-stock-may-go-up-but-should-it-2019-11-18", "https://www.nasdaq.com/articles/amgen-says-new-analysis-shows-benefit-of-repatha-in-high-risk-patients-2019-11-16", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity%3A-amgn-roku-splk-2019-11-14", "https://www.nasdaq.com/articles/amarins-stock-could-reach-%2450-per-share-soon-2019-11-13", "https://www.nasdaq.com/articles/looking-for-a-biotech-stock-thats-an-ideal-buyout-candidate-this-is-it.-2019-11-20", "https://www.nasdaq.com/articles/heres-why-fibrogens-stock-popped-friday-2019-11-11", "https://www.nasdaq.com/articles/why-amgens-stock-soared-in-october-2019-11-11", "https://www.nasdaq.com/articles/3-cancer-treatment-stocks-to-buy-right-now-2019-11-09", "https://www.nasdaq.com/articles/heres-why-cytokinetics-stock-tanked-on-thursday-2019-11-07", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity%3A-lh-csx-amgn-2019-11-07", "https://www.nasdaq.com/articles/buy-these-2-stocks-to-access-chinas-huge-healthcare-market-2019-11-06", "https://www.nasdaq.com/articles/breakingviews-biotech-upstarts-will-be-big-pharmas-china-tonic-2019-11-06", "https://www.nasdaq.com/articles/ex-dividend-reminder%3A-teleflex-amgen-and-sabra-health-care-reit-2019-11-12", "https://www.nasdaq.com/articles/amgen-reaches-analyst-target-price-2019-11-04", "https://www.nasdaq.com/articles/better-buy%3A-mirati-therapeutics-vs.-amgen-2019-11-02", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-01-2019%3A-bgneamgnamedblue-2019-11-01-0", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-01-2019%3A-bgneamgnamedblue-2019-11-01", "https://www.nasdaq.com/articles/heres-why-beigene-stock-is-soaring-today-2019-11-01", "https://www.nasdaq.com/articles/ishares-russell-3000-etf-experiences-big-inflow-2019-11-01", "https://www.nasdaq.com/articles/bgne-soars-drna-hits-new-high-on-roche-deal-fda-heeds-rephs-request-2019-11-01", "https://www.nasdaq.com/articles/2020-election-could-hurt-amgen-stocks-healthy-dividend-2019-11-05", "https://www.nasdaq.com/articles/what-should-investors-think-of-biogens-alzheimers-drug-candidate-2019-10-31", "https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-amgn-amd-cost-2019-10-31", "https://www.nasdaq.com/articles/bristol-myers-squibb-beats-expectations-in-q3-as-its-celgene-acquisition-nears-the-finish", "https://www.nasdaq.com/articles/can-this-tiny-biotech-take-down-amgen-2019-10-31", "https://www.nasdaq.com/articles/amgen-inc-amgn-q3-2019-earnings-call-transcript-2019-10-30", "https://www.nasdaq.com/articles/amgen-updates-guidance-quick-facts-2019-10-29", "https://www.nasdaq.com/articles/amgen-inc.-q3-adjusted-earnings-beat-estimates-2019-10-29", "https://www.nasdaq.com/articles/amgen-to-acquire-20.5-stake-in-beigene-for-approx.-%242.7-bln-quick-facts-2019-10-31", "https://www.nasdaq.com/articles/is-gossamer-bio-a-buy-2019-10-29", "https://www.nasdaq.com/articles/why-shockwave-medical-is-not-a-buy-2019-10-29", "https://www.nasdaq.com/articles/amgen-q3-19-earnings-conference-call-at-5%3A00-pm-et-2019-10-29", "https://www.nasdaq.com/articles/5-top-healthcare-etfs-2019-10-26", "https://www.nasdaq.com/articles/amgen-decides-to-discontinue-original-list-price-option-for-repatha-2019-10-24", "https://www.nasdaq.com/articles/daily-dividend-report%3A-aep-leco-bac-wfc-amgn-2019-10-23", "https://www.nasdaq.com/articles/proshares-proshares-ultrapro-qqq-experiences-big-outflow-2019-10-23", "https://www.nasdaq.com/articles/heres-why-mirati-therapeutics-stock-is-on-the-move-again-today-2019-10-29", "https://www.nasdaq.com/articles/is-mirati-therapeutics-a-good-stock-to-buy-now-2019-10-20", "https://www.nasdaq.com/articles/amgen%3A-fda-approves-earlier-use-of-nplate-to-treat-immune-thrombocytopenia-2019-10-18", "https://www.nasdaq.com/articles/amgen-%3A-evenity-gets-positive-chmp-opinion-for-treatment-of-severe-osteoporosis-2019-10-18", "https://www.nasdaq.com/articles/will-the-pace-of-ma-pick-up-following-the-biotech-sectors-pounding-2019-10-11", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity%3A-pd-amgn-ibm-2019-10-07", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-07-2019%3A-jnj-abt-pfe-mrk-amgn-mreo-xent-capr-2019-10-07", "https://www.nasdaq.com/articles/how-amazon-is-shaking-up-telemedicine-plus-1-winner-and-1-loser-exiting-esmo-2019-10-04", "https://www.nasdaq.com/articles/amgen-appoints-peter-griffith-as-cfo-succeeding-david-meline-effective-jan.-1-2019-10-23", "https://www.nasdaq.com/articles/2-great-stocks-you-can-buy-on-sale-2019-10-03", "https://www.nasdaq.com/articles/winners-and-losers-of-europes-big-cancer-meeting-2019-10-02", "https://www.nasdaq.com/articles/the-medicines-company-surges-on-positive-drug-trial-results-2019-10-01", "https://www.nasdaq.com/articles/the-medicines-company-is-up-161-year-to-date-but-heres-a-better-way-to-play-the-drugmakers", "https://www.nasdaq.com/articles/is-amgen-really-as-cheap-as-it-looks-2019-09-28", "https://www.nasdaq.com/articles/notable-friday-option-activity%3A-amgn-oke-axdx-2019-09-27", "https://www.nasdaq.com/articles/cancer-results-to-watch-at-this-weekends-european-society-of-medical-oncology-congress", "https://www.nasdaq.com/articles/interesting-amgn-put-and-call-options-for-november-22nd-2019-10-03", "https://www.nasdaq.com/articles/interesting-amgn-put-and-call-options-for-november-8th-2019-09-26", "https://www.nasdaq.com/articles/tqqq-adbe-cost-amgn%3A-large-inflows-detected-at-etf-2019-09-26", "https://www.nasdaq.com/articles/3-biotechs-with-the-biggest-cash-stockpiles-2019-09-20", "https://www.nasdaq.com/articles/could-amgens-latest-bad-news-boost-the-chances-of-more-acquisitions-2019-09-18", "https://www.nasdaq.com/articles/health-care-sector-update-for-09-17-2019%3A-immpabtacrsadptamgn-2019-09-17", "https://www.nasdaq.com/articles/health-care-sector-update-for-09-17-2019%3A-abtacrsadptamgn-2019-09-17", "https://www.nasdaq.com/articles/heres-why-alder-biopharmaceuticals-is-rocketing-higher-today-2019-09-16", "https://www.nasdaq.com/articles/better-buy%3A-biogen-vs.-amgen-2019-09-27", "https://www.nasdaq.com/articles/amgens-phase-3-candor-study-meets-primary-endpoint-of-pfs-quick-facts-2019-09-13", "https://www.nasdaq.com/articles/analysts-see-10-gains-ahead-for-the-holdings-of-eqwl-2019-09-12", "https://www.nasdaq.com/articles/does-acadia-pharmaceuticals-have-more-room-to-run-2019-09-11", "https://www.nasdaq.com/articles/why-amgen-stock-perked-up-last-month-2019-09-11", "https://www.nasdaq.com/articles/5-things-youll-want-to-know-about-amgens-future-2019-09-11", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-fbt-amgn-nbix-alny-2019-09-10", "https://www.nasdaq.com/articles/amgen-to-present-at-the-morgan-stanley-global-conference-webcast-at-9%3A10-am-et-2019-09-10", "https://www.nasdaq.com/articles/is-ishares-nasdaq-biotechnology-index-fund-a-buy-2019-09-15", "https://www.nasdaq.com/articles/amarin%3A-keep-your-dry-powder-ready-2019-09-09", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-amgn-nflx-2019-09-09", "https://www.nasdaq.com/articles/sp-500-movers%3A-amgn-lb-2019-09-09", "https://www.nasdaq.com/articles/health-care-sector-update-for-09-09-2019%3A-acad-axnx-amgn-jnj-pfe-abt-mrk-2019-09-09", "https://www.nasdaq.com/articles/novartis%3A-aimovig-shows-long-term-efficacy-in-treatment-of-episodic-migraine-2019-09-09", "https://www.nasdaq.com/articles/heres-why-arrowhead-pharmaceuticals-rose-17.6-in-august-2019-09-08", "https://www.nasdaq.com/articles/amgen-drug-shrinks-54-of-lung-cancer-tumors-in-study-2019-09-08", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity%3A-yum-amgn-evri-2019-09-09", "https://www.nasdaq.com/articles/why-amgens-spending-billions-to-buy-this-1-drug-plus-heart-disease-has-a-new-enemy-2019-09", "https://www.nasdaq.com/articles/4-biotech-stocks-with-big-catalysts-in-september-2019-09-06", "https://www.nasdaq.com/articles/heres-why-alexion-pharmaceuticals-dropped-11-in-august-2019-09-05", "https://www.nasdaq.com/articles/heres-why-the-medicines-company-stock-soared-again-on-tuesday-2019-09-03", "https://www.nasdaq.com/articles/spy-brk.b-nflx-amgn%3A-etf-inflow-alert-2019-08-30", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-right-now-2019-08-28", "https://www.nasdaq.com/articles/4-biotech-stocks-to-buy-that-are-on-the-move-2019-08-27", "https://www.nasdaq.com/articles/better-buy%3A-amgen-vs.-celgene-2019-09-08", "https://www.nasdaq.com/articles/celgenes-%2413.4-billion-deal-with-amgen-is-a-win-win-win-2019-08-26", "https://www.nasdaq.com/articles/5-top-stock-trades-for-tuesday%3A-nflx-amgn-acb-bmy-2019-08-26", "https://www.nasdaq.com/articles/celgene-news%3A-celg-stock-jumps-on-sale-of-otezla-to-amgen-2019-08-26", "https://www.nasdaq.com/articles/should-amgen-finally-buy-alexion-pharmaceuticals-2019-08-25", "https://www.nasdaq.com/articles/3-reasons-why-amgen-could-actually-acquire-alexion-2019-08-24", "https://www.nasdaq.com/articles/alxn-takeover-rumors-amgns-jasmine-blooms-clsd-sees-the-writing-on-the-wall-2019-08-23", "https://www.nasdaq.com/articles/spdr-sp-500-etf-trust-experiences-big-outflow-2019-08-22", "https://www.nasdaq.com/articles/what-happened-in-the-stock-market-today-2019-08-26", "https://www.nasdaq.com/articles/is-amgen-a-buy-2019-08-18", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-spyg-avgo-amgn-adp-2019-08-14", "https://www.nasdaq.com/articles/wednesdays-vital-data%3A-amgen-american-airlines-and-apple-2019-08-14", "https://www.nasdaq.com/articles/amgen-inc.-amgn-ex-dividend-date-scheduled-for-august-14-2019-2019-08-13", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity%3A-apa-stt-amgn-2019-08-12", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-meli-amgn-2019-08-12", "https://www.nasdaq.com/articles/ex-dividend-reminder%3A-teleflex-amgen-and-u.s.-physical-therapy-2019-08-12", "https://www.nasdaq.com/articles/arrowhead-pharmaceuticals%3A-buy-at-the-high-2019-08-21", "https://www.nasdaq.com/articles/sandoz-to-appeal-u.s.-court-ruling-in-biosimilar-erelzi-u.s.-patent-case-2019-08-11", "https://www.nasdaq.com/articles/amgn-named-a-top-socially-responsible-dividend-stock-2019-08-07", "https://www.nasdaq.com/articles/5-strong-buy-dividend-stocks-with-high-upside-2019-08-06", "https://www.nasdaq.com/articles/9-catalysts-that-will-drive-chinese-biotech-stocks-much-higher-2019-08-05", "https://www.nasdaq.com/articles/daily-dividend-report%3A-dk-spns-sbr-tg-amgn-2019-08-05", "https://www.nasdaq.com/articles/3-lung-cancer-stocks-that-could-soar-in-september-2019-08-04", "https://www.nasdaq.com/articles/ishares-u.s.-healthcare-etf-experiences-big-outflow-2019-08-02", "https://www.nasdaq.com/articles/sp-500-movers%3A-nktr-amgn-2019-08-12", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-31-2019%3A-nuvaamgnacrs-2019-07-31", "https://www.nasdaq.com/articles/are-amgen-and-gilead-sciences-better-buys-after-second-quarter-earnings-2019-07-31", "https://www.nasdaq.com/articles/amgen-inc-amgn-q2-2019-earnings-call-transcript-2019-07-31", "https://www.nasdaq.com/articles/amgen-manages-to-tread-water-for-another-quarter-2019-07-31", "https://www.nasdaq.com/articles/amgen-inc.-q2-adjusted-earnings-beat-estimates-2019-07-30", "https://www.nasdaq.com/articles/amgen-q2-19-earnings-conference-call-at-5%3A30-pm-et-2019-07-30", "https://www.nasdaq.com/articles/amgn-september-6th-options-begin-trading-2019-07-29", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-31-2019%3A-dmpinuvaamgnacrs-2019-07-31", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-31-2019%3A-nuvaamgnacrs-2019-07-31", "https://www.nasdaq.com/articles/are-amgen-and-gilead-sciences-better-buys-after-second-quarter-earnings-2019-07-31", "https://www.nasdaq.com/articles/the-implied-analyst-12-month-target-for-eqwl-2019-07-22", "https://www.nasdaq.com/articles/acwi-baba-ko-amgn%3A-etf-inflow-alert-2019-07-17", "https://www.nasdaq.com/articles/amgn-august-30th-options-begin-trading-2019-07-15", "https://www.nasdaq.com/articles/what-happened-in-the-stock-market-today-2019-07-12", "https://www.nasdaq.com/articles/the-10-biggest-healthcare-stocks-2019-07-10", "https://www.nasdaq.com/articles/10-biggest-cancer-fighting-stocks-2019-07-27", "https://www.nasdaq.com/articles/heres-why-coherus-biosciences-is-falling-today-2019-07-08", "https://www.nasdaq.com/articles/the-health-care-select-sector-spdr-fund-experiences-big-outflow-2019-07-08", "https://www.nasdaq.com/articles/why-amgen-is-a-top-25-dividend-giant-amgn-2019-07-08", "https://www.nasdaq.com/articles/heres-why-amgen-stock-gained-10-in-june-2019-07-06", "https://www.nasdaq.com/articles/how-to-invest-in-biotech-stocks-2019-07-02", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity%3A-amp-avgo-amgn-2019-07-01", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-right-now-2019-06-30", "https://www.nasdaq.com/articles/notable-monday-option-activity%3A-stz-chgg-amgn-2019-07-08", "https://www.nasdaq.com/articles/3-cancer-treatment-stocks-to-buy-2019-06-29", "https://www.nasdaq.com/articles/heres-why-dova-pharmaceuticals-stock-jumped-higher-today-2019-06-27", "https://www.nasdaq.com/articles/xlv-amgn-lly-syk%3A-etf-outflow-alert-2019-06-27", "https://www.nasdaq.com/articles/the-10-biggest-biotech-stocks-2019-06-25", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-unh-rht-amgn-2019-06-19", "https://www.nasdaq.com/articles/3-large-cap-biotech-stocks-to-buy-for-massive-gains-2019-06-19", "https://www.nasdaq.com/articles/iwf-acn-cost-amgn%3A-large-inflows-detected-at-etf-2019-06-18", "https://www.nasdaq.com/articles/where-will-cara-therapeutics-be-in-5-years-2019-06-29", "https://www.nasdaq.com/articles/3-stocks-to-buy-and-hold-for-the-next-50-years-2019-06-16", "https://www.nasdaq.com/articles/sso-mdt-ibm-amgn%3A-large-outflows-detected-etf-2019-06-10", "https://www.nasdaq.com/articles/health-care-sector-update-for-06-07-2019%3A-crspvrtxljpcmrtxamgn-2019-06-07", "https://www.nasdaq.com/articles/5-healthcare-stocks-to-pick-up-from-the-wreckage-2019-06-06", "https://www.nasdaq.com/articles/5-reasons-pfizer-sat-potential-new-alzheimers-drug-2019-06-06", "https://www.nasdaq.com/articles/3-cancer-stocks-given-lift-amgen-2019-06-04", "https://www.nasdaq.com/articles/better-buy%3A-biogen-vs.-amgen-2019-06-03", "https://www.nasdaq.com/articles/3-big-drugmakers-most-likely-to-make-acquisitions-after-pfizers-surprise-deal-2019-06-18", "https://www.nasdaq.com/articles/amgen-reports-positive-data-amg-510-early-phase-1-study-quick-facts-2019-06-03", "https://www.nasdaq.com/articles/notable-friday-option-activity%3A-tmus-amgn-arr-2019-05-31", "https://www.nasdaq.com/articles/sso-amzn-amgn-lin%3A-large-outflows-detected-etf-2019-05-31", "https://www.nasdaq.com/articles/ranking-the-top-10-stock-buybacks-of-last-year-2019-05-30", "https://www.nasdaq.com/articles/2-healthcare-stocks-doubled-investors-money-2019-2019-05-28", "https://www.nasdaq.com/articles/3-charts-every-amgen-investor-needs-see-2019-05-26", "https://www.nasdaq.com/articles/interesting-amgn-put-and-call-options-july-5th-2019-05-23", "https://www.nasdaq.com/articles/heres-why-mirati-therapeutics-jumping-today-2019-06-03", "https://www.nasdaq.com/articles/amgen-offers-buy-nuevolution-sek-32.50/shr-cash-quick-facts-2019-05-22", "https://www.nasdaq.com/articles/who-had-better-quarter%3A-gilead-sciences-or-amgen-2019-05-17", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-16-2019%3A-bluemrtxagioedapamgn-2019-05-16", "https://www.nasdaq.com/articles/heres-why-mirati-therapeutics-surging-today-2019-05-16", "https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-agn-dal-amgn-2019-05-16", "https://www.nasdaq.com/articles/3-stocks-big-news-coming-asco-2019-2019-05-15", "https://www.nasdaq.com/articles/health-care-sector-update-05/10/2019%3A-jnj-pfe-abt-mrk-amgn-gene-pirs-tgtx-2019-05-10", "https://www.nasdaq.com/articles/ibb-celg-gild-amgn%3A-etf-inflow-alert-2019-05-23", "https://www.nasdaq.com/articles/why-are-investors-passing-teva-pharmaceutical-industries-2019-05-05", "https://www.nasdaq.com/articles/june-14th-options-now-available-amgen-amgn-2019-05-02", "https://www.nasdaq.com/articles/5-top-stock-trades-thursday%3A-cvs-twlo-el-amgn-2019-05-01", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-amgn-aapl-2019-05-01", "https://www.nasdaq.com/articles/amgen-inc-amgn-q1-2019-earnings-call-transcript-2019-05-01", "https://www.nasdaq.com/articles/amgen-reports-unusual-slide-backward-2019-04-30", "https://www.nasdaq.com/articles/amgen-earnings%3A-amgn-stock-dips-slightly-despite-q1-eps-sales-beat-2019-04-30", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-ezpw-amgn-etsy-2019-05-08", "https://www.nasdaq.com/articles/why-are-investors-passing-teva-pharmaceutical-industries-2019-05-05", "https://www.nasdaq.com/articles/amgen-q1-19-earnings-conference-call-5%3A00-pm-et-2019-04-30", "https://www.nasdaq.com/articles/4-more-healthcare-earnings-reports-watch-week-2019-04-30", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-saia-coty-amgn-2019-04-26", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-iyh-abbv-amgn-mdt-2019-04-22", "https://www.nasdaq.com/articles/pfizer-stock-suffers-underappreciated-drugs-pipeline-2019-04-22", "https://www.nasdaq.com/articles/amgen-oversold-2019-04-18", "https://www.nasdaq.com/articles/amgen-updates-earnings-guidance-quick-facts-2019-04-30", "https://www.nasdaq.com/articles/why-amgen-stock-could-break-out-new-highs-2019-04-16", "https://www.nasdaq.com/articles/radius-health-rdus-rallies-33.4-ytd-on-robust-tymlos-sales-2019-04-16-0", "https://www.nasdaq.com/articles/amgen-sets-21900-annual-price-new-evenity-bone-drug-2019-04-15", "https://www.nasdaq.com/articles/better-buy-amgen-vs-gilead-sciences-2019-04-13", "https://www.nasdaq.com/articles/proshares-ultrapro-sp500-experiences-big-outflow-2019-04-10", "https://www.nasdaq.com/articles/fda-approves-amgens-osteoporosis-drug-evenity-2019-04-09", "https://www.nasdaq.com/articles/heres-why-novartis-sliding-today-2019-04-09", "https://www.nasdaq.com/articles/3-big-stock-charts-for-thursday%3A-citrix-systems-goldman-sachs-group-and-amgen-2019-04-18", "https://www.nasdaq.com/articles/5-stocks-age-miracles-2019-04-09", "https://www.nasdaq.com/articles/amgens-postmenopausal-osteoporosis-drug-gets-fda-greenlight-2019-04-09", "https://www.nasdaq.com/articles/amgens-postmenopausal-osteoporosis-drug-gets-fda-approval-2019-04-09", "https://www.nasdaq.com/articles/heres-why-novartis-sliding-today-2019-04-09-0", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-3-yield-mark-2019-04-08", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-3-yield-mark-2019-04-08-0", "https://www.nasdaq.com/articles/why-amgens-giving-novartis-headache-2019-04-07", "https://www.nasdaq.com/articles/why-amgen-can-deliver-medical-and-financial-miracles-2019-04-09", "https://www.nasdaq.com/articles/novartis-amgen-in-legal-dispute-over-migraine-drug-aimovig-2019-04-05-0", "https://www.nasdaq.com/articles/novartis-sues-amgen-over-migraine-treatment-aimovig-2019-04-04", "https://www.nasdaq.com/articles/pfizers-new-lung-cancer-drug-vizimpro-gets-eu-approval-2019-04-04-0", "https://www.nasdaq.com/articles/novartis-resubmits-bla-to-fda-for-biosimilar-of-neulasta-2019-04-04-0", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-vym-pfe-ibm-amgn-2019-04-02", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-vym-pfe-ibm-amgn-2019-04-02-0", "https://www.nasdaq.com/articles/bmos-got-point-about-teva-stock-are-investors-willing-listen-2019-04-01", "https://www.nasdaq.com/articles/why-amgens-giving-novartis-headache-2019-04-07-0", "https://www.nasdaq.com/articles/novartis-amgen-in-legal-dispute-over-migraine-drug-aimovig-2019-04-05-0", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-apple-amgen-united-technologies-travelers-and-xilinx", "https://www.nasdaq.com/articles/abbvies-psoriasis-drug-skyrizi-gets-first-approval-in-japan-2019-03-26", "https://www.nasdaq.com/articles/top-research-reports-apple-amgen-united-technologies-2019-03-26", "https://www.nasdaq.com/articles/qual-mo-amgn-mco-large-inflows-detected-etf-2019-03-25", "https://www.nasdaq.com/articles/may-3rd-options-now-available-amgen-amgn-2019-03-25", "https://www.nasdaq.com/articles/biogen-stock-fell-too-far-unfortunate-news-2019-03-22", "https://www.nasdaq.com/articles/bmos-got-point-about-teva-stock-are-investors-willing-listen-2019-04-01-0", "https://www.nasdaq.com/articles/spectrum-pharma-sppi-withdraws-rolontis-bla-shares-down-2019-03-18", "https://www.nasdaq.com/articles/amarins-vascepa-cuts-occurrence-serious-heart-problems-30-pct-2019-03-18", "https://www.nasdaq.com/articles/regeneron-sanofi-get-ec-nod-for-label-expansion-of-praluent-2019-03-18", "https://www.nasdaq.com/articles/better-buy-amgen-vs-gilead-sciences-2019-03-17", "https://www.nasdaq.com/articles/ishares-edge-msci-usa-quality-factor-etf-experiences-big-inflow-2019-03-15", "https://www.nasdaq.com/articles/roche-gets-approval-for-label-expansion-of-mabthera-in-europe-2019-03-15", "https://www.nasdaq.com/articles/roche-receives-ec-approval-for-label-expansion-of-hemlibra-2019-03-14", "https://www.nasdaq.com/articles/heres-why-cytokinetics-stock-jumped-today-2019-03-20", "https://www.nasdaq.com/articles/pfizers-herceptin-biosimilar-trazimera-gets-fda-approval-2019-03-12", "https://www.nasdaq.com/articles/roches-rhhby-tecentriq-gets-fda-approval-for-breast-cancer-2019-03-12", "https://www.nasdaq.com/articles/is-amgen-amgn-a-profitable-pick-forvalue-investors-now-2019-03-11", "https://www.nasdaq.com/articles/amgn-named-top-dividend-stock-nasdaq-100-dividend-channel-32-yield-2019-03-11", "https://www.nasdaq.com/articles/better-buy-amgen-vs-biogen-2019-03-10", "https://www.nasdaq.com/articles/daily-dividend-report-mtn-amt-amat-bmy-amgn-2019-03-08", "https://www.nasdaq.com/articles/rsi-alert-amgen-now-oversold-2019-03-07", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-march-14-2019-2019-03-13", "https://www.nasdaq.com/articles/ligand-sells-promacta-rights-for-%24827m-updates-19-view-2019-03-06", "https://www.nasdaq.com/articles/3-big-pharmas-trying-pop-rebate-bubble-2019-03-06", "https://www.nasdaq.com/articles/us-fda-chief-tough-e-cigs-steps-down-surprise-resignation-2019-03-06", "https://www.nasdaq.com/articles/us-fda-chief-tough-e-cigarettes-steps-down-abruptly-2019-03-06", "https://www.nasdaq.com/articles/us-stocks-wall-st-sinks-3rd-day-healthcare-energy-slump-2019-03-06", "https://www.nasdaq.com/articles/wall-st-sinks-3rd-day-healthcare-energy-slump-2019-03-06", "https://www.nasdaq.com/articles/wall-st-falls-3rd-day-healthcare-energy-slump-2019-03-06", "https://www.nasdaq.com/articles/lillys-emgality-gets-fda-priority-review-for-cluster-headache-2019-03-06", "https://www.nasdaq.com/articles/wall-street-eyes-third-day-losses-healthcare-sector-weighs-2019-03-06", "https://www.nasdaq.com/articles/us-stocks-wall-street-eyes-third-day-losses-healthcare-sector-weighs-2019-03-06", "https://www.nasdaq.com/articles/merck-gets-chmp-nod-for-six-week-dosing-option-of-keytruda-2019-03-05", "https://www.nasdaq.com/articles/us-fda-chief-gottlieb-resigns-2019-03-05", "https://www.nasdaq.com/articles/us-fda-chief-gottlieb-resigning-2019-03-05", "https://www.nasdaq.com/articles/ishares-russell-1000-growth-etf-experiences-big-inflow-2019-03-04", "https://www.nasdaq.com/articles/abbvie-gets-chmp-nod-for-psoriasis-candidate-risankizumab-2019-03-04", "https://www.nasdaq.com/articles/us-stocks-wall-st-falls-3rd-day-healthcare-energy-slump-2019-03-06", "https://www.nasdaq.com/articles/radius-rdus-posts-narrower-q4-loss-on-robust-tymlos-sales-2019-03-01", "https://www.nasdaq.com/articles/sanofi-regeneron-disagree-with-jury-verdict-in-amgens-favor-2019-02-26", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-bac-amgn-tzoo-2019-02-26", "https://www.nasdaq.com/articles/roche-rhhby-to-acquire-spark-therapeutics-for-%244.8-billion-2019-02-25", "https://www.nasdaq.com/articles/sanofi-regeneron-lose-us-patent-challenge-amgen-cholesterol-drug-2019-02-25", "https://www.nasdaq.com/articles/better-buy-amgen-vs-celgene-2019-02-24", "https://www.nasdaq.com/articles/amgen-starts-phase-iii-enrollment-for-heart-failure-drug-2019-02-22", "https://www.nasdaq.com/articles/spectrum-sppi-misses-earnings-estimates-in-q4-tops-sales-2019-03-01", "https://www.nasdaq.com/articles/merck-gets-priority-review-for-keytruda-in-third-line-sclc-2019-02-21", "https://www.nasdaq.com/articles/amgn-april-5th-options-begin-trading-2019-02-21", "https://www.nasdaq.com/articles/abbvies-ra-candidate-upadacitinib-gets-fda-priority-review-2019-02-20", "https://www.nasdaq.com/articles/mercks-keytruda-fails-to-meet-endpoint-in-liver-cancer-study-2019-02-20", "https://www.nasdaq.com/articles/top-analyst-reports-walmart-amgen-and-honda-2019-02-20", "https://www.nasdaq.com/articles/roches-rhhby-bla-for-lymphoma-drug-gets-priority-review-2019-02-19", "https://www.nasdaq.com/articles/merck-gets-priority-review-for-keytruda-combo-in-kidney-cancer-2019-02-18", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-walmart-amgen-honda-transcanada-and-transunion-2019-02", "https://www.nasdaq.com/articles/teva-teva-q4-earnings-miss19-view-weak-shares-down-2019-02-14", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-february-14-2019-2019-02-13", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-february-14-2019-2019-02-13", "https://www.nasdaq.com/articles/key-takeaways-from-eli-lillys-lly-q4-earnings-report-2019-02-13", "https://www.nasdaq.com/articles/mercks-keytruda-gets-fda-priority-review-for-head-neck-cancer-2019-02-12", "https://www.nasdaq.com/articles/abbvie-buys-rights-to-novel-immunotherapy-for-multiple-myeloma-2019-02-12", "https://www.nasdaq.com/articles/sanofi-regeneron-cut-price-of-pcsk9-inhibitor-praluent-by-60-2019-02-12", "https://www.nasdaq.com/articles/amgen-buy-2019-02-17", "https://www.nasdaq.com/articles/sanofi-and-regeneron-cut-list-price-cholesterol-drug-60-pct-2019-02-11", "https://www.nasdaq.com/articles/heres-why-coherus-biosciences-rose-487-january-2019-02-11", "https://www.nasdaq.com/articles/ligand-lgnd-beats-on-q4-earnings-sales-raises-19-view-2019-02-08", "https://www.nasdaq.com/articles/5-reasons-eli-lilly-investors-look-can-look-past-lartruvos-failure-2019-02-07", "https://www.nasdaq.com/articles/lilly-lly-lags-q4-earnings-lowers-2019-view-stock-down-2019-02-06", "https://www.nasdaq.com/articles/amgen-top-socially-responsible-dividend-stock-31-yield-amgn-2019-02-06", "https://www.nasdaq.com/articles/facing-crackdown-canada-drugmakers-offered-billions-price-cuts-2019-02-06", "https://www.nasdaq.com/articles/iwv-pep-abbv-amgn-etf-outflow-alert-2019-02-11", "https://www.nasdaq.com/articles/after-hours-most-active-feb-5-2019-brx-snap-et-s-eca-m-czr-msft-kura-ea-amgn-urbn-2019-02", "https://www.nasdaq.com/articles/teva-gains-positive-chmp-opinion-for-migraine-drug-ajovy-2019-02-04", "https://www.nasdaq.com/articles/pfizers-pfe-new-lung-cancer-drug-vizimpro-gets-chmp-nod-2019-02-04", "https://www.nasdaq.com/articles/war-high-drug-prices-could-boost-biosimilars-2019-02-03", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-xlv-amgn-abbv-lly-2019-02-01", "https://www.nasdaq.com/articles/optum-cover-amgen-eli-lilly-migraine-drugs-exclude-teva-2019-02-01", "https://www.nasdaq.com/articles/mercks-keytruda-tops-2-billion-quarterly-sales-shares-rise-2019-02-01", "https://www.nasdaq.com/articles/roche-submits-sbla-to-fda-for-label-expansion-of-kadcyla-2019-02-05", "https://www.nasdaq.com/articles/roche-rhhby-2018-sales-up-on-solid-new-drugs-performance-2019-02-01", "https://www.nasdaq.com/articles/top-us-insurer-cover-amgen-eli-lilly-migraine-drugs-exclude-teva-2019-02-01", "https://www.nasdaq.com/articles/novartis-nvs-q4-earnings-miss-estimates-revenues-up-y-y-2019-01-31", "https://www.nasdaq.com/articles/amgen-inc-amgn-q4-2018-earnings-conference-call-transcript-2019-01-30", "https://www.nasdaq.com/articles/nasdaq-100-movers-amgn-amd-2019-01-30", "https://www.nasdaq.com/articles/amgen-amgn-q4-earnings-beat-estimates-2019-guidance-tepid-2019-01-30", "https://www.nasdaq.com/articles/pfizer-pfe-q4-earnings-beat-2019-view-tepid-stock-dips-2019-01-29", "https://www.nasdaq.com/articles/merck-quarterly-profit-beats-estimates-keytruda-strength-2019-02-01", "https://www.nasdaq.com/articles/amgen-q4-18-earnings-conference-call-500-pm-et-2019-01-29", "https://www.nasdaq.com/articles/amgen-2019-forecast-falls-short-expectations-shares-dip-2019-01-29", "https://www.nasdaq.com/articles/amgen-quarterly-profit-tops-street-view-2019-forecast-falls-short-2019-01-29", "https://www.nasdaq.com/articles/after-hours-earnings-report-january-29-2019-aapl-amgn-cni-syk-ilmn-ebay-eqr-amd-bxp-algn", "https://www.nasdaq.com/articles/amgen-amgn-to-report-q4-earnings%3A-whats-in-the-cards-2019-01-28", "https://www.nasdaq.com/articles/notable-monday-option-activity-gpre-yumc-amgn-2019-01-28", "https://www.nasdaq.com/articles/abbvie-abbv-misses-on-q4-earnings-revenues-shares-down-2019-01-25", "https://www.nasdaq.com/articles/amgen-leaves-investors-mixed-emotions-2019-01-29", "https://www.nasdaq.com/articles/health-care-sector-update-01252019-chrsamgnrmdaznidxgabbv-2019-01-25", "https://www.nasdaq.com/articles/see-which-latest-13f-filers-holds-amgen-2019-01-25", "https://www.nasdaq.com/articles/cvs-cover-migraine-drugs-teva-lilly-excludes-amgen-2019-01-25", "https://www.nasdaq.com/articles/pfizer-pfe-to-report-q4-earnings%3A-whats-in-the-cards-2019-01-24", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-celgene-regeneron-pharmaceuticals-amgen-alnylam", "https://www.nasdaq.com/articles/ishares-us-healthcare-etf-experiences-big-inflow-2019-01-24", "https://www.nasdaq.com/articles/is-a-surprise-in-the-cards-for-novartis-nvs-in-q4-earnings-2019-01-24", "https://www.nasdaq.com/articles/amgen-allergans-rituxan-biosimilar-meets-goal-in-phase-iii-2019-01-25", "https://www.nasdaq.com/articles/health-care-sector-update-01252019-chrsamgnrmdaznidxgabbv-2019-01-25", "https://www.nasdaq.com/articles/can-amgen-amgn-keep-the-earnings-surprise-streak-alive-2019-01-21", "https://www.nasdaq.com/articles/whats-in-store-for-bristol-myers-bmy-in-q4-earnings-2019-01-21", "https://www.nasdaq.com/articles/biogen-biib-q4-earnings-coming-up%3A-whats-in-the-cards-2019-01-21", "https://www.nasdaq.com/articles/which-big-pharma-stocks-lose-most-war-drug-price-hikes-2019-01-20", "https://www.nasdaq.com/articles/amgen-amgn-gains-but-lags-market%3A-what-you-should-know-2019-01-18", "https://www.nasdaq.com/articles/amgens-postmenopausal-osteoporosis-drug-gets-fda-panel-nod-2019-01-17", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-amgen-vertex-get-ec-nod-for-label-expansion-of-drugs-2019-01-23", "https://www.nasdaq.com/articles/amgens-postmenopausal-osteoporosis-drug-wins-fda-panel-backing-2019-01-16", "https://www.nasdaq.com/articles/3-top-big-pharma-stocks-buy-now-2019-01-15", "https://www.nasdaq.com/articles/whats-in-store-for-merck-in-2019-after-a-solid-run-in-18-2019-01-14", "https://www.nasdaq.com/articles/heres-why-you-should-invest-in-illumina-ilmn-stock-now-2019-01-14", "https://www.nasdaq.com/articles/amgens-osteoporosis-candidate-evenity-gets-approval-in-japan-2019-01-09", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xlv-mrk-abt-amgn-2019-01-07", "https://www.nasdaq.com/articles/us-supreme-court-rejects-amgen-over-cholesterol-medication-patent-fight-2019-01-07", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-ibb-amgn-ilmn-regn-2019-01-16", "https://www.nasdaq.com/articles/us-top-court-rejects-amgen-over-cholesterol-medication-patent-fight-2019-01-07", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-vs-amgen-2019-01-06", "https://www.nasdaq.com/articles/heres-why-bluebird-bio-shares-got-knocked-down-193-december-2019-01-04", "https://www.nasdaq.com/articles/merck-buys-nash-candidate-keytruda-wins-5-approvals-in-japan-2019-01-04", "https://www.nasdaq.com/articles/teva-pharmaceutical-posting-strong-gain-after-resolving-dispute-amgen-2019-01-03", "https://www.nasdaq.com/articles/spectrum-pharma-fully-enrolls-1st-cohort-in-poziotinib-study-2019-01-03", "https://www.nasdaq.com/articles/will-pfizers-pfe-stock-keep-up-the-momentum-in-2019-2019-01-03", "https://www.nasdaq.com/articles/amgen-top-25-dividend-giant-297-yield-amgn-2019-01-07", "https://www.nasdaq.com/articles/teva-teva-ends-dispute-with-amgen-over-generic-sensipar-2019-01-03", "https://www.nasdaq.com/articles/3-pharma-stocks-revving-for-growth-2019-01-02", "https://www.nasdaq.com/articles/teva-amgen-end-dispute-over-generic-cinacalcet-hcl-tablets-2019-01-02", "https://www.nasdaq.com/articles/teva-amgen-settle-dispute-over-tevas-generic-cinacalet-hcl-product-2019-01-02", "https://www.nasdaq.com/articles/forget-glaxosmithkline-eli-lilly-better-big-pharma-stock-2018-12-29", "https://www.nasdaq.com/articles/will-abbvie-abbv-shares-regain-lost-momentum-in-2019-2018-12-28", "https://www.nasdaq.com/articles/spectrum-pharma-files-bla-for-neutropenia-candidate-rolontis-2018-12-28", "https://www.nasdaq.com/articles/amgen-amgn-stock-moves-1.52%3A-what-you-should-know-2019-01-03", "https://www.nasdaq.com/articles/abbvie-stock-3-pros-and-3-cons-consider-investing-abbv-2018-12-27", "https://www.nasdaq.com/articles/amgen-amgn-stock-moves-1%3A-what-you-should-know-2018-12-24", "https://www.nasdaq.com/articles/mercks-sbla-for-keytruda-in-lung-cancer-gets-extended-review-2018-12-21", "https://www.nasdaq.com/articles/abbvie-abbv-seeks-approval-for-ra-candidate-upadacitinib-2018-12-21", "https://www.nasdaq.com/articles/allergan-drops-stops-textured-breast-implant-sales-in-europe-2018-12-20", "https://www.nasdaq.com/articles/mercks-keytruda-gets-fda-approval-for-rare-skin-cancer-2018-12-20", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-aduro-vertex-evofem-and-incyte-2018-12-20", "https://www.nasdaq.com/articles/qual-ma-mo-amgn-large-inflows-detected-etf-2018-12-27", "https://www.nasdaq.com/articles/abbvie-stock-3-pros-and-3-cons-consider-investing-abbv-2018-12-27", "https://www.nasdaq.com/articles/amgen-amgn-stock-moves-1%3A-what-you-should-know-2018-12-24", "https://www.nasdaq.com/articles/forget-bluebird-bio-amgen-better-biotech-stock-2018-12-19", "https://www.nasdaq.com/articles/amgen-and-molecular-partners-collaborate-immuno-oncology-2018-12-18", "https://www.nasdaq.com/articles/ishares-msci-world-etf-experiences-big-inflow-2018-12-18", "https://www.nasdaq.com/articles/mercks-keytruda-gets-eu-nod-as-adjuvant-therapy-for-melanoma-2018-12-18", "https://www.nasdaq.com/articles/teva-reports-positive-top-line-data-for-migraine-candidate-2018-12-18", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-december-2018-12-20", "https://www.nasdaq.com/articles/amgen-amgn-stock-sinks-as-market-gains%3A-what-you-should-know-2018-12-18", "https://www.nasdaq.com/articles/pfizers-pfe-biosimilar-of-avastin-gets-positive-chmp-nod-2018-12-17", "https://www.nasdaq.com/articles/better-buy-biogen-vs-amgen-2018-12-15", "https://www.nasdaq.com/articles/5-biotech-stocks-set-bounce-back-19-after-rough-ride-2018-12-14", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-3-yield-mark-2018-12-14", "https://www.nasdaq.com/articles/gilead-sciences-top-socially-responsible-dividend-stock-34-yield-gild-2018-12-13", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-december-13-2018-2018-12-12", "https://www.nasdaq.com/articles/biotech-stocks-made-big-progress-toward-preventing-heart-attacks-2018-2018-12-18", "https://www.nasdaq.com/articles/why-arrowhead-pharmaceuticals-surged-11-higher-today-2018-12-12", "https://www.nasdaq.com/articles/health-care-sector-update-12112018-entx-amgn-itci-nvs-jnj-pfe-mrk-abt-2018-12-11", "https://www.nasdaq.com/articles/wall-street-heads-higher-open-chinas-trade-concessions-trigger-risk-rally-2018-12-11", "https://www.nasdaq.com/articles/health-care-sector-update-12112018-oprxitcientxamgnrarx-2018-12-11", "https://www.nasdaq.com/articles/health-care-sector-update-12112018-itcientxamgnrarx-2018-12-11", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-inflow-2018-12-10", "https://www.nasdaq.com/articles/amgen-amgn-continues-to-reward-shareholders-ups-dividend-2018-12-10", "https://www.nasdaq.com/articles/amgen-amgn-gains-but-lags-market%3A-what-you-should-know-2018-12-12", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-kodk-amgn-nyt-2018-12-07", "https://www.nasdaq.com/articles/can-celgene-and-bluebird-bio-survive-two-pronged-attack-2018-12-05", "https://www.nasdaq.com/articles/amgens-bite-immunotherapies-show-promise-in-early-studies-2018-12-04", "https://www.nasdaq.com/articles/abbvie-settles-with-pfizer-for-humira-biosimilar-in-u.s.-2018-12-03", "https://www.nasdaq.com/articles/fda-committee-to-review-amgens-amgn-osteoporosis-candidate-2018-12-03", "https://www.nasdaq.com/articles/amgen-reaches-analyst-target-price-2018-12-03", "https://www.nasdaq.com/articles/mondays-etf-movers-xbi-xlv-2018-12-03", "https://www.nasdaq.com/articles/daily-dividend-report-amgn-aes-erie-vtr-mrvl-2018-12-10", "https://www.nasdaq.com/articles/3-big-stock-charts-wednesday-delta-air-lines-amgen-and-mondelez-international-2018-11-28", "https://www.nasdaq.com/articles/novartis-nvs-receives-ec-approval-for-neulasta-biosimilar-2018-11-28", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-amgn-v-ko-2018-11-28", "https://www.nasdaq.com/articles/5-biotech-stocks-scoop-big-dividends-2018-11-27", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-spyg-abt-bkng-amgn-2018-11-26", "https://www.nasdaq.com/articles/4-reasons-why-lilly-is-up-more-than-30-this-year-so-far-2018-11-26", "https://www.nasdaq.com/articles/roche-abbvie-get-fda-approval-for-venclexta-label-expansion-2018-11-22", "https://www.nasdaq.com/articles/amgen-amgn-gains-as-market-dips%3A-what-you-should-know-2018-11-29", "https://www.nasdaq.com/articles/amgen-amgn-great-stock-value-investors-2018-11-19", "https://www.nasdaq.com/articles/amgens-blincyto-gets-positive-chmp-opinion-for-line-extension-2018-11-19", "https://www.nasdaq.com/articles/drug-pricing-resurfaces-pfizer-to-raise-cost-of-41-drugs-2018-11-19", "https://www.nasdaq.com/articles/amgen-amgn-gains-as-market-dips%3A-what-you-should-know-2018-11-19", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-spyg-amgn-tmo-lly-2018-11-16", "https://www.nasdaq.com/articles/lilly-offers-updates-on-progress-of-headache-disorder-drugs-2018-11-15", "https://www.nasdaq.com/articles/mercks-keytruda-improves-survival-in-esophageal-cancer-study-2018-11-15", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gilds-drug-wins-nod-in-china-arena-up-on-licensing-deal-2018-11-21", "https://www.nasdaq.com/articles/roches-tecentriq-gets-priority-review-for-breast-cancer-2018-11-14", "https://www.nasdaq.com/articles/ex-dividend-reminder-aqua-america-amgen-and-jones-lang-lasalle-2018-11-13", "https://www.nasdaq.com/articles/mercks-mrk-keytruda-gets-fda-approval-for-liver-cancer-2018-11-12", "https://www.nasdaq.com/articles/amgen-amgn-stock-moves-0.83%3A-what-you-should-know-2018-11-12", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-pfizer-inc-2018-11-11", "https://www.nasdaq.com/articles/6-pharmaceutical-stocks-to-buy-after-the-midterms-2018-11-09", "https://www.nasdaq.com/articles/spectrum-sppi-earnings-and-sales-beat-estimates-in-q3-2018-11-09", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-november-15-2018-2018-11-14", "https://www.nasdaq.com/articles/roches-tecentriq-gets-priority-review-for-breast-cancer-2018-11-14", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xlv-amgn-mdt-lly-2018-11-07", "https://www.nasdaq.com/articles/amgen-amgn-counts-on-new-drugs-amid-rising-biosimilar-woes-2018-11-07", "https://www.nasdaq.com/articles/3-cancer-stocks-watch-december-2018-11-07", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-november-08-2018-2018-11-07", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-intercontinental-exchange-total-s.a.-royal-dutch", "https://www.nasdaq.com/articles/5-top-stocks-make-most-divided-congress-2018-11-07", "https://www.nasdaq.com/articles/ligand-lgnd-beats-on-q3-earnings-revenues-raises-view-2018-11-09", "https://www.nasdaq.com/articles/election-day-2018-here-are-winners-losers-2018-11-06", "https://www.nasdaq.com/articles/amgen-amgn-outpaces-stock-market-gains%3A-what-you-should-know-2018-11-05", "https://www.nasdaq.com/articles/3-top-biotech-stocks-pes-below-14-2018-11-03", "https://www.nasdaq.com/articles/drug-stocks-to-post-earnings-on-nov-5%3A-myl-nbix-rare-taro-2018-11-02", "https://www.nasdaq.com/articles/teva-teva-q3-earnings-beat-2018-eps-view-up-shares-rise-2018-11-02", "https://www.nasdaq.com/articles/radius-health-rdus-posts-narrower-than-expected-q3-loss-2018-11-02", "https://www.nasdaq.com/articles/notable-friday-option-activity-aal-amgn-qcom-2018-11-02", "https://www.nasdaq.com/articles/7-healthcare-stocks-soaring-election-results-2018-11-07", "https://www.nasdaq.com/articles/biotech-etfs-in-focus-on-string-of-q3-earnings-beat-2018-11-01", "https://www.nasdaq.com/articles/amgen-amgn-beats-on-earnings-sales-in-q3-raises-view-2018-10-31", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-facebook-amgen-and-mgm-resorts-international-2018-10-31", "https://www.nasdaq.com/articles/community-healths-cyh-q3-loss-widens-admissions-drop-2018-10-30", "https://www.nasdaq.com/articles/pfizer-pfe-beats-on-q3-earnings-meets-sales-narrows-view-2018-10-30", "https://www.nasdaq.com/articles/amgen-inc-amgn-q3-2018-earnings-conference-call-transcript-2018-10-30", "https://www.nasdaq.com/articles/aging-blockbusters-send-amgen-incs-bottom-line-lower-2018-10-30", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-sciences-amgen-vertex-pharmaceuticals-celgene", "https://www.nasdaq.com/articles/amgen-amgn-q3-earnings-and-revenues-beat-estimates-2018-10-30", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-400-follow-through-indicator-21-sensitive-2018-10-30", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-30-2018-fb-amgn-tmus-bidu-psa-apc-ea-ebay-cxo-oke-eix", "https://www.nasdaq.com/articles/amgn-crosses-above-key-moving-average-level-2018-10-29", "https://www.nasdaq.com/articles/ishares-russell-1000-growth-etf-experiences-big-inflow-2018-10-29", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-allergan-regeneron-pharmaceuticals-amgen-alnylam", "https://www.nasdaq.com/articles/big-pharma-bet-isnt-paying-yet-and-its-costing-you-2018-10-28", "https://www.nasdaq.com/articles/facebook-beats-q3-estimates-swings-positive-plus-amgn-mgm-2018-10-30", "https://www.nasdaq.com/articles/whats-in-the-cards-for-glaxo-gsk-this-earnings-season-2018-10-26", "https://www.nasdaq.com/articles/anthem-antm-q3-earnings%3A-whats-in-store-for-the-stock-2018-10-26", "https://www.nasdaq.com/articles/why-amgen-amgn-might-surprise-this-earnings-season-2018-10-26", "https://www.nasdaq.com/articles/5-drug-biotech-stocks-likely-to-beat-estimates-in-q3-earnings-2018-10-26", "https://www.nasdaq.com/articles/whats-in-the-cards-for-hca-healthcare-hca-in-q3-earnings-2018-10-26", "https://www.nasdaq.com/articles/pfizer-pfe-to-report-q3-earnings%3A-whats-in-the-cards-2018-10-25", "https://www.nasdaq.com/articles/can-amgen-amgn-keep-the-earnings-streak-alive-in-q3-2018-10-25", "https://www.nasdaq.com/articles/amgen-oversold-2018-10-26", "https://www.nasdaq.com/articles/whats-in-the-cards-for-glaxo-gsk-this-earnings-season-2018-10-26", "https://www.nasdaq.com/articles/anthem-antm-q3-earnings%3A-whats-in-store-for-the-stock-2018-10-26", "https://www.nasdaq.com/articles/why-amgen-amgn-might-surprise-this-earnings-season-2018-10-26", "https://www.nasdaq.com/articles/is-a-beat-in-the-cards-for-allergan-agn-in-q3-earnings-2018-10-24", "https://www.nasdaq.com/articles/incyte-incy-to-report-q3-earnings%3A-whats-in-the-cards-2018-10-24", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-amtd-lad-amgn-2018-10-24", "https://www.nasdaq.com/articles/bristol-myers-bmy-beats-on-q3-earnings-raises-eps-view-2018-10-25", "https://www.nasdaq.com/articles/amgen-amgn-q3-earnings-preview%3A-what-to-look-out-for-2018-10-23", "https://www.nasdaq.com/articles/4-high-dividend-stocks-to-grow-profits-2018-10-23", "https://www.nasdaq.com/articles/whats-in-store-for-celgene-corp.-celg-q3-earnings-2018-10-23", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-vertex-vrtx-this-earnings-season-2018-10-22", "https://www.nasdaq.com/articles/whats-in-store-for-anika-therapeutics-anik-in-q3-earnings-2018-10-22", "https://www.nasdaq.com/articles/will-gilead-gild-hiv-sales-offset-hcv-sales-decline-in-q3-2018-10-22", "https://www.nasdaq.com/articles/alexion-alxn-to-report-q3-earnings%3A-whats-in-the-cards-2018-10-22", "https://www.nasdaq.com/articles/daily-dividend-report-amgn-met-mco-amp-nem-2018-10-24", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-amgen-inc-2018-10-21", "https://www.nasdaq.com/articles/3-dividend-stocks-income-2018-10-20", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-spyg-intc-cmcsa-amgn-2018-10-19", "https://www.nasdaq.com/articles/amgn-or-ilmn%3A-which-is-the-better-value-stock-right-now-2018-10-19", "https://www.nasdaq.com/articles/amgen-amgn-dips-more-than-broader-markets%3A-what-you-should-know-2018-10-19", "https://www.nasdaq.com/articles/biogen-biib-q3-earnings-coming-up%3A-whats-in-the-cards-2018-10-19", "https://www.nasdaq.com/articles/health-care-sector-update-10172018-tevaesrxamgnnvwllyvtvtkdmnfms-2018-10-17", "https://www.nasdaq.com/articles/novartis-nvs-q3-earnings-in-line-revenues-beat-estimates-2018-10-22", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-amgen-inc-2018-10-21", "https://www.nasdaq.com/articles/3-dividend-stocks-income-2018-10-20", "https://www.nasdaq.com/articles/abbvie-settles-with-novartis-to-delay-humira-biosimilar-in-us-2018-10-12", "https://www.nasdaq.com/articles/health-care-sector-update-10122018-aphb-trvn-nvo-amgn-mrk-abt-pfe-jnj-2018-10-12", "https://www.nasdaq.com/articles/notable-friday-option-activity-wdc-amgn-axs-2018-10-12", "https://www.nasdaq.com/articles/jj-jnj-to-set-the-ball-rolling-for-pharma-q3-earnings-2018-10-11", "https://www.nasdaq.com/articles/validea-warren-buffett-strategy-daily-upgrade-report-10112018-2018-10-11", "https://www.nasdaq.com/articles/4-strong-stocks-buy-double-big-takeover-targets-2018-10-16", "https://www.nasdaq.com/articles/thursdays-etf-unusual-volume-pbe-2018-10-11", "https://www.nasdaq.com/articles/heres-why-bluebird-bio-dropped-133-september-2018-10-11", "https://www.nasdaq.com/articles/roche-rhhby-presents-encouraging-data-on-ms-drug-ocrevus-2018-10-10", "https://www.nasdaq.com/articles/bauschs-bryhali-gets-tentative-fda-nod-for-plaque-psoriasis-2018-10-09", "https://www.nasdaq.com/articles/kala-pharmaceuticals-kala-catches-eye%3A-stock-jumps-7.4-2018-10-09", "https://www.nasdaq.com/articles/fda-sets-action-date-for-recros-pain-management-candidate-2018-10-09", "https://www.nasdaq.com/articles/10-sp-500-stocks-to-buy-for-the-long-term-2018-10-09", "https://www.nasdaq.com/articles/validea-peter-lynch-strategy-daily-upgrade-report-10112018-2018-10-11", "https://www.nasdaq.com/articles/arrowhead-pharmaceuticals-inc-buy-dip-2018-10-08", "https://www.nasdaq.com/articles/roches-hemlibra-receives-fda-approval-for-label-expansion-2018-10-05", "https://www.nasdaq.com/articles/roche-rhhby-presents-encouraging-data-on-sma-drug-risdiplam-2018-10-04", "https://www.nasdaq.com/articles/amgen-gets-fda-nod-for-once-weekly-regimen-of-kyprolis-combo-2018-10-03", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-alxn-on-acquisition-spree-fda-nod-for-regn-amgn-drugs-2018-10-03", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-chevron-amgen-thermo-fisher-estee-lauder-and-delta-air", "https://www.nasdaq.com/articles/dr.-reddys-sells-antibiotic-production-hub-to-uae-drugmaker-2018-10-02", "https://www.nasdaq.com/articles/5-reasons-why-investors-should-bet-on-merck-mrk-stock-2018-10-08", "https://www.nasdaq.com/articles/5-breakout-stocks-to-buy-2018-09-28", "https://www.nasdaq.com/articles/eli-lilly-lly-gets-fda-nod-for-migraine-drug-emgality-2018-09-28", "https://www.nasdaq.com/articles/november-9th-options-now-available-amgen-amgn-2018-09-27", "https://www.nasdaq.com/articles/amarins-stock-soars-as-fish-oil-drug-lowers-heart-risks-2018-09-27", "https://www.nasdaq.com/articles/3-drugmakers-not-pleased-amarins-fish-oil-triumph-2018-09-26", "https://www.nasdaq.com/articles/lillys-migraine-drug-emgality-wins-positive-chmp-opinion-2018-09-24", "https://www.nasdaq.com/articles/why-amgen-amgn-is-poised-to-beat-earnings-estimates-again-2018-09-24", "https://www.nasdaq.com/articles/is-amgen-amgn-stock-outpacing-its-medical-peers-this-year-2018-10-01", "https://www.nasdaq.com/articles/pfizers-pneumococcal-vaccine-gets-breakthrough-therapy-status-2018-09-21", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-buy-2018-09-21", "https://www.nasdaq.com/articles/iwb-pg-wmt-amgn-etf-inflow-alert-2018-09-20", "https://www.nasdaq.com/articles/7-best-biotech-stocks-investors-who-hate-risk-2018-09-20", "https://www.nasdaq.com/articles/abbvie-faces-california-insurance-department-suit-for-humira-2018-09-19", "https://www.nasdaq.com/articles/astrazenecas-fasenra-long-term-asthma-study-data-positive-2018-09-19", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-play-amgn-crr-2018-09-19", "https://www.nasdaq.com/articles/mylans-biosimilar-of-neulasta-gets-positive-chmp-opinion-2018-09-24", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-unitedhealth-adobe-amgen-ups-and-bayer-2018-09-18", "https://www.nasdaq.com/articles/top-research-reports-unitedhealth-adobe-amgen-2018-09-17", "https://www.nasdaq.com/articles/tevas-teva-migraine-drug-ajovy-receives-fda-approval-2018-09-17", "https://www.nasdaq.com/articles/allergan-frown-lines-study-passes-test-on-higher-botox-dose-2018-09-17", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-martin-zweig-9162018-2018-09-16", "https://www.nasdaq.com/articles/now-good-time-buy-amgen-2018-09-15", "https://www.nasdaq.com/articles/why-bluebird-and-celgene-should-worry-about-amgens-latest-clinical-victory-2018-09-14", "https://www.nasdaq.com/articles/does-ajovys-approval-make-teva-pain-free-stock-buy-2018-09-18", "https://www.nasdaq.com/articles/merck-gets-priority-review-for-yet-another-keytruda-sbla-2018-09-13", "https://www.nasdaq.com/articles/why-amgen-will-likely-be-boring-dividend-stock-over-next-few-years-2018-09-13", "https://www.nasdaq.com/articles/regeneron-sanofis-sbla-for-praluent-to-be-reviewed-by-fda-2018-09-12", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-september-13-2018-2018-09-12", "https://www.nasdaq.com/articles/3-small-biotech-stocks-that-almost-doubled-in-past-month-2018-09-11", "https://www.nasdaq.com/articles/mercks-keytruda-combo-gets-nod-for-lung-cancer-in-europe-2018-09-11", "https://www.nasdaq.com/articles/3-top-dividend-stocks-buy-right-now-2018-09-11", "https://www.nasdaq.com/articles/is-amgen-amgn-a-great-stock-for-value-investors-2018-09-14", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-amgn-rlgy-grub-2018-09-11", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-iwf-nvda-amgn-mo-2018-09-10", "https://www.nasdaq.com/articles/astrazenecas-asthma-drug-gets-breakthrough-therapy-status-2018-09-07", "https://www.nasdaq.com/articles/pfizers-skin-disease-drug-gets-breakthrough-therapy-status-2018-09-06", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-puma-biotechnology-mannkind-united-therapeutics", "https://www.nasdaq.com/articles/mercks-keytruda-gets-priority-review-for-rare-skin-cancer-2018-09-05", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-amgn-pbyi-get-ec-nod-for-their-drugs-mnkd-soars-2018-09-05", "https://www.nasdaq.com/articles/amgen-reaches-analyst-target-price-2018-09-11", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-gilead-sciences-inc-2018-09-02", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-iwf-nvda-amgn-mo-2018-08-31", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gild-gets-ec-nod-for-yescarta-amgn-submits-kyprolis-snda-2018-08-29", "https://www.nasdaq.com/articles/pfizer-stock-up-this-year-so-far%3A-whats-going-in-its-favor-2018-08-29", "https://www.nasdaq.com/articles/amgen-files-for-once-weekly-regimen-for-myeloma-drug-kyprolis-2018-08-28", "https://www.nasdaq.com/articles/5-reasons-why-you-should-add-lilly-stock-to-your-portfolio-2018-08-27", "https://www.nasdaq.com/articles/why-is-amgen-amgn-up-1.3-since-last-earnings-report-2018-08-27", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-gm-axp-amgn-2018-09-04", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-gilead-sciences-inc-2018-09-02", "https://www.nasdaq.com/articles/spdr-portfolio-total-stock-market-etf-experiences-big-inflow-2018-08-23", "https://www.nasdaq.com/articles/trade-day-amgen-strong-stock-giddy-industry-2018-08-23", "https://www.nasdaq.com/articles/amgen-inc-buy-2018-08-22", "https://www.nasdaq.com/articles/5-drug-stocks-to-buy-while-the-pharma-sector-is-on-sale-2018-08-22", "https://www.nasdaq.com/articles/merck-gets-fda-nod-for-keytruda-lung-cancer-label-expansion-2018-08-21", "https://www.nasdaq.com/articles/roche-rhhby-gets-fda-approval-for-cobas-efgr-mutation-test-2018-08-24", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-august-16-2018-2018-08-15", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-august-16-2018-2018-08-15", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-amgn-trn-aeo-2018-08-15", "https://www.nasdaq.com/articles/allergans-agn-stock-up-4.2-since-q2-earnings%3A-heres-why-2018-08-14", "https://www.nasdaq.com/articles/top-research-reports-unitedhealth-pepsico-amgen-more-2018-08-14", "https://www.nasdaq.com/articles/heres-why-merck-mrk-stock-is-up-since-q2-earnings-release-2018-08-14", "https://www.nasdaq.com/articles/ex-dividend-reminder-amgen-allergan-and-south-state-2018-08-14", "https://www.nasdaq.com/articles/amgen-stock-up-this-year-so-far%3A-will-the-rally-continue-2018-08-20", "https://www.nasdaq.com/articles/3-strong-buy-stocks-for-the-week-2018-08-13", "https://www.nasdaq.com/articles/spectrum-sppi-earnings-and-sales-miss-estimates-in-q2-2018-08-10", "https://www.nasdaq.com/articles/why-amgen-top-socially-responsible-dividend-stock-amgn-2018-08-09", "https://www.nasdaq.com/articles/5-companies-making-giant-buybacks-2018-08-08", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-amgen-inc-2018-08-08", "https://www.nasdaq.com/articles/radius-rdus-q2-loss-narrower-than-expected-tymlos-sales-up-2018-08-07", "https://www.nasdaq.com/articles/ligand-lgnd-beats-on-q2-earnings-revenues-raises-view-2018-08-07", "https://www.nasdaq.com/articles/heres-why-lilly-lly-stock-is-up-15-since-q2-earnings-2018-08-13", "https://www.nasdaq.com/articles/3-healthcare-stocks-to-buy-for-the-sector-rebound-2018-08-06", "https://www.nasdaq.com/articles/two-pharma-giants-successfully-navigate-challenging-climate-2018-08-03", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-radius-health-rdus-in-q2-earnings-2018-08-02", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-syna-amgn-ipi-2018-08-02", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-celgene-amgen-vertex-impress-in-q2-gileads-ceo-to-exit-2018-08-01", "https://www.nasdaq.com/articles/daily-dividend-report-arcc-lfus-vnom-main-aapl-amgn-syk-2018-08-01", "https://www.nasdaq.com/articles/pfizer-pfe-beats-on-q2-earnings-sales-ups-profit-view-2018-07-31", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2018-08-06", "https://www.nasdaq.com/articles/3-healthcare-stocks-to-buy-for-the-sector-rebound-2018-08-06", "https://www.nasdaq.com/articles/two-pharma-giants-successfully-navigate-challenging-climate-2018-08-03", "https://www.nasdaq.com/articles/amgen-incs-young-lineup-offsets-enbrel-losses-style-2018-07-26", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-455-follow-through-indicator-22-sensitive-2018-07-26", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-26-2018-amzn-intc-amgn-sbux-ea-afl-ew-lrcx-ftv-dfs-dlr", "https://www.nasdaq.com/articles/mercks-keytruda-improves-survival-in-head-neck-cancer-study-2018-07-25", "https://www.nasdaq.com/articles/will-pfizer-pfe-keep-the-earnings-streak-alive-in-q2-2018-07-25", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-inflow-2018-07-27", "https://www.nasdaq.com/articles/amgen-amgn-to-report-q2-earnings%3A-will-it-beat-again-2018-07-23", "https://www.nasdaq.com/articles/abbvies-stock-bargain-after-falling-8-last-week-2018-07-23", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-ibb-biib-gild-amgn-2018-07-19", "https://www.nasdaq.com/articles/biogen-biib-to-report-q2-earnings%3A-whats-in-the-cards-2018-07-19", "https://www.nasdaq.com/articles/can-eli-lilly-lly-keep-the-earnings-streak-alive-in-q2-2018-07-19", "https://www.nasdaq.com/articles/abbvie-settles-with-mylan-to-delay-humira-biosimilar-in-u.s.-2018-07-18", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-amgn-resubmits-evenity-bla-advaxis-soars-regulatory-updates-2018-07", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-keryx-kerx-this-earnings-season-2018-07-24", "https://www.nasdaq.com/articles/roches-flu-drug-meets-primary-endpoint-in-phase-iii-study-2018-07-17", "https://www.nasdaq.com/articles/pfizers-xtandi-gets-fda-nod-for-expanded-patient-population-2018-07-16", "https://www.nasdaq.com/articles/is-a-surprise-in-the-cards-for-novartis-in-q2-earnings-2018-07-16", "https://www.nasdaq.com/articles/pacira-focused-on-exparel-development-amid-competition-2018-07-16", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-amgen-2018-07-15", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-johnson-johnson-2018-07-13", "https://www.nasdaq.com/articles/is-the-options-market-predicting-a-spike-in-amgen-amgn-stock-2018-07-13", "https://www.nasdaq.com/articles/novartis-q2-earnings-miss-sales-top-on-cosentyx-entresto-2018-07-18", "https://www.nasdaq.com/articles/amgen-resubmits-bla-to-fda-for-osteoporosis-candidate-evenity-2018-07-13", "https://www.nasdaq.com/articles/august-31st-options-now-available-amgen-amgn-2018-07-12", "https://www.nasdaq.com/articles/mercks-keytruda-gets-fdas-priority-review-for-liver-cancer-2018-07-12", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-ibb-gild-amgn-biib-2018-07-11", "https://www.nasdaq.com/articles/3-huge-biotech-winners-2018-so-far-2018-07-11", "https://www.nasdaq.com/articles/moving-average-crossover-alert%3A-amgen-amgn-2018-07-10", "https://www.nasdaq.com/articles/amgen-reaches-analyst-target-price-2018-07-10", "https://www.nasdaq.com/articles/2-overlooked-biotech-stocks-buy-now-2018-07-13", "https://www.nasdaq.com/articles/amgen-resubmits-bla-to-fda-for-osteoporosis-candidate-evenity-2018-07-13", "https://www.nasdaq.com/articles/notable-friday-option-activity-amgn-fast-bgs-2018-07-06", "https://www.nasdaq.com/articles/why-biotech-stocks-rallied-biogens-alzheimers-test-2018-07-06", "https://www.nasdaq.com/articles/heres-why-abbvie-stock-is-good-for-your-portfolios-health-2018-07-05", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gilds-positive-chmp-nod-regulatory-updates-more-2018-07-05", "https://www.nasdaq.com/articles/biotech-stock-outlook%3A-short-term-pricing-pain-to-prevail-2018-07-05", "https://www.nasdaq.com/articles/ibb-gild-amgn-biib-large-outflows-detected-etf-2018-07-03", "https://www.nasdaq.com/articles/why-amgen-top-25-dividend-giant-amgn-2018-07-09", "https://www.nasdaq.com/articles/should-value-investors-consider-amgen-amgn-stock-now-2018-07-02", "https://www.nasdaq.com/articles/4-drug-and-biotech-stocks-awaiting-fda-decisions-july-2018-07-02", "https://www.nasdaq.com/articles/4-drug-and-biotech-stocks-awaiting-fda-decisions-in-july-2018-07-02", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-pfizer-inc-2018-07-01", "https://www.nasdaq.com/articles/4-biotech-stocks-bet-second-half-2018-2018-06-29", "https://www.nasdaq.com/articles/5-cheap-large-cap-stocks-buy-now-2018-06-28", "https://www.nasdaq.com/articles/mylan-lupin-collaborate-for-the-proposed-biosimilar-enbrel-2018-06-28", "https://www.nasdaq.com/articles/mercks-keytruda-gets-priority-review-in-difficult-lung-cancer-2018-07-03", "https://www.nasdaq.com/articles/should-value-investors-consider-amgen-amgn-stock-now-2018-07-02", "https://www.nasdaq.com/articles/4-drug-and-biotech-stocks-awaiting-fda-decisions-july-2018-07-02", "https://www.nasdaq.com/articles/mercks-keytruda-under-fda-review-for-advanced-melanoma-2018-06-26", "https://www.nasdaq.com/articles/top-stock-reports-facebook-amgen-abbott-2018-06-26", "https://www.nasdaq.com/articles/amgens-repatha-reduces-bad-cholestrol-in-type-ii-diabetes-2018-06-25", "https://www.nasdaq.com/articles/roches-rhhby-study-on-tecentriq-for-lung-cancer-positive-2018-06-25", "https://www.nasdaq.com/articles/amgen-announces-top-line-data-from-remicade-biosimilar-study-2018-06-28", "https://www.nasdaq.com/articles/merck-mrk-stock-up-so-far-this-year-on-keytruda-strength-2018-06-22", "https://www.nasdaq.com/articles/xlv-abbv-amgn-mdt-etf-outflow-alert-2018-06-21", "https://www.nasdaq.com/articles/amgen-gets-eu-nod-to-add-survival-data-on-blincytos-label-2018-06-20", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-srpt-sldb-soar-on-positive-data-anik-ziop-crash-2018-06-20", "https://www.nasdaq.com/articles/teva-to-discontinue-a-fremanezumab-study-on-cluster-headache-2018-06-18", "https://www.nasdaq.com/articles/10-top-stock-picks-wall-streets-best-analysts-2018-06-18", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-nke-apc-amgn-2018-06-15", "https://www.nasdaq.com/articles/long-term-investors-take-note-these-5-big-pharma-companies-have-best-pipelines-2018-06-24", "https://www.nasdaq.com/articles/allergan-agn-presents-positive-data-on-glaucoma-candidate-2018-06-14", "https://www.nasdaq.com/articles/mercks-keytruda-gets-fda-nod-for-2nd-lymphoma-indication-2018-06-14", "https://www.nasdaq.com/articles/roches-rhhby-avastin-gets-label-expansion-approval-by-fda-2018-06-14", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-xlv-abbv-amgn-mdt-2018-06-13", "https://www.nasdaq.com/articles/mercks-mrk-keytruda-gets-fda-approval-for-cervical-cancer-2018-06-13", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-axon-soars-amgen-drugs-get-fda-ec-nod-2018-06-13", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-june-14-2018-2018-06-13", "https://www.nasdaq.com/articles/roche-announces-positive-data-on-gazyva-and-ms-drug-ocrevus-2018-06-15", "https://www.nasdaq.com/articles/allergans-second-anti-cgrp-drug-positive-in-mid-stage-study-2018-06-12", "https://www.nasdaq.com/articles/amgen-gets-fda-nod-to-add-aspire-data-on-kyprolis-label-2018-06-12", "https://www.nasdaq.com/articles/amgens-amgn-prolia-gets-label-expansion-approval-in-europe-2018-06-11", "https://www.nasdaq.com/articles/jak-inhibitors-prospects-strong-4-stocks-ruling-space-2018-06-11", "https://www.nasdaq.com/articles/roche-rituxan-label-expanded-by-fda-for-pemphigus-vulgaris-2018-06-08", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-regeneron-celgene-amgen-impress-at-asco-2018-06-06", "https://www.nasdaq.com/articles/merck-presents-positive-melanoma-data-on-keytruda-at-asco-2018-06-05", "https://www.nasdaq.com/articles/humiras-sales-will-decline-and-its-fantastic-news-abbvie-2018-06-13", "https://www.nasdaq.com/articles/mylan-myl-gets-fda-approval-for-biosimilar-of-neulasta-2018-06-05", "https://www.nasdaq.com/articles/watch-out-amgen-here-comes-mylan-2018-06-05", "https://www.nasdaq.com/articles/eli-lillys-olumiant-gets-fda-nod-for-rheumatoid-arthritis-2018-06-04", "https://www.nasdaq.com/articles/mercks-mrk-keytruda-lung-cancer-data-in-focus-at-asco-2018-06-04", "https://www.nasdaq.com/articles/biogen-inc-stock-got-an-upgrade-but-should-you-listen-2018-06-04", "https://www.nasdaq.com/articles/novartis-announces-positive-data-on-kisqali-and-tasigna-2018-06-04", "https://www.nasdaq.com/articles/amgen-inc-amgn-buy-2018-06-03", "https://www.nasdaq.com/articles/health-care-select-sector-spdr-fund-experiences-big-inflow-2018-06-05", "https://www.nasdaq.com/articles/notable-friday-option-activity-trip-mar-amgn-2018-06-01", "https://www.nasdaq.com/articles/trade-day-amgen-inc-clears-breakout-hurdle-2018-05-31", "https://www.nasdaq.com/articles/biotech-etfs-are-best-way-play-recovering-sector-2018-05-30", "https://www.nasdaq.com/articles/july-6th-options-now-available-amgen-amgn-2018-05-24", "https://www.nasdaq.com/articles/why-is-amgen-amgn-up-3.7-since-its-last-earnings-report-2018-05-24", "https://www.nasdaq.com/articles/mercks-keytruda-shows-survival-benefit-in-squamous-nsclc-2018-05-24", "https://www.nasdaq.com/articles/3-top-biosimilars-will-lift-pfizer-inc-stock-even-more-2018-05-24", "https://www.nasdaq.com/articles/3-reasons-gilead-sciences-better-value-stock-amgen-2018-06-03", "https://www.nasdaq.com/articles/fda-confirms-september-action-date-for-tevas-migraine-drug-2018-05-24", "https://www.nasdaq.com/articles/novartis-gets-approval-for-remicade-biosimilar-in-europe-2018-05-24", "https://www.nasdaq.com/articles/allergan-stock-down-since-q1-earnings-report%3A-heres-why-2018-05-23", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-dgro-amgn-mdt-bmy-2018-05-23", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-fda-gives-nod-to-amgens-drugs-eu-approves-exelixis-cabometyx-2018", "https://www.nasdaq.com/articles/amgen-breaks-above-200-day-moving-average-bullish-amgn-2018-05-22", "https://www.nasdaq.com/articles/amgens-label-expansion-application-for-prolia-gets-fda-nod-2018-05-22", "https://www.nasdaq.com/articles/little-biotech-best-migraine-stock-buy-now-2018-05-24", "https://www.nasdaq.com/articles/migraine-space-in-focus-as-amgn-nvs-aimovig-gets-fda-nod-2018-05-21", "https://www.nasdaq.com/articles/roche-rhhby-announces-positive-data-on-hemophilia-drug-2018-05-21", "https://www.nasdaq.com/articles/intraday-update-small-caps-keep-faith-blue-chips-blue-face-2018-05-18", "https://www.nasdaq.com/articles/amgens-migraine-drug-aimovig-gets-fda-approval-shares-up-2018-05-18", "https://www.nasdaq.com/articles/health-care-sector-update-05182018-amrxvlrxamgnnvsazn-2018-05-18", "https://www.nasdaq.com/articles/health-care-sector-update-05182018-vlrxamgnnvsazn-2018-05-18", "https://www.nasdaq.com/articles/xlv-mrk-amgn-gild-etf-inflow-alert-2018-05-17", "https://www.nasdaq.com/articles/company-news-for-may-21-2018-2018-05-21", "https://www.nasdaq.com/articles/why-spectrum-pharmaceuticals-inc-big-today-2018-05-17", "https://www.nasdaq.com/articles/pfizer-gets-fda-nod-for-amgen-jjs-anemia-drug-biosimilar-2018-05-16", "https://www.nasdaq.com/articles/eli-lillys-cluster-headache-candidate-succeeds-in-phase-iii-2018-05-16", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-may-16-2018-2018-05-15", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-biogen-inc-2018-05-15", "https://www.nasdaq.com/articles/ex-dividend-reminder-eli-lilly-amgen-and-simon-property-group-2018-05-14", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-xrx-algn-amgn-2018-05-14", "https://www.nasdaq.com/articles/amgens-amgn-repatha-gains-eu-nod-to-include-outcomes-data-2018-05-17", "https://www.nasdaq.com/articles/trump-announces-plan-reign-drug-prices-and-pharma-stocks-rally-2018-05-11", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-may-11-2018-2018-05-10", "https://www.nasdaq.com/articles/ligand-lgnd-beats-on-q1-earnings-revenues-keeps-view-2018-05-09", "https://www.nasdaq.com/articles/vym-vz-mrk-amgn-large-inflows-detected-etf-2018-05-09", "https://www.nasdaq.com/articles/7-strong-buy-dividend-stocks-should-rip-higher-2018-05-09", "https://www.nasdaq.com/articles/whats-in-store-for-radius-health-rdus-in-q1-earnings-2018-05-07", "https://www.nasdaq.com/articles/are-these-disappointing-drugs-back-track-billions-2018-05-05", "https://www.nasdaq.com/articles/radius-health-rdus-incurs-narrower-than-expected-q1-loss-2018-05-11", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-apple-exxonmobil-citigroup-and-amgen-2018-05-04", "https://www.nasdaq.com/articles/clinical-stage-biotechs-tackling-huge-health-issue-it-has-overcome-pessimistic-investors", "https://www.nasdaq.com/articles/top-analyst-reports-apple-exxonmobil-citigroup-amgen-2018-05-03", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-alxn-vrtx-post-solid-results-gild-disappoints-in-q1-2018-05-02", "https://www.nasdaq.com/articles/xlv-mrk-amgn-gild-large-outflows-detected-etf-2018-05-01", "https://www.nasdaq.com/articles/nasdaq-100-movers-stx-swks-2018-05-01", "https://www.nasdaq.com/articles/pfizer-pfe-stock-falls-on-q1-sales-miss-earnings-beat-2018-05-01", "https://www.nasdaq.com/articles/spectrum-sppi-earnings-and-sales-beat-estimates-in-q1-2018-05-04", "https://www.nasdaq.com/articles/roche-rhhby-q1-earnings%3A-ocrevus-perjeta-drive-sales-beat-2018-04-27", "https://www.nasdaq.com/articles/company-news-for-apr-26-2018-2018-04-26", "https://www.nasdaq.com/articles/amgen-amgn-earnings-beat-estimates-in-q1-revenues-up-y-y-2018-04-25", "https://www.nasdaq.com/articles/morning-movers-boeing-booms-wynn-loses-2018-04-25", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-prta-down-amgn-revises-view-biib-misses-on-sales-2018-04-25", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-amgn-axp-ftr-2018-04-25", "https://www.nasdaq.com/articles/whats-in-the-cards-for-biomarin-bmrn-in-q1-earnings-2018-04-24", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-3-yield-mark-2018-04-30", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-celgene-2018-04-24", "https://www.nasdaq.com/articles/amgen-inc-amgn-beats-q1-estimates-posts-weak-f18-guidance-2018-04-24", "https://www.nasdaq.com/articles/after-hours-earnings-report-april-24-2018-amgn-txn-cb-cof-ilmn-ew-eqr-wynn-bxp-mkl-tss-pkg", "https://www.nasdaq.com/articles/eli-lilly-and-co-produced-monstrous-q1-beat-it-enough-2018-04-24", "https://www.nasdaq.com/articles/drug-biotech-stock-q1-earnings-due-on-apr-24%3A-lly-biib-amgn-2018-04-23", "https://www.nasdaq.com/articles/mylan-nv-still-undervalued-despite-unveiling-new-products-2018-04-23", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2018-04-20", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-vertex-vrtx-this-earnings-season-2018-04-24", "https://www.nasdaq.com/articles/whats-in-store-for-biogen-biib-this-earnings-season-2018-04-20", "https://www.nasdaq.com/articles/jj-novartis-q1-earnings-impress%3A-will-others-follow-suit-2018-04-20", "https://www.nasdaq.com/articles/3-stocks-you-can-safely-own-until-2030-2018-04-20", "https://www.nasdaq.com/articles/mylan-nv-could-be-closer-breakout-most-traders-realize-2018-04-19", "https://www.nasdaq.com/articles/big-biotech-etf-can-bounce-back-2018-04-18", "https://www.nasdaq.com/articles/amgens-aimovig-reduces-episodic-migraine-in-30-patients-2018-04-18", "https://www.nasdaq.com/articles/7-retirement-stocks-coming-correction-2018-04-18", "https://www.nasdaq.com/articles/amgen-amgn-to-report-q1-earnings%3A-is-a-beat-in-the-cards-2018-04-20", "https://www.nasdaq.com/articles/whats-in-store-for-novartis-nvs-this-earnings-season-2018-04-17", "https://www.nasdaq.com/articles/xlv-pfe-mrk-amgn-etf-inflow-alert-2018-04-12", "https://www.nasdaq.com/articles/jj-jnj-to-begin-pharma-q1-earnings%3A-whats-in-store-2018-04-12", "https://www.nasdaq.com/articles/mylan-fujifilm-kyowa-team-up-to-market-humira-biosimilar-2018-04-12", "https://www.nasdaq.com/articles/mercks-keytruda-offers-survival-benefit-in-lung-cancer-study-2018-04-10", "https://www.nasdaq.com/articles/4-drugbiotech-stocks-buy-ahead-world-health-day-2018-04-06", "https://www.nasdaq.com/articles/novartis-announces-data-on-cardiovascular-drug-entresto-2018-04-05", "https://www.nasdaq.com/articles/roche-hemophilia-drug-gets-breakthrough-therapy-designation-2018-04-18", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-edge-falls-alks-down-fda-oks-amgn-drug-label-expansion-2018-04-04", "https://www.nasdaq.com/articles/rigel-rigl-sinks-on-failure-of-mid-stage-study-on-lead-drug-2018-04-04", "https://www.nasdaq.com/articles/morning-movers-tesla-and-markets-are-back-solid-ground-2018-04-03", "https://www.nasdaq.com/articles/amgens-amgn-xgeva-gets-eu-approval-for-expanded-label-2018-04-03", "https://www.nasdaq.com/articles/better-dividend-stock-buy-abbvie-inc-vs-pfizer-inc-2018-04-03", "https://www.nasdaq.com/articles/amgens-blincyto-gets-fda-nod-for-minimum-residual-disease-2018-04-02", "https://www.nasdaq.com/articles/peek-under-hood-rsp-has-14-upside-2018-03-30", "https://www.nasdaq.com/articles/lillys-cyramza-shows-survival-benefit-in-liver-cancer-study-2018-04-05", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-verona-squibb-protagonist-and-amgen-2018-03-29", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-ptgx-down-vrna-up-amgns-repatha-gets-positive-opinion-2018-03-28", "https://www.nasdaq.com/articles/results-renew-optimism-esperion-therapeutics-2018-03-27", "https://www.nasdaq.com/articles/5-biotech-stocks-amazing-pipelines-2018-03-27", "https://www.nasdaq.com/articles/amgens-repatha-gains-chmp-nod-to-include-outcomes-data-2018-03-26", "https://www.nasdaq.com/articles/novartis-gets-positive-chmp-opinion-on-biosimilar-remicade-2018-03-26", "https://www.nasdaq.com/articles/merck-eisai-get-japanese-nod-for-lenvima-label-expansion-2018-03-26", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-amgen-inc-2018-03-30", "https://www.nasdaq.com/articles/celgene-corporation-looks-cheap-considering-its-potential-2018-03-23", "https://www.nasdaq.com/articles/radius-health-down-on-negative-chmp-opinion-for-lead-drug-2018-03-23", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-fedex-thermo-fisher-sherwin-williams-and", "https://www.nasdaq.com/articles/stemline-therapeutics-inc-stock-investors-are-betting-not-investing-2018-03-23", "https://www.nasdaq.com/articles/roches-rhhby-lucentis-0.3-mg-pfs-receives-fda-approval-2018-03-22", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-amgn-2018-03-22", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-gilead-sciences-inc-2018-03-21", "https://www.nasdaq.com/articles/ishares-core-high-dividend-etf-experiences-big-outflow-2018-03-23", "https://www.nasdaq.com/articles/despite-struggles-celgene-corporation-stock-still-buy-2018-03-19", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-right-now-2018-03-19", "https://www.nasdaq.com/articles/5-must-see-quotes-abbvies-management-2018-03-16", "https://www.nasdaq.com/articles/mercks-keytruda-gets-priority-review-for-cervical-cancer-2018-03-14", "https://www.nasdaq.com/articles/ibb-amgn-gild-regn-etf-outflow-alert-2018-03-14", "https://www.nasdaq.com/articles/is-amgen-inc.-amgn-a-great-stock-for-value-investors-2018-03-14", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-march-15-2018-2018-03-14", "https://www.nasdaq.com/articles/radius-health-announces-positive-data-on-lead-drug-tymlos-2018-03-19", "https://www.nasdaq.com/articles/amgen-inc-stock-spring-about-pop-2018-03-13", "https://www.nasdaq.com/articles/amgen-stock-split-history-2018-03-13", "https://www.nasdaq.com/articles/regeneron-takes-aim-amgen-and-esperion-therapeutics-2018-03-12", "https://www.nasdaq.com/articles/regeneron-and-sanofi-announce-positive-data-on-praluent-2018-03-12", "https://www.nasdaq.com/articles/why-coherus-biosciences-skyrocketing-today-2018-03-09", "https://www.nasdaq.com/articles/merck-to-pay-%24300m-upfront-to-co-develop-eisais-cancer-drug-2018-03-08", "https://www.nasdaq.com/articles/daily-dividend-report-gd-cl-mtn-hmn-pm-amgn-dvn-2018-03-08", "https://www.nasdaq.com/articles/bull-day-regeneron-regn-2018-03-14", "https://www.nasdaq.com/articles/wednesdays-vital-data-alibaba-group-holding-ltd-baba-amgen-inc-amgn-and-advanced-micro", "https://www.nasdaq.com/articles/why-esperion-therapeutics-shares-fell-despite-its-good-news-2018-03-07", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-iwb-amgn-gild-utx-2018-03-06", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-march-2018-03-06", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-amgn-nflx-amzn-2018-03-06", "https://www.nasdaq.com/articles/interesting-amgn-put-and-call-options-may-18th-2018-03-05", "https://www.nasdaq.com/articles/10-companies-making-huge-stock-buybacks-2018-2018-03-05", "https://www.nasdaq.com/articles/spectrum-sppi-q4-loss-widens-y-y-sales-miss-stock-falls-2018-03-07", "https://www.nasdaq.com/articles/after-hours-most-active-mar-2-2018-f-fe-orcl-bac-teva-amgn-ftr-qcom-ge-qqq-msft-csx-2018", "https://www.nasdaq.com/articles/amgen-amgn-gets-chmp-nod-to-expand-eu-label-of-neulasta-2018-03-01", "https://www.nasdaq.com/articles/biotech-etfs-head-to-head%3A-xbi-vs.-ibb.-2018-03-01", "https://www.nasdaq.com/articles/notable-thursday-option-activity-amgn-kfy-tast-2018-03-01", "https://www.nasdaq.com/articles/biotech-stock-round-up%3A-celgene-suffers-setback-gilead-teams-up-with-sangamo-2018-02-28", "https://www.nasdaq.com/articles/3-reasons-abbvie-inc-stock-could-keep-soaring-2018-2018-02-27", "https://www.nasdaq.com/articles/3-top-pharma-stocks-dividend-yields-over-3-2018-02-27", "https://www.nasdaq.com/articles/radius-rdus-q4-loss-wider-than-expected-on-higher-expenses-2018-03-02", "https://www.nasdaq.com/articles/iusg-mcd-abt-amgn-etf-inflow-alert-2018-02-23", "https://www.nasdaq.com/articles/health-care-sector-update-02232018-blcm-pfe-pbyi-amgn-4507jp-2018-02-23", "https://www.nasdaq.com/articles/health-care-sector-update-02232018-amgnpbyiblcmpfe-2018-02-23", "https://www.nasdaq.com/articles/ligand-lgnd-q4-earnings-revenues-top-2018-view-solid-2018-02-22", "https://www.nasdaq.com/articles/amgen-inc-buy-2018-02-21", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-total-marriott-pge-and-vertex-2018-02-21", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-ddd-algn-amgn-2018-02-21", "https://www.nasdaq.com/articles/radius-health-rdus-to-disappoint-investors-in-q4-earnings-2018-02-26", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-benjamin-graham-2182018-2018-02-18", "https://www.nasdaq.com/articles/roche-rhhby-to-acquire-flatiron-health-for-%241.9-billion-2018-02-16", "https://www.nasdaq.com/articles/abbvie-hikes-dividend-by-35-launches-%2410b-buyback-plan-2018-02-16", "https://www.nasdaq.com/articles/vym-ge-mcd-amgn-large-inflows-detected-etf-2018-02-15", "https://www.nasdaq.com/articles/did-abbvie-inc-just-become-most-shareholder-friendly-stock-america-2018-02-15", "https://www.nasdaq.com/articles/3-tough-questions-amgen-2018-02-15", "https://www.nasdaq.com/articles/can-immunogens-key-ovarian-cancer-candidate-drive-growth-2018-02-14", "https://www.nasdaq.com/articles/novartis-psoriasis-drug-cosentyx-positive-in-scalp-study-2018-02-20", "https://www.nasdaq.com/articles/roches-rituxan-gets-priority-review-for-label-expansion-2018-02-14", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-february-14-2018-2018-02-13", "https://www.nasdaq.com/articles/3-dividend-stocks-know-investors-2018-02-13", "https://www.nasdaq.com/articles/agenus-inc-buy-2018-02-13", "https://www.nasdaq.com/articles/trade-day-amgen-inc-remains-promising-biotechnology-play-2018-02-13", "https://www.nasdaq.com/articles/ex-dividend-reminder-amgen-primerica-and-monmouth-real-estate-investment-2018-02-12", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-celgene-2018-02-11", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-february-15-2018-2018-02-14", "https://www.nasdaq.com/articles/novartis-cosentyx-label-expanded-to-include-scalp-psoriasis-2018-02-08", "https://www.nasdaq.com/articles/spectrum-pharmas-rolontis-positive-in-pivotal-cancer-study-2018-02-06", "https://www.nasdaq.com/articles/roche-reports-positive-data-from-tecentriq-avastin-study-2018-02-06", "https://www.nasdaq.com/articles/amgen-breaks-below-200-day-moving-average-notable-amgn-2018-02-06", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-wyn-amgn-mon-2018-02-06", "https://www.nasdaq.com/articles/amgen-q4-earnings-results-2-things-hate-and-2-things-2018-02-03", "https://www.nasdaq.com/articles/amgen-amgn-q4-earnings-sales-lag-2018-sales-view-soft-2018-02-02", "https://www.nasdaq.com/articles/forget-amgen-cara-therapeutics-inc-better-growth-stock-2018-02-09", "https://www.nasdaq.com/articles/amgen-topples-after-fourth-quarter-sales-earnings-lag-2018-02-01", "https://www.nasdaq.com/articles/validea-john-neff-strategy-daily-upgrade-report-212018-2018-02-01", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-400-follow-through-indicator-23-sensitive-2018-02-01", "https://www.nasdaq.com/articles/after-hours-earnings-report-february-1-2018-aapl-amzn-googl-v-amgn-ew-msi-emn-fbhs-xl-cpt", "https://www.nasdaq.com/articles/amgen-gets-chmp-nod-to-add-endeavor-data-on-kyprolis-label-2018-01-31", "https://www.nasdaq.com/articles/why-earnings-season-could-be-great-for-amgen-amgn-2018-01-31", "https://www.nasdaq.com/articles/vtv-ge-amgn-abt-etf-inflow-alert-2018-01-30", "https://www.nasdaq.com/articles/roche-rhhby-posts-solid-2017-sales-on-tecentriq-alecensa-2018-02-01", "https://www.nasdaq.com/articles/roche-gets-breakthrough-therapy-designation-for-asd-drug-2018-01-30", "https://www.nasdaq.com/articles/meredith-mdp-hikes-dividend-4.8-just-ahead-of-q2-earnings-2018-01-30", "https://www.nasdaq.com/articles/amgn-named-top-dividend-stock-nasdaq-100-dividend-channel-27-yield-2018-01-30", "https://www.nasdaq.com/articles/amgn-october-19th-options-begin-trading-2018-01-29", "https://www.nasdaq.com/articles/will-amgen-amgn-benefit-from-growth-drugs-in-q4-earnings-2018-01-29", "https://www.nasdaq.com/articles/novartis-lutathera-gets-fda-approval-for-pancreatic-tumors-2018-01-29", "https://www.nasdaq.com/articles/roche-hemophilia-drug-hemlibra-gets-positive-chmp-opinion-2018-01-29", "https://www.nasdaq.com/articles/pfizer-pfe-stock-falls-despite-q4-earnings-sales-beat-2018-01-30", "https://www.nasdaq.com/articles/heres-why-abbvies-stock-skyrocketing-126-today-2018-01-26", "https://www.nasdaq.com/articles/5-biotech-and-pharmaceutical-stocks-going-bonkers-2018-01-26", "https://www.nasdaq.com/articles/why-amgen-top-socially-responsible-dividend-stock-amgn-2018-01-24", "https://www.nasdaq.com/articles/novartis-nvs-q4-earnings-sales-top-on-cosentyx-entresto-2018-01-24", "https://www.nasdaq.com/articles/amgens-migraine-drug-hits-primary-endpoint-in-phase-iiib-2018-01-23", "https://www.nasdaq.com/articles/amgen-reaches-analyst-target-price-2018-01-23", "https://www.nasdaq.com/articles/why-dividend-investors-want-own-abbvie-2018-2018-01-28", "https://www.nasdaq.com/articles/novartis-announces-positive-results-on-migraine-candidate-2018-01-23", "https://www.nasdaq.com/articles/stocks-shutdown-vote-looms-halliburton-breaks-out-2018-01-22", "https://www.nasdaq.com/articles/merck-reports-positive-phase-iii-liver-cancer-data-on-keytruda-2018-01-22", "https://www.nasdaq.com/articles/whats-in-the-cards-for-novartis-nvs-this-earnings-season-2018-01-22", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-unitedhealth-amgen-united-technologies-csx-and-general", "https://www.nasdaq.com/articles/ideal-stock-evaluation-system-2018-01-22", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-iwb-amgn-gild-abt-2018-01-22", "https://www.nasdaq.com/articles/biotech-ma-strong-start-2018-more-deals-follow-2018-01-23", "https://www.nasdaq.com/articles/novartis-announces-positive-results-on-migraine-candidate-2018-01-23", "https://www.nasdaq.com/articles/heres-why-nektar-stock-skyrocketed-almost-500-in-a-year-2018-01-19", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-johnson-johnson-abbvie-amgen-novo-nordisk-and-zoetis", "https://www.nasdaq.com/articles/amgen-gets-fda-nod-to-add-endeavor-data-on-kyprolis-label-2018-01-18", "https://www.nasdaq.com/articles/can-these-4-large-cap-drug-stocks-deliver-an-encore-in-18-2018-01-18", "https://www.nasdaq.com/articles/best-etfs-2018-spdr-sp-biotech-etf-xbi-will-continue-rock-2018-01-17", "https://www.nasdaq.com/articles/what-expect-amgen-inc-2018-2018-01-21", "https://www.nasdaq.com/articles/will-2018-be-amgen-incs-best-year-yet-2018-01-17", "https://www.nasdaq.com/articles/5-big-biotech-stocks-buy-2018-2018-01-17", "https://www.nasdaq.com/articles/will-amgen-amgn-continue-to-tread-growth-path-this-year-2018-01-16", "https://www.nasdaq.com/articles/novartis-nvs-announces-acceptance-of-humira-bla-by-the-fda-2018-01-16", "https://www.nasdaq.com/articles/how-biotech-stock-could-top-bigger-rivals-preventing-migraines-2018-01-16", "https://www.nasdaq.com/articles/xlv-mrk-amgn-gild-etf-outflow-alert-2018-01-12", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-celgene-amgen-exelixis-alexion-and-vertex-2018-01-12", "https://www.nasdaq.com/articles/biotech-stock-roundup-juno-surges-acquisition-rumor-concert-down-patent-news-2018-01-17", "https://www.nasdaq.com/articles/jeff-sessions-taking-some-steam-out-marijuana-stocks-rally-2018-01-11", "https://www.nasdaq.com/articles/astrazenecas-asthma-drug-benralizumab-gets-approval-in-eu-2018-01-11", "https://www.nasdaq.com/articles/heres-what-abbvies-management-just-said-about-its-future-2018-01-11", "https://www.nasdaq.com/articles/heres-why-arrowhead-pharmaceuticals-inc-today-2018-01-11", "https://www.nasdaq.com/articles/apple-microsoft-may-get-big-tax-break-having-unusual-calendars-2018-01-11", "https://www.nasdaq.com/articles/june-2019-options-now-available-amgen-amgn-2018-01-10", "https://www.nasdaq.com/articles/novartis-starts-trial-on-psoriasis-drug-cosentyx-biosoimilar-2018-01-10", "https://www.nasdaq.com/articles/mercks-keytruda-on-a-roll%3A-can-it-retain-the-spark-in-2018-2018-01-12", "https://www.nasdaq.com/articles/jeff-sessions-taking-some-steam-out-marijuana-stocks-rally-2018-01-11", "https://www.nasdaq.com/articles/better-stock-abbvie-inc-abbv-vs-johnson-johnson-jnj-2018-01-10", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-mlm-wtw-amgn-2018-01-10", "https://www.nasdaq.com/articles/amgen-announces-acceptance-of-maa-for-evenity-in-europe-2018-01-09", "https://www.nasdaq.com/articles/mercks-mrk-keytruda-succeeds-in-high-risk-melanoma-study-2018-01-09", "https://www.nasdaq.com/articles/5-things-amgens-ceo-just-said-investors-need-know-2018-01-09", "https://www.nasdaq.com/articles/abbvie-stock-still-strong-buy-2018-01-09", "https://www.nasdaq.com/articles/humana-extends-contract-with-tivity-health-spurs-healthcare-2018-01-10", "https://www.nasdaq.com/articles/2-top-dividend-stocks-buy-2018-2018-01-07", "https://www.nasdaq.com/articles/3-big-biotech-stocks-buy-january-2018-01-06", "https://www.nasdaq.com/articles/key-biosimilar-approvals-in-2017%3A-progress-report-2018-01-05", "https://www.nasdaq.com/articles/immunogen-starts-phase-i-study-on-leukemia-candidate-imgn632-2018-01-05", "https://www.nasdaq.com/articles/xlv-amgn-gild-lly-large-outflows-detected-etf-2018-01-04", "https://www.nasdaq.com/articles/can-abbvie-abbv-stock-keep-the-momentum-alive-in-2018-2018-01-04", "https://www.nasdaq.com/articles/3-large-cap-pharma-stocks-to-watch-out-for-this-new-year-2018-01-04", "https://www.nasdaq.com/articles/amgens-amgn-xgeva-gets-fda-approval-for-multiple-myeloma-2018-01-08", "https://www.nasdaq.com/articles/why-these-2-biotechs-could-outperform-amid-hyper-competition-2018-01-02", "https://www.nasdaq.com/articles/one-safe-way-get-558-dividend-yield-2017-12-29", "https://www.nasdaq.com/articles/another-reason-2018-might-not-be-banner-year-biotech-mergers-2017-12-27", "https://www.nasdaq.com/articles/ishares-russell-1000-value-etf-experiences-big-inflow-2017-12-27", "https://www.nasdaq.com/articles/heres-how-abbvie-inc-crushed-it-2017-2017-12-23", "https://www.nasdaq.com/articles/why-is-nektar-nktr-stock-up-more-than-350-this-year-2017-12-22", "https://www.nasdaq.com/articles/spectrum-pharma-dismisses-ceo-makes-leadership-changes-2017-12-18", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-january-2018-01-03", "https://www.nasdaq.com/articles/why-these-2-biotechs-could-outperform-amid-hyper-competition-2018-01-02", "https://www.nasdaq.com/articles/one-safe-way-get-558-dividend-yield-2017-12-29", "https://www.nasdaq.com/articles/another-reason-2018-might-not-be-banner-year-biotech-mergers-2017-12-27", "https://www.nasdaq.com/articles/ishares-russell-1000-value-etf-experiences-big-inflow-2017-12-27", "https://www.nasdaq.com/articles/heres-how-abbvie-inc-crushed-it-2017-2017-12-23", "https://www.nasdaq.com/articles/pfizers-arthritis-drug-gets-fda-nod-for-label-expansion-2017-12-15", "https://www.nasdaq.com/articles/5-best-selling-drugs-2017-2017-12-18", "https://www.nasdaq.com/articles/amgn-dividend-yield-pushes-past-3-2017-12-14", "https://www.nasdaq.com/articles/daily-dividend-report-amgn-ben-wdfc-o-xray-2017-12-13", "https://www.nasdaq.com/articles/amgen-even-biotech-stocks-boost-their-dividends-2017-12-13", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-december-14-2017-2017-12-13", "https://www.nasdaq.com/articles/heres-why-everyones-so-excited-about-bluebird-bio-2017-12-13", "https://www.nasdaq.com/articles/roche-abbvie-report-positive-phase-iii-results-on-venclexta-2017-12-13", "https://www.nasdaq.com/articles/jim-simons-pioneer-quant-manager-2017-12-12", "https://www.nasdaq.com/articles/how-10-top-yielding-nasdaq-dividend-stocks-can-boost-your-portfolio-2017-12-14", "https://www.nasdaq.com/articles/roche-reports-positive-data-from-tecentriq-combination-study-2017-12-11", "https://www.nasdaq.com/articles/heres-why-radius-health-rising-today-2017-12-08", "https://www.nasdaq.com/articles/sanofi-begins-combo-studies-on-multiple-myeloma-candidate-2017-12-08", "https://www.nasdaq.com/articles/iwd-pm-mdt-amgn-large-inflows-detected-etf-2017-12-07", "https://www.nasdaq.com/articles/abbvie-jjs-imbruvica-succeeds-in-combo-study-with-rituxan-2017-12-06", "https://www.nasdaq.com/articles/biotech-stock-roundup-fda-nod-amgen-pcsk9-inhibitor-revance-rt002-data-2017-12-06", "https://www.nasdaq.com/articles/roches-avastin-gets-full-fda-approval-for-brain-cancer-2017-12-06", "https://www.nasdaq.com/articles/3-stocks-focus-biotech-ma-hopes-2018-rise-2017-12-11", "https://www.nasdaq.com/articles/mylan-up-on-fda-approval-amazons-rumored-pharmacy-interest-2017-12-04", "https://www.nasdaq.com/articles/amgens-pcsk9-inhibitor-gets-fda-nod-for-stroke-prevention-2017-12-04", "https://www.nasdaq.com/articles/how-biotechs-drugmakers-would-fare-under-senates-tax-bill-2017-12-04", "https://www.nasdaq.com/articles/amgen-regeneron-prep-battle-2018-over-cholesterol-drugs-2017-12-04", "https://www.nasdaq.com/articles/why-amgen-could-have-edge-over-these-rivals-preventing-migraines-2017-11-30", "https://www.nasdaq.com/articles/abbvie-stock-up-more-than-30-so-far-in-2h17%3A-heres-why-2017-11-30", "https://www.nasdaq.com/articles/5-biotech-and-pharma-stocks-fda-catalysts-december-2017-11-30", "https://www.nasdaq.com/articles/abbvie-psoriasis-candidate-succeeds-in-4th-phase-iii-study-2017-12-05", "https://www.nasdaq.com/articles/why-medicines-co-tumbling-despite-270-million-deal-2017-11-29", "https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-amgn-2017-11-29", "https://www.nasdaq.com/articles/ishares-russell-1000-value-etf-experiences-big-inflow-2017-11-29", "https://www.nasdaq.com/articles/biotech-stock-roundup-regeneron-down-eylea-data-biogen-alkermes-ms-deal-2017-11-29", "https://www.nasdaq.com/articles/will-new-drug-approvals-boost-novartis-nvs-portfolio-2017-11-24", "https://www.nasdaq.com/articles/nektar-nktr-stock-up-more-than-300-this-year%3A-heres-why-2017-11-24", "https://www.nasdaq.com/articles/jj-seeks-darzalexs-label-expansion-in-first-line-setting-2017-11-22", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-hca-amgn-ffiv-2017-11-30", "https://www.nasdaq.com/articles/why-coke-could-be-next-ge-and-1-stock-buy-instead-2017-11-20", "https://www.nasdaq.com/articles/amgen-amgn-unveils-auto-injector-device-for-enbrel-in-us-2017-11-20", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-dgro-mrk-wmt-amgn-2017-11-17", "https://www.nasdaq.com/articles/marco-investment-management-llc-buys-dowdupont-inc-apple-inc-jpmorgan-chase-sells-ei-2017", "https://www.nasdaq.com/articles/astrazenecas-azn-asthma-drug-benralizumab-approved-by-fda-2017-11-15", "https://www.nasdaq.com/articles/two-sigma-advisers-llc-buys-dowdupont-inc-pfizer-inc-caterpillar-inc-sells-ei-2017-11-15", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-november-16-2017-2017-11-15", "https://www.nasdaq.com/articles/bet-biogen-inc-easy-profits-new-year-2017-11-21", "https://www.nasdaq.com/articles/biotech-stock-roundup-dynavax-vaccine-gets-fda-nod-loxo-inks-deal-bayer-2017-11-15", "https://www.nasdaq.com/articles/amgen-oversold-2017-11-14", "https://www.nasdaq.com/articles/ex-dividend-reminder-us-physical-therapy-allergan-and-amgen-2017-11-14", "https://www.nasdaq.com/articles/novartis-nvs-arms-biosimilars-study-results-encourage-2017-11-14", "https://www.nasdaq.com/articles/amgen-gets-positive-chmp-opinion-to-expand-nplates-label-2017-11-13", "https://www.nasdaq.com/articles/ligand-lgnd-q3-earnings-revenues-top-2017-view-raised-2017-11-10", "https://www.nasdaq.com/articles/xlv-mrk-abbv-amgn-etf-outflow-alert-2017-11-09", "https://www.nasdaq.com/articles/sum-parts-xlv-could-be-worth-90-2017-11-15", "https://www.nasdaq.com/articles/heres-why-insulet-corporations-investors-are-pumped-2017-11-03", "https://www.nasdaq.com/articles/7-stocks-primed-deliver-12-annual-returns-forever-2017-11-03", "https://www.nasdaq.com/articles/radius-health-rdus-earnings-miss-in-q3-tymlos-in-focus-2017-11-03", "https://www.nasdaq.com/articles/sanofi-sny-q3-earnings-in-line-sales-lag-diabetes-weak-2017-11-02", "https://www.nasdaq.com/articles/looking-great-stocks-first-use-checklist-identify-great-bases-2017-11-02", "https://www.nasdaq.com/articles/iwd-mrk-wmt-amgn-etf-inflow-alert-2017-11-01", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-november-09-2017-2017-11-08", "https://www.nasdaq.com/articles/pfizer-pfe-beats-on-q3-earnings-raises-2017-eps-view-2017-10-31", "https://www.nasdaq.com/articles/pfizer-inc-stock-boring-and-thats-perfect-2017-10-31", "https://www.nasdaq.com/articles/amgn-named-top-dividend-stock-nasdaq-100-dividend-channel-26-yield-2017-10-31", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-comcast-mcdonalds-waste-management-and-bbt-2017", "https://www.nasdaq.com/articles/me-too-push-biopharma-crowding-psoriasis-market-2017-10-29", "https://www.nasdaq.com/articles/abbvie-abbv-q3-earnings-top-revenues-in-line-view-up-2017-10-27", "https://www.nasdaq.com/articles/biomarin-bmrn-q3-loss-narrows-profit-guidance-raised-2017-10-27", "https://www.nasdaq.com/articles/biotech-stock-roundup-celgene-amgen-gilead-hit-q3-results-vertex-beats-all-fronts-2017-11", "https://www.nasdaq.com/articles/abbvie-dividend-does-it-2017-10-27", "https://www.nasdaq.com/articles/3-value-stocks-52-week-highs-still-worth-buying-2017-10-27", "https://www.nasdaq.com/articles/argyle-capital-management-inc-buys-dowdupont-inc-ww-grainger-inc-cvs-health-corp-sells-e", "https://www.nasdaq.com/articles/buy-dip-amgen-inc-while-wall-street-fears-it-2017-10-26", "https://www.nasdaq.com/articles/amgen-amgn-q3-earnings-top-sales-decline-y-y-stock-falls-2017-10-26", "https://www.nasdaq.com/articles/bristol-myers-more-bad-medicine-market-2017-10-26", "https://www.nasdaq.com/articles/key-predictions-for-q3-earnings-reports-of-abbv-mrk-2017-10-26", "https://www.nasdaq.com/articles/will-radius-health-rdus-disappoint-this-earnings-season-2017-10-27", "https://www.nasdaq.com/articles/trade-day-amgen-inc-nears-buy-point-again-2017-10-26", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-thursday%3A-amgen-inc.-amgn-buffalo-wild-wings-bwld-and-las-vegas-sands", "https://www.nasdaq.com/articles/whats-behind-amgens-q3-revenue-decline-2017-10-25", "https://www.nasdaq.com/articles/three-biotech-firms-top-third-quarter-views-only-one-pops-2017-10-25", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-545-follow-through-indicator-28-sensitive-2017-10-25", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-25-2017-amgn-su-lvs-nxpi-vrtx-psa-afl-dlr-now-wcn-abx", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-amgn-luv-trip-2017-10-25", "https://www.nasdaq.com/articles/futures-trending-higher-earnings-give-hope-ecb-extends-asset-purchase-program-2017-10-26", "https://www.nasdaq.com/articles/biogen-biib-tops-q3-earnings-sales-spinraza-sales-up-2017-10-24", "https://www.nasdaq.com/articles/iwd-mrk-wmt-amgn-etf-inflow-alert-2017-10-24", "https://www.nasdaq.com/articles/novartis-nvs-q3-earnings-sales-top-on-new-drugs-strength-2017-10-24", "https://www.nasdaq.com/articles/drug-biotech-stocks-q3-earnings-on-oct-25%3A-amgn-gsk-vrtx-2017-10-24", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-amgen-2017-10-24", "https://www.nasdaq.com/articles/boeing-grubhub-nike-glaxo-amgen-visa-lead-investing-action-plan-2017-10-24", "https://www.nasdaq.com/articles/health-care-sector-update-10232017-jnj-pfe-abt-mrk-amgn-tig-azn-2017-10-23", "https://www.nasdaq.com/articles/daily-dividend-report-bac-wfc-amgn-mpc-txt-met-2017-10-25", "https://www.nasdaq.com/articles/10-more-retirement-stocks-to-buy-and-hold-for-the-rest-of-your-life-2017-10-20", "https://www.nasdaq.com/articles/whats-in-the-cards-for-amgen-amgn-this-earnings-season-2017-10-20", "https://www.nasdaq.com/articles/catch-falling-knife-go-long-celgene-corporation-2017-10-20", "https://www.nasdaq.com/articles/oakbrook-investments-llc-buys-starbucks-corp-biogen-inc-dowdupont-inc-sells-western-2017", "https://www.nasdaq.com/articles/teva-submits-bla-to-fda-for-migraine-candidate-fremanezumab-2017-10-19", "https://www.nasdaq.com/articles/merriman-wealth-management-llc-buys-vanguard-sp-500-powershares-ftse-rafi-us-1500-2017-10", "https://www.nasdaq.com/articles/3-top-stocks-billionaires-love-2017-10-19", "https://www.nasdaq.com/articles/ibds-no-1-group-under-pressure-these-6-key-earnings-loom-sp-500-futures-2017-10-23", "https://www.nasdaq.com/articles/whats-in-the-cards-for-novartis-nvs-this-earnings-season-2017-10-18", "https://www.nasdaq.com/articles/how-allergans-public-relations-backlash-deepened-week-2017-10-17", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-gilead-teva-pfizer-and-amgen-2017-10-17", "https://www.nasdaq.com/articles/immunogen-to-push-leukemia-candidate-into-phase-i-trial-2017-10-17", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-iwd-wmt-amgn-slb-2017-10-16", "https://www.nasdaq.com/articles/celgene-blood-cancer-treatment-just-tip-its-disruptive-science-2017-10-16", "https://www.nasdaq.com/articles/trump-likely-sign-executive-order-drug-pricing-any-day-2017-10-16", "https://www.nasdaq.com/articles/2-great-stocks-retirees-2017-10-19", "https://www.nasdaq.com/articles/better-buy-abbvie-inc-vs-merck-2017-10-14", "https://www.nasdaq.com/articles/why-2017-could-be-stocks-best-year-yet-2017-10-13", "https://www.nasdaq.com/articles/dubuque-bank-trust-co-buys-heartland-financial-usa-inc-vanguard-total-stock-market-2017-10", "https://www.nasdaq.com/articles/3-stocks-baby-boomers-reach-their-goals-2017-10-12", "https://www.nasdaq.com/articles/mylan-gets-complete-response-letter-for-biosimilar-neulasta-2017-10-11", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgens-imlygic-data-promising-regeneron-scores-win-pcsk9-lawsuit", "https://www.nasdaq.com/articles/how-safe-abbvies-dividend-2017-10-11", "https://www.nasdaq.com/articles/edmp-inc-buys-tanger-factory-outlet-centers-inc-cvs-health-corp-penske-automotive-group", "https://www.nasdaq.com/articles/amgen-label-expansion-application-for-prolia-accepted-by-fda-2017-10-10", "https://www.nasdaq.com/articles/amgen-wins-reprieve-its-2nd-best-selling-drug-2017-10-10", "https://www.nasdaq.com/articles/forget-teva-teva-buy-these-5-drug-stocks-instead-2017-10-09", "https://www.nasdaq.com/articles/cancer-space-last-week-update%3A-pipeline-expansion-in-focus-2017-10-09", "https://www.nasdaq.com/articles/3-best-healthcare-dividend-aristocrat-stocks-you-can-buy-right-now-2017-10-08", "https://www.nasdaq.com/articles/abbvies-fast-becoming-top-stock-buy-now-2017-10-08", "https://www.nasdaq.com/articles/3-blockbuster-drugs-still-cost-more-they-should-2017-10-07", "https://www.nasdaq.com/articles/dows-merck-bails-cholesterol-drug-prodding-shares-down-2017-10-11", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-iwd-mrk-wmt-amgn-2017-10-06", "https://www.nasdaq.com/articles/health-care-sector-update-10062017-jnj-pfe-abt-mrk-amgn-kdmn-2017-10-06", "https://www.nasdaq.com/articles/regeneron-and-sanofi-get-favorable-ruling-against-amgen-2017-10-06", "https://www.nasdaq.com/articles/everything-going-right-abbvie-it-best-biotech-stock-buy-right-now-2017-10-06", "https://www.nasdaq.com/articles/3-top-stocks-wall-street-insiders-love-2017-10-06", "https://www.nasdaq.com/articles/marshwinds-advisory-co-buys-dowdupont-inc-bhp-billiton-enbridge-inc-sells-ei-2017-10-06", "https://www.nasdaq.com/articles/why-regenerons-patent-win-worse-amgen-you-think-2017-10-06", "https://www.nasdaq.com/articles/dirt-cheap-biotech-stock-bargain-buy-2017-10-07", "https://www.nasdaq.com/articles/abbvie-abbv-stock-up-almost-17-in-one-month%3A-heres-why-2017-10-05", "https://www.nasdaq.com/articles/3-big-pharma-stocks-set-succeed-2017-10-05", "https://www.nasdaq.com/articles/stocks-rising-relative-strength-amgen-2017-10-05", "https://www.nasdaq.com/articles/amgen-enters-into-an-immuno-oncology-partnership-with-cytomx-2017-10-04", "https://www.nasdaq.com/articles/wall-streets-winning-streak-pauses-private-sector-hiring-slows-2017-10-04", "https://www.nasdaq.com/articles/health-care-sector-update-10042017-ctmxamgnmyltevarigl-2017-10-04", "https://www.nasdaq.com/articles/biotech-stock-roundup-endocyte-shoots-deal-amgen-abbvie-settle-humira-litigation-2017-10", "https://www.nasdaq.com/articles/regeneron-pops-after-judge-tosses-ban-amgen-rivaling-med-2017-10-05", "https://www.nasdaq.com/articles/health-care-sector-update-10042017-sbbpctmxamgnclsn-2017-10-04", "https://www.nasdaq.com/articles/amgen-cytomx-join-immuno-oncology-collaboration-2017-10-04", "https://www.nasdaq.com/articles/health-care-sector-update-10042017-riglctmxamgnclsn-2017-10-04", "https://www.nasdaq.com/articles/midday-update-us-stocks-turn-positive-after-tillerson-denies-plans-resign-2017-10-04", "https://www.nasdaq.com/articles/cytomx-breaks-out-mash-amgen-immuno-oncology-2017-10-04", "https://www.nasdaq.com/articles/3-top-ranked-big-biotech-stocks-to-buy-now-2017-10-03", "https://www.nasdaq.com/articles/why-shares-abbvie-soared-18-september-2017-10-03", "https://www.nasdaq.com/articles/close-update-wall-street-extends-winning-streak-new-record-highs-2017-10-04", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-amgn-amd-payx-2017-10-03", "https://www.nasdaq.com/articles/why-biotech-suffered-2-day-headache-rare-disease-trial-2017-10-03", "https://www.nasdaq.com/articles/abbvie-patent-deal-staves-amgen-competition-others-lurk-2017-10-02", "https://www.nasdaq.com/articles/abbvie-stock-upgraded-what-you-need-know-2017-10-02", "https://www.nasdaq.com/articles/abbvie-better-late-never-2017-10-02", "https://www.nasdaq.com/articles/radius-rdus-enrols-first-patient-in-breast-cancer-study-2017-10-02", "https://www.nasdaq.com/articles/how-good-abbvies-humira-deal-amgen-2017-09-29", "https://www.nasdaq.com/articles/3-dividend-stocks-should-thrive-recession-2017-10-03", "https://www.nasdaq.com/articles/abbvie-amgen-resolve-humira-patent-dispute-2017-09-29", "https://www.nasdaq.com/articles/sanofi-rides-on-genzyme-vaccines-unit-diabetes-sales-weak-2017-09-28", "https://www.nasdaq.com/articles/why-blackberry-abbvie-and-bluebird-bio-jumped-today-2017-09-28", "https://www.nasdaq.com/articles/biotechs-beating-market-are-they-buy-range-2017-09-28", "https://www.nasdaq.com/articles/biotech-stocks-watch-and-pharma-industry-news-2017-09-28", "https://www.nasdaq.com/articles/why-amgens-drug-win-sent-abbvie-stock-stratosphere-2017-09-28", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-fvd-bms-amgn-cmi-2017-09-27", "https://www.nasdaq.com/articles/how-will-trumps-proposed-tax-reform-impact-drug-companies-2017-09-29", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-reiterates-2017-outlook-intercept-hit-ocaliva-safety-issues", "https://www.nasdaq.com/articles/mercks-keytruda-gets-fda-nod-for-advanced-gastric-cancer-2017-09-25", "https://www.nasdaq.com/articles/pfizer-sues-jj-accuses-it-of-preventing-inflectra-uptake-2017-09-21", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-amgn-ffiv-ebix-2017-09-21", "https://www.nasdaq.com/articles/4-sell-ranked-biotech-stocks-with-falling-estimates-to-avoid-2017-09-21", "https://www.nasdaq.com/articles/biotech-stock-roundup-fda-nod-first-cancer-biosimilar-halo-deals-raised-outlook-2017-09-20", "https://www.nasdaq.com/articles/novartis-poised-to-grow-on-oncology-portfolio-biosimilars-2017-09-20", "https://www.nasdaq.com/articles/trade-of-the-day%3A-amgen-inc.-amgn-stock-has-plenty-more-upside-2017-09-27", "https://www.nasdaq.com/articles/is-amgen-amgn-a-great-stock-for-value-investors-2017-09-19", "https://www.nasdaq.com/articles/novartis-announces-positive-data-on-urticaria-drug-xolair-2017-09-18", "https://www.nasdaq.com/articles/3-great-income-stocks-could-double-their-dividends-2017-09-17", "https://www.nasdaq.com/articles/spdr-sp-biotech-etf-xbi%3A-the-quick-guide-to-xbi-2017-09-16", "https://www.nasdaq.com/articles/amgen-allergans-avastin-biosimilar-secures-fda-approval-2017-09-15", "https://www.nasdaq.com/articles/3-reasons-why-gilead-sciences-stock-buy-now-2017-09-15", "https://www.nasdaq.com/articles/top-research-reports-philip-morris-amgen-union-pacific-2017-09-15", "https://www.nasdaq.com/articles/ishares-russell-1000-value-etf-experiences-big-inflow-2017-09-19", "https://www.nasdaq.com/articles/biosimilar-2017-progress-report%3A-stocks-in-focus-2017-09-14", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-amgn-rcl-cvx-2017-09-14", "https://www.nasdaq.com/articles/4-biotech-stocks-for-the-long-term-2017-09-13", "https://www.nasdaq.com/articles/amgen-reaches-analyst-target-price-2017-09-13", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-september-14-2017-2017-09-13", "https://www.nasdaq.com/articles/5-compelling-reasons-why-abbvies-dividend-will-keep-growing-2017-09-13", "https://www.nasdaq.com/articles/novartis-bla-for-biosimilar-of-rituxan-accepted-by-the-fda-2017-09-12", "https://www.nasdaq.com/articles/biosimilar-cure-sky-high-cancer-drug-prices-2017-09-14", "https://www.nasdaq.com/articles/abbvies-ra-candidate-meets-primary-endpoint-in-phase-iii-2017-09-12", "https://www.nasdaq.com/articles/5-things-regenerons-ceo-said-biotech-stock-sank-2017-09-12", "https://www.nasdaq.com/articles/3-things-amgen-incs-management-just-said-youll-want-know-2017-09-12", "https://www.nasdaq.com/articles/interesting-amgn-put-and-call-options-january-2020-2017-09-11", "https://www.nasdaq.com/articles/tqqq-amgn-khc-pcln-etf-outflow-alert-2017-09-11", "https://www.nasdaq.com/articles/amgen-astrazeneca-asthma-candidate-tezepelumab-shows-promise-2017-09-07", "https://www.nasdaq.com/articles/astrazenecas-copd-candidate-duaklir-reports-positive-data-2017-09-07", "https://www.nasdaq.com/articles/supercharge-your-portfolio-with-amgen-inc.-amgn-stock-2017-09-12", "https://www.nasdaq.com/articles/mercks-mrk-keytruda-gets-eu-approval-for-bladder-cancer-2017-09-06", "https://www.nasdaq.com/articles/ligand-lgnd-diabetes-candidate-positive-in-phase-ii-study-2017-09-06", "https://www.nasdaq.com/articles/biotech-stock-roundup-cellectis-down-clinical-hold-insmed-soars-positive-data-2017-09-06", "https://www.nasdaq.com/articles/only-2-biotech-stocks-higher-dividend-yield-sp-500-2017-09-04", "https://www.nasdaq.com/articles/key-fda-regulatory-events-watch-out-sep-2017-2017-09-04", "https://www.nasdaq.com/articles/amgen-gets-eu-nod-to-expand-hyperparathyroidism-drug-label-2017-09-01", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-tqqq-amgn-khc-pcln-2017-09-01", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-amgn-cvx-cmcsa-2017-09-07", "https://www.nasdaq.com/articles/mercks-mrk-keytruda-gets-eu-approval-for-bladder-cancer-2017-09-06", "https://www.nasdaq.com/articles/amgen-presents-new-repatha-analysis-from-fourier-study-2017-08-29", "https://www.nasdaq.com/articles/3-dividend-stocks-thrive-market-crashes-2017-08-29", "https://www.nasdaq.com/articles/3-reasons-to-be-cautious-on-vertex-pharmaceuticals-incorporated-vrtx-stock-2017-08-29", "https://www.nasdaq.com/articles/why-i-love-abbvie-inc-2017-08-27", "https://www.nasdaq.com/articles/system-rigged-against-biosimilars-2017-08-26", "https://www.nasdaq.com/articles/smart-money-likes-these-5-stocks-2017-08-31", "https://www.nasdaq.com/articles/amgen-amgn-down-6.4-since-earnings-report%3A-can-it-rebound-2017-08-25", "https://www.nasdaq.com/articles/can-sanofi-sny-sustain-the-solid-1h-momentum-in-2h17-2017-08-24", "https://www.nasdaq.com/articles/proshares-ultrapro-qqq-experiences-big-inflow-2017-08-24", "https://www.nasdaq.com/articles/3-reasons-abbvie-better-dividend-stock-gilead-sciences-2017-08-23", "https://www.nasdaq.com/articles/biotech-stock-roundup-eu-label-expansion-alexion-biib-facing-drug-price-probe-2017-08-23", "https://www.nasdaq.com/articles/4-biotech-stocks-add-your-portfolio-post-q2-earnings-2017-08-22", "https://www.nasdaq.com/articles/what-will-drive-regeneron-pharmaceuticals-growth-higher-here-2017-08-22", "https://www.nasdaq.com/articles/biogens-humira-biosimilar-imraldi-gets-approval-in-eu-2017-08-25", "https://www.nasdaq.com/articles/netherlands-taking-aim-one-americas-fastest-growing-sectors-2017-08-20", "https://www.nasdaq.com/articles/add-parts-pwv-could-be-worth-39-2017-08-18", "https://www.nasdaq.com/articles/amgen-collaboration-humana-patients-benefit-2017-08-18", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-tqqq-goog-amgn-biib-2017-08-16", "https://www.nasdaq.com/articles/chiron-investment-management-llc-buys-ishares-iboxx-investment-grade-corporate-bond-gilead", "https://www.nasdaq.com/articles/can-ligands-captisol-deals-boost-growth-in-the-long-run-2017-08-15", "https://www.nasdaq.com/articles/are-amgens-new-drugs-doing-well-enough-to-drive-sales-2017-08-15", "https://www.nasdaq.com/articles/3-large-cap-biotech-stocks-to-scrape-from-the-selloff-2017-08-21", "https://www.nasdaq.com/articles/netherlands-taking-aim-one-americas-fastest-growing-sectors-2017-08-20", "https://www.nasdaq.com/articles/add-parts-pwv-could-be-worth-39-2017-08-18", "https://www.nasdaq.com/articles/amgen-collaboration-humana-patients-benefit-2017-08-18", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-tqqq-goog-amgn-biib-2017-08-16", "https://www.nasdaq.com/articles/graham-disciple-charles-brandes-5-largest-2nd-quarter-new-buys-2017-08-09", "https://www.nasdaq.com/articles/heres-why-coherus-biosciences-rose-much-222-today-2017-08-08", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-august-16-2017-2017-08-15", "https://www.nasdaq.com/articles/xlv-unh-mrk-amgn-etf-inflow-alert-2017-08-08", "https://www.nasdaq.com/articles/ray-gerald-l-associates-ltd-buys-norfolk-southern-corp-splunk-inc-oneok-inc-sells-2017-08", "https://www.nasdaq.com/articles/heres-why-array-biopharma-inc-fell-137-july-2017-08-07", "https://www.nasdaq.com/articles/radius-rdus-q2-loss-wider-than-expected-on-higher-expenses-2017-08-04", "https://www.nasdaq.com/articles/allergan-agn-q2-earnings-sales-top-restasis-sales-down-2017-08-03", "https://www.nasdaq.com/articles/health-care-sector-update-08032017-jnj-pfe-abt-mrk-amgn-regn-teva-2017-08-03", "https://www.nasdaq.com/articles/pfizer-pfe-surpasses-q2-earnings-estimates-misses-sales-2017-08-01", "https://www.nasdaq.com/articles/ligand-lgnd-q2-earnings-revenues-top-2017-view-raised-2017-08-08", "https://www.nasdaq.com/articles/sanofi-sny-q2-earnings-in-line-sales-lag17-view-raised-2017-07-31", "https://www.nasdaq.com/articles/daily-dividend-report-k-cboe-hta-amgn-syy-2017-07-31", "https://www.nasdaq.com/articles/health-care-sector-update-07282017-jnj-pfe-abt-mrk-amgn-abbv-nuva-2017-07-28", "https://www.nasdaq.com/articles/eliot-finkel-investment-counsel-llc-buys-extra-space-storage-inc-bank-nova-scotia-chevron", "https://www.nasdaq.com/articles/see-which-latest-13f-filers-holds-amgen-2017-07-27", "https://www.nasdaq.com/articles/company-news-for-july-27-2017-2017-07-27", "https://www.nasdaq.com/articles/arthur-m-cohen-associates-llc-buys-brookfield-infrastructure-partners-lp-fortive-corp-2017", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xlv-amgn-aet-antm-2017-07-31", "https://www.nasdaq.com/articles/amgn-named-top-socially-responsible-dividend-stock-2017-07-27", "https://www.nasdaq.com/articles/argyle-capital-management-inc-buys-dxc-technology-co-cvs-health-corp-cr-2017-07-26", "https://www.nasdaq.com/articles/like-facebook-inc-fb-stock-protect-yourself-anyway.-2017-07-26", "https://www.nasdaq.com/articles/nvidia-corporation-nvda-stock-isnt-as-attractive-as-the-company-2017-07-26", "https://www.nasdaq.com/articles/amgen-inc.-amgn-stock-is-a-trade-for-ailing-portfolios-2017-07-26", "https://www.nasdaq.com/articles/amgen-amgn-stock-falls-despite-q2-earnings-sales-beat-2017-07-26", "https://www.nasdaq.com/articles/2-incredibly-cheap-dividend-stocks-2017-07-26", "https://www.nasdaq.com/articles/validea-martin-zweig-strategy-daily-upgrade-report-7272017-2017-07-27", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-545-follow-through-indicator-31-sensitive-2017-07-25", "https://www.nasdaq.com/articles/biogen-biib-tops-q2-earnings-sales-spinraza-sales-up-2017-07-25", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-25-2017-t-amgn-txn-cb-cni-esrx-eqr-amp-wcn-wynn-amd-tss", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-amgn-nem-jpm-2017-07-25", "https://www.nasdaq.com/articles/3-large-cap-biotech-stocks-to-buy-now-2017-07-24", "https://www.nasdaq.com/articles/big-pharma-q2-earnings-releases-on-jul-25%3A-lly-biib-amgn-2017-07-24", "https://www.nasdaq.com/articles/3-stocks-are-absurdly-cheap-right-now-2017-07-23", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-biogen-top-q2-estimates-update-incyte-ra-drug-2017-07-26", "https://www.nasdaq.com/articles/amgen-amgn-to-report-q2-earnings%3A-whats-in-the-cards-2017-07-21", "https://www.nasdaq.com/articles/3-dividend-stocks-thrive-market-crashes-2017-07-21", "https://www.nasdaq.com/articles/oakbrook-investments-llc-buys-schlumberger-jpmorgan-chase-visa-inc-sells-ww-2017-07-20", "https://www.nasdaq.com/articles/biotech-stock-roundup-vertex-boosted-cf-data-fda-nod-gilead-puma-drugs-2017-07-19", "https://www.nasdaq.com/articles/3-dividend-stocks-thrive-both-bull-and-bear-markets-2017-07-19", "https://www.nasdaq.com/articles/ligand-signs-agreement-with-amgen-grants-rights-to-captisol-2017-07-18", "https://www.nasdaq.com/articles/novartis-tops-q2-earnings-sandoz-faces-pricing-pressure-2017-07-18", "https://www.nasdaq.com/articles/xlv-unh-mrk-amgn-large-outflows-detected-etf-2017-07-21", "https://www.nasdaq.com/articles/amgen-amgn-to-report-q2-earnings%3A-whats-in-the-cards-2017-07-21", "https://www.nasdaq.com/articles/wells-fargo-co-wfc-stock-slumps-following-solid-q2-earnings-report-2017-07-14", "https://www.nasdaq.com/articles/can-novartis-nvs-spring-a-surprise-this-earnings-season-2017-07-14", "https://www.nasdaq.com/articles/trade-of-the-day%3A-amgen-inc.-amgn-stock-is-a-standout-2017-07-14", "https://www.nasdaq.com/articles/notable-friday-option-activity-regn-ddd-amgn-2017-07-14", "https://www.nasdaq.com/articles/amgen-applies-have-kyprolis-label-updated-2017-07-14", "https://www.nasdaq.com/articles/why-did-radius-health-rdus-stock-plummet-today-2017-07-17", "https://www.nasdaq.com/articles/mylans-biosimilar-herceptin-gets-fda-advisory-committee-nod-2017-07-17", "https://www.nasdaq.com/articles/edmp-inc-buys-penske-automotive-group-inc-ventas-inc-store-capital-corp-sells-alphabet", "https://www.nasdaq.com/articles/can-immunogens-lead-pipeline-cancer-candidate-boost-growth-2017-07-13", "https://www.nasdaq.com/articles/amgen-gets-fda-nod-to-broaden-leukemia-drug-blincytos-label-2017-07-12", "https://www.nasdaq.com/articles/biotech-stock-roundup-arena-shoots-study-data-celg-inks-immuno-oncology-deal-2017-07-12", "https://www.nasdaq.com/articles/3-dividend-stocks-healthcare-2017-07-11", "https://www.nasdaq.com/articles/health-care-select-sector-spdr-fund-experiences-big-inflow-2017-07-13", "https://www.nasdaq.com/articles/novartis-cosentyx-superior-to-stelara-in-psoriasis-study-2017-07-10", "https://www.nasdaq.com/articles/heres-whats-behind-amgen-incs-102-gain-june-2017-07-10", "https://www.nasdaq.com/articles/country-club-trust-company-na-buys-ishares-msci-eafe-macquarie-infrastructure-corp-royal", "https://www.nasdaq.com/articles/are-medicines-companys-key-drugs-set-for-growth-in-2017-2017-07-10", "https://www.nasdaq.com/articles/3-dividend-stocks-you-may-be-overlooking-2017-07-09", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-celgene-corporation-2017-07-08", "https://www.nasdaq.com/articles/merck-falls-as-fda-puts-hold-on-3-keytruda-myeloma-studies-2017-07-06", "https://www.nasdaq.com/articles/amgen-inc.-amgn-stock-is-the-cure-for-ailing-portfolios-2017-07-10", "https://www.nasdaq.com/articles/xlv-unh-mrk-amgn-large-inflows-detected-etf-2017-07-05", "https://www.nasdaq.com/articles/biotech-stock-roundup-cara-plunges-study-data-regulatory-updates-more-2017-07-05", "https://www.nasdaq.com/articles/pfizers-pfe-leukemia-candidate-receives-approval-in-eu-2017-07-03", "https://www.nasdaq.com/articles/key-fda-events-watch-out-jul-2017-2017-07-03", "https://www.nasdaq.com/articles/10-biotech-stocks-with-game-changing-dates-in-q3-2017-07-03", "https://www.nasdaq.com/articles/3-charts-show-why-buy-gilead-sciences-stock-now-2017-07-02", "https://www.nasdaq.com/articles/tevas-teva-filing-for-biosimilar-rituxan-accepted-by-fda-2017-06-30", "https://www.nasdaq.com/articles/3-best-fidelity-funds-to-finish-2017-2017-07-06", "https://www.nasdaq.com/articles/dova-pharmaceuticals-targets-9-figure-opportunity-should-you-buy-its-ipo-2017-06-30", "https://www.nasdaq.com/articles/alders-shares-dip-despite-positive-migraine-trial-results-2017-06-28", "https://www.nasdaq.com/articles/novartis-erelzi-biosimilar-of-enbrel-approved-in-europe-2017-06-28", "https://www.nasdaq.com/articles/abbvie-has-most-valuable-late-stage-pipeline-its-stock-buy-2017-06-28", "https://www.nasdaq.com/articles/health-care-select-sector-spdr-fund-experiences-big-inflow-2017-06-27", "https://www.nasdaq.com/articles/amgen-gets-positive-chmp-opinion-for-mimpara-label-expansion-2017-06-27", "https://www.nasdaq.com/articles/roches-rhhby-combination-cancer-remedy-wins-fda-approval-2017-06-26", "https://www.nasdaq.com/articles/amgens-colorectal-cancer-drug-gets-fda-nod-to-expand-label-2017-06-30", "https://www.nasdaq.com/articles/mercks-keytruda-on-a-roll%3A-can-it-retain-the-momentum-2017-06-22", "https://www.nasdaq.com/articles/if-esperion-wants-market-next-big-cholesterol-drug-it-will-take-strategy-2017-06-22", "https://www.nasdaq.com/articles/novartis-migraine-drug-accepted-amd-positive-in-phase-iii-2017-06-21", "https://www.nasdaq.com/articles/small-cancer-biotech-space-in-focus-3-stocks-up-100-more-2017-06-21", "https://www.nasdaq.com/articles/biotech-stock-roundup-clovis-soars-rubraca-data-seattle-hit-study-halt-2017-06-21", "https://www.nasdaq.com/articles/ligand-gets-milestone-payment-on-partner-drug-fda-approval-2017-06-21", "https://www.nasdaq.com/articles/5-biotech-stocks-that-are-roaring-back-to-life-2017-06-21", "https://www.nasdaq.com/articles/allergan-continues-to-focus-on-acquisitions-and-branded-unit-2017-06-26", "https://www.nasdaq.com/articles/5-most-profitable-big-pharma-stocks-market-right-now-2017-06-20", "https://www.nasdaq.com/articles/3-dividend-stocks-long-term-investors-2017-06-20", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-rht-ctsh-amgn-2017-06-20", "https://www.nasdaq.com/articles/health-care-select-sector-spdr-fund-experiences-big-inflow-2017-06-19", "https://www.nasdaq.com/articles/abbvie-abbv-stock-hits-52-week-high%3A-more-room-to-run-2017-06-19", "https://www.nasdaq.com/articles/3-most-wildly-overvalued-stocks-biotech-least-paper-2017-06-19", "https://www.nasdaq.com/articles/abbvie-stock-just-hit-52-week-high-heres-why-it-should-go-even-higher-2017-06-18", "https://www.nasdaq.com/articles/amgens-xgeva-myeloma-label-expansion-sbla-accepted-by-fda-2017-06-20", "https://www.nasdaq.com/articles/2-incredibly-cheap-biotech-stocks-2017-06-16", "https://www.nasdaq.com/articles/3-biotech-trades-to-diversify-your-portfolio-2017-06-16", "https://www.nasdaq.com/articles/3-stocks-could-double-your-money-2017-06-16", "https://www.nasdaq.com/articles/is-amgen-amgn-a-great-stock-for-value-investors-2017-06-16", "https://www.nasdaq.com/articles/nektar-nktr-stock-rallied-almost-50-this-year%3A-heres-why-2017-06-16", "https://www.nasdaq.com/articles/will-these-cutting-edge-cancer-killers-reignite-biotech-rally-2017-06-15", "https://www.nasdaq.com/articles/biotech-stock-roundup-management-changes-biogen-alexion-gild-files-hiv-drug-2017-06-15", "https://www.nasdaq.com/articles/supreme-court-just-made-big-opportunity-biosimilars-even-bigger-2017-06-17", "https://www.nasdaq.com/articles/novartis-nvs-announced-positive-data-on-psoriasis-cosentyx-2017-06-15", "https://www.nasdaq.com/articles/why-is-immunogen-imgn-stock-up-131-this-year-2017-06-15", "https://www.nasdaq.com/articles/coherus-stock-plummets-as-fda-rejects-neulasta-biosimilar-2017-06-13", "https://www.nasdaq.com/articles/merck-stalls-enrolment-in-two-myeloma-studies-of-keytruda-2017-06-13", "https://www.nasdaq.com/articles/amgens-multiple-myeloma-drug-receives-nice-recommendation-2017-06-13", "https://www.nasdaq.com/articles/health-care-sector-update-06132017-jnj-pfe-abt-mrk-amgn-chrs-imnp-2017-06-13", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-june-14-2017-2017-06-13", "https://www.nasdaq.com/articles/3-dividend-stocks-astute-investors-2017-06-15", "https://www.nasdaq.com/articles/sanofi-regenerons-praluent-cuts-bad-cholesterol-in-studies-2017-06-12", "https://www.nasdaq.com/articles/health-care-sector-update-06122017-hyhgtxichrsamgn-2017-06-12", "https://www.nasdaq.com/articles/health-care-sector-update-06122017-trovazngtxichrsamgn-2017-06-12", "https://www.nasdaq.com/articles/bib-celg-amgn-incy-etf-inflow-alert-2017-06-09", "https://www.nasdaq.com/articles/abbvie-abbv-announced-positive-phase-iii-ra-candidate-data-2017-06-08", "https://www.nasdaq.com/articles/teva-migraine-candidate-succeeds-in-second-phase-iii-study-2017-06-08", "https://www.nasdaq.com/articles/allergan-to-buy-keller-funnel-boost-plastic-surgery-unit-2017-06-08", "https://www.nasdaq.com/articles/why-coherus-biosciences-stock-getting-hammered-today-2017-06-12", "https://www.nasdaq.com/articles/sanofi-regenerons-praluent-cuts-bad-cholesterol-in-studies-2017-06-12", "https://www.nasdaq.com/articles/mercks-cancer-drug-keytruda-positive-in-clinical-studies-2017-06-06", "https://www.nasdaq.com/articles/3-value-stocks-perfect-retirement-2017-06-06", "https://www.nasdaq.com/articles/amgen-files-for-repatha-in-the-u.s.-eu-for-expanded-use-2017-06-06", "https://www.nasdaq.com/articles/amgen-amgn-presents-positive-clinical-data-on-cancer-drugs-2017-06-05", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-amgn-wyn-mnk-2017-06-05", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xlv-mdt-amgn-celg-2017-05-31", "https://www.nasdaq.com/articles/health-care-sector-update-06082017-jnj-pre-abt-mrk-amgn-chrs-tvty-axn-2017-06-08", "https://www.nasdaq.com/articles/5-best-dividend-stocks-cholesterol-drugs-2017-05-30", "https://www.nasdaq.com/articles/amgen-amgn-down-4.5-since-earnings-report%3A-can-it-rebound-2017-05-30", "https://www.nasdaq.com/articles/3-dividend-stocks-thrive-market-crashes-2017-05-27", "https://www.nasdaq.com/articles/pfizers-epogen-biosimilar-gets-positive-fda-committee-vote-2017-05-26", "https://www.nasdaq.com/articles/3-top-dividend-stocks-generic-drugs-2017-05-26", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-regeneron-amgen-and-celgene-2017-05-25", "https://www.nasdaq.com/articles/radius-health-osteoporosis-drug-positive-in-phase-iii-study-2017-05-25", "https://www.nasdaq.com/articles/how-regeneron-pharmaceuticals-inc-makes-most-its-money-2017-05-31", "https://www.nasdaq.com/articles/biotech-stock-roundup-fda-nod-regeneron-ra-drug-amgen-hit-study-data-2017-05-24", "https://www.nasdaq.com/articles/3-reasons-gilead-sciences-inc-better-dividend-stock-amgen-inc-2017-05-24", "https://www.nasdaq.com/articles/stock-turned-1000-153-million-less-33-years-2017-05-23", "https://www.nasdaq.com/articles/insider-buying-evidence-2017-05-23", "https://www.nasdaq.com/articles/edward-owens-buys-abbott-labs-sells-allergan-amgen-aetna-2017-05-23", "https://www.nasdaq.com/articles/3-big-stock-charts-for-monday%3A-bristol-myers-squibb-co-bmy-pfizer-inc.-pfe-and-amgen-inc.", "https://www.nasdaq.com/articles/amgen-oversold-2017-05-22", "https://www.nasdaq.com/articles/mercks-mrk-keytruda-gets-fda-nod-for-solid-tumor-cancers-2017-05-24", "https://www.nasdaq.com/articles/amgen-inc-amgn-stock-dips-osteoporosis-drug-disappointment-2017-05-22", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-sso-mrk-mcd-amgn-2017-05-22", "https://www.nasdaq.com/articles/nasdaq-100-movers-amgn-wynn-2017-05-22", "https://www.nasdaq.com/articles/is-the-snap-inc-snap-stock-bounce-for-real-2017-05-22", "https://www.nasdaq.com/articles/why-apple-inc.-aapl-stock-is-vulnerable-right-now-2017-05-22", "https://www.nasdaq.com/articles/amgen-evenity-approval-derailed-on-cardiovascular-side-effect-2017-05-22", "https://www.nasdaq.com/articles/3-best-dividend-stocks-arthritis-medication-2017-05-22", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-amgn-afl-nog-2017-05-22", "https://www.nasdaq.com/articles/these-3-biotech-stocks-have-ballooned-2017-will-they-pop-2017-05-22", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-monday%3A-amgen-inc.-amgn-lockheed-martin-corporation-lmt-and-ford", "https://www.nasdaq.com/articles/hbk-investments-l-p-buys-nxp-semiconductors-nv-spdr-sp-500-amgen-inc-sells-st-jude-2017-05", "https://www.nasdaq.com/articles/astrazeneca-azn-gets-positive-chmp-opinion-for-brodalumab-2017-05-22", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-3-yield-mark-2017-05-22", "https://www.nasdaq.com/articles/health-care-sector-update-05222017-rdusamgneyegvrxbstg-2017-05-22", "https://www.nasdaq.com/articles/heres-why-radius-health-gained-much-202-today-2017-05-22", "https://www.nasdaq.com/articles/starbucks-corporation-sbux-stock-is-waking-up.-drink-up-2017-05-22", "https://www.nasdaq.com/articles/mercks-mrk-keytruda-gets-fda-nod-for-two-new-indications-2017-05-19", "https://www.nasdaq.com/articles/implied-fmk-analyst-target-price-32-2017-05-19", "https://www.nasdaq.com/articles/market-tailwind-has-lifted-top-fidelity-mutual-fund-managers-portfolio-2017-05-19", "https://www.nasdaq.com/articles/whats-your-flavor-dont-worry-theres-etf-2017-05-19", "https://www.nasdaq.com/articles/abbvie-down-on-humira-patent-loss%3A-is-more-damage-in-store-2017-05-18", "https://www.nasdaq.com/articles/salesforce.com-inc.-crm-stock-roars-into-earnings-2017-05-17", "https://www.nasdaq.com/articles/amgen-inc.-amgn-stock-has-the-cure-for-boring-portfolios-2017-05-17", "https://www.nasdaq.com/articles/amgen-amgn-submits-bla-to-fda-for-migraine-drug-erenumab-2017-05-19", "https://www.nasdaq.com/articles/health-care-sector-update-05162017-mnkdakbafmsetrm-2017-05-16", "https://www.nasdaq.com/articles/3-best-dividend-stocks-biotech-2017-05-16", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-j.c.-penney-amazon-verizon-citigroup-and-amgen-2017-05", "https://www.nasdaq.com/articles/lillys-migraine-drug-phase-iii-trials-meet-primary-endpoint-2017-05-15", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-amgen-inc-2017-05-14", "https://www.nasdaq.com/articles/regeneron-pharmaceuticals-stock-still-buy-after-its-big-bounce-2017-05-12", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-xlv-mrk-unh-amgn-2017-05-12", "https://www.nasdaq.com/articles/celgenes-celg-revlimid-looks-solid-on-label-expansion-2017-05-16", "https://www.nasdaq.com/articles/ex-dividend-reminder-consolidated-edison-amgen-and-simon-property-group-2017-05-11", "https://www.nasdaq.com/articles/bellevue-group-ag-buys-align-technology-inc-anthem-inc-walgreens-boots-alliance-inc-sells", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-amgn-2017-05-10", "https://www.nasdaq.com/articles/ligand-pharmaceuticals-lgnd-q1-earnings-miss-estimates-2017-05-10", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-wfm-ingn-amgn-2017-05-10", "https://www.nasdaq.com/articles/mylan-myl-beats-on-q1-earnings-revenues-miss-estimates-2017-05-10", "https://www.nasdaq.com/articles/allergan-agn-beats-q1-earnings-estimates-ups-2017-view-2017-05-09", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-may-15-2017-2017-05-12", "https://www.nasdaq.com/articles/xlv-unh-amgn-mdt-etf-inflow-alert-2017-05-04", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-gilead-celgene-q1-earnings-sunesis-down-vosaroxin-update-2017", "https://www.nasdaq.com/articles/9-brand-name-companies-provide-least-5-401k-match-2017-05-03", "https://www.nasdaq.com/articles/5-things-abbvie-management-just-said-youll-want-know-2017-05-03", "https://www.nasdaq.com/articles/pfizer-pfe-q1-earnings-beat-sales-lag-2017-view-intact-2017-05-02", "https://www.nasdaq.com/articles/radius-health-rdus-posts-wider-q1-loss-tymlos-approved-2017-05-02", "https://www.nasdaq.com/articles/regeneron-finally-getting-back-track-2017-04-29", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-johnson-johnson-2017-05-07", "https://www.nasdaq.com/articles/sanofi-sny-q1-earnings-top-sales-rise-y-y-shares-up-2017-04-28", "https://www.nasdaq.com/articles/these-7-drugmakers-relied-price-hikes-100-their-earnings-growth-2016-2017-04-28", "https://www.nasdaq.com/articles/amgen-amgn-q1-earnings-top-sales-miss-shares-decline-2017-04-27", "https://www.nasdaq.com/articles/starbucks-corporation-sbux-should-dip-after-earnings-and-thats-ok-2017-04-27", "https://www.nasdaq.com/articles/amgens-q1-results-highlight-need-acquisition-2017-04-27", "https://www.nasdaq.com/articles/will-amazon.com-inc.-amzn-stock-hit-%24950-its-not-a-given.-2017-04-27", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-thursday%3A-nokia-oyj-adr-nok-amgen-inc.-amgn-and-paypal-holdings-inc", "https://www.nasdaq.com/articles/amgen-bear-case-bull-2017-04-29", "https://www.nasdaq.com/articles/sanofi-sny-q1-earnings-top-sales-rise-y-y-shares-up-2017-04-28", "https://www.nasdaq.com/articles/these-7-drugmakers-relied-price-hikes-100-their-earnings-growth-2016-2017-04-28", "https://www.nasdaq.com/articles/sso-mrk-unh-amgn-large-outflows-detected-etf-2017-04-26", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-biogen-2017-04-26", "https://www.nasdaq.com/articles/5-fantastic-earnings-charts-2017-04-26", "https://www.nasdaq.com/articles/after-hours-earnings-report-april-26-2017-amgn-pypl-su-lvs-psa-eqix-avb-fisv-orly-efx-wcn", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-600-follow-through-indicator-32-sensitive-2017-04-26", "https://www.nasdaq.com/articles/3-best-long-term-dividend-stocks-buy-now-amgnhon-cvs-2017-04-26", "https://www.nasdaq.com/articles/whats-in-store-for-merck-mrk-this-earnings-season-2017-04-26", "https://www.nasdaq.com/articles/pfizer-pfe-q1-earnings%3A-will-it-pull-off-a-surprise-2017-04-26", "https://www.nasdaq.com/articles/sso-mrk-unh-amgn-large-outflows-detected-etf-2017-04-26", "https://www.nasdaq.com/articles/gilead-gild-q1-earnings%3A-stock-likely-to-beat-estimates-2017-04-25", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-wdc-tho-amgn-2017-04-25", "https://www.nasdaq.com/articles/novartis-tops-q1-earnings%3A-cosentyx-entresto-boost-sales-2017-04-25", "https://www.nasdaq.com/articles/what-options-traders-expect-from-amgen-inc.-amgn-earnings-2017-04-25", "https://www.nasdaq.com/articles/biogen-biib-q1-earnings-sales-top-spinraza-sales-strong-2017-04-25", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-pfizer-2017-04-24", "https://www.nasdaq.com/articles/celgene-celg-to-post-q1-earnings%3A-whats-in-the-cards-2017-04-24", "https://www.nasdaq.com/articles/read-you-buy-biotech-stocks-2017-04-23", "https://www.nasdaq.com/articles/amgen-amgn-to-report-q1-earnings%3A-will-it-beat-again-2017-04-21", "https://www.nasdaq.com/articles/alexion-alxn-q1-earnings%3A-can-the-stock-pull-a-surprise-2017-04-21", "https://www.nasdaq.com/articles/universal-health-uhs-q1-earnings%3A-whats-in-the-cards-2017-04-21", "https://www.nasdaq.com/articles/eli-lilly-lly-to-report-q1-earnings%3A-whats-in-the-cards-2017-04-20", "https://www.nasdaq.com/articles/whats-in-store-for-agenus-agen-this-earnings-season-2017-04-24", "https://www.nasdaq.com/articles/whats-in-store-for-biogen-biib-this-earnings-season-2017-04-20", "https://www.nasdaq.com/articles/whats-in-the-cards-for-centene-cnc-this-earnings-season-2017-04-20", "https://www.nasdaq.com/articles/xlv-amgn-mdt-lly-large-inflows-detected-etf-2017-04-18", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-alphabet-amgen-lowes-bristol-myers-and-priceline-2017", "https://www.nasdaq.com/articles/5-major-drug-stocks-likely-to-beat-q1-earnings-estimates-2017-04-17", "https://www.nasdaq.com/articles/abbvie-inc-bear-case-bull-2017-04-14", "https://www.nasdaq.com/articles/mylan-down-on-fda-warning-letter-to-manufacturing-facility-2017-04-12", "https://www.nasdaq.com/articles/novartis-nvs-q1-earnings%3A-will-the-stock-disappoint-2017-04-20", "https://www.nasdaq.com/articles/anths-anth-blisibimod-completes-dosing-in-phase-iii-study-2017-04-11", "https://www.nasdaq.com/articles/country-club-trust-company-na-buys-wisdomtree-europe-hedged-equity-fund-vanguard-2017-04", "https://www.nasdaq.com/articles/3-top-dividend-stocks-healthcare-sector-2017-04-11", "https://www.nasdaq.com/articles/3-big-drugmakers-most-likely-buy-incyte-2017-04-11", "https://www.nasdaq.com/articles/10-reasons-amgen-could-be-worlds-most-perfect-stock-2017-04-10", "https://www.nasdaq.com/articles/3-big-biotech-stocks-big-time-catalysts-2017-04-08", "https://www.nasdaq.com/articles/analysts-release-new-health-care-stock-ratings-2017-04-07", "https://www.nasdaq.com/articles/amgens-offering-money-back-guarantee-repatha-will-it-be-enough-2017-04-12", "https://www.nasdaq.com/articles/3-top-big-pharma-stocks-buy-now-2017-04-06", "https://www.nasdaq.com/articles/analysts-anticipate-10-gains-ahead-xlv-2017-04-06", "https://www.nasdaq.com/articles/why-radius-health-inc-tumbled-86-march-2017-04-06", "https://www.nasdaq.com/articles/amgen-files-for-xgeva-label-expansion-to-include-myeloma-2017-04-05", "https://www.nasdaq.com/articles/biotech-stock-roundup-acorda-down-court-ruling-patent-challenge-celg-drug-2017-04-05", "https://www.nasdaq.com/articles/why-is-amgen-amgn-up-12.9-since-the-last-earnings-report-2017-04-05", "https://www.nasdaq.com/articles/rosenbaum-jay-d-buys-salesforcecom-newell-brands-general-dynamics-sells-walt-disney-co", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-dgro-mrk-amgn-wmt-2017-04-06", "https://www.nasdaq.com/articles/3-top-big-pharma-stocks-buy-now-2017-04-06", "https://www.nasdaq.com/articles/healthcare-winners-and-losers-following-ahcas-failure-2017-04-02", "https://www.nasdaq.com/articles/better-buy-celgene-corporation-vs-amgen-inc-2017-04-01", "https://www.nasdaq.com/articles/could-pfizer-buy-esperion-therapeutics-2017-03-31", "https://www.nasdaq.com/articles/mylan-receives-crl-for-generic-advair-diskus-from-the-fda-2017-03-31", "https://www.nasdaq.com/articles/fda-grants-amgen-priority-review-blincyto-sbla-2017-03-31", "https://www.nasdaq.com/articles/whats-next-amgens-repatha-2017-04-04", "https://www.nasdaq.com/articles/3-best-cholesterol-drug-stocks-buy-2017-2017-03-30", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-xlv-mrk-unh-amgn-2017-03-29", "https://www.nasdaq.com/articles/biotech-stock-roundup-regeneron-tesaro-drugs-approved-vertex-scores-big-study-2017-03-29", "https://www.nasdaq.com/articles/3-drugmakers-boatloads-cash-spend-2017-03-29", "https://www.nasdaq.com/articles/pfizers-arthritis-drug-xeljanz-gets-marketing-nod-in-europe-2017-03-28", "https://www.nasdaq.com/articles/3-big-stock-charts-for-tuesday%3A-alphabet-inc-googl-amgen-inc.-amgn-and-united-parcel", "https://www.nasdaq.com/articles/biotech-etfs-defy-trump-tweets-rally-what-can-send-them-higher-2017-03-28", "https://www.nasdaq.com/articles/amgens-leukemia-drug-accepted-for-priority-review-by-fda-2017-03-30", "https://www.nasdaq.com/articles/mercks-ketruda-gets-positive-chmp-opinion-for-lymphoma-2017-03-27", "https://www.nasdaq.com/articles/5-stocks-ridiculously-fast-growing-dividends-2017-03-27", "https://www.nasdaq.com/articles/amgens-humira-biosimilar-approved-europe-2017-03-27", "https://www.nasdaq.com/articles/amgens-amgn-humira-biosimilar-receives-approval-in-eu-2017-03-24", "https://www.nasdaq.com/articles/pfizers-immunotherapy-for-skin-cancer-gets-fda-approval-2017-03-24", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-berkshire-hathaway-amgen-walgreens-boots-alliance", "https://www.nasdaq.com/articles/why-youre-smart-buy-jazz-pharmaceuticals-plc-2017-03-24", "https://www.nasdaq.com/articles/jj-jnj-anaemia-drug-marketing-label-expanded-in-europe-2017-03-27", "https://www.nasdaq.com/articles/health-etf-wobbles-vote-bill-replace-obamacare-nears-gold-gains-2017-03-22", "https://www.nasdaq.com/articles/zacks-investment-ideas-feature-highlights%3A-nasdaq-biotechnology-index-gilead-valeant", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-down-repatha-data-nektar-surges-pain-results-2017-03-22", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-xlv-unh-amgn-mdt-2017-03-21", "https://www.nasdaq.com/articles/3-biotech-stocks-are-broker-favorites-2017-03-21", "https://www.nasdaq.com/articles/biotech-bull-making-comeback-2017-03-21", "https://www.nasdaq.com/articles/amgen-amgn%3A-repatha-outcomes-data-disappoint-shares-drop-2017-03-20", "https://www.nasdaq.com/articles/how-company-taking-amgen-2017-03-23", "https://www.nasdaq.com/articles/health-etf-wobbles-vote-bill-replace-obamacare-nears-gold-gains-2017-03-22", "https://www.nasdaq.com/articles/zacks-investment-ideas-feature-highlights%3A-nasdaq-biotechnology-index-gilead-valeant", "https://www.nasdaq.com/articles/amgen-inc-amgn-offers-money-back-guarantee-heart-attack-victims-repatha-2017-03-17", "https://www.nasdaq.com/articles/mid-day-market-update-us-stocks-turn-negative-avexis-shares-spike-higher-2017-03-17", "https://www.nasdaq.com/articles/privacy-revamp-makes-facebook-inc-fb-stock-even-more-attractive-2017-03-17", "https://www.nasdaq.com/articles/amgen-inc.-amgn-stock-crashed.-heres-how-to-trade-it.-2017-03-17", "https://www.nasdaq.com/articles/why-biotech-stock-gilead-gild-could-be-value-trap-2017-03-20", "https://www.nasdaq.com/articles/stock-market-news-for-march-17-2017-2017-03-17", "https://www.nasdaq.com/articles/what-are-sanofis-sny-strengths-and-challenges-in-2017-2017-03-17", "https://www.nasdaq.com/articles/market-close-report-nasdaq-trading-volume-joins-top-ten-ranking-year-nasdaq-composite-26", "https://www.nasdaq.com/articles/why-amgen-amtrust-financial-services-and-brf-slumped-today-2017-03-17", "https://www.nasdaq.com/articles/heres-why-amgen-medicines-company-and-esperion-therapeutics-are-all-tanking-today-2017-03", "https://www.nasdaq.com/articles/pfizers-arthritis-drug-xeljanz-gets-marketing-nod-in-china-2017-03-16", "https://www.nasdaq.com/articles/nasdaq-100-movers-amgn-adbe-2017-03-17", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgens-data-repatha-catalyst-soars-firdapse-data-2017-03-16", "https://www.nasdaq.com/articles/mercks-mrk-keytruda-gets-fda-nod-for-lymphoma-indication-2017-03-15", "https://www.nasdaq.com/articles/amgens-repatha-meets-primary-endpoint-in-phase-iii-study-2017-03-14", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-amgn-rok-orcl-2017-03-14", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-xlv-amgn-mdt-abbv-2017-03-13", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-march-14-2017-2017-03-13", "https://www.nasdaq.com/articles/19-best-selling-prescription-drugs-all-time-2017-03-13", "https://www.nasdaq.com/articles/does-amgen-offer-a-great-value-buying-opportunity-right-now-2017-03-16", "https://www.nasdaq.com/articles/why-amgen-amgn-stock-rallied-after-q4-earnings-release-2017-03-10", "https://www.nasdaq.com/articles/after-hours-most-active-mar-10-2017-dish-ge-lltc-fnb-intc-qqq-gm-agn-v-bac-abco-amgn-2017", "https://www.nasdaq.com/articles/abbvie-stock-upgraded-what-you-need-know-2017-03-10", "https://www.nasdaq.com/articles/abbvie-cowen-healthcare-conference-4-things-youll-want-know-2017-03-09", "https://www.nasdaq.com/articles/daily-dividend-report-pba-plce-amgn-spls-vgr-2017-03-08", "https://www.nasdaq.com/articles/j2-global-ehealth-pfizer-amgen-and-mylan-highlighted-as-zacks-bull-and-bear-of-the-day", "https://www.nasdaq.com/articles/novartis-nvs-reports-positive-data-on-biosimilar-humira-2017-03-07", "https://www.nasdaq.com/articles/which-biotech-best-dividend-stock-2017-03-11", "https://www.nasdaq.com/articles/why-amgen-amgn-stock-rallied-after-q4-earnings-release-2017-03-10", "https://www.nasdaq.com/articles/xlv-amgn-mdt-abbv-etf-inflow-alert-2017-03-03", "https://www.nasdaq.com/articles/heres-why-amgen-stock-rose-105-february-2017-03-03", "https://www.nasdaq.com/articles/mylan-myl-beats-on-q4-earnings-stock-up-on-strong-view-2017-03-02", "https://www.nasdaq.com/articles/why-perrigo-company-plc-stock-crashed-tuesday-2017-03-01", "https://www.nasdaq.com/articles/biotech-stock-roundup-kite-soars-car-t-data-exel-immuno-oncology-deals-2017-03-01", "https://www.nasdaq.com/articles/heres-why-esperion-therapeutics-inc-stock-popped-today-2017-03-01", "https://www.nasdaq.com/articles/3-biotech-stocks-you-dont-have-babysit-2017-03-07", "https://www.nasdaq.com/articles/amgen-dividend-history-whats-ahead-biotech-pioneer-2017-02-28", "https://www.nasdaq.com/articles/3-ways-to-play-this-biotech-stocks-dip-2017-02-27", "https://www.nasdaq.com/articles/numeric-investors-llc-buys-gilead-sciences-microsoft-baxter-international-sells-facebook", "https://www.nasdaq.com/articles/3-stocks-you-dont-have-babysit-2017-02-26", "https://www.nasdaq.com/articles/ligand-lgnd-q4-earnings-down-y-y-revenues-miss-estimates-2017-02-24", "https://www.nasdaq.com/articles/notable-friday-option-activity-celg-amgn-lmt-2017-02-24", "https://www.nasdaq.com/articles/better-cloud-growth-stock-twilio-inc-vs-veeva-systems-2017-02-23", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-johnson-johnson-pfizer-glaxo-amgens-and-lilly-2017-02", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-tqqq-amgn-khc-chtr-2017-02-22", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-procter-gamble-bank-of-america-netflix-and-honda", "https://www.nasdaq.com/articles/heart-thumping-game-changing-ways-were-treating-cardiovascular-disease-2017-02-22", "https://www.nasdaq.com/articles/who-could-buy-bristol-myers-squibb-2017-02-22", "https://www.nasdaq.com/articles/study-reveals-pcsk9-drugs-can-save-heart-disease-patients-2017-02-21", "https://www.nasdaq.com/articles/valeants-vrx-plaque-psoriasis-drug-approved-in-the-u.s.-2017-02-17", "https://www.nasdaq.com/articles/pfizers-xeljanz-combo-comparable-to-abbvies-humira-2017-02-17", "https://www.nasdaq.com/articles/should-i-buy-procter-gamble-co-pg-stock-3-pros-3-cons-2017-02-23", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-tqqq-amgn-khc-chtr-2017-02-22", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-procter-gamble-bank-of-america-netflix-and-honda", "https://www.nasdaq.com/articles/heart-thumping-game-changing-ways-were-treating-cardiovascular-disease-2017-02-22", "https://www.nasdaq.com/articles/who-could-buy-bristol-myers-squibb-2017-02-22", "https://www.nasdaq.com/articles/stock-index-etfs-nail-another-gain-health-stocks-lead-2017-02-15", "https://www.nasdaq.com/articles/want-get-biotech-check-out-these-3-stocks-2017-02-15", "https://www.nasdaq.com/articles/amgen-looking-to-broaden-leukemia-drug-blincytos-label-2017-02-15", "https://www.nasdaq.com/articles/mylans-proposed-biosimailar-for-cancer-under-review-in-u.s.-2017-02-17", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-february-15-2017-2017-02-14", "https://www.nasdaq.com/articles/daniel-loeb-picks-rate-sensitive-financials-drops-pharma-2017-02-13", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-amgn-amba-axon-2017-02-13", "https://www.nasdaq.com/articles/primecap-management-buys-astrazeneca-plc-alkermes-plc-whirlpool-sells-union-pacific-2017", "https://www.nasdaq.com/articles/hunter-associates-inc-buys-pfizer-procter-gamble-co-rr-2017-02-10", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-february-13-2017-2017-02-10", "https://www.nasdaq.com/articles/3-beaten-down-stocks-ready-bounce-back-2017-02-10", "https://www.nasdaq.com/articles/vanguard-growth-etf-experiences-big-inflow-2017-02-14", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-february-15-2017-2017-02-14", "https://www.nasdaq.com/articles/sanofi-sny-q4-earnings-in-line-can-sell-praulent-for-now-2017-02-09", "https://www.nasdaq.com/articles/why-coherus-biosciences-falling-today-2017-02-08", "https://www.nasdaq.com/articles/allergan-agn-tops-q4-earnings-2017-sales-view-upbeat-2017-02-08", "https://www.nasdaq.com/articles/amgens-secondary-hyperparathyroidism-drug-approved-in-u.s.-2017-02-08", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-celgene-2017-02-08", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-gilead-report-4q-results-ariad-seeks-eu-nod-brigatinib-2017-02", "https://www.nasdaq.com/articles/van-strum-towne-inc-buys-charles-schwab-bank-americaoration-3m-co-sells-eaton-2017-02-10", "https://www.nasdaq.com/articles/sapphire-star-partners-lp-buys-cirrus-logic-cracker-barrel-old-country-store-vascular-2017", "https://www.nasdaq.com/articles/vug-amgn-mmm-abbv-large-inflows-detected-etf-2017-02-06", "https://www.nasdaq.com/articles/company-news-for-february-06-2017-2017-02-06", "https://www.nasdaq.com/articles/mercks-keytruda-gets-priority-review-for-bladder-cancer-2017-02-06", "https://www.nasdaq.com/articles/trumps-plan-lower-drug-costs-fairy-tale-2017-02-05", "https://www.nasdaq.com/articles/nasdaq-100-movers-amzn-amgn-2017-02-03", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-friday%3A-amgen-inc.-amgn-gopro-inc-gpro-and-visa-inc-v-2017-02-03", "https://www.nasdaq.com/articles/regeneron-regn-q4-earnings%3A-will-the-stock-disappoint-2017-02-08", "https://www.nasdaq.com/articles/amgen-amgn-q4-earnings-top-repatha-positive-in-cv-study-2017-02-03", "https://www.nasdaq.com/articles/why-morgan-stanley-amgen-and-tableau-software-jumped-today-2017-02-03", "https://www.nasdaq.com/articles/market-close-report-historical-high-reached-nasdaq-composite-index-closes-566677-2017-02", "https://www.nasdaq.com/articles/why-medicines-company-rocketed-higher-today-2017-02-03", "https://www.nasdaq.com/articles/why-esperion-therapeutics-inc-soaring-today-2017-02-03", "https://www.nasdaq.com/articles/health-care-sector-update-02032017-cbmceruidxg-2017-02-03", "https://www.nasdaq.com/articles/biotech-stock-roundup-celgene-biogen-abbv-post-q4-results-catabasis-falls-dmd-data-2017-02", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-amgen-amgn-stock-2017-02-03", "https://www.nasdaq.com/articles/amgen-amgn-q4-earnings-top-repatha-positive-in-cv-study-2017-02-03", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-synergy-pharmaceuticals-amgen-valeant-pharmaceuticals", "https://www.nasdaq.com/articles/drug-stocks-to-report-q4-earnings-on-feb-2%3A-mrk-amgn-2017-02-01", "https://www.nasdaq.com/articles/should-you-sell-amgen-amgn-before-earnings-2017-02-01", "https://www.nasdaq.com/articles/these-3-biotech-stocks-are-ridiculously-cheap-2017-02-01", "https://www.nasdaq.com/articles/merck-keytruda-gets-eu-approval-for-first-line-lung-cancer-2017-02-01", "https://www.nasdaq.com/articles/mallinckrodt-mnk-earnings-this-quarter%3A-stock-to-disappoint-2017-02-01", "https://www.nasdaq.com/articles/after-hours-earnings-report-february-2-2017-amzn-v-amgn-hig-ess-msi-cmg-mtd-kim-hbi-csc", "https://www.nasdaq.com/articles/amgen-inc.-amgn-q4-earnings-preview-2017-02-01", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-synergy-pharmaceuticals-amgen-valeant-pharmaceuticals", "https://www.nasdaq.com/articles/pfizer-pfe-gets-positive-chmp-opinion-for-arthritis-drug-2017-01-30", "https://www.nasdaq.com/articles/amgen-wins-favorable-chmp-opinion-for-humira-biosimilar-2017-01-30", "https://www.nasdaq.com/articles/united-bank-buys-fortis-sells-itc-holdings-revance-therapeutics-t-rowe-price-group-2017-01", "https://www.nasdaq.com/articles/amgen-inc.%3A-capture-stronger-upside-in-amgn-stock-2017-01-27", "https://www.nasdaq.com/articles/stock-market-news-for-january-27-2017-2017-01-27", "https://www.nasdaq.com/articles/pfizer-pfe-q4-earnings-lag-sales-top-17-sales-view-soft-2017-01-31", "https://www.nasdaq.com/articles/4-fda-decisions-watch-out-feb-2017-2017-01-31", "https://www.nasdaq.com/articles/stock-market-roundup-jan-31-nasdaq-rebounds-amid-trump-biotech-meeting-2017-01-31", "https://www.nasdaq.com/articles/biogen-biib-q4-earnings-top-estimates-17-sales-view-soft-2017-01-26", "https://www.nasdaq.com/articles/novartis-nvs-beats-q4-earnings-might-spin-off-alcon-2017-01-25", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-and-hold-stress-free-2017-01-24", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-vug-amgn-mmm-abbv-2017-01-19", "https://www.nasdaq.com/articles/health-care-sector-update-01272017-amgn-2017-01-27", "https://www.nasdaq.com/articles/why-the-amgen-inc.-amgn-patent-case-is-so-important-2017-01-18", "https://www.nasdaq.com/articles/4-top-biotech-mutual-funds-for-2017-2017-01-18", "https://www.nasdaq.com/articles/5-biotech-stocks-youll-want-watch-1st-quarter-2017-01-18", "https://www.nasdaq.com/articles/value-investing-2017-3-stocks-put-your-radar-2017-01-18", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-celgene-corporation-2017-01-17", "https://www.nasdaq.com/articles/donald-trump-just-leveled-drug-companies-these-4-words-2017-01-14", "https://www.nasdaq.com/articles/coherus-offers-positive-phase-iii-data-on-humira-biosimilar-2017-01-13", "https://www.nasdaq.com/articles/can-amgen-amgn-be-a-top-choice-for-value-investors-2017-01-19", "https://www.nasdaq.com/articles/apple-inc.-aapl-stock-cuts-production-but-it-may-not-be-time-to-run-2017-01-11", "https://www.nasdaq.com/articles/should-you-buy-amgen-inc.-amgn-stock-3-pros-3-cons-2017-01-11", "https://www.nasdaq.com/articles/spdr-sp-biotech-etf-xbi%3A-get-on-board-the-biotech-train-2017-01-11", "https://www.nasdaq.com/articles/biotech-stock-roundup-ariad-be-acquired-52b-vertex-outlook-falls-short-2017-01-11", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-biib-mrk-amgn-2017-01-11", "https://www.nasdaq.com/articles/stock-market-news-for-january-10-2017-2017-01-10", "https://www.nasdaq.com/articles/amgen-inks-multiple-deals-offers-update-on-repatha-lawsuit-2017-01-10", "https://www.nasdaq.com/articles/3-cheap-value-stocks-buy-today-2017-01-12", "https://www.nasdaq.com/articles/rosenbaum-jay-d-buys-comcast-corp-lowes-companies-inc-travelers-companies-inc-sells-2017", "https://www.nasdaq.com/articles/why-amgens-stock-slumped-2016-2017-01-10", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-tqqq-amgn-khc-gild-2017-01-09", "https://www.nasdaq.com/articles/pfizers-humira-biosimilar-meets-primary-endpoint-in-study-revised-2017-01-09", "https://www.nasdaq.com/articles/why-biotech-titans-are-clashing-over-cholesterol-2017-01-08", "https://www.nasdaq.com/articles/midday-update-stocks-regain-upward-momentum-after-mixed-jobs-report-2017-01-06", "https://www.nasdaq.com/articles/amgn-crosses-above-key-moving-average-level-2017-01-06", "https://www.nasdaq.com/articles/kite-pharma-inks-deals-for-car-t-cell-drug-in-japan-china-2017-01-10", "https://www.nasdaq.com/articles/sp-500-movers-regn-amgn-2017-01-06", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-friday%3A-amgen-inc.-amgn-gap-inc-gps-and-pricesmart-inc.-psmt-2017-01", "https://www.nasdaq.com/articles/health-care-sector-update-01062017-mdco-sny-regn-jnj-pfe-abt-mrk-amgn-2017-01-06", "https://www.nasdaq.com/articles/stock-futures-turn-positive-gains-hourly-earnings-2017-01-06", "https://www.nasdaq.com/articles/pfizers-humira-biosimilar-meets-primary-endpoint-in-study-2017-01-06", "https://www.nasdaq.com/articles/amgens-repatha-wins-over-sanofi-regenerons-praluent-2017-01-06", "https://www.nasdaq.com/articles/why-regeneron-pharmaceuticals-sears-holdings-and-shake-shack-slumped-today-2017-01-06", "https://www.nasdaq.com/articles/nasdaq-100-movers-regn-amgn-2017-01-06", "https://www.nasdaq.com/articles/sp-500-movers-regn-amgn-2017-01-06", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-friday%3A-amgen-inc.-amgn-gap-inc-gps-and-pricesmart-inc.-psmt-2017-01", "https://www.nasdaq.com/articles/biotech-stock-roundup-inotek-plunges-pipeline-setback-kite-files-ind-study-initiation-2017", "https://www.nasdaq.com/articles/kite-pharma-kite-to-move-cancer-candidate-into-phase-i-2017-01-04", "https://www.nasdaq.com/articles/health-care-sector-update-01042017-snyamgnregncbayagrx-2017-01-04", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-m-apa-amgn-2017-01-03", "https://www.nasdaq.com/articles/biotech-stocks-what-watch-2017-2017-01-01", "https://www.nasdaq.com/articles/close-update-labor-market-report-powers-sp-500-and-nasdaq-record-highs-2017-01-06", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-comcast-amgen-general-mills-target-and-ford-2017-01-05", "https://www.nasdaq.com/articles/these-3-dividend-stocks-are-ridiculously-cheap-2017-01-04", "https://www.nasdaq.com/articles/6-dividend-stocks-increasing-payouts-amgn-cvs-mco-fitb-bxp-chh-2016-12-27", "https://www.nasdaq.com/articles/3-big-pharma-stocks-fastest-growing-dividends-2016-12-25", "https://www.nasdaq.com/articles/ligand-lgnd-signs-licensing-deals-with-ono-and-novartis-2016-12-23", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-tqqq-amgn-khc-gild-2016-12-22", "https://www.nasdaq.com/articles/2-healthcare-stocks-better-dividends-hcp-inc-2016-12-31", "https://www.nasdaq.com/articles/oef-v-ibm-amgn-large-outflows-detected-etf-2016-12-30", "https://www.nasdaq.com/articles/3-big-stock-charts-for-tuesday%3A-darden-restaurants-inc.-dri-amgen-inc.-amgn-and", "https://www.nasdaq.com/articles/amgen-files-for-approval-of-osteoporosis-drug-in-japan-2016-12-20", "https://www.nasdaq.com/articles/great-news-clinical-trial-success-rates-are-first-time-more-decade-2016-12-19", "https://www.nasdaq.com/articles/merck-keytruda-gets-chmp-nod-for-first-line-lung-cancer-2016-12-19", "https://www.nasdaq.com/articles/3-small-biotech-stocks-big-biotechs-2016-12-18", "https://www.nasdaq.com/articles/daily-dividend-report-amgn-fitb-mco-wor-wdr-2016-12-21", "https://www.nasdaq.com/articles/gilead-sciences-biggest-mistake-2016-2016-12-16", "https://www.nasdaq.com/articles/pfizer%3A-fda-approves-eczema-ointment-xtandi-fails-study-2016-12-15", "https://www.nasdaq.com/articles/5-fairly-valued-dividend-growth-stocks-healthcare-sector-2016-12-15", "https://www.nasdaq.com/articles/big-pharma-face-off%3A-is-merck-more-attractive-than-jj-2016-12-15", "https://www.nasdaq.com/articles/xlv-amgn-abbv-gild-etf-outflow-alert-2016-12-14", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-sale-2016-12-13", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-amgen-inc-2016-12-13", "https://www.nasdaq.com/articles/stock-exchange-do-emotions-and-symbolism-affect-technical-analysis-2016-12-16", "https://www.nasdaq.com/articles/gilead-sciences-biggest-mistake-2016-2016-12-16", "https://www.nasdaq.com/articles/mondays-vital-data%3A-bank-of-america-corp-bac-apple-inc.-aapl-and-seadrill-ltd-sdrl-2016-12", "https://www.nasdaq.com/articles/amgen-inc.-amgn-stock-might-be-on-santas-buy-list-2016-12-12", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-biogen-2016-12-11", "https://www.nasdaq.com/articles/biogen-inc-biib-stock-trade-showcases-the-art-of-the-steal-2016-12-08", "https://www.nasdaq.com/articles/stock-market-news-for-december-08-2016-2016-12-08", "https://www.nasdaq.com/articles/biotech-stock-roundup-actelion-remains-ma-spotlight-ash-data-focus-2016-12-07", "https://www.nasdaq.com/articles/harvard-biosciences-recent-acquisitions-make-difference-initiate-buy-rating-2016-12-13", "https://www.nasdaq.com/articles/yieldboost-amgen-47-using-options-2016-12-12", "https://www.nasdaq.com/articles/mondays-vital-data%3A-bank-of-america-corp-bac-apple-inc.-aapl-and-seadrill-ltd-sdrl-2016-12", "https://www.nasdaq.com/articles/amgen-inc.-amgn-stock-might-be-on-santas-buy-list-2016-12-12", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-biogen-2016-12-11", "https://www.nasdaq.com/articles/biogen-inc-biib-stock-trade-showcases-the-art-of-the-steal-2016-12-08", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-amgen-2016-11-30", "https://www.nasdaq.com/articles/pfizer-merck-kgaa%3A-priority-review-for-cancer-drug-avelumab-2016-11-30", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-pfizer-2016-12-07", "https://www.nasdaq.com/articles/3-top-dividend-stocks-buy-2017-2016-11-29", "https://www.nasdaq.com/articles/merck%3A-keytrudas-priority-review-for-new-cancer-indication-2016-11-29", "https://www.nasdaq.com/articles/jj-immunotherapy-darzalex-okd-for-label-expansion-by-fda-2016-11-22", "https://www.nasdaq.com/articles/5-biotech-stocks-george-soros-buying-2016-11-22", "https://www.nasdaq.com/articles/novartis-nvs-reports-favorable-data-on-enbrel-biosimilar-2016-11-21", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-cisco-nextera-energy-abbvie-and-ebay-2016-11-21", "https://www.nasdaq.com/articles/novartis-amgen-migraine-drug-positive-in-phase-iii-study-2016-11-18", "https://www.nasdaq.com/articles/biotech-stock-roundup-actelion-soars-acquisition-talks-another-clinical-hold-juno-2016-11", "https://www.nasdaq.com/articles/aegerions-juxtapid-gets-pricing-authorization-in-japan-2016-11-18", "https://www.nasdaq.com/articles/top-research-reports-cisco-amgen-nextera-energy-2016-11-18", "https://www.nasdaq.com/articles/amgens-migraine-drug-hits-primary-endpoint-in-strive-study-2016-11-17", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-wednesday%3A-amgen-inc.-amgn-cisco-systems-inc.-csco-and-netapp-inc.", "https://www.nasdaq.com/articles/3-beaten-down-biotech-stocks-to-buy-for-huge-gains-2016-11-17", "https://www.nasdaq.com/articles/amgen-files-for-avastin-biosimilar-repatha-data-positive-2016-11-16", "https://www.nasdaq.com/articles/biotech-stock-roundup-biotech-stocks-soar-election-results-gilead-hbv-drug-approved-2016", "https://www.nasdaq.com/articles/regeneron-sanofis-praluent-cv-outcomes-study-to-continue-2016-11-18", "https://www.nasdaq.com/articles/3-biotech-etfs-for-decades-of-big-returns-2016-11-15", "https://www.nasdaq.com/articles/how-invest-during-trump-presidency-2016-11-14", "https://www.nasdaq.com/articles/amgen-presents-osteoporosis-data-parsabiv-approved-in-eu-2016-11-14", "https://www.nasdaq.com/articles/fidelity-healthcare-fund-5-things-you-should-know-2016-11-14", "https://www.nasdaq.com/articles/3-drugmakers-probably-have-lower-tax-rates-you-do-2016-11-13", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-november-14-2016-2016-11-11", "https://www.nasdaq.com/articles/drug-stocks-q3-earnings-to-watch-on-nov-14%3A-args-ast-2016-11-11", "https://www.nasdaq.com/articles/immunotherapy-next-hot-industry-biotech-stock-investors-2016-11-16", "https://www.nasdaq.com/articles/kite-pharma-q3-loss-betters-estimate-kte-c19-on-track-2016-11-10", "https://www.nasdaq.com/articles/5-top-biotech-stocks-buy-trump-victory-2016-11-10", "https://www.nasdaq.com/articles/peek-into-drug-stocks-q3-earnings-on-nov-11%3A-xbit-reph-2016-11-10", "https://www.nasdaq.com/articles/biotech-stock-roundup-ionis-soars-spinraza-data-regenerons-q3-results-mixed-2016-11-09", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-johnson-johnson-2016-11-08", "https://www.nasdaq.com/articles/iyh-unh-amgn-abbv-etf-outflow-alert-2016-11-08", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-november-09-2016-2016-11-08", "https://www.nasdaq.com/articles/stock-exchange-post-election-technical-analysis-useful-2016-11-11", "https://www.nasdaq.com/articles/biotech-etfs-slumping-on-q3-results-2016-11-08", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-amgen-vertex-valeant-pharmaceuticals-international", "https://www.nasdaq.com/articles/spxts-underlying-holdings-imply-14-gain-potential-2016-11-07", "https://www.nasdaq.com/articles/2-reasons-why-ishares-nasdaq-biotechnology-index-etf-tumbled-11-october-2016-11-07", "https://www.nasdaq.com/articles/abbvies-dividend-worth-risk-2016-11-06", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-mylan-lilly-pfizer-novartis-and-amgen-2016-11-04", "https://www.nasdaq.com/articles/why-abbvie-shares-tumbled-116-october-2016-11-04", "https://www.nasdaq.com/articles/why-amgen-inc-shares-nose-dived-154-october-2016-11-08", "https://www.nasdaq.com/articles/allergan-agn-lags-q3-earnings-cuts-view-ups-buyback-2016-11-02", "https://www.nasdaq.com/articles/10-billion-flop-amgen-stock-still-buy-2016-11-02", "https://www.nasdaq.com/articles/pfizers-surprising-news-upends-market-next-gen-cholesterol-busters-2016-11-01", "https://www.nasdaq.com/articles/pfizer-pfe-q3-earnings-lag-cuts-view-sheds-bococizumab-2016-11-01", "https://www.nasdaq.com/articles/drug-stocks-to-watch-for-earnings-on-nov-2-agn-zts-more-2016-11-01", "https://www.nasdaq.com/articles/3-things-you-really-need-know-about-pfizers-q3-results-2016-11-01", "https://www.nasdaq.com/articles/genetic-stocks-to-watch-for-earnings-on-nov-1%3A-gild-more-2016-10-31", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-down-enbrel-sales-regenerons-sarilumab-faces-delay-2016-11-03", "https://www.nasdaq.com/articles/amgen-inc-amgn-stock-sinks-despite-q3-earnings-beat-2016-10-28", "https://www.nasdaq.com/articles/nasdaq-100-movers-amgn-srcl-2016-10-28", "https://www.nasdaq.com/articles/amgen-amgn-q3-earnings-sales-top-enbrel-hurts-stock-2016-10-28", "https://www.nasdaq.com/articles/why-amgen-mckesson-and-stonemor-partners-slumped-today-2016-10-28", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-519010-down-2587-points-2016-10-28", "https://www.nasdaq.com/articles/5-things-amgen-incs-management-wants-you-know-2016-10-28", "https://www.nasdaq.com/articles/heres-why-amgen-amgn-stock-slid-over-10-today-2016-10-28", "https://www.nasdaq.com/articles/will-trend-cost-biotech-stock-investors-lots-money-2016-10-30", "https://www.nasdaq.com/articles/amgen-inc-amgn-stock-sinks-despite-q3-earnings-beat-2016-10-28", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-600-follow-through-indicator-27-sensitive-2016-10-27", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-27-2016-amzn-googl-amgn-bidu-syk-mck-afl-lnkd-rsg-expe", "https://www.nasdaq.com/articles/biotech-stock-roundup-clinical-holds-hit-inovio-aduro-vertex-q3-results-miss-estimates", "https://www.nasdaq.com/articles/gilead-sciences-gild-q3-earnings%3A-stock-to-disappoint-2016-10-26", "https://www.nasdaq.com/articles/can-prothena-prta-pull-a-surprise-this-earnings-season-2016-10-26", "https://www.nasdaq.com/articles/biogen-biib-beats-on-q3-earnings-tecfidera-propels-sales-2016-10-26", "https://www.nasdaq.com/articles/amgen-inc-tumbles-11-pricing-concerns-mount-lead-drug-enbrel-2016-10-28", "https://www.nasdaq.com/articles/novartis-nvs-tops-q3-earnings-misses-sales-estimates-2016-10-25", "https://www.nasdaq.com/articles/merck-keytruda-gets-fda-approval-for-first-line-lung-cancer-2016-10-25", "https://www.nasdaq.com/articles/3-key-questions-amgen-inc-q3-2016-10-25", "https://www.nasdaq.com/articles/agenus-agen%3A-whats-ahead-for-the-stock-in-q3-earnings-2016-10-24", "https://www.nasdaq.com/articles/can-abbvie-abbv-sustain-earnings-beat-trend-in-q3-2016-10-24", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-amgn-cemp-rdus-2016-10-24", "https://www.nasdaq.com/articles/health-care-sector-update-10242016-aacunisino-2016-10-24", "https://www.nasdaq.com/articles/is-a-surprise-coming-for-amgen-amgn-this-earnings-season-2016-10-26", "https://www.nasdaq.com/articles/amgens-amgn-xgeva-meets-endpoint-in-phase-iii-study-2016-10-21", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-pfizer-novartis-ag-amgen-merck-and-momenta", "https://www.nasdaq.com/articles/glaxosmithkline-gsk-q3-earnings%3A-whats-in-the-cards-2016-10-21", "https://www.nasdaq.com/articles/bristol-myers-squibb-bmy-q3-earnings%3A-whats-in-store-2016-10-21", "https://www.nasdaq.com/articles/best-and-worst-biotech-etfs-2016-tell-tale-about-industry-2016-10-21", "https://www.nasdaq.com/articles/7-drug-stocks-consider-biosimilars-pick-pace-2016-10-20", "https://www.nasdaq.com/articles/can-biogen-biib-keep-the-earnings-streak-alive-in-q3-2016-10-20", "https://www.nasdaq.com/articles/will-amgen-amgn-sustain-its-earnings-beat-trend-in-q3-2016-10-21", "https://www.nasdaq.com/articles/novartis-nvs-q3-earnings%3A-stock-to-beat-estimates-again-2016-10-20", "https://www.nasdaq.com/articles/celgene-celg-q3-earnings%3A-whats-in-store-for-the-stock-2016-10-20", "https://www.nasdaq.com/articles/can-eli-lilly-lly-pull-a-surprise-this-earnings-season-2016-10-19", "https://www.nasdaq.com/articles/can-merck-mrk-keep-the-earnings-streak-alive-in-q3-2016-10-19", "https://www.nasdaq.com/articles/3-stocks-supplement-your-social-security-benefits-2016-10-19", "https://www.nasdaq.com/articles/pfizer-to-launch-remicade-biosimilar-in-u.s.-in-november-2016-10-18", "https://www.nasdaq.com/articles/whats-in-store-for-biomarin-bmrn-this-earnings-season-2016-10-20", "https://www.nasdaq.com/articles/health-care-select-sector-spdr-fund-experiences-big-inflow-2016-10-13", "https://www.nasdaq.com/articles/jj-jnj-likely-to-beat-earnings-estimates-in-q3-again-2016-10-13", "https://www.nasdaq.com/articles/abbott-labs-abt-q3-earnings%3A-whats-ahead-for-the-stock-2016-10-13", "https://www.nasdaq.com/articles/stock-market-news-for-october-12-2016-2016-10-12", "https://www.nasdaq.com/articles/better-buy-regeneron-pharmaceuticals-inc-vs-roche-holding-ag-2016-10-12", "https://www.nasdaq.com/articles/teva-acquires-rights-to-oncology-biosimilar-candidates-2016-10-11", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-right-now-2016-10-11", "https://www.nasdaq.com/articles/daily-dividend-report-amgn-lly-wy-hsy-vmc-unm-2016-10-17", "https://www.nasdaq.com/articles/pfizer-to-sell-hospira-infusion-unit-to-icu-medical-for-%241b-2016-10-07", "https://www.nasdaq.com/articles/3-ways-rockwell-medical-inc-could-turn-things-around-2016-10-07", "https://www.nasdaq.com/articles/xlv-amgn-mdt-abbv-etf-outflow-alert-2016-10-05", "https://www.nasdaq.com/articles/amgen-announces-publication-of-blincyto-phase-i-ii-data-2016-10-04", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-october-2016-10-02", "https://www.nasdaq.com/articles/marketplace-roundtable-state-biotech-2016-10-01", "https://www.nasdaq.com/articles/3-healthcare-stocks-could-raise-their-dividends-2016-10-01", "https://www.nasdaq.com/articles/6-healthcare-stocks-investors-cant-miss-in-q3-earnings-2016-10-07", "https://www.nasdaq.com/articles/it-too-late-get-millionaire-maker-stock-2016-09-30", "https://www.nasdaq.com/articles/allergan-focus-on-brands-biosimilar-products-acquisitions-2016-09-30", "https://www.nasdaq.com/articles/why-arrowhead-pharmaceuticals-stock-spiked-today-2016-09-29", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-lower-pepsico-beats-q3-expectations-2016-09-29", "https://www.nasdaq.com/articles/health-care-sector-update-09292016-arwramgnaegritci-2016-09-29", "https://www.nasdaq.com/articles/3-reasons-not-to-lose-faith-in-amgen-inc.-amgn-2016-09-28", "https://www.nasdaq.com/articles/momenta-to-regain-rights-to-humira-biosimilar-from-shire-2016-09-28", "https://www.nasdaq.com/articles/amgen-amgn-migraine-drug-hits-phase-iii-primary-endpoint-2016-09-30", "https://www.nasdaq.com/articles/amgens-multiple-myeloma-drug-kyprolis-fails-in-phase-iii-2016-09-28", "https://www.nasdaq.com/articles/xlv-amgn-mdt-gild-etf-inflow-alert-2016-09-27", "https://www.nasdaq.com/articles/nasdaq-100-movers-gild-nclh-2016-09-27", "https://www.nasdaq.com/articles/amgen-ucbs-bla-for-osteoporosis-drug-accepted-in-the-u.s.-2016-09-27", "https://www.nasdaq.com/articles/biosimilars-limelight-fda-approval-amgen-drug-2016-09-27", "https://www.nasdaq.com/articles/heres-why-ligand-pharmaceuticals-inc-plunging-today-2016-09-27", "https://www.nasdaq.com/articles/amgens-biosimilar-of-abbvies-humira-gets-fda-approval-2016-09-26", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgens-kyprolis-disappoints-array-cancer-data-2016-09-28", "https://www.nasdaq.com/articles/amgen-amgn-repatha-meets-endpoints-in-phase-iii-study-2016-09-21", "https://www.nasdaq.com/articles/stock-market-news-for-september-21-2016-2016-09-21", "https://www.nasdaq.com/articles/trade-of-the-day%3A-ishares-nasdaq-biotechnology-index-etf-ibb-is-turning-things-around-2016", "https://www.nasdaq.com/articles/biotech-etf-best-level-january-are-you-braced-bumps-2016-09-20", "https://www.nasdaq.com/articles/know-you-buy-these-85-blue-chips-2016-09-20", "https://www.nasdaq.com/articles/amgen-amgn-parsabiv-gets-positive-chmp-opinion-in-eu-2016-09-19", "https://www.nasdaq.com/articles/new-market-biggest-investment-idea-decade-2016-09-17", "https://www.nasdaq.com/articles/humira-alternative-gets-fda-approval-abbvie-trouble-2016-09-26", "https://www.nasdaq.com/articles/novartis-reports-positive-phase-ii-data-on-migraine-drug-2016-09-16", "https://www.nasdaq.com/articles/spdr-sp-biotech-etf-xbi%3A-the-bears-got-nothin-on-biotech-stocks-2016-09-15", "https://www.nasdaq.com/articles/stock-market-news-for-september-15-2016-2016-09-15", "https://www.nasdaq.com/articles/third-avenue-fund-comments-amgen-2016-09-14", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-spectrum-pharmaceuticals-amgen-abbvie-and-vertex", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-september-14-2016-2016-09-13", "https://www.nasdaq.com/articles/sp-500-movers-aal-prgo-2016-09-12", "https://www.nasdaq.com/articles/iwf-v-pep-amgn-etf-outflow-alert-2016-09-16", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-amgn-ulta-aig-2016-09-12", "https://www.nasdaq.com/articles/two-things-you-must-understand-about-biotech-investing-2016-09-11", "https://www.nasdaq.com/articles/biotech-etf-unusual-investment-strategy-2016-09-09", "https://www.nasdaq.com/articles/market-treaded-water-august-investors-shifted-growth-stocks-switching-back-2016-09-09", "https://www.nasdaq.com/articles/mercks-lung-cancer-drug-keytruda-under-priority-review-2016-09-08", "https://www.nasdaq.com/articles/3-attractive-income-stocks-whose-dividends-could-double-2016-09-08", "https://www.nasdaq.com/articles/biotech-stock-roundup-colucid-soars-migraine-data-dynavax-drug-fda-panel-meeting-cancelled", "https://www.nasdaq.com/articles/3-drug-stocks-could-benefit-key-fda-events-sep-2016-2016-09-12", "https://www.nasdaq.com/articles/biotech-stock-roundup-gilead-patent-infringement-lawsuit-enbrel-biosimilar-approved-2016", "https://www.nasdaq.com/articles/why-cytokinetics-inc-got-hammered-today-2016-09-01", "https://www.nasdaq.com/articles/the-medicines-co.-offers-update-on-dyslipidemia-programs-2016-08-31", "https://www.nasdaq.com/articles/novartis-nvs-gets-fda-nod-for-biosimilar-version-of-enbrel-2016-08-31", "https://www.nasdaq.com/articles/amgen-amgn-reports-positive-data-on-prolia-and-repatha-2016-08-30", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-tqqq-amgn-khc-gild-2016-08-29", "https://www.nasdaq.com/articles/regeneron-sanofi-present-positive-phase-iii-praluent-data-2016-08-29", "https://www.nasdaq.com/articles/amgen-gets-fda-approval-for-label-expansion-of-blincyto-2016-09-02", "https://www.nasdaq.com/articles/amgen-gets-crl-for-secondary-hyperparathyroidism-drug-2016-08-25", "https://www.nasdaq.com/articles/health-care-sector-update-08252016-amgnpvct-2016-08-25", "https://www.nasdaq.com/articles/commit-purchase-amgen-135-earn-55-using-options-2016-08-24", "https://www.nasdaq.com/articles/jj-jnj-seeks-eu-approval-for-darzalexs-expanded-use-2016-08-24", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-august-25-2016-2016-08-24", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-dvax-amgn-ndsn-2016-08-22", "https://www.nasdaq.com/articles/3-reasons-medivation-juiciest-target-biotech-2016-08-21", "https://www.nasdaq.com/articles/these-next-generation-cholesterol-drugs-could-raise-us-healthcare-costs-119-billion-year", "https://www.nasdaq.com/articles/cytokinetics-amyotrophic-lateral-sclerosis-study-enrolled-2016-08-18", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-vertex-aurinia-aveo-and-amgen-2016-08-18", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-biogen-2016-08-17", "https://www.nasdaq.com/articles/biotech-stock-roundup-vertex-slips-study-halt-aurinia-plunges-lupus-data-2016-08-17", "https://www.nasdaq.com/articles/another-endorsement-biotech-etfs-2016-08-16", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-tuesday%3A-twilio-inc-twlo-hain-celestial-group-inc-hain-and-wal-mart", "https://www.nasdaq.com/articles/amgen-inc-amgn-amgen-stock-is-a-powerhouse-2016-08-16", "https://www.nasdaq.com/articles/3-cheap-dividend-stocks-you-can-buy-right-now-2016-08-19", "https://www.nasdaq.com/articles/prices-these-4-top-selling-prescription-drugs-have-more-doubled-2010-2016-08-13", "https://www.nasdaq.com/articles/prices-these-4-top-selling-prescription-drugs-have-more-doubled-2010-2016-08-12", "https://www.nasdaq.com/articles/martin-whitmans-third-avenue-management-purchases-8-stocks-2016-08-12", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-regeneron-biomarin-abbvie-amgen-and-biogen-2016-08-12", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-august-15-2016-2016-08-12", "https://www.nasdaq.com/articles/4-reasons-amgen-inc-shareholders-netted-13-gain-july-2016-08-11", "https://www.nasdaq.com/articles/biotech-stock-roundup-earnings-focus-abbvie-takes-steps-block-humira-copycat-2016-08-11", "https://www.nasdaq.com/articles/7-battered-biotech-stocks-buy-2016-08-14", "https://www.nasdaq.com/articles/kite-pharma-kite-q2-loss-wider-focus-kte-c19-2016-08-09", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-dgro-abbv-amgn-ups-2016-08-08", "https://www.nasdaq.com/articles/kite-kite-q2-earnings-whats-store-stock-2016-08-04", "https://www.nasdaq.com/articles/finding-value-sp-500-9-healthcare-dividend-growth-stocks-part-1-2016-08-04", "https://www.nasdaq.com/articles/why-advaxis-inc-shares-are-soaring-11-again-today-2016-08-03", "https://www.nasdaq.com/articles/ibb-significantly-overbought-sharp-declines-imminent-2016-08-03", "https://www.nasdaq.com/articles/mid-day-market-update-dow-drops-over-100-points-avon-shares-surge-following-earnings-beat", "https://www.nasdaq.com/articles/stock-market-news-for-august-09-2016-2016-08-09", "https://www.nasdaq.com/articles/2-biotech-funds-leading-nascent-bull-market-which-right-you-2016-08-02", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-down-15-retailmenot-shares-gain-strong-results-2016", "https://www.nasdaq.com/articles/which-latest-13f-filers-holds-amgen-2016-08-02", "https://www.nasdaq.com/articles/qqq-etf-posts-52-week-high-energy-stocks-sag-oil-drops-40-2016-08-01", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-bib-amgn-celg-biib-2016-07-29", "https://www.nasdaq.com/articles/ucb-ucbjf-posts-1h16-results-reaffirms-2016-guidance-2016-07-29", "https://www.nasdaq.com/articles/company-news-for-july-29-2016-2016-07-29", "https://www.nasdaq.com/articles/close-update-stocks-pressured-earnings-worries-about-economy-2016-08-02", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-facebook-amgen-whole-foods-and-groupon-2016-07-28", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biogen-gilead-abbvie-amgen-and-celgene-2016-07-28", "https://www.nasdaq.com/articles/amgen-amgn-tops-q2-earnings-revenues-raises-view-2016-07-28", "https://www.nasdaq.com/articles/2-large-cap-drug-stocks-watch-earnings-abbv-mrk-2016-07-28", "https://www.nasdaq.com/articles/facebook-fb-owns-q2-earnings-huge-beat-plus-grpn-gpro-and-more-2016-07-27", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-q2-results-impress-gilead-hcv-franchise-under-pressure-2016", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-27-2016-fb-amgn-mck-psa-su-nxpi-orly-pxd-abx-vrtx-mar-o", "https://www.nasdaq.com/articles/amgn-named-top-socially-responsible-dividend-stock-2016-07-29", "https://www.nasdaq.com/articles/5-drug-stocks-earnings-on-jul-27%3A-amgn-vrtx-more-2016-07-26", "https://www.nasdaq.com/articles/abbvie-abbv-q2-earnings-will-stock-pull-surprise-2016-07-26", "https://www.nasdaq.com/articles/alexion-alxn-q2-earnings%3A-stock-likely-to-disappoint-2016-07-26", "https://www.nasdaq.com/articles/one-biotech-plays-red-light-green-light-fda-2016-07-26", "https://www.nasdaq.com/articles/merck-mrk-q2-earnings-will-stock-pull-surprise-2016-07-26", "https://www.nasdaq.com/articles/ariad-aria-report-q2-earnings-will-stock-surprise-2016-07-26", "https://www.nasdaq.com/articles/bristol-myers-bmy%3A-stock-to-beat-earnings-again-in-q2-2016-07-25", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-636-follow-through-indicator-27-sensitive-2016-07-27", "https://www.nasdaq.com/articles/outerwall-inc%3A-what-the-buyout-means-for-outr-stock-2016-07-25", "https://www.nasdaq.com/articles/amgen-inc-amgn-stock-may-be-prepping-surge-2016-07-25", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-bristol-myers-pfizer-sanofi-amgen-and-biogen-2016-07-25", "https://www.nasdaq.com/articles/glaxo-gsk-q2-earnings%3A-can-the-stock-pull-a-surprise-2016-07-25", "https://www.nasdaq.com/articles/vertex-vrtx-report-q2-earnings-surprise-store-2016-07-25", "https://www.nasdaq.com/articles/amgen-amgn-may-beat-q2-earnings-will-stock-gain-2016-07-25", "https://www.nasdaq.com/articles/biotech-earnings-battle-gilead-gild-vs-amgen-amgn-2016-07-25", "https://www.nasdaq.com/articles/celgene-celg-q2-earnings%3A-can-the-stock-pull-a-surprise-2016-07-25", "https://www.nasdaq.com/articles/outerwall-inc%3A-what-the-buyout-means-for-outr-stock-2016-07-25", "https://www.nasdaq.com/articles/amgen-inc-amgn-stock-may-be-prepping-surge-2016-07-25", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-bristol-myers-pfizer-sanofi-amgen-and-biogen-2016-07-25", "https://www.nasdaq.com/articles/glaxo-gsk-q2-earnings%3A-can-the-stock-pull-a-surprise-2016-07-25", "https://www.nasdaq.com/articles/vertex-vrtx-report-q2-earnings-surprise-store-2016-07-25", "https://www.nasdaq.com/articles/amgen-amgn-may-beat-q2-earnings-will-stock-gain-2016-07-25", "https://www.nasdaq.com/articles/biotech-stock-roundup-celgene-immuno-oncology-deal-zafgen-drops-lead-drug-2016-07-20", "https://www.nasdaq.com/articles/daily-dividend-report-amgn-nlsn-mac-cf-ee-wwd-2016-07-25", "https://www.nasdaq.com/articles/implied-moat-analyst-target-price-38-2016-07-18", "https://www.nasdaq.com/articles/3-drug-stocks-report-earnings-jul-19-jnj-nvs-neog-2016-07-18", "https://www.nasdaq.com/articles/valeants-vrx-brodalumab-bla-up-for-review-in-the-u.s.-2016-07-18", "https://www.nasdaq.com/articles/3-biotech-stocks-conservative-investors-2016-07-17", "https://www.nasdaq.com/articles/4-rock-solid-cheap-biotech-stocks-2016-07-16", "https://www.nasdaq.com/articles/5-figures-look-when-johnson-johnson-reports-its-second-quarter-results-2016-07-15", "https://www.nasdaq.com/articles/novartis-enbrel-biosimilar-gets-fda-panel-recommendation-2016-07-14", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-sso-amgn-mcd-cvs-2016-07-19", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-juno-amgen-abbvie-gilead-and-cytrx-2016-07-14", "https://www.nasdaq.com/articles/heres-why-regeneron-pharmaceuticals-inc-dropped-another-12-june-2016-07-13", "https://www.nasdaq.com/articles/biotech-stock-roundup-juno-and-out-clinical-hold-amgen-biosimilar-gets-panel-backing-2016", "https://www.nasdaq.com/articles/amgens-repatha-gains-fda-approval-for-new-dosing-option-2016-07-12", "https://www.nasdaq.com/articles/instant-analysis-amgens-latest-approval-raises-bar-yet-again-regeneron-pharmaceuticals-inc", "https://www.nasdaq.com/articles/amgen-humira-biosimilar-briefing-documents-look-good-2016-07-11", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-iwf-googl-goog-amgn-2016-07-07", "https://www.nasdaq.com/articles/amgen-and-daiichi-sankyo-team-up-for-biosimilars-in-japan-2016-07-14", "https://www.nasdaq.com/articles/amgens-kyprolis-gains-approval-in-eu-for-label-expansion-2016-07-06", "https://www.nasdaq.com/articles/should-davitas-dva-stock-be-in-your-portfolio-now-2016-07-06", "https://www.nasdaq.com/articles/astrazeneca-skin-drug-tralokinumab-rights-licensed-leo-2016-07-06", "https://www.nasdaq.com/articles/5-dividend-growth-stocks-to-excel-in-any-market-condition-2016-07-06", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-now-2016-07-04", "https://www.nasdaq.com/articles/3-healthcare-stocks-could-raise-their-dividends-2016-07-02", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-above-200-dma-2016-07-01", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-wal-mart-stores-home-depot-amgen-united-parcel-service-and", "https://www.nasdaq.com/articles/amgens-kyprolis-gains-approval-in-eu-for-label-expansion-2016-07-06", "https://www.nasdaq.com/articles/should-davitas-dva-stock-be-in-your-portfolio-now-2016-07-06", "https://www.nasdaq.com/articles/astrazeneca-skin-drug-tralokinumab-rights-licensed-leo-2016-07-06", "https://www.nasdaq.com/articles/5-dividend-growth-stocks-to-excel-in-any-market-condition-2016-07-06", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-wake-brexit-vote-2016-06-24", "https://www.nasdaq.com/articles/the-ishares-nasdaq-biotechnology-index-ibb%3A-biotech-stocks-are-pushing-for-recovery-2016", "https://www.nasdaq.com/articles/pfizers-pcsk9-inhibitor-tops-two-additional-phase-iii-studies-2016-06-29", "https://www.nasdaq.com/articles/3-most-important-data-releases-and-fda-decisions-second-half-2016-2016-06-23", "https://www.nasdaq.com/articles/ixj-amgn-agn-celg-large-inflows-detected-etf-2016-06-20", "https://www.nasdaq.com/articles/2-biotech-stocks-could-raise-their-dividends-and-1-wont-2016-06-18", "https://www.nasdaq.com/articles/amgens-biosimilar-of-abbvies-humira-to-face-fda-panel-2016-06-14", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-june-14-2016-2016-06-13", "https://www.nasdaq.com/articles/tricking-common-cold-destroying-cancer-2016-06-13", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-pjp-agn-amgn-lly-2016-06-10", "https://www.nasdaq.com/articles/how-former-market-darling-became-undervalued-stock-2016-06-23", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-slips-ms-results-asco-data-focus-2016-06-08", "https://www.nasdaq.com/articles/ibb-ishares-nasdaq-biotechnology-index-etf-still-buy-2016-06-07", "https://www.nasdaq.com/articles/why-kite-pharma-shares-vaulted-107-higher-may-2016-06-06", "https://www.nasdaq.com/articles/better-dividend-stock-pfizer-vs-amgen-2016-06-06", "https://www.nasdaq.com/articles/new-17-billion-market-youve-probably-never-heard-and-3-stocks-poised-profit-2016-06-04", "https://www.nasdaq.com/articles/3-biotechs-expecting-market-moving-trial-results-soon-2016-06-04", "https://www.nasdaq.com/articles/sso-amgn-cvs-abbv-large-outflows-detected-etf-2016-06-01", "https://www.nasdaq.com/articles/novartis-nvs-announces-positive-results-on-migraine-drug-2016-06-09", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-june-02-2016-2016-06-01", "https://www.nasdaq.com/articles/merck-abbvie-amgen-drugs-step-closer-eu-approval-2016-05-31", "https://www.nasdaq.com/articles/3-growth-stocks-buy-june-2016-05-28", "https://www.nasdaq.com/articles/interested-medivation-take-number-2016-05-27", "https://www.nasdaq.com/articles/yieldboost-amgn-64-using-options-2016-05-25", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-above-200-dma-2016-05-25", "https://www.nasdaq.com/articles/billionaires-lightened-their-load-these-3-widely-held-stocks-q1-2016-05-24", "https://www.nasdaq.com/articles/regeneron-reports-interim-data-on-cholesterol-lowering-drug-2016-06-01", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-june-02-2016-2016-06-01", "https://www.nasdaq.com/articles/biotech-stock-roundup-pfizer-buy-anacor-52b-pipeline-setbacks-aduro-trevena-2016-05-19", "https://www.nasdaq.com/articles/thinking-about-buying-gold-think-again-2016-05-16", "https://www.nasdaq.com/articles/drug-stocks-reporting-earnings-on-may-17%3A-axon-fwp-2016-05-16", "https://www.nasdaq.com/articles/math-shows-eusa-can-go-48-2016-05-16", "https://www.nasdaq.com/articles/biotech-stock-roundup-medivation-buyout-rumors-continue-newlink-plunges-late-stage-data", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-may-13-2016-2016-05-12", "https://www.nasdaq.com/articles/heres-what-pfizers-telling-us-about-biotech-ma-2016-05-21", "https://www.nasdaq.com/articles/xlv-unh-gild-amgn-etf-outflow-alert-2016-05-19", "https://www.nasdaq.com/articles/biotech-stock-roundup-pfizer-buy-anacor-52b-pipeline-setbacks-aduro-trevena-2016-05-19", "https://www.nasdaq.com/articles/drug-stocks-q1-earnings-slated-on-may-11%3A-acrs-ears-more-2016-05-10", "https://www.nasdaq.com/articles/kite-pharma-kite-posts-narrower-expected-loss-q1-2016-05-10", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-may-11-2016-2016-05-10", "https://www.nasdaq.com/articles/drug-stocks-reporting-on-may-10%3A-xon-aria-cprx-more-2016-05-09", "https://www.nasdaq.com/articles/drug-stocks-earnings-previews%3A-fgen-irwd-enta-flml-2016-05-06", "https://www.nasdaq.com/articles/bristol-myers-abbvie-empliciti-gets-approved-in-the-eu-2016-05-12", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-gilead-celgene-medivation-and-biogen-2016-05-05", "https://www.nasdaq.com/articles/amgn-makes-notable-cross-below-critical-moving-average-2016-05-04", "https://www.nasdaq.com/articles/kite-kite-report-q1-earnings-will-stock-disappoint-2016-05-04", "https://www.nasdaq.com/articles/health-care-select-sector-spdr-fund-experiences-big-inflow-2016-05-04", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-impresses-gilead-disappoints-q1-biogen-spin-hemophilia-2016-05", "https://www.nasdaq.com/articles/biotech-stocks-earnings-preview%3A-regn-lgnd-ecyt-more-2016-05-03", "https://www.nasdaq.com/articles/regeneron-pharmaceuticals-inc-has-lot-prove-may-5-2016-05-03", "https://www.nasdaq.com/articles/biotech-stocks-reporting-may-9-incy-hznp-juno-more-2016-05-06", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-johnson-johnson-pfizer-mylan-and-mallinckrodt", "https://www.nasdaq.com/articles/aside-1-eyesore-amgen-delivers-another-solid-quarter-2016-05-02", "https://www.nasdaq.com/articles/biotech-etfs-sink-on-mixed-q1-results-2016-05-02", "https://www.nasdaq.com/articles/trade-day-ibb-breaking-down-2016-05-02", "https://www.nasdaq.com/articles/amgen-inc-amgn-earnings-prove-it-should-be-your-portfolio-2016-04-29", "https://www.nasdaq.com/articles/3-drug-stocks-reporting-early-next-week%3A-pfe-myl-mnk-2016-04-29", "https://www.nasdaq.com/articles/amgen-amgn-tops-q1-earnings-revenues-ups-view-2016-04-29", "https://www.nasdaq.com/articles/insulet-pumps-out-69-revenue-growth-q1-reaffirms-2016-guidance-2016-05-03", "https://www.nasdaq.com/articles/q1-earnings-reports-continue-deluge-amzn-gild-amgn-2016-04-28", "https://www.nasdaq.com/articles/amgen-amgn-beats-q1-earnings-estimates-raises-2016-outlook-2016-04-28", "https://www.nasdaq.com/articles/celgene-corporation-short-term-long-term-guidance-medium-term-not-so-much-2016-04-28", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-700-follow-through-indicator-28-sensitive-2016-04-28", "https://www.nasdaq.com/articles/after-hours-earnings-report-april-28-2016-amzn-gild-amgn-bidu-hig-rsg-expe-ess-bmrn-lnkd", "https://www.nasdaq.com/articles/fvd-lmbs-big-etf-inflows-2016-04-27", "https://www.nasdaq.com/articles/see-which-latest-13f-filers-holds-amgen-2016-04-27", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-friday%3A-amgen-inc.-amgn-gilead-sciences-inc.-gild-and-tivo-inc.-tivo", "https://www.nasdaq.com/articles/aegerion-aegr%3A-can-the-stock-surprise-in-q1-earnings-2016-04-27", "https://www.nasdaq.com/articles/aerie-aeri%3A-can-the-stock-pull-a-surprise-in-q1-earnings-2016-04-27", "https://www.nasdaq.com/articles/biotech-stock-gilead-gild-likely-to-beat-in-q1-earnings-2016-04-26", "https://www.nasdaq.com/articles/health-care-select-sector-spdr-fund-experiences-big-inflow-2016-04-26", "https://www.nasdaq.com/articles/celgene-celg-q1-earnings%3A-whats-in-store-for-the-stock-2016-04-25", "https://www.nasdaq.com/articles/centene-cnc-q1-earnings%3A-surprise-in-store-for-stock-2016-04-25", "https://www.nasdaq.com/articles/aetna-aet-q1-earnings%3A-is-a-surprise-in-store-for-stock-2016-04-25", "https://www.nasdaq.com/articles/4-biotech-stocks-reporting-apr-28-amgn-gild-alxn-celg-2016-04-27", "https://www.nasdaq.com/articles/anthem-antm%3A-stock-poised-to-beat-on-q1-earnings-2016-04-25", "https://www.nasdaq.com/articles/amgen-amgn-may-beat-q1-earnings-will-stock-gain-2016-04-25", "https://www.nasdaq.com/articles/what-to-expect-from-hubbell-hubb-this-earnings-season-2016-04-25", "https://www.nasdaq.com/articles/5-biotech-stocks-to-bet-on-this-earnings-season-2016-04-25", "https://www.nasdaq.com/articles/3-data-points-will-likely-define-amgens-first-quarter-report-april-28-2016-04-25", "https://www.nasdaq.com/articles/does-biotechs-recent-bounce-have-legs-2016-04-23", "https://www.nasdaq.com/articles/bristol-myers-bmy-q1-earnings%3A-can-the-stock-surprise-2016-04-22", "https://www.nasdaq.com/articles/biomarin-bmrn-q1-earnings%3A-stock-likely-to-beat-estimates-2016-04-25", "https://www.nasdaq.com/articles/abbvie-abbv-likely-beat-q1-earnings-stock-gain-2016-04-22", "https://www.nasdaq.com/articles/glaxo-gsk-q1-earnings%3A-whats-in-store-for-the-stock-2016-04-22", "https://www.nasdaq.com/articles/will-currency-competition-hurt-lillys-lly-q1-earnings-2016-04-21", "https://www.nasdaq.com/articles/amgens-amgn-phase-iii-study-results-on-nplate-published-2016-04-20", "https://www.nasdaq.com/articles/20-reasons-buy-amgen-and-never-sell-2016-04-20", "https://www.nasdaq.com/articles/health-care-sector-update-04202016-cara-amgn-mrk-abt-pfe-jnj-stj-2016-04-20", "https://www.nasdaq.com/articles/biotech-stock-roundup-medivation-buyout-rumors-resurface-synta-merger-deal-2016-04-20", "https://www.nasdaq.com/articles/vertex-vrtx-report-q1-earnings-surprise-store-2016-04-22", "https://www.nasdaq.com/articles/3-biotech-stocks-that-could-endure-hillary-clinton-2016-04-19", "https://www.nasdaq.com/articles/health-care-sector-update-04182016-mdvn-biib-amgn-mrk-abt-pfe-jnj-2016-04-18", "https://www.nasdaq.com/articles/will-ms-franchise-sales-boost-biogens-biib-1q-earnings-2016-04-18", "https://www.nasdaq.com/articles/health-care-sector-update-04152016-amgn-mrk-abt-pfe-jnj-vrx-mrns-2016-04-15", "https://www.nasdaq.com/articles/surprising-analyst-12-month-target-iwl-2016-04-15", "https://www.nasdaq.com/articles/will-perrigo-prgo-surprise-earnings-estimates-in-q1-2016-04-15", "https://www.nasdaq.com/articles/iwf-amgn-unh-ma-large-outflows-detected-etf-2016-04-14", "https://www.nasdaq.com/articles/health-care-sector-update-04192016-scmp-amgn-mrk-abt-pfe-jnj-2016-04-19", "https://www.nasdaq.com/articles/trade-day-pounce-amgn-stock-pullback-2016-04-14", "https://www.nasdaq.com/articles/health-care-sector-update-04132016-ocls-psti-amgn-mrk-abt-pfe-jnj-2016-04-13", "https://www.nasdaq.com/articles/3-biotech-takeover-targets-could-get-bought-soon-2016-04-13", "https://www.nasdaq.com/articles/health-care-sector-update-04122016-amgn-mrk-abt-pfe-jnj-clvs-cbrp-2016-04-12", "https://www.nasdaq.com/articles/shares-regeneron-pharmaceuticals-inc-struggled-march-heres-why-2016-04-11", "https://www.nasdaq.com/articles/novartis-binocrits-subcutaneous-formula-gets-ec-approval-2016-04-11", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-iwb-gild-amgn-sbux-2016-04-06", "https://www.nasdaq.com/articles/health-care-sector-update-04142016-amgn-mrk-abt-pfe-jnj-abbv-enta-snta-2016-04-14", "https://www.nasdaq.com/articles/7-healthcare-stocks-to-buy-for-your-retirement-2016-04-06", "https://www.nasdaq.com/articles/forget-regeneron-pharmaceuticals-inc-these-2-stocks-are-better-buys-2016-04-05", "https://www.nasdaq.com/articles/amgen-news-could-be-game-changer-its-fight-against-sanofi-and-regeneron-pharmaceuticals", "https://www.nasdaq.com/articles/amgen-breaks-above-200-day-moving-average-bullish-amgn-2016-04-04", "https://www.nasdaq.com/articles/3-biotech-stocks-on-the-verge-of-an-overdue-run-amgn-gild-regn-2016-04-04", "https://www.nasdaq.com/articles/better-buy-regeneron-pharmaceuticals-inc-vs-amgen-2016-04-04", "https://www.nasdaq.com/articles/pfizers-pcsk9-inhibitor-positive-second-phase-iii-study-2016-04-04", "https://www.nasdaq.com/articles/pfizers-pfe-biosimilar-of-remicade-receives-fda-approval-2016-04-06", "https://www.nasdaq.com/articles/post-conference-get-together-2016-04-02", "https://www.nasdaq.com/articles/4-best-biotech-stocks-of-the-first-quarter-of-2016-2016-04-01", "https://www.nasdaq.com/articles/celator-pharmaceuticals-inc-stock-worth-buying-2016-04-01", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-celgene-corp-2016-04-01", "https://www.nasdaq.com/articles/community-banks-can-be-teddy-bears-shield-against-market-2016-04-01", "https://www.nasdaq.com/articles/why-fitbit-inc-fit-medivation-inc-mdvn-and-tesla-motors-inc-tsla-are-3-of-todays-best", "https://www.nasdaq.com/articles/health-care-sector-update-03312016-mdvnazngildamgnsnygnvalife-2016-03-31", "https://www.nasdaq.com/articles/could-be-next-big-pharma-buyout-2016-04-03", "https://www.nasdaq.com/articles/opko-health-inc-fda-denial-wont-kill-opk-2016-03-30", "https://www.nasdaq.com/articles/3-biotech-stocks-you-dont-have-babysit-2016-03-29", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-spy-jnj-unh-amgn-2016-03-28", "https://www.nasdaq.com/articles/last-weeks-best-healthcare-etf-2016-03-28", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-amgen-regeneron-ionis-and-biogen-2016-03-28", "https://www.nasdaq.com/articles/4-surging-stocks-brokers-love-healthcare-sector-2016-03-28", "https://www.nasdaq.com/articles/9-things-you-need-know-about-biosimilar-drugs-2016-03-28", "https://www.nasdaq.com/articles/3-biotech-stocks-that-make-the-grade-for-investors-2016-03-30", "https://www.nasdaq.com/articles/gilead-biogens-patent-woes-amgen-scores-win-patent-litigation-2016-03-24", "https://www.nasdaq.com/articles/jj-roche-tie-up-to-study-dual-immunotherapy-combination-2016-03-23", "https://www.nasdaq.com/articles/stock-market-news-for-march-22-2012-2016-03-22", "https://www.nasdaq.com/articles/gilead-and-4-other-buy-stocks-biotech-industry-2016-03-22", "https://www.nasdaq.com/articles/biogen-inc-vs-amgen-which-big-biotech-smarter-buy-today-2016-03-21", "https://www.nasdaq.com/articles/forget-cvs-health-corp-here-are-2-better-dividend-stocks-2016-03-21", "https://www.nasdaq.com/articles/ucb-and-amgen-report-positive-data-on-osteoporosis-drug-2016-03-21", "https://www.nasdaq.com/articles/regeneron-sanofi-report-positive-phase-iii-data-on-praluent-2016-03-24", "https://www.nasdaq.com/articles/amgen-inc-amgn-stock-looking-break-out-2016-03-18", "https://www.nasdaq.com/articles/kite-collaborates-with-roche-for-immunotherapy-cocktail-2016-03-18", "https://www.nasdaq.com/articles/how-risky-opko-health-inc-stock-2016-03-18", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-valeant-pfizer-amgen-and-biogen-2016-03-17", "https://www.nasdaq.com/articles/amgen-wins-pcsk9-lawsuit-sanofi-and-regeneron-to-appeal-2016-03-17", "https://www.nasdaq.com/articles/why-investors-should-sell-these-biotech-stocks-buy-gilead-instead-2016-03-15", "https://www.nasdaq.com/articles/biotech-investing-guide-3-stocks-buy-and-3-avoid-2016-03-11", "https://www.nasdaq.com/articles/big-biotech-etf-faces-key-technical-test-2016-03-18", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-biogen-2016-03-10", "https://www.nasdaq.com/articles/abbvies-boehringer-deal-boost-immunology-pipeline-2016-03-08", "https://www.nasdaq.com/articles/whats-in-store-for-trovagene-trov-in-q4-earnings-2016-03-07", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-valeant-pharmaceuticals-international-gilead-sciences", "https://www.nasdaq.com/articles/eli-lillys-ixekizumab-positive-in-plaque-psoriasis-studies-2016-03-07", "https://www.nasdaq.com/articles/what-does-trumps-healthcare-plan-mean-investors-2016-03-04", "https://www.nasdaq.com/articles/3-reasons-novartis-stock-could-rise-2016-03-04", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-march-14-2016-2016-03-11", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-amgen-baxalta-ptc-therapeutics-and-cara", "https://www.nasdaq.com/articles/amgen-seeks-fda-approval-for-blincytos-label-expansion-2016-03-02", "https://www.nasdaq.com/articles/biotech-stock-roundup-gilead-hiv-drug-approved-baxalta-immuno-oncology-deal-2016-03-02", "https://www.nasdaq.com/articles/kite-pharma-q4-loss-wider-focus-remains-kte-c19-2016-03-01", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-march-02-2016-2016-03-01", "https://www.nasdaq.com/articles/did-amgens-experimental-osteoporosis-drug-just-whiff-plate-2016-02-29", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-catalyst-pharma-ptc-therapeutics-radius-health-amgen", "https://www.nasdaq.com/articles/daily-dividend-report-gd-avgo-amgn-pxd-hes-hrb-2016-03-03", "https://www.nasdaq.com/articles/biotech-stock-roundup-ptct-plunges-rtf-fda-radius-shoots-amgen-data-2016-02-25", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-cvr-refining-essex-property-trust-avalonbay", "https://www.nasdaq.com/articles/5-must-see-comments-amgens-top-executives-2016-02-23", "https://www.nasdaq.com/articles/amgen-ucbs-romosozumab-positive-late-stage-study-2016-02-23", "https://www.nasdaq.com/articles/health-care-sector-update-02222016-unisamgntrvncmrx-2016-02-22", "https://www.nasdaq.com/articles/midday-update-oil-lifts-dow-seven-week-high-energy-stocks-lead-broad-based-rally-markets", "https://www.nasdaq.com/articles/why-radius-health-inc-screaming-higher-today-2016-02-22", "https://www.nasdaq.com/articles/kite-kite-report-4q-earnings-whats-store-2016-02-26", "https://www.nasdaq.com/articles/astrazeneca-zurampic-gets-eu-nod-brilique-label-expanded-2016-02-22", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-amgen-inc-2016-02-21", "https://www.nasdaq.com/articles/iwv-orcl-amgn-cvs-large-outflows-detected-etf-2016-02-19", "https://www.nasdaq.com/articles/can-biotech-stocks-bounce-back-2016-02-19", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-february-18th-2016-02-18", "https://www.nasdaq.com/articles/astrazeneca-cancer-drug-gets-breakthrough-therapy-status-2016-02-18", "https://www.nasdaq.com/articles/health-care-sector-update-02162016-amgn-cphr-2016-02-16", "https://www.nasdaq.com/articles/5-beaten-down-stocks-strong-dividend-yields-2016-02-22", "https://www.nasdaq.com/articles/amgens-aranesp-meets-primary-endpoint-in-phase-iii-study-2016-02-16", "https://www.nasdaq.com/articles/gilead-sciences-wants-make-being-shareholder-worth-it-2016-02-13", "https://www.nasdaq.com/articles/novartis-filing-for-neulasta-biosimilar-accepted-in-the-eu-2016-02-12", "https://www.nasdaq.com/articles/fda-panel-decision-just-changed-game-2016-02-11", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-february-11-2016-2016-02-10", "https://www.nasdaq.com/articles/pfizers-biosimilar-of-remicade-recommended-for-approval-2016-02-10", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-february-10-2016-2016-02-09", "https://www.nasdaq.com/articles/novartis-acquires-rights-to-biosimilar-of-remicade-from-pfizer-2016-02-16", "https://www.nasdaq.com/articles/ligand-pharmaceuticals-lgnd%3A-q4-earnings-preview-2016-02-08", "https://www.nasdaq.com/articles/biogen-inc-takes-aim-johnson-johnson-2016-02-07", "https://www.nasdaq.com/articles/amgens-blincyto-and-repatha-positive-in-phase-iii-studies-2016-02-05", "https://www.nasdaq.com/articles/will-2016-be-amgen-incs-best-year-yet-2016-02-03", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-iusg-amgn-unp-rai-2016-02-02", "https://www.nasdaq.com/articles/why-nantkwest-shares-fell-41-january-2016-02-02", "https://www.nasdaq.com/articles/company-news-for-february-01-2016-2016-02-01", "https://www.nasdaq.com/articles/biotech-etfs-slide-as-stocks-report-mixed-q4-results-2016-02-09", "https://www.nasdaq.com/articles/biotech-billionaire-launches-his-most-auspicious-project-yet-2016-01-31", "https://www.nasdaq.com/articles/where-invest-money-2016-7-great-ideas-2016-01-30", "https://www.nasdaq.com/articles/abbvie-there-aint-no-stinkin-biosimilar-threat-2016-01-30", "https://www.nasdaq.com/articles/amgens-q4-crushed-estimates-and-answered-3-important-questions-process-2016-01-29", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amazon.com-microsoft-visa-skyworks-solutions-and-amgen", "https://www.nasdaq.com/articles/amgen-tops-q4-earnings-revenues-ups-2016-outlook-2016-01-29", "https://www.nasdaq.com/articles/biotech-etf-ibb-hits-new-52-week-low-2016-01-29", "https://www.nasdaq.com/articles/3-biotech-stocks-you-dont-have-babysit-2016-02-01", "https://www.nasdaq.com/articles/q4-pedal-metal-amzn-msft-v-more-2016-01-28", "https://www.nasdaq.com/articles/amgen-amgn-beats-q4-earnings-revenue-estimates-2016-01-28", "https://www.nasdaq.com/articles/celgene-corporation-looks-forward-2016-01-28", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-700-follow-through-indicator-32-sensitive-2016-01-28", "https://www.nasdaq.com/articles/after-hours-earnings-report-january-28-2016-msft-amzn-v-amgn-ea-swks-wdc-klac-emn-cpt-flex", "https://www.nasdaq.com/articles/3-key-numbers-monitor-when-amgen-reports-fourth-quarter-results-2016-01-27", "https://www.nasdaq.com/articles/amgens-biosimilar-of-abbvies-humira-under-fda-review-2016-01-27", "https://www.nasdaq.com/articles/top-biotechs-2016-2016-01-28", "https://www.nasdaq.com/articles/q4-pedal-metal-amzn-msft-v-more-2016-01-28", "https://www.nasdaq.com/articles/amgen-amgn-beats-q4-earnings-revenue-estimates-2016-01-28", "https://www.nasdaq.com/articles/3-reasons-be-bearish-cvs-health-2016-01-25", "https://www.nasdaq.com/articles/amgen-presents-encouraging-phase-iii-data-on-vectibix-2016-01-25", "https://www.nasdaq.com/articles/novartis-nvs-to-report-q4-earnings%3A-will-it-disappoint-2016-01-25", "https://www.nasdaq.com/articles/last-weeks-best-healthcare-etf-2016-01-23", "https://www.nasdaq.com/articles/amgen-kyprolis-label-expanded-repatha-approved-in-japan-2016-01-22", "https://www.nasdaq.com/articles/3-healthcare-stocks-you-dont-have-babysit-2016-01-27", "https://www.nasdaq.com/articles/weekly-play-sell-calls-sector-ibb-2016-01-20", "https://www.nasdaq.com/articles/biotech-stock-roundup-sarepta-plunges-briefing-documents-acorda-buy-biotie-2016-01-20", "https://www.nasdaq.com/articles/3-slides-perfectly-sum-where-abbvie-headed-next-2016-01-19", "https://www.nasdaq.com/articles/biogens-biib-biosimilar-of-amgens-enbrel-gets-eu-nod-2016-01-18", "https://www.nasdaq.com/articles/best-healthcare-etf-week-2016-01-17", "https://www.nasdaq.com/articles/abbvies-management-just-made-some-pretty-bold-predictions-2016-01-16", "https://www.nasdaq.com/articles/7-battered-biotech-stocks-bargains-or-busts-2016-01-14", "https://www.nasdaq.com/articles/5-burning-questions-we-want-answered-when-johnson-johnson-reports-its-q4-results-2016-01", "https://www.nasdaq.com/articles/5-slides-tell-you-everything-you-need-know-about-amgen-2016-01-13", "https://www.nasdaq.com/articles/3-stocks-better-dividends-cvs-health-corporation-2016-01-13", "https://www.nasdaq.com/articles/coherus-biosciences-and-baxalta-take-aim-amgen-and-pfizer-2016-01-12", "https://www.nasdaq.com/articles/4-great-retirement-stocks-buy-2016-2016-01-11", "https://www.nasdaq.com/articles/agree-buy-amgen-95-earn-57-using-options-2016-01-08", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-abbvie-amgen-ligand-pharmaceuticals-revance", "https://www.nasdaq.com/articles/stocks-mutual-funds-rose-q4-despite-dec-woes-2016-01-08", "https://www.nasdaq.com/articles/was-celgene-corporations-bad-news-really-bad-2016-01-14", "https://www.nasdaq.com/articles/iusg-amgn-unh-celg-large-outflows-detected-etf-2016-01-07", "https://www.nasdaq.com/articles/biotech-stock-roundup-mannkind-tanks-deal-termination-speedy-review-gilead-drug-2016-01-06", "https://www.nasdaq.com/articles/doctorx-positions-2016-my-no-1-risk-factor-flood-money-biotech-2016-01-06", "https://www.nasdaq.com/articles/why-amgen-top-25-dividend-giant-amgn-2016-01-05", "https://www.nasdaq.com/articles/midday-update-stocks-unravel-global-growth-concerns-mid-east-tensions-soft-u-s-data-also", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-tesla-motors-delivers-17400-vehicles-fourth", "https://www.nasdaq.com/articles/stock-futures-fall-chinese-manufacturing-slows-mid-east-tensions-escalate-2016-01-04", "https://www.nasdaq.com/articles/5-biotech-stocks-doubled-2015-2016-01-07", "https://www.nasdaq.com/articles/health-care-sector-update-01042016-rwlkunismymx-2016-01-04", "https://www.nasdaq.com/articles/what-does-2016-hold-biotech-stocks-2016-01-03", "https://www.nasdaq.com/articles/alan-fournier-sells-gm-buys-molson-coors-brewing-2016-01-03", "https://www.nasdaq.com/articles/biggest-healthcare-headlines-2015-2016-01-03", "https://www.nasdaq.com/articles/will-2016-be-johnson-johnsons-best-year-yet-2016-01-01", "https://www.nasdaq.com/articles/will-amgen-inc-raise-its-dividend-2016-2015-12-31", "https://www.nasdaq.com/articles/amgn-named-top-socially-responsible-dividend-stock-2015-12-30", "https://www.nasdaq.com/articles/health-care-sector-update-01042016-amagunismymx-2016-01-04", "https://www.nasdaq.com/articles/tuesdays-etf-movers-vpl-econ-2015-12-29", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-iwb-amgn-ma-abbv-2015-12-29", "https://www.nasdaq.com/articles/celgene-corporations-best-drug-2015-2015-12-29", "https://www.nasdaq.com/articles/enzon-pharmaceuticals-inc-enzn-ex-dividend-date-scheduled-december-30-2015-2015-12-29", "https://www.nasdaq.com/articles/what-happened-biotech-2015-2015-12-28", "https://www.nasdaq.com/articles/worst-regeneron-pharmaceuticals-inc-headlines-2015-2015-12-26", "https://www.nasdaq.com/articles/biotech-industry-could-offer-early-profit-2016-2015-12-24", "https://www.nasdaq.com/articles/ligand-lgnd-upgraded-to-buy-perfect-for-your-portfolio-2015-12-30", "https://www.nasdaq.com/articles/biotech-stock-roundup-kalobios-removes-ceo-shkreli-actelion-pah-drug-approved-2015-12-23", "https://www.nasdaq.com/articles/pfizer-incs-biggest-disappointment-2015-2015-12-22", "https://www.nasdaq.com/articles/baxalta-momentas-humira-biosimilar-meets-trial-objective-2015-12-22", "https://www.nasdaq.com/articles/9-great-dividend-paying-stocks-2016-2015-12-21", "https://www.nasdaq.com/articles/why-aegerion-pharmaceuticals-stock-bolted-higher-today-2015-12-21", "https://www.nasdaq.com/articles/5-cant-miss-drug-approvals-2015-2015-12-20", "https://www.nasdaq.com/articles/stock-market-news-for-december-17-2015-2015-12-17", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-actelion-amgen-gilead-abbvie-and-biomarin-2015-12-24", "https://www.nasdaq.com/articles/best-amgen-inc-headlines-2015-2015-12-17", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-ariad-clovis-oncology-regeneron-and-akebia", "https://www.nasdaq.com/articles/4-top-dividend-plays-help-cure-stock-price-blues-2015-12-17", "https://www.nasdaq.com/articles/big-biotech-amgen-facing-pivotal-year-2016-2015-12-17", "https://www.nasdaq.com/articles/instant-analysis-amgen-cranks-dividend-27-higher-2015-12-17", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-hikes-first-quarter-dividend-ariad-lowers-iclusig-outlook-2015", "https://www.nasdaq.com/articles/amgen-returns-more-to-shareholders-hikes-dividend-by-27-2015-12-16", "https://www.nasdaq.com/articles/company-news-for-december-17-2015-2015-12-17", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-above-200-dma-2015-12-15", "https://www.nasdaq.com/articles/did-cvs-health-just-make-huge-mistake-2015-12-15", "https://www.nasdaq.com/articles/amgen-regains-rights-to-prolia-xgeva-vectibix-from-glaxo-2015-12-15", "https://www.nasdaq.com/articles/best-johnson-johnson-headlines-2015-2015-12-14", "https://www.nasdaq.com/articles/why-akebia-therapeutics-shares-soared-10-today-2015-12-14", "https://www.nasdaq.com/articles/top-fda-drug-approvals-2015-high-cholesterol-2015-12-12", "https://www.nasdaq.com/articles/ibb-amgn-regn-biib-large-outflows-detected-etf-2015-12-11", "https://www.nasdaq.com/articles/daily-dividend-report-amgn-cvs-ben-mco-usb-gis-sre-o-2015-12-16", "https://www.nasdaq.com/articles/merck-and-eli-lilly-expand-immuno-oncology-collaboration-2015-12-11", "https://www.nasdaq.com/articles/3-attractive-income-stocks-whose-dividends-could-double-2015-12-10", "https://www.nasdaq.com/articles/aegerion-pharmaceuticals-lost-third-its-value-november-time-buy-2015-12-09", "https://www.nasdaq.com/articles/novartis-biosimilar-for-pfizers-enbrel-accepted-in-the-eu-2015-12-09", "https://www.nasdaq.com/articles/health-care-sector-update-12092015-chrsamgnaezsaezto-2015-12-09", "https://www.nasdaq.com/articles/top-3-drug-approvals-2015-2015-12-08", "https://www.nasdaq.com/articles/amgen-seeks-kyprolis-label-expansion-inks-deals-with-merck-2015-12-07", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-december-14-2015-2015-12-11", "https://www.nasdaq.com/articles/health-care-sector-update-12042015-ptla-gale-amgn-2015-12-04", "https://www.nasdaq.com/articles/powershares-dynamic-pharmaceuticals-portfolio-experiences-big-inflow-2015-12-03", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-repros-therapeutics-abbvie-amgen-xoma-and-gilead-2015", "https://www.nasdaq.com/articles/foamix-pharmaceuticals-ltd-hopes-profit-eli-lillys-and-amgens-side-effect-2015-12-03", "https://www.nasdaq.com/articles/stock-market-news-for-december-02-2015-2015-12-02", "https://www.nasdaq.com/articles/biotech-stock-roundup-repros-tanks-crl-abbvie-multiple-myeloma-drug-approved-2015-12-02", "https://www.nasdaq.com/articles/stock-market-news-for-december-04-2015-2015-12-04", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-december-02-2015-2015-12-01", "https://www.nasdaq.com/articles/amgen-inc-takes-aim-abbvie-inc-2015-11-28", "https://www.nasdaq.com/articles/what-healthcare-dividend-stock-best-2015-11-28", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biomarin-amgen-vertex-gilead-biogen-and-repros-2015-11", "https://www.nasdaq.com/articles/amgen-seeks-fda-approval-for-first-biosimilar-of-humira-2015-11-27", "https://www.nasdaq.com/articles/biotech-stock-roundup-kalobios-soars-shkreli-steps-fda-panel-not-convinced-about-biomarin", "https://www.nasdaq.com/articles/johnson-johnsons-latest-fda-approval-could-spell-problems-amgen-2015-11-25", "https://www.nasdaq.com/articles/cvs-health-plays-favorites-new-cholesterol-drugs-2015-12-01", "https://www.nasdaq.com/articles/amgens-repatha-gets-preferred-position-cvs-formularies-2015-11-24", "https://www.nasdaq.com/articles/iyh-amgn-celg-lly-etf-outflow-alert-2015-11-23", "https://www.nasdaq.com/articles/relevance-portfolio-holdings-3-concentrated-funds-buy-sell-2015-11-23", "https://www.nasdaq.com/articles/5-things-amgen-inc-wants-you-know-2015-11-21", "https://www.nasdaq.com/articles/best-healthcare-etf-week-2015-11-20", "https://www.nasdaq.com/articles/better-dividend-stock-amgen-or-astrazeneca-plc-2015-11-20", "https://www.nasdaq.com/articles/amgens-multiple-myeloma-drug-kyprolis-gains-eu-approval-2015-11-20", "https://www.nasdaq.com/articles/healthcares-greatest-dividend-stocks-2015-11-24", "https://www.nasdaq.com/articles/novartis%3A-fda-accepts-bla-for-biosimilar-version-of-neulasta-2015-11-19", "https://www.nasdaq.com/articles/3-biotech-stocks-you-dont-have-babysit-2015-11-17", "https://www.nasdaq.com/articles/amgn-crosses-above-key-moving-average-level-2015-11-17", "https://www.nasdaq.com/articles/primecap-sells-stake-technology-company-2015-11-16", "https://www.nasdaq.com/articles/these-2-companies-could-revolutionize-heart-disease-prevention-2015-11-14", "https://www.nasdaq.com/articles/bounty-data-pushes-amgen-higher-14-october-2015-11-13", "https://www.nasdaq.com/articles/ibb-regn-amgn-celg-etf-outflow-alert-2015-11-13", "https://www.nasdaq.com/articles/amgens-repatha-too-bloody-pricey-uk-2015-11-19", "https://www.nasdaq.com/articles/4-observations-you-may-have-overlooked-celgenes-q3-earnings-report-2015-11-12", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-november-12-2015-2015-11-11", "https://www.nasdaq.com/articles/5-biotech-stocks-good-growth-prospects-2015-11-10", "https://www.nasdaq.com/articles/why-aegerion-pharmaceuticals-crashing-today-2015-11-10", "https://www.nasdaq.com/articles/kite-kite-report-3q-earnings-whats-store-2015-11-10", "https://www.nasdaq.com/articles/7-cash-rich-stocks-buy-now-2015-11-09", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-november-10-2015-2015-11-09", "https://www.nasdaq.com/articles/kite-pharma-kite-posts-narrower-expected-loss-3q-2015-11-13", "https://www.nasdaq.com/articles/what-does-2016-hold-closely-watched-biotech-etf-2015-11-09", "https://www.nasdaq.com/articles/insulet-delivers-healthy-q3-revenue-growth-stock-pumps-14-2015-11-07", "https://www.nasdaq.com/articles/biotech-sees-better-than-expected-earnings%3A-etfs-in-focus-2015-11-06", "https://www.nasdaq.com/articles/gilead-and-2-biotech-picks-value-investors-will-love-2015-11-06", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-2-yield-mark-2015-11-06", "https://www.nasdaq.com/articles/ibb-celg-regn-amgn-large-inflows-detected-etf-2015-11-05", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-abbvie-amgen-dyax-repros-and-gilead-2015-11-05", "https://www.nasdaq.com/articles/health-care-sector-update-11092015-kpti-amgn-2015-11-09", "https://www.nasdaq.com/articles/what-awaits-ligand-pharmaceuticals-lgnd-in-q3-earnings-2015-11-05", "https://www.nasdaq.com/articles/celgene-corporation-mixed-bag-earnings-2015-11-05", "https://www.nasdaq.com/articles/biotech-stock-roundup-abbvies-humira-remains-strong-shire-buy-dyax-2015-11-04", "https://www.nasdaq.com/articles/what-expect-celgene-corporations-earnings-report-2015-11-03", "https://www.nasdaq.com/articles/4-questions-ask-ahead-celgenes-q3-report-2015-11-02", "https://www.nasdaq.com/articles/10-stocks-with-10-plus-gains-in-october-2015-11-02", "https://www.nasdaq.com/articles/amgen-clobbers-estimates-q3-thanks-new-drug-growth-1-portfolio-segment-clearly-disappoint", "https://www.nasdaq.com/articles/focus-on-health-care-savings%3A-5-generic-drug-stocks-to-buy-2015-11-05", "https://www.nasdaq.com/articles/amgen-ups-2015-outlook-q3-earnings-revenue-beat-2015-10-29", "https://www.nasdaq.com/articles/united-therapeutics-beats-q3-earnings-revenues-2015-10-28", "https://www.nasdaq.com/articles/agenus-q3-loss-wider-than-expected-pipeline-in-focus-2015-10-28", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-tops-estimates-fda-approves-alexions-strensiq-2015-10-28", "https://www.nasdaq.com/articles/amgen-amgn-stock-climbing-q3-earnings-and-revenue-beat-2015-10-28", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-800-follow-through-indicator-31-sensitive-2015-10-28", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-28-2015-amgn-psa-su-vrtx-wmb-orly-nxpi-mar-wpz-eqix", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-ibb-amgn-celg-regn-2015-10-29", "https://www.nasdaq.com/articles/midday-update-stocks-slump-economic-data-disappoints-oil-drops-fomc-looms-2015-10-27", "https://www.nasdaq.com/articles/bristol-myers-beats-on-q3-earnings-guidance-encouraging-2015-10-27", "https://www.nasdaq.com/articles/aegerion-aegr-q3-earnings-preview%3A-whats-in-the-cards-2015-10-27", "https://www.nasdaq.com/articles/spectrum-sppi-initiates-phase-iii-on-apaziquone-under-spa-2015-10-27", "https://www.nasdaq.com/articles/biodelivery-endo-up-on-fda-approval-of-pain-drug-belbuca-2015-10-27", "https://www.nasdaq.com/articles/amgen-breaks-above-200-day-moving-average-bullish-amgn-2015-10-26", "https://www.nasdaq.com/articles/5-things-amgen-investors-want-know-when-it-reports-its-q3-results-2015-10-26", "https://www.nasdaq.com/articles/novartis-nvs-misses-on-q3-earnings-maintains-2015-view-2015-10-28", "https://www.nasdaq.com/articles/midday-update-stocks-slump-economic-data-disappoints-oil-drops-fomc-looms-2015-10-27", "https://www.nasdaq.com/articles/you-mad-bro-these-giant-companies-might-pay-lower-tax-rates-you-2015-10-24", "https://www.nasdaq.com/articles/acorda-up-on-q3-earnings-revenue-beat-ampyra-in-focus-2015-10-23", "https://www.nasdaq.com/articles/spectrum-pharmaceuticals-evomela-gets-crl-in-the-u.s.-2015-10-23", "https://www.nasdaq.com/articles/foamix-starts-patient-enrollment-in-phase-ii-study-on-fmx103-2015-10-23", "https://www.nasdaq.com/articles/battle-royale-amgen-inc-vs-biogen-inc-2015-10-23", "https://www.nasdaq.com/articles/exelixis-starts-cometriq-rolling-nda-filing-for-kidney-cancer-2015-10-23", "https://www.nasdaq.com/articles/will-express-scripts-esrx-surprise-q3-earnings-estimates-2015-10-26", "https://www.nasdaq.com/articles/relypsas-hyperkalemia-drug-veltassa-approved-in-the-u.s.-2015-10-23", "https://www.nasdaq.com/articles/stock-market-news-for-october-22-2015-2015-10-22", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-altria-nike-apple-amgen-and-home-depot-2015-10-22", "https://www.nasdaq.com/articles/biogen-tops-q3-earnings-announces-job-cuts-ups-view-2015-10-21", "https://www.nasdaq.com/articles/ivv-pfe-unh-amgn-large-inflows-detected-etf-2015-10-21", "https://www.nasdaq.com/articles/stock-market-news-for-october-21-2015-2015-10-21", "https://www.nasdaq.com/articles/illumina-tops-q3-earnings-meets-revenues-15-view-cut-2015-10-21", "https://www.nasdaq.com/articles/ebays-ebay-1st-earnings-without-paypal%3A-whats-in-store-revised-2015-10-23", "https://www.nasdaq.com/articles/kite-kite-kte-c19-endorsed-for-eu-orphan-status-yet-again-2015-10-21", "https://www.nasdaq.com/articles/stock-market-news-for-october-20-2015-2015-10-20", "https://www.nasdaq.com/articles/texas-instruments-txn-q3-earnings%3A-what-to-expect-2015-10-19", "https://www.nasdaq.com/articles/eli-lillys-failure-success-these-companies-2015-10-19", "https://www.nasdaq.com/articles/will-tecfidera-slowdown-hit-biogen-biib-earnings-q3-2015-10-19", "https://www.nasdaq.com/articles/lilly-lly-poised-beat-earnings-expectations-q3-2015-10-19", "https://www.nasdaq.com/articles/zafgen-continues-to-fall-partial-clinical-hold-on-beloranib-2015-10-19", "https://www.nasdaq.com/articles/go-back-future-these-5-market-crushing-stocks-2015-10-21", "https://www.nasdaq.com/articles/will-currency-hit-abbott-laboratories-abt-in-q3-earnings-2015-10-19", "https://www.nasdaq.com/articles/will-hubbell-hub-b-disappoint-earnings-estimates-in-q3-2015-10-19", "https://www.nasdaq.com/articles/5-best-bargains-stock-market-2015-10-18", "https://www.nasdaq.com/articles/3-blue-chip-biotech-stocks-worth-buying-long-haul-2015-10-17", "https://www.nasdaq.com/articles/cms-hikes-medicare-rate-for-genomics-breast-cancer-test-revised-2015-10-16", "https://www.nasdaq.com/articles/cellectis-s.a.-clls-jumps%3A-stock-adds-7.6-in-session-2015-10-16", "https://www.nasdaq.com/articles/fda-turns-pfizer-away-few-are-surprised-2015-10-16", "https://www.nasdaq.com/articles/whats-in-store-for-morningstar-morn-in-q3-earnings-2015-10-19", "https://www.nasdaq.com/articles/medicare-initiates-coverage-on-genomic-prostate-cancer-test-2015-10-16", "https://www.nasdaq.com/articles/5-immunotherapy-stocks-watch-treating-cancer-2015-10-16", "https://www.nasdaq.com/articles/what-to-expect-from-lam-researchs-lrcx-q1-earnings-2015-10-16", "https://www.nasdaq.com/articles/ebays-ebay-1st-earnings-without-paypal%3A-whats-in-store-2015-10-16", "https://www.nasdaq.com/articles/will-nielsens-nlsn-earnings-disappoint-estimates-in-q3-2015-10-16-0", "https://www.nasdaq.com/articles/daily-dividend-report-amgn-wba-utx-cat-aon-wy-cf-2015-10-15", "https://www.nasdaq.com/articles/breaking-down-biotechs-bloodbath-which-companies-buy-2015-10-15", "https://www.nasdaq.com/articles/will-nielsens-nlsn-earnings-disappoint-estimates-in-q3-2015-10-16", "https://www.nasdaq.com/articles/zafgen-reports-patient-death-in-late-stage-beloranib-study-2015-10-15", "https://www.nasdaq.com/articles/stock-market-news-for-october-14-2015-2015-10-14", "https://www.nasdaq.com/articles/vital-therapies-vtl-looks-good%3A-stock-jumps-12.2-2015-10-14", "https://www.nasdaq.com/articles/5-stocks-searching-cancer-cure-right-now-2015-10-14", "https://www.nasdaq.com/articles/theravance-tbph-advances-td-0714-submits-ind-to-fda-2015-10-14", "https://www.nasdaq.com/articles/iyh-pfe-unh-amgn-etf-inflow-alert-2015-10-13", "https://www.nasdaq.com/articles/hooker-furniture-yum-brands-amgen-and-astra-zeneca-highlighted-as-zacks-bull-and-bear-of", "https://www.nasdaq.com/articles/biodeliverys-bunavail-supply-hit-by-specification-issues-2015-10-15", "https://www.nasdaq.com/articles/alimera-sciences-alim-in-focus%3A-stock-rises-12.3-2015-10-13", "https://www.nasdaq.com/articles/lilly-lly-halts-cetp-inhibitor-development-shares-tumble-2015-10-13", "https://www.nasdaq.com/articles/celgene-celg-posts-encouraging-one-year-data-on-otezla-2015-10-13", "https://www.nasdaq.com/articles/alexion-alxn-presents-positive-5-year-data-on-strensiq-2015-10-13", "https://www.nasdaq.com/articles/cms-hikes-medicare-rate-for-genomics-breast-cancer-test-2015-10-13", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-october-12th-2015-10-12", "https://www.nasdaq.com/articles/will-currency-play-spoilsport-jjs-jnj-q3-earnings-2015-10-12", "https://www.nasdaq.com/articles/osiris-therapeutics-inc-osir-ex-dividend-date-scheduled-october-14-2015-2015-10-13", "https://www.nasdaq.com/articles/amgen-was-clobbered-september-heres-why-2015-10-09", "https://www.nasdaq.com/articles/stock-market-news-for-october-08-2015-2015-10-08", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-regeneron-acorda-amicus-and-abbvie-2015-10-08", "https://www.nasdaq.com/articles/3-pharma-stocks-big-margins-safety-2015-10-08", "https://www.nasdaq.com/articles/cholesterol-busters-will-be-cheaper-remain-top-sellers-2015-10-07", "https://www.nasdaq.com/articles/stock-market-news-for-october-07-2015-2015-10-07", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-cvs-health-amgen-eli-lilly-abbvie-and-teva", "https://www.nasdaq.com/articles/winners-and-losers-eli-lillys-cetp-drug-failure-2015-10-12", "https://www.nasdaq.com/articles/amgen-was-clobbered-september-heres-why-2015-10-09", "https://www.nasdaq.com/articles/stock-market-news-for-october-08-2015-2015-10-08", "https://www.nasdaq.com/articles/infinity-infi-updates-on-duvelisib-and-ipi-549-on-rd-day-2015-10-07", "https://www.nasdaq.com/articles/4-pharma-stocks-gaining-high-pricing-power-2015-10-06", "https://www.nasdaq.com/articles/who-wins-and-loses-tpp-2015-10-06", "https://www.nasdaq.com/articles/mercks-mrk-all-oral-ribavirin-free-hcv-data-published-2015-10-06", "https://www.nasdaq.com/articles/amgen-turning-tables-generic-competition-2015-10-07", "https://www.nasdaq.com/articles/express-scripts-includes-praluent-and-repatha-in-formulary-2015-10-07", "https://www.nasdaq.com/articles/novartis-nvs-sandoz-files-for-enbrel-biosimilar-in-the-u.s.-2015-10-05", "https://www.nasdaq.com/articles/3-rock-solid-dividend-stocks-you-can-buy-right-now-2015-10-04", "https://www.nasdaq.com/articles/amgen-novartis-crosshair-2015-10-02", "https://www.nasdaq.com/articles/health-care-sector-update-10022015-chrsamgnxnptfold-2015-10-02", "https://www.nasdaq.com/articles/can-you-guess-which-surprising-company-trying-become-cardiovascular-drug-giant-2015-10-01", "https://www.nasdaq.com/articles/stock-market-news-for-october-01-2015-2015-10-01", "https://www.nasdaq.com/articles/baxalta-momenta-begin-pivotal-study-on-biosimilar-of-humira-2015-10-06", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-express-scripts-abbvie-amgen-anika-therapeutics-and-pdl", "https://www.nasdaq.com/articles/esperion-plunges-on-fda-advice-for-cardiovascular-study-2015-09-30", "https://www.nasdaq.com/articles/ligand-sage-captisol-partnership-to-also-include-sage-689-2015-09-30", "https://www.nasdaq.com/articles/clovis-rociletinib-under-review-in-u.s.-eu-for-lung-cancer-2015-09-30", "https://www.nasdaq.com/articles/buy-3-compelling-biotech-stocks-at-bargain-prices-2015-09-29", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-fitbit-hain-celestial-group-nautilus-and-amgen-2015-09", "https://www.nasdaq.com/articles/4-fit-healthy-stocks-to-love-on-world-heart-day-2015-09-28", "https://www.nasdaq.com/articles/pfizer-raises-2015-outlook-hospira-acquisition-shares-2015-10-01", "https://www.nasdaq.com/articles/regeneron-sanofis-pcsk9-inhibitor-praluent-approved-in-eu-2015-09-28", "https://www.nasdaq.com/articles/price-war-new-cholesterol-drugs-heating-2015-09-25", "https://www.nasdaq.com/articles/iyh-pfe-unh-amgn-large-inflows-detected-etf-2015-09-25", "https://www.nasdaq.com/articles/stock-market-news-for-september-25-2015-2015-09-25", "https://www.nasdaq.com/articles/health-care-sector-update-09252015-navb-biib-amgn-2015-09-25", "https://www.nasdaq.com/articles/amgen-becomes-oversold-2015-09-25", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-juno-amgen-gilead-intra-cellular-and-traconthe-zacks", "https://www.nasdaq.com/articles/stock-market-news-for-september-28-2015-2015-09-28", "https://www.nasdaq.com/articles/amgen-gets-step-closer-multibillion-dollar-market-2015-09-24", "https://www.nasdaq.com/articles/amgen-allergans-biosimilar-of-avastin-tops-phase-iii-study-2015-09-24", "https://www.nasdaq.com/articles/biotech-stock-roundup-clintons-tweet-shakes-biotech-stocks-amgen-pipeline-boosting-deals", "https://www.nasdaq.com/articles/amgens-billion-dollar-cholesterol-curbing-bet-2015-09-23", "https://www.nasdaq.com/articles/5-biotech-stocks-hit-hard-hillary-clintons-tweet-2015-09-22", "https://www.nasdaq.com/articles/amgens-kyprolis-label-expansion-under-priority-review-2015-09-21", "https://www.nasdaq.com/articles/3-stocks-battling-heart-disease-2-buy-1-sell-2015-09-20", "https://www.nasdaq.com/articles/will-fda-approve-all-3-these-cancer-drugs-october-2015-09-24", "https://www.nasdaq.com/articles/amgen-gets-step-closer-multibillion-dollar-market-2015-09-24", "https://www.nasdaq.com/articles/amgen-allergans-biosimilar-of-avastin-tops-phase-iii-study-2015-09-24", "https://www.nasdaq.com/articles/nasdaq-100-movers-avgo-jd-2015-09-16", "https://www.nasdaq.com/articles/which-biotech-blue-chip-stock-best-buy-2015-09-14", "https://www.nasdaq.com/articles/amgen-seeks-fda-approval-for-repathas-new-dosing-option-2015-09-14", "https://www.nasdaq.com/articles/will-kite-kite-get-orphan-status-again-eu-kte-c19-2015-09-14", "https://www.nasdaq.com/articles/these-3-numbers-say-amgen-inc-cheap-2015-09-12", "https://www.nasdaq.com/articles/yellen-doesnt-raise-rates%3A-4-biotech-stocks-to-buy-2015-09-18", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-september-14-2015-2015-09-11", "https://www.nasdaq.com/articles/better-buy-amgen-inc-or-regeneron-pharmaceuticals-inc-2015-09-11", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-tetraphase-geron-alexion-and-acadia-2015-09-10", "https://www.nasdaq.com/articles/biotech-stock-roundup-biosimilar-competition-amgen-tetraphase-hit-disappointing-data-2015", "https://www.nasdaq.com/articles/attention-biotech-investors-biosimilars-are-finally-here-2015-09-09", "https://www.nasdaq.com/articles/you-dont-have-wait-next-big-thing-biotech-its-already-here-2015-09-06", "https://www.nasdaq.com/articles/biotech-blue-chip-amgen-took-drubbing-last-month-heres-why-2015-09-05", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-pjp-mdco-amgn-agn-2015-09-11", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-september-14-2015-2015-09-11", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-xlv-gild-agn-amgn-2015-09-02", "https://www.nasdaq.com/articles/amgens-next-generation-cholesterol-drug-approved-pricing-huge-concern-2015-09-02", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-news-ariad-takeover-target-2015-09-02", "https://www.nasdaq.com/articles/amgen-novartis-team-up-bone-drug-positive-in-phase-iii-2015-09-02", "https://www.nasdaq.com/articles/regeneron-and-sanofi-present-encouraging-praluent-data-2015-09-02", "https://www.nasdaq.com/articles/pcsk9-drugs-are-here-and-way-over-there-2015-09-04", "https://www.nasdaq.com/articles/amgen-incs-fda-approval-holds-blockbuster-potential-2015-09-02", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-september-02-2015-2015-09-01", "https://www.nasdaq.com/articles/word-advice-amgen-objects-mirror-are-closer-they-appear-2015-08-31", "https://www.nasdaq.com/articles/alnylam-presents-positive-data-on-pcsk9-synthesis-inhibitor-2015-08-31", "https://www.nasdaq.com/articles/amgens-pcsk9-inhibitor-repatha-approved-us-2015-08-28", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-vital-therapies-amgen-biomarin-acorda-and-macrocure", "https://www.nasdaq.com/articles/biotech-stock-roundup-acorda-gains-patent-issues-vital-crushed-liver-data-2015-08-26", "https://www.nasdaq.com/articles/astrazeneca-strikes-deal-with-valeant-for-psoriasis-drug-2015-09-02", "https://www.nasdaq.com/articles/amgen-incs-fda-approval-holds-blockbuster-potential-2015-09-02", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-september-02-2015-2015-09-01", "https://www.nasdaq.com/articles/word-advice-amgen-objects-mirror-are-closer-they-appear-2015-08-31", "https://www.nasdaq.com/articles/biotech-stock-roundup-kite-addresses-patient-death-concerns-omeros-soars-data-2015-08-19", "https://www.nasdaq.com/articles/esperions-good-news-actually-bad-2015-08-19", "https://www.nasdaq.com/articles/kite-pharma-provides-update-death-not-related-kte-c19-2015-08-18", "https://www.nasdaq.com/articles/ishares-us-healthcare-etf-experiences-big-inflow-2015-08-17", "https://www.nasdaq.com/articles/xlv-gild-agn-amgn-large-outflows-detected-etf-2015-08-25", "https://www.nasdaq.com/articles/why-eli-lilly-lly-was-bright-spot-market-thursday-2015-08-21", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-amgn-2015-08-21", "https://www.nasdaq.com/articles/concern-amgen-investors-shouldnt-take-lightly-2015-08-20", "https://www.nasdaq.com/articles/biotech-stock-roundup-kite-addresses-patient-death-concerns-omeros-soars-data-2015-08-19", "https://www.nasdaq.com/articles/enzon-pharmaceuticals-inc-enzn-ex-dividend-date-scheduled-august-13-2015-2015-08-12", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-august-13-2015-2015-08-12", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-august-13-2015-2015-08-12", "https://www.nasdaq.com/articles/better-dividend-stock-gilead-sciences-inc-vs-amgen-inc-2015-08-17", "https://www.nasdaq.com/articles/cvs-healths-anti-tobacco-strategy-paying-2015-08-08", "https://www.nasdaq.com/articles/health-care-select-sector-spdr-fund-experiences-big-inflow-2015-08-07", "https://www.nasdaq.com/articles/will-kite-pharma-kite-miss-earnings-estimates-yet-again-analyst-blog-2015-08-07", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-vertex-regeneron-baxalta-and-vivus-press-releases", "https://www.nasdaq.com/articles/3-reasons-behind-amgens-15-gain-july-2015-08-06", "https://www.nasdaq.com/articles/aegerions-loss-narrower-than-expected-view-maintained-analyst-blog-2015-08-06", "https://www.nasdaq.com/articles/biotech-stock-roundup-baxalta-rejects-shire-bid-amgens-beat-raise-quarter-analyst-blog", "https://www.nasdaq.com/articles/kite-pharma-2q-loss-wider-expected-pipeline-focus-analyst-blog-2015-08-11", "https://www.nasdaq.com/articles/mixed-biotech-earnings-put-these-etfs-in-focus-etf-news-and-commentary-2015-08-04", "https://www.nasdaq.com/articles/will-ligand-pharmaceuticals-lgnd-beat-earnings-in-q2-analyst-blog-2015-08-03", "https://www.nasdaq.com/articles/nasdaq-100-movers-wfm-amgn-2015-07-31", "https://www.nasdaq.com/articles/amgen-beats-q2-earnings-revenues-raises-outlook-analyst-blog-2015-07-31", "https://www.nasdaq.com/articles/amgen-crushes-wall-streets-expectations-q2-figure-bit-worrisome-2015-07-31", "https://www.nasdaq.com/articles/fbt-amgn-tech-nktr-etf-inflow-alert-2015-07-30", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biogen-abbvie-regeneron-amgen-and-xoma-press-releases", "https://www.nasdaq.com/articles/what-company-will-be-fastest-growing-big-cap-biotech-2015-08-05", "https://www.nasdaq.com/articles/even-recent-declines-investors-still-love-biotech-etfs-2015-07-30", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-30-2015-amgn-brcm-lnkd-ea-eix-ess-hbi-uhs-expe-wu-mtd-dlr", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-700-follow-through-indicator-29-sensitive-2015-07-30", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-down-tecfidera-issues-regenerons-praluent-gets-fda-nod", "https://www.nasdaq.com/articles/merck-tops-q2-earnings-revenues-revises-outlook-analyst-blog-2015-07-28", "https://www.nasdaq.com/articles/nasdaq-100-movers-bidu-amgn-2015-07-28", "https://www.nasdaq.com/articles/will-amgen-amgn-keep-earnings-streak-alive-2q-analyst-blog-2015-07-28", "https://www.nasdaq.com/articles/key-takeaways-amgens-amgn-q2-earnings-report-stocks-news-2015-07-30", "https://www.nasdaq.com/articles/even-recent-declines-investors-still-love-biotech-etfs-2015-07-30", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-30-2015-amgn-brcm-lnkd-ea-eix-ess-hbi-uhs-expe-wu-mtd-dlr", "https://www.nasdaq.com/articles/regeneron-pharmaceuticals-and-sanofi-grab-blockbuster-fda-approval-2015-07-27", "https://www.nasdaq.com/articles/big-day-biotech-and-its-not-going-so-well-2015-07-27", "https://www.nasdaq.com/articles/shires-shpg-q2-earnings-lag-estimates-2015-view-raised-analyst-blog-2015-07-24", "https://www.nasdaq.com/articles/amgn-dividend-yield-pushes-past-2-2015-07-24", "https://www.nasdaq.com/articles/forget-biogen-buy-these-promising-biotech-stocks-instead-analyst-blog-2015-07-27", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-pcsk9-inhibitor-first-gain-approval-exelixis-positive-data", "https://www.nasdaq.com/articles/2015s-top-6-big-pharma-headlines-thus-far-2015-07-22", "https://www.nasdaq.com/articles/amgens-repatha-gains-eu-nod-first-pcsk9-drug-approved-analyst-blog-2015-07-22", "https://www.nasdaq.com/articles/amgen-inc-grabs-potential-blockbuster-approval-2015-07-22", "https://www.nasdaq.com/articles/qld-alxn-aal-amgn-etf-outflow-alert-2015-07-21", "https://www.nasdaq.com/articles/amgen-popular-amongst-latest-13f-filers-2015-07-21", "https://www.nasdaq.com/articles/will-abbott-laboratories-abt-miss-earnings-this-season-analyst-blog-2015-07-20", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-exelixis-regeneron-five-prime-therapeutics-and", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-pcsk9-inhibitor-first-gain-approval-exelixis-positive-data", "https://www.nasdaq.com/articles/8-biotech-stocks-buy-2015-07-16", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-cat-csx-amgn-2015-07-15", "https://www.nasdaq.com/articles/amgen-breaks-above-200-day-moving-average-bullish-amgn-2015-07-14", "https://www.nasdaq.com/articles/stock-market-news-for-july-14-2015-market-news-2015-07-14", "https://www.nasdaq.com/articles/ishares-russell-1000-etf-experiences-big-inflow-2015-07-13", "https://www.nasdaq.com/articles/15-trillion-reasons-invest-these-companies-2015-07-12", "https://www.nasdaq.com/articles/amgen-reports-positive-data-on-leukemia-drug-blincyto-analyst-blog-2015-07-17", "https://www.nasdaq.com/articles/health-care-sector-update-07092015-myl-regn-azn-2015-07-09", "https://www.nasdaq.com/articles/amgens-single-most-important-fda-decision-2015-nearly-here-2015-07-09", "https://www.nasdaq.com/articles/allergan-buys-rights-to-mercks-migraine-drugs-for-%24250m-analyst-blog-2015-07-08", "https://www.nasdaq.com/articles/are-biotechs-bubble-2015-07-07", "https://www.nasdaq.com/articles/nasdaq-100-movers-bidu-aal-2015-07-06", "https://www.nasdaq.com/articles/2-dividend-stocks-buy-market-crash-2015-07-06", "https://www.nasdaq.com/articles/ibb-celg-amgn-regn-large-inflows-detected-etf-2015-07-02", "https://www.nasdaq.com/articles/regeneron-and-sanofi-report-positive-data-on-praluent-analyst-blog-2015-07-09", "https://www.nasdaq.com/articles/stock-market-news-for-june-30-2015-market-news-2015-06-30", "https://www.nasdaq.com/articles/amgen-among-3-medical-giants-healthy-payouts-2015-06-30", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biomarin-vical-epizyme-amgen-and-medicines-co-press", "https://www.nasdaq.com/articles/biotech-stock-roundup-biomarin-jumps-dwarfism-data-vical-plunges-vaccine-data-analyst-blog", "https://www.nasdaq.com/articles/stock-market-news-for-june-23-2015-market-news-2015-06-23", "https://www.nasdaq.com/articles/kite-pharma-and-bluebird-tie-hpv-cancer-targets-analyst-blog-2015-06-23", "https://www.nasdaq.com/articles/proshares-releases-2-new-leveraged-biotech-etfs-2015-06-23", "https://www.nasdaq.com/articles/stock-market-news-for-july-01-2015-market-news-2015-07-01", "https://www.nasdaq.com/articles/stock-market-news-for-june-30-2015-market-news-2015-06-30", "https://www.nasdaq.com/articles/nasdaq-composites-new-high-built-solid-growth-2015-06-19", "https://www.nasdaq.com/articles/biotech-etfs-hit-new-2015-highs-2015-06-18", "https://www.nasdaq.com/articles/5-healthcare-stocks-dividend-lovers-2015-06-17", "https://www.nasdaq.com/articles/stock-market-news-for-june-15-2015-market-news-2015-06-15", "https://www.nasdaq.com/articles/3-big-healthcare-trends-wall-street-overlooking-2015-06-14", "https://www.nasdaq.com/articles/amgen-presents-interim-data-on-migraine-drug-amg-334-analyst-blog-2015-06-22", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-june-12-2015-2015-06-11", "https://www.nasdaq.com/articles/merck-mrk-presents-multiple-biosimilar-and-diabetes-data-analyst-blog-2015-06-11", "https://www.nasdaq.com/articles/why-drugmaker-abbvie-can-power-past-patent-expiration-2015-06-11", "https://www.nasdaq.com/articles/biotech-stock-roundup-fda-panel-recommends-regenerons-praluent-sage-gains-data-analyst", "https://www.nasdaq.com/articles/stock-market-news-for-june-10-2015-market-news-2015-06-10", "https://www.nasdaq.com/articles/regeneron-sanofis-praluent-gets-positive-fda-panel-vote-analyst-blog-2015-06-10", "https://www.nasdaq.com/articles/amgen-breaks-below-200-day-moving-average-notable-amgn-2015-06-09", "https://www.nasdaq.com/articles/3-things-abbvie-incs-management-wants-you-know-2015-06-11", "https://www.nasdaq.com/articles/regeneron-sanofis-pcsk9-drug-praluent-set-for-fda-panel-analyst-blog-2015-06-08", "https://www.nasdaq.com/articles/cholesterol-drugs-3-stocks-watch-week-2015-06-08", "https://www.nasdaq.com/articles/these-3-ultra-rare-diseases-are-utterly-terrifying-2015-06-07", "https://www.nasdaq.com/articles/biotech-stock-roundup-immunogen-soars-asco-data-amgen-collaborates-roche-analyst-blog-2015", "https://www.nasdaq.com/articles/vug-orcl-amgn-act-etf-outflow-alert-2015-06-03", "https://www.nasdaq.com/articles/mercks-keytruda-under-priority-review-lung-cancer-analyst-blog-2015-06-02", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-june-03-2015-2015-06-02", "https://www.nasdaq.com/articles/amgens-repatha-briefing-document-gives-mixed-review-analyst-blog-2015-06-09", "https://www.nasdaq.com/articles/regeneron-sanofis-pcsk9-drug-praluent-set-for-fda-panel-analyst-blog-2015-06-08", "https://www.nasdaq.com/articles/cholesterol-drugs-3-stocks-watch-week-2015-06-08", "https://www.nasdaq.com/articles/investing-beginners-how-start-biotech-2015-05-30", "https://www.nasdaq.com/articles/amgen-inc-why-you-shouldnt-count-chickens-they-hatch-2015-05-30", "https://www.nasdaq.com/articles/primecap-sells-portions-its-top-two-stakes-2015-05-27", "https://www.nasdaq.com/articles/actavis-continue-selling-namenda-ir-under-court-ruling-analyst-blog-2015-05-26", "https://www.nasdaq.com/articles/vug-orcl-amgn-act-etf-inflow-alert-2015-05-26", "https://www.nasdaq.com/articles/roche-collaborates-with-amgen-for-immuno-oncology-analyst-blog-2015-06-02", "https://www.nasdaq.com/articles/astrazeneca-amgen-end-psoriasis-drug-brodalumab-deal-analyst-blog-2015-05-25", "https://www.nasdaq.com/articles/healthcare-investment-opportunities-long-term-2015-05-23", "https://www.nasdaq.com/articles/health-care-sector-update-05222015-srpt-amgn-mrk-2015-05-22", "https://www.nasdaq.com/articles/stock-market-news-for-may-21-2015-market-news-2015-05-21", "https://www.nasdaq.com/articles/jj-jnj-file-more-10-new-products-2019-analyst-blog-2015-05-21", "https://www.nasdaq.com/articles/forget-mannkind-stocks-price-heres-what-you-need-focus-instead-2015-05-19", "https://www.nasdaq.com/articles/amgens-pcsk9-inhibitor-step-closer-eu-approval-analyst-blog-2015-05-25", "https://www.nasdaq.com/articles/kite-pharma-narrows-q1-loss-misses-estimates-gives-view-analyst-blog-2015-05-18", "https://www.nasdaq.com/articles/2-stocks-jaw-dropping-growth-potential-2015-05-17", "https://www.nasdaq.com/articles/xlv-pfe-act-amgn-etf-inflow-alert-2015-05-15", "https://www.nasdaq.com/articles/amgen-announces-positive-results-on-migraine-candidate-analyst-blog-2015-05-15", "https://www.nasdaq.com/articles/will-kite-pharma-kite-miss-earnings-estimates-yet-again-analyst-blog-2015-05-14", "https://www.nasdaq.com/articles/best-breed-dividend-stocks-2015-05-13", "https://www.nasdaq.com/articles/5-largest-markets-pharmaceuticals-2015-05-12", "https://www.nasdaq.com/articles/stock-market-news-for-may-19-2015-market-news-2015-05-19", "https://www.nasdaq.com/articles/kite-pharma-narrows-q1-loss-misses-estimates-gives-view-analyst-blog-2015-05-18", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-may-12-2015-2015-05-11", "https://www.nasdaq.com/articles/best-and-worst-etfs-week-amid-biotech-rebound-2015-05-09", "https://www.nasdaq.com/articles/regeneron-earnings-shine-all-eyes-are-pipeline-2015-05-08", "https://www.nasdaq.com/articles/will-ligand-pharmaceuticals-lgnd-miss-on-q1-earnings-analyst-blog-2015-05-07", "https://www.nasdaq.com/articles/beyond-pharma-3-healthcare-choices-analyst-blog-2015-05-05", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-may-13-2015-2015-05-12", "https://www.nasdaq.com/articles/biotechs-blue-chip-stocks-2015-05-04", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-celladon-kite-pharma-pharmacyclics-and-vertex", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-celladon-biogen-celgene-and-gilead-press-releases", "https://www.nasdaq.com/articles/express-scripts-issues-upbeat-outlook-despite-shifting-competitive-landscape-2015-04-29", "https://www.nasdaq.com/articles/3-stable-large-cap-biotech-stocks-to-buy-now-analyst-blog-2015-04-29", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-celladon-amgen-biogen-and-alnylam-pharmaceuticals-press", "https://www.nasdaq.com/articles/celldex-1q-loss-narrower-expected-pipeline-focus-analyst-blog-2015-04-29", "https://www.nasdaq.com/articles/acorda-posts-1q-loss-ampyra-generic-challenges-focus-analyst-blog-2015-05-04", "https://www.nasdaq.com/articles/biotechs-blue-chip-stocks-2015-05-04", "https://www.nasdaq.com/articles/iyh-amgn-act-mdt-etf-inflow-alert-2015-04-28", "https://www.nasdaq.com/articles/stock-market-news-for-april-28-2015-market-news-2015-04-28", "https://www.nasdaq.com/articles/pfizer-beats-q1-earnings-cuts-view-currency-woes-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/5-biotech-stocks-to-avoid-after-mondays-slump-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/internet-things-about-solve-biotechs-oldest-problem-2015-04-27", "https://www.nasdaq.com/articles/biotech-bubble-bursting-3-stocks-i-want-buy-2015-04-27", "https://www.nasdaq.com/articles/merck-mrk-beats-q1-earnings-revenues-ups-view-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/nasdaq-joins-record-high-club-2015-04-24", "https://www.nasdaq.com/articles/illuminas-earnings-set-positive-tone-biotech-2015-04-24", "https://www.nasdaq.com/articles/amgen-incs-dividend-sustainable-2015-04-23", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-medicines-athersys-and-alnylam-press-releases", "https://www.nasdaq.com/articles/amgen-inc-earnings-4-things-you-probably-overlooked-2015-04-23", "https://www.nasdaq.com/articles/actelion-aliof-beats-q1-earnings-revenue-expectations-analyst-blog-2015-04-22", "https://www.nasdaq.com/articles/amgen-beats-q1-earnings-revenues-ups-earnings-view-analyst-blog-2015-04-22", "https://www.nasdaq.com/articles/are-biosimilars-next-big-thing-biotech-2015-04-25", "https://www.nasdaq.com/articles/alnylam-reports-positive-patisiran-results-shares-up-analyst-blog-2015-04-22", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-starts-earnings-season-strong-note-setbacks-ampio-athersys", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-800-follow-through-indicator-33-sensitive-2015-04-21", "https://www.nasdaq.com/articles/everything-investors-should-know-about-amgen-q1-earnings-stocks-news-2015-04-21", "https://www.nasdaq.com/articles/after-hours-earnings-report-april-21-2015-amgn-yhoo-ace-syk-yum-ilmn-dfs-brcm-cmg-isrg-vmw", "https://www.nasdaq.com/articles/oncolytics-reolysin-gets-one-more-orphan-drug-status-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/trovagenes-trov-pcm-data-impresses-shares-rally-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/pfizers-cancer-drug-meets-first-primary-endpoint-in-phase-iii-analyst-blog-2015-04-22", "https://www.nasdaq.com/articles/will-abbott-labs-abt-disappoint-on-earnings-this-quarter-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/3-best-stocks-investing-cholesterol-drugs-2015-04-18", "https://www.nasdaq.com/articles/biotech-investors-shouldnt-miss-these-stocks-this-earnings-earnings-esp-2015-04-17", "https://www.nasdaq.com/articles/amgen-gets-fda-nod-for-chronic-heart-failure-drug-corlanor-analyst-blog-2015-04-16", "https://www.nasdaq.com/articles/3-biotech-stocks-under-%2410-with-amazing-growth-prospects-analyst-blog-2015-04-15", "https://www.nasdaq.com/articles/3-biotech-stocks-may-disappear-2020-2015-04-15", "https://www.nasdaq.com/articles/biogen-reports-new-data-from-acute-optic-neuritis-study-analyst-blog-2015-04-15", "https://www.nasdaq.com/articles/will-amgen-amgn-keep-earnings-streak-alive-1q-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/biotech-stock-roundup-favorable-briefing-documents-mdcos-kengreal-alexion-soliris-label", "https://www.nasdaq.com/articles/jj-beats-q1-earnings-cuts-view-currency-woes-analyst-blog-2015-04-14", "https://www.nasdaq.com/articles/alnylam-reports-publication-of-new-data-on-hemophilia-drug-analyst-blog-2015-04-14", "https://www.nasdaq.com/articles/aveo-upgraded-to-strong-buy-add-to-your-portfolio-analyst-blog-2015-04-14", "https://www.nasdaq.com/articles/arca-biopharma-gains-on-fast-track-status-for-gencaro-analyst-blog-2015-04-14", "https://www.nasdaq.com/articles/amgen-upgraded-to-strong-buy-perfect-for-your-portfolio-analyst-blog-2015-04-13", "https://www.nasdaq.com/articles/10-largest-companies-market-cap-biotech-2015-04-11", "https://www.nasdaq.com/articles/bayer-to-expand-copanlisib-program-by-three-new-studies-analyst-blog-2015-04-15", "https://www.nasdaq.com/articles/stock-market-news-for-april-09-2015-market-news-2015-04-09", "https://www.nasdaq.com/articles/oncolytics-reolysin-filed-for-gastric-cancer-orphan-status-analyst-blog-2015-04-09", "https://www.nasdaq.com/articles/halozyme-to-advance-pegph20-following-fda-meet-analyst-blog-2015-04-09", "https://www.nasdaq.com/articles/biotech-stock-roundup-alkermes-drug-fares-well-targacept-slides-deal-termination-analyst", "https://www.nasdaq.com/articles/could-celgene-corporation-muscle-its-way-past-amgen-inc-2015-04-06", "https://www.nasdaq.com/articles/can-pharma-go-good-great-2015-04-05", "https://www.nasdaq.com/articles/why-smart-money-loves-biotech-stock-2015-04-05", "https://www.nasdaq.com/articles/how-amgen-could-side-step-sting-patent-expiration-2015-04-11", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-horizon-pharma-hyperion-therapeutics-conatus-amgen-and", "https://www.nasdaq.com/articles/biotech-stock-roundup-horizon-buy-hyperion-conatus-liver-disease-data-analyst-blog-2015-04", "https://www.nasdaq.com/articles/why-coherus-biosciences-inc-shares-burst-today-2015-04-01", "https://www.nasdaq.com/articles/amgens-kyprolis-gets-fda-priority-review-for-expanded-use-analyst-blog-2015-03-31", "https://www.nasdaq.com/articles/proshares-ultra-qqq-experiences-big-outflow-2015-03-30", "https://www.nasdaq.com/articles/hospira-presents-data-on-retacrit-an-epogen-biosimilar-analyst-blog-2015-03-30", "https://www.nasdaq.com/articles/5-freakishly-expensive-cancer-drugs-2015-03-28", "https://www.nasdaq.com/articles/safest-biotech-bet-market-2015-04-04", "https://www.nasdaq.com/articles/3-top-stocks-obamacare-lovers-2015-03-28", "https://www.nasdaq.com/articles/investors-might-want-stay-away-biotech-etf-2015-03-27", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biogen-prothena-vertex-gilead-and-amgen-press-releases", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-2-yield-mark-2015-03-26", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-soars-alzheimers-data-gilead-hcv-drugs-label-update-analyst", "https://www.nasdaq.com/articles/ligand-pharmaceuticals-biotechs-jack-all-trades-2015-03-25", "https://www.nasdaq.com/articles/why-immunogen-inc-soaring-higher-today-2015-03-23", "https://www.nasdaq.com/articles/could-these-experimental-drugs-eclipse-harvonis-historic-launch-2015-03-28", "https://www.nasdaq.com/articles/celg-stock-heres-why-celgene-worth-snapping-2015-03-23", "https://www.nasdaq.com/articles/biotechnology-one-last-great-growth-frontiers-retail-investors-2015-03-23", "https://www.nasdaq.com/articles/amgen-seeks-approval-for-pcsk9-inhibitor-repatha-in-japan-analyst-blog-2015-03-23", "https://www.nasdaq.com/articles/dividend-stocks-2-avoid-1-buy-2015-03-21", "https://www.nasdaq.com/articles/drug-spending-soaring-3-takeaways-you-cant-miss-2015-03-21", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-xlv-amgn-biib-celg-2015-03-20", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-regeneron-nektar-acadia-and-pharmacyclics-press", "https://www.nasdaq.com/articles/market-could-grow-6250-10-years-2015-03-23", "https://www.nasdaq.com/articles/regeneron-hits-a-52-week-high-on-positive-praluent-data-analyst-blog-2015-03-18", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-regeneron-shine-acc-nektar-drug-disappoints-analyst-blog-2015", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-orexigen-mannkind-amgen-medivation-and-express-scripts", "https://www.nasdaq.com/articles/esperion-soars-on-positive-phase-iib-data-on-etc-1002-analyst-blog-2015-03-18", "https://www.nasdaq.com/articles/where-radius-health-now-2015-03-17", "https://www.nasdaq.com/articles/zacks-investment-ideas-feature-highlights%3A-biogen-amgen-spdr-sp-biotech-etf-bioshares", "https://www.nasdaq.com/articles/regeneron-sanofis-pcsk9-drug-praluent-data-published-analyst-blog-2015-03-16", "https://www.nasdaq.com/articles/can-biotech-stock-go-good-great-2015-03-19", "https://www.nasdaq.com/articles/should-gilead-sciences-incs-slowing-growth-concern-investors-2015-03-15", "https://www.nasdaq.com/articles/3-biotech-etfs-crushing-market-2015-etf-news-and-commentary-2015-03-13", "https://www.nasdaq.com/articles/akebia-completes-enrolment-in-phase-ii-renal-anemia-study-analyst-blog-2015-03-12", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-iwb-qcom-cvs-amgn-2015-03-10", "https://www.nasdaq.com/articles/why-abbvie-incs-21-billion-deal-had-happen-2015-03-09", "https://www.nasdaq.com/articles/3-cheap-dividend-stocks-you-can-buy-right-now-2015-03-08", "https://www.nasdaq.com/articles/2-tiny-biotechs-could-have-blockbuster-opportunity-2015-03-07", "https://www.nasdaq.com/articles/amgen-presents-encouraging-pcsk9-inhibitor-repatha-data-analyst-blog-2015-03-16", "https://www.nasdaq.com/articles/daily-dividend-report-gd-tyc-amgn-dvn-pxd-hes-hrb-2015-03-05", "https://www.nasdaq.com/articles/amgen-celimmune-tie-up-for-autoimmune-disorder-drug-analyst-blog-2015-03-03", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-march-03-2015-2015-03-02", "https://www.nasdaq.com/articles/amgens-kyprolis-fares-better-velcade-study-analyst-blog-2015-03-02", "https://www.nasdaq.com/articles/amgens-kyprolis-under-eu-review-analyst-blog-2015-02-28", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-iyh-mrk-gild-amgn-2015-02-27", "https://www.nasdaq.com/articles/amgen-reports-encouraging-late-stage-data-on-amg-416-analyst-blog-2015-02-26", "https://www.nasdaq.com/articles/weekly-market-wrap-march-6-2015-2015-03-06", "https://www.nasdaq.com/articles/billionaire-george-soros-just-bought-these-3-stocks-should-you-2015-02-21", "https://www.nasdaq.com/articles/pssst-pfizer-just-told-investors-next-big-thing-2015-02-21", "https://www.nasdaq.com/articles/3-biotech-stocks-short-term-bullish-trades-2015-02-20", "https://www.nasdaq.com/articles/20-billion-market-whats-best-stock-buy-2015-02-20", "https://www.nasdaq.com/articles/ishares-sp-500-growth-etf-experiences-big-outflow-2015-02-18", "https://www.nasdaq.com/articles/stock-market-news-for-february-18-2015-market-news-2015-02-18", "https://www.nasdaq.com/articles/why-cytokinetics-inc-shares-soared-today-2015-02-17", "https://www.nasdaq.com/articles/nasdaq-100-turns-30%3A-tracking-innovation-large-cap-growth-2015-02-23", "https://www.nasdaq.com/articles/1-sentence-tells-you-everything-you-need-know-about-each-these-10-big-pharma-earnings-rep", "https://www.nasdaq.com/articles/forget-gilead-sciences-here-are-3-better-biotech-stocks-2015-02-12", "https://www.nasdaq.com/articles/amgens-skin-cancer-drug-to-face-fda-advisory-panel-analyst-blog-2015-02-12", "https://www.nasdaq.com/articles/will-kite-pharma-kite-disappoint-this-earnings-season-analyst-blog-2015-02-11", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-february-11-2015-2015-02-10", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-february-10-2015-2015-02-09", "https://www.nasdaq.com/articles/3-all-or-nothing-biotech-stocks-were-closely-watching-2015-02-09", "https://www.nasdaq.com/articles/why-shares-cytokinetics-incorporated-skyrocketed-2015-02-13", "https://www.nasdaq.com/articles/fantastic-news-revolutionary-new-breast-cancer-drug-way-2015-02-08", "https://www.nasdaq.com/articles/which-biotech-stock-should-pfizer-inc-buy-2015-02-08", "https://www.nasdaq.com/articles/amgen-director-buys-3000-shares-2015-02-06", "https://www.nasdaq.com/articles/gilead-amgen-q4-earnings-weak-outlook-affect-biotech-etfs-etf-news-and-commentary-2015-02", "https://www.nasdaq.com/articles/bluebird-bios-thalassemia-drug-gets-breakthrough-status-analyst-blog-2015-02-05", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-impresses-4q-results-gilead-abbvie-hcv-drugs-focus-analyst", "https://www.nasdaq.com/articles/merck-mrk-beats-q4-earnings-guidance-falls-short-analyst-blog-2015-02-04", "https://www.nasdaq.com/articles/3-medical-advancements-you-may-be-missing-out-2015-02-08", "https://www.nasdaq.com/articles/5-things-amgen-incs-management-wants-you-know-2015-02-03", "https://www.nasdaq.com/articles/iyh-gild-amgn-abbv-etf-outflow-alert-2015-02-03", "https://www.nasdaq.com/articles/3-companies-better-dividends-johnson-johnson-2015-02-03", "https://www.nasdaq.com/articles/can-biotech-duplicate-its-2014-performance-or-it-time-jump-ship-2015-02-01", "https://www.nasdaq.com/articles/can-you-guess-what-legal-drug-outsells-nfl-2015-01-31", "https://www.nasdaq.com/articles/3-biotech-giants-shouldnt-pay-dividend-2015-01-31", "https://www.nasdaq.com/articles/big-pharma-close-look-one-key-player-2015-01-31", "https://www.nasdaq.com/articles/amgen-reveals-positive-results-on-biosimilar-candidate-analyst-blog-2015-02-04", "https://www.nasdaq.com/articles/pfizer-beats-q4-earnings-guides-below-expectations-analyst-blog-2015-01-27", "https://www.nasdaq.com/articles/amgen-inc-earnings-1-sentence-tells-you-everything-you-need-know-2015-01-27", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-778-follow-through-indicator-34-sensitive-2015-01-27", "https://www.nasdaq.com/articles/after-hours-earnings-report-january-27-2015-aapl-t-amgn-cni-yhoo-ace-syk-ilmn-wdc-ea-vmw", "https://www.nasdaq.com/articles/iyh-amgn-abbv-celg-large-inflows-detected-etf-2015-01-26", "https://www.nasdaq.com/articles/trovagene-partners-with-leading-cancer-research-institutes-analyst-blog-2015-01-26", "https://www.nasdaq.com/articles/these-3-pharmaceutical-companies-control-roughly-half-all-cancer-drug-sales-2015-01-25", "https://www.nasdaq.com/articles/amgen-beats-q4-earnings-revenues-maintains-outlook-analyst-blog-2015-01-28", "https://www.nasdaq.com/articles/will-amgen-amgn-keep-earnings-streak-alive-4q-analyst-blog-2015-01-23", "https://www.nasdaq.com/articles/medivation-and-astellas-report-terrain-data-on-xtandi-analyst-blog-2015-01-23", "https://www.nasdaq.com/articles/ucbs-new-epilepsy-drug-under-review-in-the-u.s.-eu-analyst-blog-2015-01-22", "https://www.nasdaq.com/articles/curis-up-on-immuno-oncology-agreement-with-aurigene-analyst-blog-2015-01-22", "https://www.nasdaq.com/articles/biomarin-to-raise-funds-to-finance-prosensa-acquisition-analyst-blog-2015-01-22", "https://www.nasdaq.com/articles/novartis-psoriasis-drug-cosentyx-gets-fda-approval-analyst-blog-2015-01-22", "https://www.nasdaq.com/articles/keryx-to-raise-%24110-million-through-issuance-of-shares-analyst-blog-2015-01-22", "https://www.nasdaq.com/articles/these-3-dividend-stocks-could-crush-market-2015-2015-01-24", "https://www.nasdaq.com/articles/biotech-stock-roundup-eu-approvals-abbvie-celgene-drugs-cytrx-partial-clinical-hold-lifted", "https://www.nasdaq.com/articles/bristol-myers-makes-leadership-changes-names-new-ceo-analyst-blog-2015-01-21", "https://www.nasdaq.com/articles/hospiras-plum-36o-infusion-system-gets-fda-clearance-analyst-blog-2015-01-21", "https://www.nasdaq.com/articles/alnylam-to-raise-%24450-million-through-issuance-of-shares-analyst-blog-2015-01-21", "https://www.nasdaq.com/articles/jj-beats-q4-earnings-revenues-hit-currency-analyst-blog-2015-01-20", "https://www.nasdaq.com/articles/can-abbvie-inc-overcome-humiras-looming-patent-expiration-2015-01-20", "https://www.nasdaq.com/articles/novartis-cosentyx-approved-in-europe-for-plaque-psoriasis-analyst-blog-2015-01-20", "https://www.nasdaq.com/articles/affymetrix-hits-52-week-high-on-strong-top-line-growth-analyst-blog-2015-01-21", "https://www.nasdaq.com/articles/sanofi-and-boehringer-ingelheim-ink-strategic-deal-analyst-blog-2015-01-20", "https://www.nasdaq.com/articles/abbvie-gains-eu-approval-hepatitis-c-virus-treatment-analyst-blog-2015-01-19", "https://www.nasdaq.com/articles/how-invest-aging-america-2015-01-18", "https://www.nasdaq.com/articles/these-stocks-dividends-could-soar-2015-2015-01-18", "https://www.nasdaq.com/articles/vanguard-growth-etf-experiences-big-inflow-2015-01-16", "https://www.nasdaq.com/articles/hospira-submits-retacrit-regulatory-application-to-the-fda-analyst-blog-2015-01-16", "https://www.nasdaq.com/articles/ziopharm-intrexon-ink-car-t-deal-with-md-anderson-analyst-blog-2015-01-16", "https://www.nasdaq.com/articles/supernus-downgraded-as-lead-drugs-face-patent-challenges-analyst-blog-2015-01-20", "https://www.nasdaq.com/articles/bull-day-amgen-amgn-bull-day-2015-01-16", "https://www.nasdaq.com/articles/astrazeneca-announces-encouraging-data-from-brilinta-study-analyst-blog-2015-01-15", "https://www.nasdaq.com/articles/7-things-amgen-corporations-ceo-wants-you-know-2015-01-14", "https://www.nasdaq.com/articles/3-stocks-buy-when-market-crashes-2015-01-14", "https://www.nasdaq.com/articles/amgen-maintains-2015-view-expects-several-drug-launches-analyst-blog-2015-01-14", "https://www.nasdaq.com/articles/biotech-stock-roundup-shire-acquire-npsp-celgene-pharmacyclics-give-strong-outlook-analyst", "https://www.nasdaq.com/articles/illumina-partners-lockheed-martin-for-genomics-solutions-analyst-blog-2015-01-13", "https://www.nasdaq.com/articles/amgen-amgn-reveals-mixed-results-from-vectibix-studies-analyst-blog-2015-01-16", "https://www.nasdaq.com/articles/biogen-to-acquire-convergence-expand-pain-pipeline-analyst-blog-2015-01-13", "https://www.nasdaq.com/articles/aegerion-reveals-preliminary-2014-results-and-2015-outlook-analyst-blog-2015-01-13", "https://www.nasdaq.com/articles/regeneron-sanofi-seek-pcsk9-drug-praluent-approval-in-eu-analyst-blog-2015-01-12", "https://www.nasdaq.com/articles/emergent-biosolutions-provides-preliminary-2014-results-analyst-blog-2015-01-12", "https://www.nasdaq.com/articles/conatus-announced-results-from-emricasan-studies-analyst-blog-2015-01-12", "https://www.nasdaq.com/articles/amag-provides-2014-preliminary-results-2015-guidance-analyst-blog-2015-01-12", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-kalydeco-remains-in-focus-in-2015-analyst-blog-2015-01-12", "https://www.nasdaq.com/articles/perrigo-ferrara-candy-ink-supply-deal-for-gummy-products-analyst-blog-2015-01-13", "https://www.nasdaq.com/articles/ucb-initiates-phase-iii-psoriasis-study-on-cimzia-with-dermira-analyst-blog-2015-01-09", "https://www.nasdaq.com/articles/3-pharma-stocks-soared-past-pfizer-2014-analyst-blog-2015-01-09", "https://www.nasdaq.com/articles/novartis-biosimilar-of-neupogen-gets-favorable-opinion-analyst-blog-2015-01-08", "https://www.nasdaq.com/articles/xlv-amgn-abbv-bmy-etf-outflow-alert-2015-01-07", "https://www.nasdaq.com/articles/3-tech-giants-quietly-investing-synthetic-biology-2015-01-07", "https://www.nasdaq.com/articles/enzon-pharmaceuticals-inc-enzn-ex-dividend-date-scheduled-january-08-2015-2015-01-07", "https://www.nasdaq.com/articles/nasdaq-100-movers-nxpi-biib-2015-01-06", "https://www.nasdaq.com/articles/can-you-guess-most-common-reason-people-visit-doctor-2015-01-10", "https://www.nasdaq.com/articles/kite-pharma-up-on-amgen-cancer-immunotherapy-tie-up-analyst-blog-2015-01-06", "https://www.nasdaq.com/articles/prospects-2014s-best-and-worst-performing-sectors-2015-01-05", "https://www.nasdaq.com/articles/amgen-upgraded-to-strong-buy-is-it-in-your-portfolio-analyst-blog-2015-01-05", "https://www.nasdaq.com/articles/tekmira-jumped-following-update-on-its-oncology-candidate-analyst-blog-2015-01-02", "https://www.nasdaq.com/articles/ishares-russell-1000-etf-experiences-big-inflow-2014-12-30", "https://www.nasdaq.com/articles/tevas-granix-label-expanded-to-include-self-administration-analyst-blog-2014-12-30", "https://www.nasdaq.com/articles/synthetic-biologics-unveils-top-line-safety-data-on-syn-004-analyst-blog-2014-12-29", "https://www.nasdaq.com/articles/company-news-for-january-06-2015-corporate-summary-2015-01-06", "https://www.nasdaq.com/articles/can-fite-enrols-first-patient-for-a-liver-cancer-study-analyst-blog-2014-12-29", "https://www.nasdaq.com/articles/stock-market-news-for-december-26-2014-market-news-2014-12-26", "https://www.nasdaq.com/articles/after-gilead-sciences-is-it-time-to-sell-biotech-stocks-analyst-blog-2014-12-26", "https://www.nasdaq.com/articles/3-pharma-giants-growing-significantly-faster-glaxosmithkline-plc-2014-12-26", "https://www.nasdaq.com/articles/biolinerx-out-licences-skin-lesion-treatment-candidate-analyst-blog-2014-12-26", "https://www.nasdaq.com/articles/biocryst-rises-on-positive-ebola-candidate-results-analyst-blog-2014-12-26", "https://www.nasdaq.com/articles/amgen-named-top-socially-responsible-dividend-stock-2014-12-24", "https://www.nasdaq.com/articles/kite-pharma-files-ind-for-non-hodgkin-lymphoma-drug-analyst-blog-2014-12-29", "https://www.nasdaq.com/articles/endo-biodelivery-file-regulatory-application-for-pain-drug-analyst-blog-2014-12-24", "https://www.nasdaq.com/articles/gilead-falls-on-abbvie-and-express-scripts-deal%3A-3-biotech-etfs-to-watch-etf-news-and", "https://www.nasdaq.com/articles/achillion-gains-on-positive-results-from-its-hcv-candidates-analyst-blog-2014-12-23", "https://www.nasdaq.com/articles/medivation-licenses-curetechs-cancer-drug-pidilizumab-analyst-blog-2014-12-23", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-2-yield-mark-2014-12-23", "https://www.nasdaq.com/articles/ishares-russell-1000-growth-etf-experiences-big-inflow-2014-12-22", "https://www.nasdaq.com/articles/buying-these-3-stocks-making-bet-burning-house-2014-12-22", "https://www.nasdaq.com/articles/cytokinetics-rises-after-extending-astellas-agreement-analyst-blog-2014-12-24", "https://www.nasdaq.com/articles/endo-biodelivery-file-regulatory-application-for-pain-drug-analyst-blog-2014-12-24", "https://www.nasdaq.com/articles/abbvies-all-oral-interferon-free-hcv-treatment-approved-analyst-blog-2014-12-22", "https://www.nasdaq.com/articles/celgene-gets-positive-chmp-recommendation-for-revlimid-analyst-blog-2014-12-22", "https://www.nasdaq.com/articles/why-george-soros-buying-beaten-down-biotech-stock-2014-12-21", "https://www.nasdaq.com/articles/seattle-genetics-initiates-phase-ib-study-on-leukemia-drug-analyst-blog-2014-12-19", "https://www.nasdaq.com/articles/weekly-market-wrap-december-19-2014-2014-12-19", "https://www.nasdaq.com/articles/agenus-jumps-on-positive-data-from-shingles-candidate-analyst-blog-2014-12-19", "https://www.nasdaq.com/articles/orexigens-obesity-drug-mysimba-gets-chmp-nod-analyst-blog-2014-12-22", "https://www.nasdaq.com/articles/novartis-successfully-expands-signifor-label-in-the-u.s.-analyst-blog-2014-12-17", "https://www.nasdaq.com/articles/alkermes-starts-phase-i-study-on-schizophrenia-candidate-analyst-blog-2014-12-16", "https://www.nasdaq.com/articles/acordas-ampyra-in-phase-iii-for-post-stroke-walking-deficit-analyst-blog-2014-12-16", "https://www.nasdaq.com/articles/is-illumina-ilmn-worth-adding-to-your-portfolio-analyst-blog-2014-12-16", "https://www.nasdaq.com/articles/opko-up-on-announcing-global-partnership-with-pfizer-analyst-blog-2014-12-16", "https://www.nasdaq.com/articles/novartis-ag-and-amgen-inc-take-aim-johnson-johnson-2014-12-15", "https://www.nasdaq.com/articles/halozyme-up-on-collaboration-and-licensing-deal-with-jj-analyst-blog-2014-12-18", "https://www.nasdaq.com/articles/alnylam-provides-pipeline-update-growth-strategy-analyst-blog-2014-12-15", "https://www.nasdaq.com/articles/jazz-pharmaceuticals-starts-defibrotide-rolling-nda-filing-analyst-blog-2014-12-15", "https://www.nasdaq.com/articles/puma-biotechnology-reveals-positive-interim-pb272-data-analyst-blog-2014-12-15", "https://www.nasdaq.com/articles/can-these-top-dividend-paying-stocks-soar-2015-2014-12-13", "https://www.nasdaq.com/articles/can-pfizers-cholesterol-drug-catch-competition-2014-12-11", "https://www.nasdaq.com/articles/bluebird-bio-blue-soars-on-data-from-lentiglobin-study-analyst-blog-2014-12-11", "https://www.nasdaq.com/articles/mylan-among-first-to-launch-generic-celebrex-analyst-blog-2014-12-11", "https://www.nasdaq.com/articles/alexions-soliris-receives-orphan-drug-status-in-japan-analyst-blog-2014-12-15", "https://www.nasdaq.com/articles/biotech-stock-roundup-cubist-be-acquired-merck-bluebird-shoots-ash-data-analyst-blog-2014", "https://www.nasdaq.com/articles/3-reasons-amgen-inc-could-soar-2015-2014-12-09", "https://www.nasdaq.com/articles/dynavax-astrazeneca-alter-agreement-for-asthma-product-analyst-blog-2014-12-09", "https://www.nasdaq.com/articles/alnylam-reports-positive-initial-phase-i-data-on-aln-at3-analyst-blog-2014-12-09", "https://www.nasdaq.com/articles/pharmacyclics-presents-imbruvica-data-at-the-ash-meeting-analyst-blog-2014-12-09", "https://www.nasdaq.com/articles/amgen-successfully-expands-xgeva-label-in-the-u.s.-analyst-blog-2014-12-09", "https://www.nasdaq.com/articles/novartis-reports-encouraging-data-on-biosimilar-of-neupogen-analyst-blog-2014-12-09", "https://www.nasdaq.com/articles/abbvie-reveals-phase-ii-data-on-blood-cancer-drug-at-ash-revised-analyst-blog-2014-12-10", "https://www.nasdaq.com/articles/biotech-stock-roundup-cubist-be-acquired-merck-bluebird-shoots-ash-data-analyst-blog-2014", "https://www.nasdaq.com/articles/3-reasons-amgen-inc-could-soar-2015-2014-12-09", "https://www.nasdaq.com/articles/dynavax-astrazeneca-alter-agreement-for-asthma-product-analyst-blog-2014-12-09", "https://www.nasdaq.com/articles/seattle-genetics-takedas-adcetris-shows-long-term-effect-analyst-blog-2014-12-08", "https://www.nasdaq.com/articles/abbvie-reveals-phase-ii-data-on-blood-cancer-drug-at-ash-analyst-blog-2014-12-08", "https://www.nasdaq.com/articles/3-top-large-cap-biotech-stocks-2015-2014-12-06", "https://www.nasdaq.com/articles/bayer-files-hemophilia-a-drug-marketing-application-in-eu-analyst-blog-2014-12-05", "https://www.nasdaq.com/articles/3-biotech-companies-are-making-incredibly-smart-moves-2014-12-08", "https://www.nasdaq.com/articles/regeneron-at-52-week-high-on-eylea-priority-review-status-analyst-blog-2014-12-04", "https://www.nasdaq.com/articles/why-biotech-stocks-dont-pay-dividends-2014-12-04", "https://www.nasdaq.com/articles/amgens-blincyto-gets-fda-nod-carries-boxed-warning-analyst-blog-2014-12-04", "https://www.nasdaq.com/articles/adma-biologics-ri-002-positive-in-phase-iii-study-analyst-blog-2014-12-04", "https://www.nasdaq.com/articles/synageva-completes-bla-submission-for-sebelipase-alfa-analyst-blog-2014-12-04", "https://www.nasdaq.com/articles/oncolytics-files-for-orphan-drug-designation-for-reolysin-analyst-blog-2014-12-03", "https://www.nasdaq.com/articles/biogen-up-on-encouraging-interim-data-on-alzheimers-drug-analyst-blog-2014-12-03", "https://www.nasdaq.com/articles/iwb-c-amgn-abbv-etf-inflow-alert-2014-12-04", "https://www.nasdaq.com/articles/pharmacyclics-jj-seek-imbruvica-label-expansion-in-eu-analyst-blog-2014-12-02", "https://www.nasdaq.com/articles/look-3-overbought-etfs-2014-12-02", "https://www.nasdaq.com/articles/5-things-amgen-incs-management-wants-you-know-2014-12-01", "https://www.nasdaq.com/articles/dynavax-regains-tlr-7-9-inhibitor-dv1179-rights-from-glaxo-analyst-blog-2014-12-01", "https://www.nasdaq.com/articles/celgene-hits-52-week-high-on-positive-chmp-opinion-analyst-blog-2014-12-01", "https://www.nasdaq.com/articles/alexions-soliris-gets-final-positive-nice-recommendation-analyst-blog-2014-11-28", "https://www.nasdaq.com/articles/should-gilead-sciences-inc-pay-dividend-2014-11-26", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-december-03-2014-2014-12-02", "https://www.nasdaq.com/articles/astrazeneca-amgens-brodalumab-excels-in-psoriasis-study-analyst-blog-2014-11-26", "https://www.nasdaq.com/articles/alexions-alxn-soliris-gets-orphan-drug-status-in-japan-analyst-blog-2014-11-26", "https://www.nasdaq.com/articles/amgen-ends-gastric-cancer-drug-studies-safety-review-analyst-blog-2014-11-25", "https://www.nasdaq.com/articles/gilead-sciences-inc-just-paid-125-million-something-it-cant-use-year-2014-11-24", "https://www.nasdaq.com/articles/novartis-psoriasis-drug-cosentyx-backed-for-eu-approval-analyst-blog-2014-11-24", "https://www.nasdaq.com/articles/amgen-and-abbvie-strengthen-manufacturing-facilities-in-asia-analyst-blog-2014-11-21", "https://www.nasdaq.com/articles/regeneron-sanofi-present-positive-data-on-pcsk9-drug-analyst-blog-2014-11-20", "https://www.nasdaq.com/articles/health-care-sector-update-11262014-arwr-amgn-azn-2014-11-26", "https://www.nasdaq.com/articles/biotech-and-yet-weve-just-begun-2014-11-14", "https://www.nasdaq.com/articles/3-stocks-buy-your-bull-market-profits-2014-11-13", "https://www.nasdaq.com/articles/astrazeneca-amgens-brodalumab-positive-in-psoriasis-trial-analyst-blog-2014-11-13", "https://www.nasdaq.com/articles/biotech-stock-roundup-gilead-abbvie-score-liver-meeting-dendreon-files-bankruptcy-analyst", "https://www.nasdaq.com/articles/pandering-your-wealth-away-2014-11-12", "https://www.nasdaq.com/articles/nps-pharmaceuticals-incurs-wider-q3-loss-revenues-miss-analyst-blog-2014-11-11", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-iwf-amgn-abbv-mmm-2014-11-07", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-iwf-slb-amzn-amgn-2014-11-17", "https://www.nasdaq.com/articles/why-aegerion-pharmaceuticals-inc-stock-collapsed-october-2014-11-06", "https://www.nasdaq.com/articles/etf-outlook-first-trust-amex-biotech-index-fund-etf-fbt-2014-11-06", "https://www.nasdaq.com/articles/amgen-held-latest-13f-filers-2014-11-06", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-november-06-2014-2014-11-05", "https://www.nasdaq.com/articles/alnylam-pharmaceuticals-inc-has-ratio-right-2014-11-05", "https://www.nasdaq.com/articles/5-things-celgene-corporations-management-wants-you-know-2014-11-05", "https://www.nasdaq.com/articles/why-amgen-inc-stock-surged-15-october-2014-11-03", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-november-10-2014-2014-11-07", "https://www.nasdaq.com/articles/aegerion-q3-loss-wider-than-expected-2014-view-lowered-analyst-blog-2014-10-31", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-iwf-amgn-unp-ma-2014-10-31", "https://www.nasdaq.com/articles/buy-these-top-ranked-etfs-on-solid-biotech-stock-earnings-etf-news-and-commentary-2014-10", "https://www.nasdaq.com/articles/stock-market-news-for-october-29-2014-market-news-2014-10-29", "https://www.nasdaq.com/articles/pfizer-incs-earnings-emerging-market-growth-and-patent-expirations-square-2014-10-29", "https://www.nasdaq.com/articles/amgen-up-on-strategic-initiatives-and-2015-guidance-analyst-blog-2014-10-29", "https://www.nasdaq.com/articles/ligand-pharmaceuticals-shares-fall-on-q3-earnings-miss-analyst-blog-2014-10-29", "https://www.nasdaq.com/articles/3-dividend-stocks-better-pfizer-inc-2014-11-01", "https://www.nasdaq.com/articles/amgen-beats-q3-earnings-revenues-ups-view-again-analyst-blog-2014-10-28", "https://www.nasdaq.com/articles/pfizer-beats-earnings-but-lacks-year-over-year-eps-growth-stocks-in-the-news-2014-10-28", "https://www.nasdaq.com/articles/safe-route-biotech-sector-2014-10-27", "https://www.nasdaq.com/articles/amgen-inc-earnings-restructuring-efforts-are-beginning-pay-2014-10-27", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-27-2014-amgn-tmus-ggp-avb-hig-uhs-xl-mas-agnc-pcl-ddr", "https://www.nasdaq.com/articles/3-money-making-biotech-stocks-could-go-higher-2014-10-24", "https://www.nasdaq.com/articles/will-amgen-amgn-disappoint-in-the-q3-earnings-season-analyst-blog-2014-10-24", "https://www.nasdaq.com/articles/amgen-beats-earnings-estimates-whats-next-amgn-stocks-news-2014-10-28", "https://www.nasdaq.com/articles/novartis-secukinumab-receives-favorable-fda-panel-vote-analyst-blog-2014-10-23", "https://www.nasdaq.com/articles/daniel-loeb-comments-amgen-inc-2014-10-22", "https://www.nasdaq.com/articles/biotech-stock-roundup-abbvie-calls-shire-acquisition-will-amgen-consider-breakup-analyst", "https://www.nasdaq.com/articles/celgene-corporations-earnings-preview-pay-attention-new-kids-2014-10-22", "https://www.nasdaq.com/articles/drug-etfs-attractive-buys-pullback-2014-10-22", "https://www.nasdaq.com/articles/amgen-gains-as-third-point-suggests-split-analyst-blog-2014-10-22", "https://www.nasdaq.com/articles/5-best-biotech-stocks-buy-now-2014-10-21", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-vti-pm-wmt-amgn-2014-10-23", "https://www.nasdaq.com/articles/novartis-secukinumab-receives-favorable-fda-panel-vote-analyst-blog-2014-10-23", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gilead-nabs-fda-nod-for-combo-hcv-drug-auxilium-accepts-endo-offer", "https://www.nasdaq.com/articles/quick-look-amgen-incs-drug-development-pipeline-2014-10-15", "https://www.nasdaq.com/articles/where-will-celgene-corporation-stock-be-year-now-2014-10-14", "https://www.nasdaq.com/articles/3-dividend-stocks-buy-if-market-crashes-2014-10-14", "https://www.nasdaq.com/articles/can-dividend-stock-glaxosmithkline-plc-bounce-back-2014-10-14", "https://www.nasdaq.com/articles/amgen-sues-sanofi-and-regeneron-over-pcsk9-candidate-analyst-blog-2014-10-20", "https://www.nasdaq.com/articles/amgens-blinatumomab-gets-priority-review-in-the-u.s.-analyst-blog-2014-10-13", "https://www.nasdaq.com/articles/3-companies-best-retirement-plans-2014-10-12", "https://www.nasdaq.com/articles/nasdaq-100-movers-nxpi-ctsh-2014-10-10", "https://www.nasdaq.com/articles/amgen-inc-gives-abbvie-inc-highest-form-flattery-2014-10-10", "https://www.nasdaq.com/articles/amgen-up-on-positive-phase-iii-data-on-psoriasis-biosimilar-analyst-blog-2014-10-09", "https://www.nasdaq.com/articles/amgens-data-on-evolocumab-published-in-the-lancet-analyst-blog-2014-10-08", "https://www.nasdaq.com/articles/etf-outlook-health-care-select-sector-spdr-etf-xlv-2014-10-08", "https://www.nasdaq.com/articles/novartis-releases-data-on-secukinumab-for-plaque-psoriasis-analyst-blog-2014-10-13", "https://www.nasdaq.com/articles/xlv-amgn-bmy-biib-etf-inflow-alert-2014-10-07", "https://www.nasdaq.com/articles/should-pfizer-inc-buy-surprisingly-competitive-biotech-stock-2014-10-07", "https://www.nasdaq.com/articles/atara-biotherapeutics-refiles-terms-75-million-ipo-2014-10-07", "https://www.nasdaq.com/articles/better-dividend-stock-amgen-inc-or-abbvie-inc-2014-10-06", "https://www.nasdaq.com/articles/stock-week-amgen-inc-amgn-2014-10-06", "https://www.nasdaq.com/articles/next-blue-chip-stocks-biogen-idec-2014-10-04", "https://www.nasdaq.com/articles/ligand-earns-milestone-payment-on-eu-approval-of-noxafil-analyst-blog-2014-10-02", "https://www.nasdaq.com/articles/illumina-pads-gene-sequencing-lead-pharma-deals-2014-10-08", "https://www.nasdaq.com/articles/celldex-cldx-up-on-pilot-study-initiation-on-cdx-301-analyst-blog-2014-09-26", "https://www.nasdaq.com/articles/etf-outlook-sp-health-care-select-spdr-etf-xlv-2014-09-25", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-thursday-tale-of-the-tape-2014-09-25", "https://www.nasdaq.com/articles/seattle-genetics-adcetris-positive-in-durability-analysis-analyst-blog-2014-09-25", "https://www.nasdaq.com/articles/biomarin-bmrn-faces-threat-of-genericization-for-kuvan-analyst-blog-2014-09-25", "https://www.nasdaq.com/articles/acorda-skyrockets-on-%24525m-civitas-therapeutics-deal-analyst-blog-2014-09-25", "https://www.nasdaq.com/articles/gilead-scores-with-taf-based-hiv-regimen-shares-up-analyst-blog-2014-09-25", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-xlv-jnj-amgn-bmy-2014-09-29", "https://www.nasdaq.com/articles/3-top-dividend-growth-stocks-buy-october-2014-09-24", "https://www.nasdaq.com/articles/celgenes-otezla-label-expanded-to-include-plaque-psoriasis-analyst-blog-2014-09-24", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-tuesday-tale-of-the-tape-2014-09-23", "https://www.nasdaq.com/articles/amgen-files-blinatumomab-marketing-application-in-u.s.-analyst-blog-2014-09-23", "https://www.nasdaq.com/articles/bayer-regeneron-successfully-expand-eylea-label-in-japan-analyst-blog-2014-09-23", "https://www.nasdaq.com/articles/auxilium-pharmaceuticals-favors-qlt-deal-over-endo-bid-analyst-blog-2014-09-23", "https://www.nasdaq.com/articles/glaxo-fined-roughly-%24484m-in-china-bribery-probe-analyst-blog-2014-09-22", "https://www.nasdaq.com/articles/inovio-geneone-life-science-collaborate-for-ebola-vaccine-analyst-blog-2014-09-25", "https://www.nasdaq.com/articles/xlv-jnj-amgn-bmy-etf-inflow-alert-2014-09-19", "https://www.nasdaq.com/articles/vivus-and-auxilium-announce-stendra-label-expansion-analyst-blog-2014-09-19", "https://www.nasdaq.com/articles/3-biotechs-investors-should-watch-2014-09-19", "https://www.nasdaq.com/articles/sanofi-myokardia-ink-deal-to-develop-cardiomyopathies-analyst-blog-2014-09-18", "https://www.nasdaq.com/articles/3-hot-ways-play-biotechnology-bonanza-2014-09-17", "https://www.nasdaq.com/articles/merck-posts-positive-data-on-osteoporosis-drug-odanacatib-analyst-blog-2014-09-17", "https://www.nasdaq.com/articles/ucb-amgen-reveals-positive-data-on-romosozumab-for-pmo-analyst-blog-2014-09-17", "https://www.nasdaq.com/articles/flexion-continues-to-fall-post-clinical-hold-on-fx006-analyst-blog-2014-09-22", "https://www.nasdaq.com/articles/synthetic-biologics-syn-005-gets-orphan-drug-designation-analyst-blog-2014-09-16", "https://www.nasdaq.com/articles/is-illumina-ilmn-a-buy-on-solid-q2-strategic-road-map-analyst-blog-2014-09-16", "https://www.nasdaq.com/articles/amarin-plunges-after-the-fda-denies-vascepa-spa-appeal-analyst-blog-2014-09-15", "https://www.nasdaq.com/articles/biogen-reports-positive-two-year-data-on-ms-drug-plegridy-analyst-blog-2014-09-12", "https://www.nasdaq.com/articles/health-care-select-sector-spdr-fund-experiences-big-inflow-2014-09-11", "https://www.nasdaq.com/articles/why-id-avoid-pfizer-inc-stock-despite-dividend-2014-09-11", "https://www.nasdaq.com/articles/medivation-astellas-xtandis-label-expanded-fda-analyst-blog-2014-09-11", "https://www.nasdaq.com/articles/why-amgen-incs-stock-23-2014-2014-09-17", "https://www.nasdaq.com/articles/synthetic-biologics-syn-005-gets-orphan-drug-designation-analyst-blog-2014-09-16", "https://www.nasdaq.com/articles/is-illumina-ilmn-a-buy-on-solid-q2-strategic-road-map-analyst-blog-2014-09-16", "https://www.nasdaq.com/articles/amarin-plunges-after-the-fda-denies-vascepa-spa-appeal-analyst-blog-2014-09-15", "https://www.nasdaq.com/articles/biogen-reports-positive-two-year-data-on-ms-drug-plegridy-analyst-blog-2014-09-12", "https://www.nasdaq.com/articles/health-care-select-sector-spdr-fund-experiences-big-inflow-2014-09-11", "https://www.nasdaq.com/articles/myriad-genetics-posts-encouraging-mypath-melanoma-data-analyst-blog-2014-09-10", "https://www.nasdaq.com/articles/3-reasons-sanofis-stock-could-fall-2014-09-08", "https://www.nasdaq.com/articles/medivation-eyes-blockbuster-cancer-drug-gets-ok-2014-09-11", "https://www.nasdaq.com/articles/amgen-seeks-eu-approval-for-pcsk9-inhibitor-evolocumab-analyst-blog-2014-09-04", "https://www.nasdaq.com/articles/exelixis-slumps-55-on-disappointing-cabozantinib-results-analyst-blog-2014-09-03", "https://www.nasdaq.com/articles/biotech-stock-roundup-united-therapeutics-court-ruling-amgen-files-pcsk9-inhibitor-analyst", "https://www.nasdaq.com/articles/it-time-buy-amgen-incs-stock-2014-09-03", "https://www.nasdaq.com/articles/sanofi-reports-positive-phase-iii-data-on-dengue-vaccine-analyst-blog-2014-09-03", "https://www.nasdaq.com/articles/arena-pharmaceuticals-apd811-gets-orphan-drug-status-analyst-blog-2014-09-03", "https://www.nasdaq.com/articles/3-reasons-eli-lilly-cos-stock-could-rise-2014-09-02", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-vug-fb-amgn-mcd-2014-09-04", "https://www.nasdaq.com/articles/great-cholesterol-drug-data-regeneron-pharmaceuticals-inc-and-sanofi-sa-read-fine-pri-2014", "https://www.nasdaq.com/articles/united-therapeutics-soars-on-remodulin-patent-case-win-analyst-blog-2014-09-02", "https://www.nasdaq.com/articles/regeneron-sanofi-presents-encouraging-alirocumab-data-analyst-blog-2014-09-02", "https://www.nasdaq.com/articles/pfizers-c.-difficile-vaccine-gets-fast-track-status-analyst-blog-2014-08-29", "https://www.nasdaq.com/articles/amgen-submits-regulatory-application-for-pcsk9-inhibitor-analyst-blog-2014-08-29", "https://www.nasdaq.com/articles/oncomeds-vantictumab-studies-partial-clinical-hold-lifted-analyst-blog-2014-08-29", "https://www.nasdaq.com/articles/intellipharmaceutics-oxycodone-program-to-prevent-overdose-analyst-blog-2014-08-29", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-september-03-2014-2014-09-02", "https://www.nasdaq.com/articles/nasdaq-100-movers-vip-vrtx-2014-08-28", "https://www.nasdaq.com/articles/amgens-chronic-heart-failure-drug-gets-priority-review-analyst-blog-2014-08-28", "https://www.nasdaq.com/articles/aegerion-resolves-fdas-warning-on-juxtapid-lifts-overhang-analyst-blog-2014-08-28", "https://www.nasdaq.com/articles/medicinova-rises-on-fdas-nod-on-mn-166-study-initiation-analyst-blog-2014-08-28", "https://www.nasdaq.com/articles/biotimes-ast-opc1-cleared-by-fda-for-phase-i-iia-study-analyst-blog-2014-08-28", "https://www.nasdaq.com/articles/repros-reports-encouraging-late-stage-data-on-androxal-analyst-blog-2014-08-28", "https://www.nasdaq.com/articles/vug-fb-amgn-axp-etf-inflow-alert-2014-08-27", "https://www.nasdaq.com/articles/isis-pharmaceuticals-starts-phase-iii-study-on-isis-apociiirx-analyst-blog-2014-08-29", "https://www.nasdaq.com/articles/7-things-regeneron-pharmaceuticals-incs-management-wants-you-know-2014-08-26", "https://www.nasdaq.com/articles/3-reasons-amgen-incs-stock-could-fall-2014-08-26", "https://www.nasdaq.com/articles/3-reasons-celgene-corporations-stock-could-fall-2014-08-26", "https://www.nasdaq.com/articles/kite-pharma-drug-fares-well-in-non-hodgkins-lymphoma-study-analyst-blog-2014-08-26", "https://www.nasdaq.com/articles/hcp-boasts-29-years-dividend-increases-2014-08-26", "https://www.nasdaq.com/articles/regado-slumps-on-permanent-termination-of-revolixys-study-analyst-blog-2014-08-26", "https://www.nasdaq.com/articles/vivus-acquires-certain-topamax-related-patents-from-jj-analyst-blog-2014-08-26", "https://www.nasdaq.com/articles/amicus-therapeutics-hits-52-week-high-on-migalastat-data-analyst-blog-2014-08-27", "https://www.nasdaq.com/articles/7-things-regeneron-pharmaceuticals-incs-management-wants-you-know-2014-08-26", "https://www.nasdaq.com/articles/3-reasons-amgen-incs-stock-could-fall-2014-08-26", "https://www.nasdaq.com/articles/3-reasons-celgene-corporations-stock-could-fall-2014-08-26", "https://www.nasdaq.com/articles/amgen-upgraded-to-strong-buy-analyst-blog-2014-08-22", "https://www.nasdaq.com/articles/biotech-stock-roundup-achillion-scores-mid-stage-study-gileads-sovaldi-remains-focus", "https://www.nasdaq.com/articles/3-reasons-gilead-science-incs-stock-could-rise-2014-08-20", "https://www.nasdaq.com/articles/healthcare-enjoys-growth-trends%3A-3-medical-stocks-to-buy-analyst-blog-2014-08-20", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-monday-tale-of-the-tape-2014-08-25", "https://www.nasdaq.com/articles/amgen-amgn-reports-encouraging-top-line-data-on-amg-416-analyst-blog-2014-08-19", "https://www.nasdaq.com/articles/techne-corporation-tech-ex-dividend-date-scheduled-august-19-2014-2014-08-18", "https://www.nasdaq.com/articles/3-reasons-amgen-incs-stock-could-rise-2014-08-18", "https://www.nasdaq.com/articles/ligand-up-on-multi-program-captisol-deal-with-avion-pharma-analyst-blog-2014-08-18", "https://www.nasdaq.com/articles/nasdaq-100-movers-ntap-mnst-2014-08-15", "https://www.nasdaq.com/articles/amgens-focus-study-on-multiple-myeloma-drug-kyprolis-fails-analyst-blog-2014-08-14", "https://www.nasdaq.com/articles/thursdays-etf-movers-bbh-gxc-2014-08-14", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-iyh-amgn-biib-celg-2014-08-19", "https://www.nasdaq.com/articles/iyh-jnj-pfe-amgn-etf-inflow-alert-2014-08-11", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-august-12-2014-2014-08-11", "https://www.nasdaq.com/articles/5-things-amgen-incs-management-wants-you-know-2014-08-11", "https://www.nasdaq.com/articles/nps-pharma-reports-earnings-in-q2-on-strong-gattex-sales-analyst-blog-2014-08-07", "https://www.nasdaq.com/articles/ligand-gains-on-q2-earnings-beat-increases-guidance-analyst-blog-2014-08-07", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-plans-job-cuts-regenerons-eylea-continues-impress-analyst-blog", "https://www.nasdaq.com/articles/why-amgen-incs-kyprolis-focus-failure-big-deal-2014-08-13", "https://www.nasdaq.com/articles/sp-down-3-whats-sale-ahead-wall-street-2014-08-04", "https://www.nasdaq.com/articles/sector-update-health-care-2014-08-04", "https://www.nasdaq.com/articles/sector-update-health-care-shares-flat-pre-market-trading-amgen-3-positive-kyprolis-data", "https://www.nasdaq.com/articles/celebrating-20-years-motley-fool-online-2014-08-04", "https://www.nasdaq.com/articles/midday-update-gdp-spooks-wall-street-fears-less-accommodative-fed-2014-07-30", "https://www.nasdaq.com/articles/strong-q2-growth-unnerves-wall-street-rate-hike-concerns-2014-07-30", "https://www.nasdaq.com/articles/nasdaq-100-movers-grmn-regn-2014-07-30", "https://www.nasdaq.com/articles/amgens-multiple-myeloma-drug-kyprolis-succeeds-analyst-blog-2014-08-05", "https://www.nasdaq.com/articles/closing-update-stocks-shave-post-gdp-loss-fed-lessens-rate-hike-fears-2014-07-30", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-29-2014-axp-amgn-apc-esrx-afl-eqr-amp-vrtx-mar-bxp-fisv", "https://www.nasdaq.com/articles/will-amgen-amgn-disappoint-this-earnings-season-analyst-blog-2014-07-28", "https://www.nasdaq.com/articles/daily-dividend-report-k-wwe-amgn-etr-avy-rbc-2014-07-28", "https://www.nasdaq.com/articles/bayer-amgens-nexavar-does-not-show-resilience-in-study-analyst-blog-2014-07-25", "https://www.nasdaq.com/articles/biotech-stock-roundup-abbvies-tax-inversion-amgen-drug-scores-phase-3-analyst-blog-2014-07", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-iwb-amgn-unh-bmy-2014-07-21", "https://www.nasdaq.com/articles/amgen-beats-q2-earnings-revs-ups-view-plans-job-cuts-analyst-blog-2014-07-30", "https://www.nasdaq.com/articles/amgens-amg-416-succeeds-in-phase-iii-shares-up-analyst-blog-2014-07-21", "https://www.nasdaq.com/articles/anthera-acquires-sollpura-from-eli-lilly-analyst-blog-2014-07-18", "https://www.nasdaq.com/articles/astellas-up-on-pipeline-update-oncology-in-focus-analyst-blog-2014-07-16", "https://www.nasdaq.com/articles/cytokinetics-up-on-positive-tirasemtiv-data-analyst-blog-2014-07-14", "https://www.nasdaq.com/articles/novartis-phase-iii-results-on-secukinumab-published-analyst-blog-2014-07-10", "https://www.nasdaq.com/articles/biotech-stock-roundup-regado-plunges-study-update-jazz-gains-product-acquisition-deal", "https://www.nasdaq.com/articles/alexion-pharma-looks-life-beyond-its-blockbuster-2014-07-08", "https://www.nasdaq.com/articles/astellas-up-on-pipeline-update-oncology-in-focus-revised-analyst-blog-2014-07-21", "https://www.nasdaq.com/articles/bind-therapeutics-ends-oncology-deal-with-amgen-analyst-blog-2014-07-03", "https://www.nasdaq.com/articles/sector-update-healthcare-stocks-slightly-higher-bind-therapeutics-drops-partnership-amgen", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-07-03-0", "https://www.nasdaq.com/articles/amgen-gets-breakthrough-therapy-status-for-leukemia-drug-analyst-blog-2014-07-02", "https://www.nasdaq.com/articles/bayer-inks-hemophilia-deal-with-dimension-therapeutics-analyst-blog-2014-06-25", "https://www.nasdaq.com/articles/xlv-amgn-bmy-unh-large-outflows-detected-etf-2014-06-23", "https://www.nasdaq.com/articles/muscle-loss-biotech-atara-biotherapeutics-files-50-million-ipo-2014-06-20", "https://www.nasdaq.com/articles/dow-hits-17000-jobs-report-walgreen-same-store-sales-surge-75-2014-07-03", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-06-12", "https://www.nasdaq.com/articles/amgen-astrazeneca-psoriatic-arthritis-drug-shows-improvement-analyst-blog-2014-06-12", "https://www.nasdaq.com/articles/xlv-amgn-bmy-unh-large-inflows-detected-etf-2014-06-05", "https://www.nasdaq.com/articles/stock-market-news-for-june-05-2014-market-news-2014-06-05", "https://www.nasdaq.com/articles/amgen-takes-over-44-spot-union-pacific-2014-06-04", "https://www.nasdaq.com/articles/health-care-sector-may-have-more-room-run-2014-06-03", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-june-03-2014-2014-06-02", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-pre-market-geron-gets-partial-clinical-hold-lifted", "https://www.nasdaq.com/articles/isis-shines-ptc-therapeutics-soars-analyst-blog-2014-05-28", "https://www.nasdaq.com/articles/qiagens-therascreen-kras-gets-fda-nod-analyst-blog-2014-05-28", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-xlv-mrk-amgn-bmy-2014-05-27", "https://www.nasdaq.com/articles/sector-update-healthcare-stocks-higher-pre-market-durata-sinks-11-after-strong-rally-2014", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-05-27-1", "https://www.nasdaq.com/articles/amgens-vectibix-label-expanded-analyst-blog-2014-05-27", "https://www.nasdaq.com/articles/nasdaq-100-movers-gild-vip-2014-05-23", "https://www.nasdaq.com/articles/bayer-and-orion-ink-oncology-deal-analyst-blog-2014-06-02", "https://www.nasdaq.com/articles/biotech-stock-roundup-medivation-gains-xtandi-strength-amgen-scores-late-stage-study", "https://www.nasdaq.com/articles/amgen-astrazeneca-psoriasis-drug-scores-analyst-blog-2014-05-12", "https://www.nasdaq.com/articles/wider-than-expected-loss-at-nps-pharma-shares-down-analyst-blog-2014-05-09", "https://www.nasdaq.com/articles/techne-corporation-tech-ex-dividend-date-scheduled-may-07-2014-2014-05-06", "https://www.nasdaq.com/articles/3-biotech-beats-this-earnings-season-earnings-esp-2014-05-01", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-spy-fb-cvs-amgn-2014-05-01", "https://www.nasdaq.com/articles/biotech-stock-roundup-gileads-sovaldi-shines-biogen-alexion-outlook-analyst-blog-2014-04", "https://www.nasdaq.com/articles/stock-market-news-for-may-23-2014-market-news-2014-05-23", "https://www.nasdaq.com/articles/stock-market-news-for-april-28-2014-market-news-2014-04-28", "https://www.nasdaq.com/articles/drugs-disappointed-investors-2013-infinitys-ipi-145-2014-04-28", "https://www.nasdaq.com/articles/edwards-lifesciences-q1-earnings-top-revs-miss-analyst-blog-2014-04-25", "https://www.nasdaq.com/articles/stock-market-news-for-april-24-2014-market-news-2014-04-24", "https://www.nasdaq.com/articles/earnings-from-gilead-and-amgen-put-these-etfs-in-focus-etf-news-and-commentary-2014-04-24", "https://www.nasdaq.com/articles/emergents-biothrax-gets-orphan-drug-status-analyst-blog-2014-04-24", "https://www.nasdaq.com/articles/oncogenex-gains-fast-track-status-for-custirsen-analyst-blog-2014-04-24", "https://www.nasdaq.com/articles/stock-market-news-for-april-30-2014-market-news-2014-04-30", "https://www.nasdaq.com/articles/nasdaq-100-movers-isrg-gild-2014-04-23", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-pjp-lly-mrk-amgn-2014-04-23", "https://www.nasdaq.com/articles/amgens-q1-earnings-decline-y-y-analyst-blog-2014-04-23", "https://www.nasdaq.com/articles/5-stocks-to-lose-post-earnings-analyst-blog-2014-04-23", "https://www.nasdaq.com/articles/centene-cnc-soars%3A-stock-adds-12.2-in-session-tale-of-the-tape-2014-04-23", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-pre-market-biogen-q1-results-fy-2014-guidance-2014-04", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-04-23", "https://www.nasdaq.com/articles/resmed-posts-in-line-earnings-but-misses-on-revs-analyst-blog-2014-04-24", "https://www.nasdaq.com/articles/epizyme-up-on-milestone-payment-from-glaxo-analyst-blog-2014-04-23", "https://www.nasdaq.com/articles/encouraging-results-from-pfizers-xeljanz-analyst-blog-2014-04-23", "https://www.nasdaq.com/articles/economic-news-earnings-fuel-modest-losses-us-stocks-2014-04-23", "https://www.nasdaq.com/articles/illumina-posts-better-than-expected-q1-earnings-guides-up-analyst-blog-2014-04-23", "https://www.nasdaq.com/articles/stock-market-news-for-april-22-2014-market-news-2014-04-22", "https://www.nasdaq.com/articles/sarepta-soars-on-eteplirsen-submission-plans-analyst-blog-2014-04-22", "https://www.nasdaq.com/articles/after-hours-earnings-report-april-22-2014-t-gild-amgn-cni-yum-dfs-ilmn-isrg-vmw-fti-jnpr", "https://www.nasdaq.com/articles/premarket-primer-wednesday-april-23-data-china-takes-some-pressure-beijing-2014-04-23", "https://www.nasdaq.com/articles/week-ahead-market-report-april-21-2014-2014-04-21", "https://www.nasdaq.com/articles/narrower-than-expected-loss-at-cepheid-view-tweaked-analyst-blog-2014-04-21", "https://www.nasdaq.com/articles/emergent-biosolutions-gains-on-trial-news-analyst-blog-2014-04-17", "https://www.nasdaq.com/articles/biotech-stock-roundup-mannkind-pdufa-date-pushed-out-alkermes-impresses-data-analyst-blog", "https://www.nasdaq.com/articles/dynavax-starts-phase-iii-study-on-heplisav-b-analyst-blog-2014-04-16", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-xlv-jnj-amgn-bmy-2014-04-15", "https://www.nasdaq.com/articles/ambit-biosciences-slumps%3A-ambi-falls-13.0-in-session-tale-of-the-tape-2014-04-15", "https://www.nasdaq.com/articles/will-amgen-amgn-miss-this-earnings-season-analyst-blog-2014-04-21", "https://www.nasdaq.com/articles/encouraging-results-from-lexicon-candidate-analyst-blog-2014-04-15", "https://www.nasdaq.com/articles/fda-nod-for-mercks-grastek-analyst-blog-2014-04-15", "https://www.nasdaq.com/articles/alimera-psivida-seek-fda-approval-for-iluvien-analyst-blog-2014-04-15", "https://www.nasdaq.com/articles/another-earnings-beat-from-jj-view-up-analyst-blog-2014-04-15", "https://www.nasdaq.com/articles/gilead-bucks-biotech-trend-thanks-to-sovaldi-news-analyst-blog-2014-04-14", "https://www.nasdaq.com/articles/stock-market-news-for-april-14-2014-market-news-2014-04-14", "https://www.nasdaq.com/articles/pipeline-progress-at-coronado-biosciences-analyst-blog-2014-04-14", "https://www.nasdaq.com/articles/repros-completes-enrollment-for-androxal-study-analyst-blog-2014-04-15", "https://www.nasdaq.com/articles/positive-data-on-biogen-sobis-eloctate-analyst-blog-2014-04-11", "https://www.nasdaq.com/articles/encouraging-data-from-bristol-myers-analyst-blog-2014-04-11", "https://www.nasdaq.com/articles/stock-market-news-for-april-11-2014-market-news-2014-04-11", "https://www.nasdaq.com/articles/encouraging-results-on-gileads-sovaldi-analyst-blog-2014-04-11", "https://www.nasdaq.com/articles/qiagen-expands-personalized-healthcare-pipeline-analyst-blog-2014-04-11", "https://www.nasdaq.com/articles/stock-market-news-for-april-10-2014-market-news-2014-04-10", "https://www.nasdaq.com/articles/3-top-ranked-biotech-stocks-rebound-analyst-blog-2014-04-10", "https://www.nasdaq.com/articles/positive-results-on-intercept-pharmas-oca-analyst-blog-2014-04-14", "https://www.nasdaq.com/articles/amgen-breaks-below-200-day-moving-average-notable-amgn-2014-04-10", "https://www.nasdaq.com/articles/gilead-announces-encouraging-sovaldi-data-analyst-blog-2014-04-10", "https://www.nasdaq.com/articles/positive-trial-data-lifts-alkermes-analyst-blog-2014-04-09", "https://www.nasdaq.com/articles/oncolytics-reports-additional-data-on-reolysin-analyst-blog-2014-04-09", "https://www.nasdaq.com/articles/halozyme-falls-on-phase-ii-study-halt-analyst-blog-2014-04-08", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-tuesday-tale-of-the-tape-2014-04-08", "https://www.nasdaq.com/articles/sanofi-to-file-for-lemtrada-approval-again-analyst-blog-2014-04-08", "https://www.nasdaq.com/articles/halozyme-study-under-clinical-hold-analyst-blog-2014-04-10", "https://www.nasdaq.com/articles/encouraging-pre-clinical-data-from-celldex-analyst-blog-2014-04-08", "https://www.nasdaq.com/articles/intercept-pharma-prices-1m-share-offering-shares-down-analyst-blog-2014-04-08", "https://www.nasdaq.com/articles/stock-market-news-for-april-07-2014-market-news-2014-04-07", "https://www.nasdaq.com/articles/momentum-slide-continue-netflix-facebook-analyst-blog-2014-04-07", "https://www.nasdaq.com/articles/amgens-oncology-candidate-disappoints-analyst-blog-2014-04-07", "https://www.nasdaq.com/articles/stock-market-news-for-april-04-2014-market-news-2014-04-04", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-friday-tale-of-the-tape-2014-04-04", "https://www.nasdaq.com/articles/update-on-mercks-mk-3475-analyst-blog-2014-04-08", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-ibb-amgn-biib-alxn-2014-04-03", "https://www.nasdaq.com/articles/stock-market-news-for-april-01-2014-market-news-2014-04-01", "https://www.nasdaq.com/articles/bull-day-amgen-amgn-bull-day-2014-03-31", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-03-31", "https://www.nasdaq.com/articles/healthcare-stocks-helping-pace-market-rally-amgen-climbs-fda-approval-new-cholesterol-drug", "https://www.nasdaq.com/articles/aegerion-pharmaceuticals-viability-threatened-regulatory-legal-and-market-forces-close", "https://www.nasdaq.com/articles/nasdaq-100-movers-wynn-grmn-2014-03-27", "https://www.nasdaq.com/articles/glaxo-and-amgen-terminate-agreement-analyst-blog-2014-04-04", "https://www.nasdaq.com/articles/retrophin-rtrx-catches-eye%3A-stock-moves-7.9-higher-tale-of-the-tape-2014-03-26", "https://www.nasdaq.com/articles/pharma-biotech-stock-outlook-march-2014-zacks-analyst-interviews-2014-03-26", "https://www.nasdaq.com/articles/pharma-biotech-stock-outlook-march-2014-industry-outlook-2014-03-26", "https://www.nasdaq.com/articles/update-on-celgenes-product-portfolio-analyst-blog-2014-03-25", "https://www.nasdaq.com/articles/stock-market-news-for-march-25-2014-market-news-2014-03-25", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-tuesday-tale-of-the-tape-2014-03-25", "https://www.nasdaq.com/articles/japan-approves-medivation-astellas-xtandi-analyst-blog-2014-03-25", "https://www.nasdaq.com/articles/ibb-biib-amgn-regn-etf-outflow-alert-2014-03-26", "https://www.nasdaq.com/articles/are-biotech-stocks-oversold-analyst-blog-2014-03-24", "https://www.nasdaq.com/articles/coverage-initiated-on-illumina-analyst-blog-2014-03-24", "https://www.nasdaq.com/articles/3-etfs-tumble-most-biotech-sell-etf-news-and-commentary-2014-03-24", "https://www.nasdaq.com/articles/stock-market-news-for-march-19-2014-market-news-2014-03-19", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-sp100-geron-plunges-clinical-hold-analyst-blog-2014-03-19", "https://www.nasdaq.com/articles/amgen-scores-again-with-pcsk9-inhibitor-analyst-blog-2014-03-18", "https://www.nasdaq.com/articles/stock-market-news-for-march-14-2014-market-news-2014-03-14", "https://www.nasdaq.com/articles/stock-market-news-for-march-24-2014-market-news-2014-03-24", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-regeneron-slide-pcsk9-inhibitor-concerns-analyst-blog-2014-03", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-wednesday-tale-of-the-tape-2014-03-12", "https://www.nasdaq.com/articles/bayer-amgens-nexavar-fails-in-late-stage-study-analyst-blog-2014-03-12", "https://www.nasdaq.com/articles/phase-i-data-on-rexahns-supinoxin-analyst-blog-2014-03-12", "https://www.nasdaq.com/articles/chelsea-therapeutics-posts-wider-q4-loss-analyst-blog-2014-03-12", "https://www.nasdaq.com/articles/stock-market-news-for-march-11-2014-market-news-2014-03-11", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-mixed-pre-market-synta-jumps-4-q4-results-2014-03-11", "https://www.nasdaq.com/articles/bright-outlook-at-ligand-analyst-blog-2014-03-12", "https://www.nasdaq.com/articles/ibb-biib-amgn-regn-etf-outflow-alert-2014-03-10", "https://www.nasdaq.com/articles/mondays-etf-movers-xlv-gxc-2014-03-10", "https://www.nasdaq.com/articles/stock-market-news-for-march-07-2014-market-news-2014-03-07", "https://www.nasdaq.com/articles/pipeline-progress-at-alkermes-analyst-blog-2014-03-07", "https://www.nasdaq.com/articles/profit-orphan-drugs-3-choices-revised-analyst-blog-2014-03-07", "https://www.nasdaq.com/articles/bull-day-quintiles-q-bull-day-2014-03-05", "https://www.nasdaq.com/articles/profit-orphan-drugs-3-choices-analyst-blog-2014-03-05", "https://www.nasdaq.com/articles/sector-update-healthcares-2014-03-11", "https://www.nasdaq.com/articles/are-these-biotechs-part-of-your-portfolio-analyst-blog-2014-03-03", "https://www.nasdaq.com/articles/amgen-takes-over-39-spot-mcdonalds-2014-03-03", "https://www.nasdaq.com/articles/biogen-keeps-momentum-going-ms-drug-tecfidera-2014-03-03", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-ibb-biib-gild-amgn-2014-02-28", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-march-03-2014-2014-02-28", "https://www.nasdaq.com/articles/amgen-becomes-192-most-shorted-sp-500-component-replacing-american-tower-2014-02-27", "https://www.nasdaq.com/articles/enter-biosimilars-3-stock-picks-analyst-blog-2014-02-26", "https://www.nasdaq.com/articles/myriad-genetics-up-on-prolaris-data-aims-reimbursement-analyst-blog-2014-03-04", "https://www.nasdaq.com/articles/nps-pharma-swings-to-earnings-on-strong-revenues-analyst-blog-2014-02-19", "https://www.nasdaq.com/articles/illumina-expands-in-china-analyst-blog-2014-02-14", "https://www.nasdaq.com/articles/stock-market-news-for-february-12-2014-market-news-2014-02-12", "https://www.nasdaq.com/articles/ibb-gild-biib-amgn-large-inflows-detected-etf-2014-02-11", "https://www.nasdaq.com/articles/stock-market-news-for-february-11-2014-market-news-2014-02-11", "https://www.nasdaq.com/articles/healthcare-stocks-ahead-more-1-group-agilent-amgen-teaming-new-diagnostic-equipment-2014", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-02-11", "https://www.nasdaq.com/articles/bayer-progresses-with-stivarga-analyst-blog-2014-02-21", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-february-11-2014-2014-02-10", "https://www.nasdaq.com/articles/ex-dividend-reminder-entergy-teco-energy-and-amgen-2014-02-07", "https://www.nasdaq.com/articles/merck-misses-earnings-penny-analyst-blog-2014-02-05", "https://www.nasdaq.com/articles/guidance-update-from-actavis-analyst-blog-2014-02-03", "https://www.nasdaq.com/articles/3-reasons-biotech-stock-advance-continue-2014-02-03", "https://www.nasdaq.com/articles/another-strong-earnings-beat-from-amgen-analyst-blog-2014-01-29", "https://www.nasdaq.com/articles/after-hours-earnings-report-january-28-2014-t-amgn-yhoo-ace-ilmn-bxp-vmw-ea-rkt-ajg-tss", "https://www.nasdaq.com/articles/cytokinetics-rises-on-q4-earnings-beat-analyst-blog-2014-02-10", "https://www.nasdaq.com/articles/drugmaker-merck-tries-jump-start-slow-growth-2014-01-22", "https://www.nasdaq.com/articles/illumina-labcorp-ink-multi-year-deal-analyst-blog-2014-01-22", "https://www.nasdaq.com/articles/illumina-shares-hit-52-week-high-analyst-blog-2014-01-20", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-mixe-pre-market-unitedhealth-down-2-q4-results-2014-01-16", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-01-16-0", "https://www.nasdaq.com/articles/illumina-amgen-ally-for-diagnostic-test-analyst-blog-2014-01-16", "https://www.nasdaq.com/articles/will-amgen-amgn-miss-this-earnings-season-analyst-blog-2014-01-27", "https://www.nasdaq.com/articles/stock-market-news-for-january-10-2014-corporate-summary-2014-01-10", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-data-looks-good-canf-tumbles-industry-outlook-2014-01-08", "https://www.nasdaq.com/articles/positive-data-on-amgens-romosozumab-analyst-blog-2014-01-03", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-mixed-pre-market-amgen-reports-positive-results-phase-2", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-01-02-1", "https://www.nasdaq.com/articles/amgen-inc-amgn-new-analyst-report-zacks-equity-research-zacks-equity-research-report-2013", "https://www.nasdaq.com/articles/healthcare-stocks-posting-narrow-gains-illumina-spikes-collaboration-amgen-cancer-test", "https://www.nasdaq.com/articles/pipeline-progress-at-novartis-analyst-blog-2013-12-23", "https://www.nasdaq.com/articles/setback-for-vertex-pharma-analyst-blog-2013-12-20", "https://www.nasdaq.com/articles/insider-trading-icahn-boosts-stake-nuance-and-frost-buys-more-shares-opko-2013-12-19", "https://www.nasdaq.com/articles/are-biotech-etfs-back-on-track-etf-news-and-commentary-2013-12-04", "https://www.nasdaq.com/articles/losing-my-religion-how-i-unlearned-efficient-markets-folly-2013-12-04", "https://www.nasdaq.com/articles/orphan-drug-status-for-cnats-emricasan-analyst-blog-2013-12-03", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-december-03-2013-2013-12-02", "https://www.nasdaq.com/articles/enzon-pharmaceuticals-inc-enzn-ex-dividend-date-scheduled-december-24-2013-2013-12-23", "https://www.nasdaq.com/articles/pipeline-progress-at-novartis-analyst-blog-2013-12-23", "https://www.nasdaq.com/articles/setback-for-vertex-pharma-analyst-blog-2013-12-20", "https://www.nasdaq.com/articles/insider-trading-icahn-boosts-stake-nuance-and-frost-buys-more-shares-opko-2013-12-19", "https://www.nasdaq.com/articles/data-on-amgens-pipeline-candidates-analyst-blog-2013-11-21", "https://www.nasdaq.com/articles/stock-market-news-for-november-21-2013-market-news-2013-11-21", "https://www.nasdaq.com/articles/dendreon-dndn-in-focus%3A-stock-moves-9.7-higher-tale-of-the-tape-2013-11-20", "https://www.nasdaq.com/articles/safe-way-win-biotech-growth-2013-12-02", "https://www.nasdaq.com/articles/techne-corporation-tech-ex-dividend-date-scheduled-november-07-2013-2013-11-06", "https://www.nasdaq.com/articles/top-ranked-biotech-etf-in-focus%3A-bbh-etf-news-and-commentary-2013-10-24", "https://www.nasdaq.com/articles/another-earnings-and-rev-beat-from-amgen-analyst-blog-2013-10-23", "https://www.nasdaq.com/articles/inside-biotech-etfs%3A-can-the-run-continue-etf-news-and-commentary-2013-10-22", "https://www.nasdaq.com/articles/stock-downgrades-should-nokia-shareholders-jump-out-windows-2013-10-22", "https://www.nasdaq.com/articles/stocks-gaining-bullish-earnings-benign-employment-2013-10-22", "https://www.nasdaq.com/articles/new-stock-coverage-texas-instruments-messing-us-2013-10-22", "https://www.nasdaq.com/articles/roches-gazyva-approved-in-the-u.s.-analyst-blog-2013-11-07", "https://www.nasdaq.com/articles/techne-corporation-tech-ex-dividend-date-scheduled-november-07-2013-2013-11-06", "https://www.nasdaq.com/articles/crush-sp-500-innovative-etf-2013-10-15", "https://www.nasdaq.com/articles/mixed-data-on-pfizers-xeljanz-analyst-blog-2013-10-10", "https://www.nasdaq.com/articles/biotech-etfs-plummeting-xbi-ibb-bbh-2013-10-08", "https://www.nasdaq.com/articles/encouraging-data-on-novartis-secukinumab-analyst-blog-2013-10-07", "https://www.nasdaq.com/articles/adobe-amgen-case-studies-why-do-we-fear-buying-retraces-2013-10-04", "https://www.nasdaq.com/articles/market-shrugs-weaker-expected-jobs-report-stock-inch-higher-open-2013-10-22", "https://www.nasdaq.com/articles/united-therapeutics-aims-cardiovascular-drug-ok-2013-10-22", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-09-30", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-lower-cytrx-corporation-14-pre-market-preliminary-phase-2", "https://www.nasdaq.com/articles/biotech-alexion-giant-tiny-orphan-market-2013-09-13", "https://www.nasdaq.com/articles/amgen-cytokinetics-drug-misses-primary-endpoint-analyst-blog-2013-09-05", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-september-03-2013-2013-08-30", "https://www.nasdaq.com/articles/primecap-trims-top-biotechs-and-more-2013-08-30", "https://www.nasdaq.com/articles/bayers-nexavar-holds-promise-analyst-blog-2013-10-04", "https://www.nasdaq.com/articles/sangamo-to-buy-ceregene-analyst-blog-2013-08-27", "https://www.nasdaq.com/articles/astrazeneca-to-acquire-amplimmune-analyst-blog-2013-08-27", "https://www.nasdaq.com/articles/company-news-for-august-27-2013-corporate-summary-2013-08-27", "https://www.nasdaq.com/articles/stock-upgrades-hugh-grant-eyes-hollywood-ending-monsanto-company-2013-08-27", "https://www.nasdaq.com/articles/amgen-to-acquire-onyx-pharma-analyst-blog-2013-08-26", "https://www.nasdaq.com/articles/taper-coming-despite-weak-data-ahead-wall-street-2013-08-26", "https://www.nasdaq.com/articles/bull-day-biogen-idec-biib-bull-day-2013-08-28", "https://www.nasdaq.com/articles/pre-market-primer-amgen-inc-acquire-onyx-pharmaceuticals-durable-goods-order-plunge-2013", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-08-26-1", "https://www.nasdaq.com/articles/these-etfs-house-next-biotech-takeover-targets-2013-08-26", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-365757-down-22-points-2013-08-26", "https://www.nasdaq.com/articles/dow-sp-500-erase-fridays-momentum-lackluster-data-2013-08-26", "https://www.nasdaq.com/articles/healthcare-stocks-end-red-prana-gains-speculation-future-drug-trial-success-2013-08-26", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-08-26-0", "https://www.nasdaq.com/articles/august-26%3A-will-taper-happen-despite-discouraging-data-economic-highlights-2013-08-26", "https://www.nasdaq.com/articles/healthcare-stocks-mostly-higher-response-genetics-hits-52-week-highs-pathwork-deal-onxx", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-08-26", "https://www.nasdaq.com/articles/pound-pound-are-biotechs-still-worth-their-salt-2013-08-23", "https://www.nasdaq.com/articles/healthcare-stocks-still-higher-near-closing-bell-regado-biosciences-jumps-nearly-20-market", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-08-22-0", "https://www.nasdaq.com/articles/neutral-on-onyx-pharma-analyst-blog-2013-08-22", "https://www.nasdaq.com/articles/healthcare-stocks-slightly-higher-afternoon-cytokinetics-advances-after-new-data-find-als", "https://www.nasdaq.com/articles/cytokinetics-previewing-release-data-atomic-ahf-trial-omecamtiv-mecarbil-2013-08-26", "https://www.nasdaq.com/articles/amgens-onyx-acquisition-could-be-delayed-analyst-blog-2013-08-16", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-lower-pre-bell-onyx-pharmaceuticals-down-6-stalled", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-08-15-1", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-august-14-2013-2013-08-13", "https://www.nasdaq.com/articles/techne-corporation-tech-ex-dividend-date-scheduled-august-14-2013-2013-08-13", "https://www.nasdaq.com/articles/nps-pharma-reports-loss-but-gattex-encourages-analyst-blog-2013-08-12", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-366912-1511-points-2013-08-08", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-08-22", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-365401-down-1176-points-2013-08-07", "https://www.nasdaq.com/articles/buyback-etf-defies-logic-2013-08-06", "https://www.nasdaq.com/articles/benzinga-market-primer-thursday-august-1-futures-europe-and-asia-2013-08-01", "https://www.nasdaq.com/articles/amgen-beats-on-earnings-revs-in-q2-analyst-blog-2013-07-31", "https://www.nasdaq.com/articles/benzinga-market-primer-wednesday-july-31-futures-higher-heading-fomc-decision-2013-07-31", "https://www.nasdaq.com/articles/earnings-decline-again-at-merck-analyst-blog-2013-07-30", "https://www.nasdaq.com/articles/pharma-biotech-stock-outlook-july-aug-2013-industry-outlook-2013-07-30", "https://www.nasdaq.com/articles/cytokinetics-preview-key-upcoming-clinical-trial-results-2013-08-07", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-30-2013-amgn-afl-eqr-symc-bxp-fisv-oke-vrsk-kim-oks-trmb", "https://www.nasdaq.com/articles/will-amgen-amgn-beat-earnings-analyst-blog-2013-07-29", "https://www.nasdaq.com/articles/will-merck-mrk-beat-earnings-this-quarter-analyst-blog-2013-07-29", "https://www.nasdaq.com/articles/will-pfizer-pfe-beat-earnings-analyst-blog-2013-07-29", "https://www.nasdaq.com/articles/huge-earnings-beat-from-biogen-outlook-up-again-analyst-blog-2013-07-25", "https://www.nasdaq.com/articles/amgen-servier-ink-deal-analyst-blog-2013-07-10", "https://www.nasdaq.com/articles/positive-data-for-novartis-candidate-analyst-blog-2013-07-09", "https://www.nasdaq.com/articles/pharma-biotech-stock-outlook-july-aug-2013-zacks-analyst-interviews-2013-07-30", "https://www.nasdaq.com/articles/priority-review-for-roche-candidate-analyst-blog-2013-07-05", "https://www.nasdaq.com/articles/onyx-pharma-turns-down-amgen-offer-analyst-blog-2013-07-01", "https://www.nasdaq.com/articles/stock-market-news-for-july-1-2013-market-news-2013-07-01", "https://www.nasdaq.com/articles/benzinga-market-primer-monday-july-1-2013-07-01", "https://www.nasdaq.com/articles/global-manufacturing-indexes-are-better-across-board-2013-07-01", "https://www.nasdaq.com/articles/stocks-kick-third-quarter-modest-gains-2013-07-01", "https://www.nasdaq.com/articles/biotech-etfs-surge-onyx-rejects-amgen-offer-etf-news-and-commentary-2013-07-01", "https://www.nasdaq.com/articles/estarylla-lot-recalled-by-novartis-sandoz-analyst-blog-2013-07-08", "https://www.nasdaq.com/articles/novartis-sandoz-progresses-with-biosimilars-analyst-blog-2013-06-26", "https://www.nasdaq.com/articles/amgen-xgeva-label-expanded-analyst-blog-2013-06-17", "https://www.nasdaq.com/articles/apremilast-data-presented-by-celgene-analyst-blog-2013-06-14", "https://www.nasdaq.com/articles/amgens-oncology-drug-meets-primary-endpoint-analyst-blog-2013-06-13", "https://www.nasdaq.com/articles/3-impressive-biotech-etfs-crushing-market-etf-news-and-commentary-2013-06-11", "https://www.nasdaq.com/articles/pipeline-progress-at-roche-analyst-blog-2013-06-10", "https://www.nasdaq.com/articles/enzon-pharmaceuticals-inc-enzn-ex-dividend-date-scheduled-june-05-2013-2013-06-04", "https://www.nasdaq.com/articles/look-ahead-weeks-etfs-watch-2013-06-30", "https://www.nasdaq.com/articles/chmp-positive-on-tevas-lonquex-analyst-blog-2013-06-03", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-june-03-2013-2013-05-31", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-345591-down-3539-points-2013-05-31", "https://www.nasdaq.com/articles/amgen-astellas-collaborate-analyst-blog-2013-05-29", "https://www.nasdaq.com/articles/amgen-inc-amgn-todays-most-compelling-stock-buy-2013-05-24", "https://www.nasdaq.com/articles/stock-market-news-for-may-22-2013-market-news-2013-05-22", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-349643-down-254-points-2013-05-20", "https://www.nasdaq.com/articles/stock-market-news-for-june-3-2013-market-news-2013-06-03", "https://www.nasdaq.com/articles/stock-market-news-for-may-14-2013-market-news-2013-05-14", "https://www.nasdaq.com/articles/amgen-to-set-up-jv-in-china-analyst-blog-2013-05-14", "https://www.nasdaq.com/articles/stock-market-news-for-may-13-2013-market-news-2013-05-13", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-may-14-2013-2013-05-13", "https://www.nasdaq.com/articles/q1-revenue-in-line.-amgen-deal-is-encouraging-analyst-blog-2013-05-10", "https://www.nasdaq.com/articles/sp-highlights-biotech-etfs-2013-05-10", "https://www.nasdaq.com/articles/amgen-inc-amgn-todays-most-compelling-stock-buy-2013-05-09", "https://www.nasdaq.com/articles/sanofi-regn-commence-enrollment-analyst-blog-2013-05-15", "https://www.nasdaq.com/articles/stock-market-news-for-may-14-2013-market-news-2013-05-14", "https://www.nasdaq.com/articles/amgen-to-set-up-jv-in-china-analyst-blog-2013-05-14", "https://www.nasdaq.com/articles/earnings-beat-hospira-analyst-blog-2013-05-01", "https://www.nasdaq.com/articles/biotech-sector-still-market-leader-real-time-insight-2013-04-25", "https://www.nasdaq.com/articles/stocks-market-news-for-april-25-2013-market-news-2013-04-25", "https://www.nasdaq.com/articles/stock-upgrades-yesterdays-mutiny-provides-bounty-pg-shareholders-2013-04-25", "https://www.nasdaq.com/articles/tax-benefit-boosts-amgen-earnings-analyst-blog-2013-04-24", "https://www.nasdaq.com/articles/x-factor-5-stocks-reaching-their-ex-dividend-date-may-14-2013-05-07", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-326965-32-points-2013-04-24", "https://www.nasdaq.com/articles/minyanvilles-t3-morning-market-call-bulls-and-bears-both-have-valid-arguments-2013-04-23", "https://www.nasdaq.com/articles/benzinga-market-primer-tuesday-april-23-2013-04-23", "https://www.nasdaq.com/articles/after-hours-earnings-report-april-23-2013-aapl-t-amgn-nsc-brcm-fti-ew-jnpr-bcr-slg-re-oii", "https://www.nasdaq.com/articles/will-amgen-beat-earnings-analyst-blog-2013-04-22", "https://www.nasdaq.com/articles/vertex-news-lifts-biotech-etfs-2013-04-19", "https://www.nasdaq.com/articles/stock-market-news-for-april-19-2013-market-news-2013-04-19", "https://www.nasdaq.com/articles/benzinga-market-primer-wednesday-april-24-2013-04-24", "https://www.nasdaq.com/articles/etf-showdown-pharma-fight-2013-04-11", "https://www.nasdaq.com/articles/under-hood-unheralded-biotech-etf-2013-04-11", "https://www.nasdaq.com/articles/tech-biotech-etfs-lead-markets-jump-new-highs-2013-04-10", "https://www.nasdaq.com/articles/three-market-based-etfs-trouncing-spy-2013-04-10", "https://www.nasdaq.com/articles/spectrum-progresses-with-spi-2012-analyst-blog-2013-04-09", "https://www.nasdaq.com/articles/cytokinetics-begins-ck-2127107-study-analyst-blog-2013-04-05", "https://www.nasdaq.com/articles/stock-market-news-for-april-3-2013-market-news-2013-04-03", "https://www.nasdaq.com/articles/weekly-preview-earnings-season-continues-apple-focus-2013-04-19", "https://www.nasdaq.com/articles/astrazeneca-discusses-strategy-analyst-blog-2013-03-28", "https://www.nasdaq.com/articles/biotech-breakout-boosting-etfs-2013-03-28", "https://www.nasdaq.com/articles/dead-money-sector-leading-sp-year-2013-03-25", "https://www.nasdaq.com/articles/moving-averages-indicate-these-sector-etfs-could-be-stretched-2013-03-25", "https://www.nasdaq.com/articles/markets-close-out-losing-week-note-2013-03-22", "https://www.nasdaq.com/articles/positive-data-on-amgen-candidate-analyst-blog-2013-03-21", "https://www.nasdaq.com/articles/stock-market-news-for-march-13-2013-market-news-2013-03-13", "https://www.nasdaq.com/articles/stock-market-news-for-march-28-2013-market-news-2013-03-28", "https://www.nasdaq.com/articles/stock-market-news-for-march-4-2013-market-news-2013-03-04", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-march-01-2013-2013-02-27", "https://www.nasdaq.com/articles/setback-for-amgen-analyst-blog-2013-02-27", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-311625-down-4557-points-2013-02-25", "https://www.nasdaq.com/articles/merck-signs-biosimilars-deal-analyst-blog-2013-02-21", "https://www.nasdaq.com/articles/astrazeneca-inks-deal-analyst-blog-2013-02-15", "https://www.nasdaq.com/articles/after-hours-most-active-feb-14-2013-qqq-c-amgn-fch-dell-csco-cbs-qlik-nwsa-bac-bp-ge-2013", "https://www.nasdaq.com/articles/aegerion-incurs-wider-loss-analyst-blog-2013-03-07", "https://www.nasdaq.com/articles/ucb-amgen-discontinue-study-analyst-blog-2013-02-12", "https://www.nasdaq.com/articles/techne-corporation-tech-ex-dividend-date-scheduled-february-13-2013-2013-02-11", "https://www.nasdaq.com/articles/after-hours-most-active-feb-11-2013-bac-fb-gild-ual-ttwo-fe-wfr-amgn-tlm-atvi-kors-sqnm", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-february-11-2013-2013-02-07", "https://www.nasdaq.com/articles/actavis-provides-2013-guidance-analyst-blog-2013-01-31", "https://www.nasdaq.com/articles/safest-way-play-biotech-cooks-kitchen-2013-01-25", "https://www.nasdaq.com/articles/amgen-misses-on-eps-guides-above-analyst-blog-2013-01-24", "https://www.nasdaq.com/articles/amgen-provides-long-term-update-analyst-blog-2013-02-13", "https://www.nasdaq.com/articles/after-hours-most-active-jan-24-2013-msft-qqq-amgn-nok-sbux-pfe-mrk-bac-hig-nwsa-ko-intc", "https://www.nasdaq.com/articles/amgen-gives-early-payday-bulls-2013-01-23", "https://www.nasdaq.com/articles/after-hours-earnings-report-january-23-2013-aapl-amgn-syk-cci-symc-sndk-wdc-altr-ne-var", "https://www.nasdaq.com/articles/earnings-preview%3A-amgen-analyst-blog-2013-01-22", "https://www.nasdaq.com/articles/trius-why-last-fridays-equity-offering-good-stock-2013-01-21", "https://www.nasdaq.com/articles/after-hours-most-active-jan-18-2013-lltc-bac-amgn-bmlq-o-qqq-jnj-pbi-lxp-dell-intc-atvi", "https://www.nasdaq.com/articles/management-expands-at-astrazeneca-analyst-blog-2013-01-17", "https://www.nasdaq.com/articles/etf-talk-here-your-healthcare-2013-01-24", "https://www.nasdaq.com/articles/after-hours-most-active-jan-16-2013-qqq-ebay-swy-bac-gm-amgn-ppg-msft-mt-dell-intc-cbs", "https://www.nasdaq.com/articles/after-hours-most-active-jan-15-2013-qqq-dell-mtu-tsm-bac-hca-wfc-skm-msft-amgn-yhoo-csco", "https://www.nasdaq.com/articles/amgens-dividend-policy-has-ignited-their-stock-2013-01-11", "https://www.nasdaq.com/articles/after-hours-most-active-jan-10-2013-lo-dre-siri-bac-amgn-mt-emc-hun-qqq-csco-intc-apol", "https://www.nasdaq.com/articles/biogen-submits-hemophilia-b-bla-analyst-blog-2013-01-08", "https://www.nasdaq.com/articles/biomimetics-pipeline-progresses-analyst-blog-2013-01-04", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-wednesday-tale-of-the-tape-2012-12-26", "https://www.nasdaq.com/articles/canadian-approval-for-bmys-drug-analyst-blog-2013-01-16", "https://www.nasdaq.com/articles/positive-data-on-actelion-candidate-analyst-blog-2012-12-19", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-monday-tale-of-the-tape-2012-12-17", "https://www.nasdaq.com/articles/amgen-increase-dividend-share-buy-backs-amgn-2012-12-14", "https://www.nasdaq.com/articles/market-wrap-dec14-bby-aapl-amgn-de-mro-more-2012-12-14", "https://www.nasdaq.com/articles/dividend-payer-amgen-hitting-new-highs-again-2012-12-13", "https://www.nasdaq.com/articles/short-interest-swings-biotech-stocks-biib-celg-vvus-2012-12-12", "https://www.nasdaq.com/articles/bear-of-the-day%3A-align-technology-algn-bear-of-the-day-2012-12-12", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-friday-tale-of-the-tape-2012-12-21", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-2012-12-11", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-friday-tale-of-the-tape-2012-12-07", "https://www.nasdaq.com/articles/enzon-pharmaceuticals-inc-enzn-ex-dividend-date-scheduled-december-06-2012-2012-12-04", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-2012-12-04", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-december-05-2012-2012-12-03", "https://www.nasdaq.com/articles/abbotts-humiras-label-expanded-analyst-blog-2012-11-28", "https://www.nasdaq.com/articles/best-pharma-stock-profit-patent-cliff-2012-11-26", "https://www.nasdaq.com/articles/these-etfs-are-awash-2013-takeover-targets-2012-12-12", "https://www.nasdaq.com/articles/azns-forxiga-gets-eu-approval-analyst-blog-2012-11-15", "https://www.nasdaq.com/articles/celgenes-apremilast-encourages-analyst-blog-2012-11-15", "https://www.nasdaq.com/articles/weekly-top-insider-sells-dhr-msft-goog-and-amgn-2012-10-29", "https://www.nasdaq.com/articles/out-red-and-black-john-mccamant-investment-blood-cancer-companies-2012-10-29", "https://www.nasdaq.com/articles/generic-erosion-hurts-astrazeneca-analyst-blog-2012-10-26", "https://www.nasdaq.com/articles/short-interest-swings-biotech-stocks-biib-gild-vvus-2012-10-25", "https://www.nasdaq.com/articles/beat-and-raise-quarter-for-amgen-analyst-blog-2012-10-24", "https://www.nasdaq.com/articles/biotech-etfs-fiscal-cliff-safe-haven-etf-news-and-commentary-2012-11-16", "https://www.nasdaq.com/articles/sp-likes-trio-biotech-etfs-2012-10-24", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-23-2012-amgn-ace-afl-nsc-brcm-bxp-vmw-altr-fti-chrw", "https://www.nasdaq.com/articles/deutsche-bank-upgrades-amgen-buy-sees-strong-growth-upside-and-higher-dividends-ahead-amgn", "https://www.nasdaq.com/articles/deutsche-bank-upgrades-amgen-buy-amgn-2012-10-22", "https://www.nasdaq.com/articles/its-time-sell-these-4-surging-stocks-2012-10-19", "https://www.nasdaq.com/articles/after-hours-most-active-oct-18-2012-cx-msft-qqq-siri-s-gen-vod-mmr-mrvl-amgn-nok-amd-2012", "https://www.nasdaq.com/articles/stock-market-news-for-october-17-2012-market-news-2012-10-17", "https://www.nasdaq.com/articles/amgen-reports-increased-profit-beats-analysts-expectations-amgn-2012-10-24", "https://www.nasdaq.com/articles/brian-rogers-highest-sells-kimberly-clark-pinnacle-west-capital-and-amgen-inc-2012-10-17", "https://www.nasdaq.com/articles/abbott-reports-encouraging-hcv-data-analyst-blog-2012-10-16", "https://www.nasdaq.com/articles/short-interest-swings-biotech-stocks-biib-celg-gild-2012-10-15", "https://www.nasdaq.com/articles/astrazeneca-licenses-ardelyxs-drugs-analyst-blog-2012-10-09", "https://www.nasdaq.com/articles/new-indication-for-abbotts-humira-analyst-blog-2012-10-04", "https://www.nasdaq.com/articles/52-week-high-companies-amgn-cbe-fisv-news-ace-2012-10-01", "https://www.nasdaq.com/articles/novartis-progresses-with-ain457-analyst-blog-2012-10-01", "https://www.nasdaq.com/articles/drug-market-could-expand-80-fold-2020-2012-10-17", "https://www.nasdaq.com/articles/another-approval-for-amgens-prolia-analyst-blog-2012-09-25", "https://www.nasdaq.com/articles/celgenes-drug-pipeline-news-soothes-investor-worries-2012-09-19", "https://www.nasdaq.com/articles/weekly-top-insider-sells-cof-goog-amgn-crm-and-fis-2012-09-17", "https://www.nasdaq.com/articles/amgen-bounces-back-strong-2012-performance-2012-09-14", "https://www.nasdaq.com/articles/after-hours-most-active-sep-13-2012-aeo-bac-nok-ori-c-qqq-spls-siri-dhi-amgn-hban-intc", "https://www.nasdaq.com/articles/robert-baird-cuts-amgen-neutral-recent-rally-overdone-amgn-2012-09-12", "https://www.nasdaq.com/articles/amgen-upgraded-buy-ubs-clinical-data-looking-amgn-2012-09-10", "https://www.nasdaq.com/articles/brean-murray-starts-coverage-amgen-buy-long-term-pipeline-looking-good-amgn-2012-09-27", "https://www.nasdaq.com/articles/another-approval-for-amgens-prolia-analyst-blog-2012-09-25", "https://www.nasdaq.com/articles/celgenes-drug-pipeline-news-soothes-investor-worries-2012-09-19", "https://www.nasdaq.com/articles/astrazeneca-recruits-new-ceo-analyst-blog-2012-08-29", "https://www.nasdaq.com/articles/amgen-doing-fine-despite-challenges-2012-08-21", "https://www.nasdaq.com/articles/takeda-halts-gamma-study-in-japan-analyst-blog-2012-08-16", "https://www.nasdaq.com/articles/pipeline-setback-at-amgen-analyst-blog-2012-08-13", "https://www.nasdaq.com/articles/5-familiar-stocks-sell-or-short-investment-ideas-2012-08-03", "https://www.nasdaq.com/articles/pipeline-progress-at-celg-shares-up-analyst-blog-2012-09-07", "https://www.nasdaq.com/articles/amgen-beats-raises-guidance-analyst-blog-2012-07-27", "https://www.nasdaq.com/articles/biotechs-motion-new-drug-pipeline-brims-2012-07-27", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-26-2012-amzn-amgn-arba-atr-afsi-apkt-bjri-amkr-abax-bas", "https://www.nasdaq.com/articles/suggestions-summer-reading-growth-investors-2012-07-23", "https://www.nasdaq.com/articles/good-news-for-celgenes-pipeline-analyst-blog-2012-07-16", "https://www.nasdaq.com/articles/better-investors-men-or-women-2012-07-13", "https://www.nasdaq.com/articles/merck-osteoporosis-candidate-scores-analyst-blog-2012-07-13", "https://www.nasdaq.com/articles/top-performing-funds-latch-biotech-and-discount-retail-stocks-2012-08-02", "https://www.nasdaq.com/articles/after-hours-most-active-jul-11-2012-lsi-fcx-psec-phm-bac-fb-acc-wm-qcom-amgn-acwi-sbac", "https://www.nasdaq.com/articles/merck-kgaas-erbitux-disappoints-analyst-blog-2012-07-10", "https://www.nasdaq.com/articles/fda-label-expansion-for-erbitux-analyst-blog-2012-07-09", "https://www.nasdaq.com/articles/amgen-acquires-kai-analyst-blog-2012-07-09", "https://www.nasdaq.com/articles/davita-to-settle-epogen-lawsuit-analyst-blog-2012-07-06", "https://www.nasdaq.com/articles/amgens-sensipar-disappoints-analyst-blog-2012-06-11", "https://www.nasdaq.com/articles/dr.-reddys-merck-serono-team-up-analyst-blog-2012-06-08", "https://www.nasdaq.com/articles/new-highs-new-lows-yield-greed-2012-07-12", "https://www.nasdaq.com/articles/after-hours-most-active-jul-11-2012-lsi-fcx-psec-phm-bac-fb-acc-wm-qcom-amgn-acwi-sbac", "https://www.nasdaq.com/articles/merck-kgaas-erbitux-disappoints-analyst-blog-2012-07-10", "https://www.nasdaq.com/articles/fda-label-expansion-for-erbitux-analyst-blog-2012-07-09", "https://www.nasdaq.com/articles/amgen-acquires-kai-analyst-blog-2012-07-09", "https://www.nasdaq.com/articles/davita-to-settle-epogen-lawsuit-analyst-blog-2012-07-06", "https://www.nasdaq.com/articles/stocks-rebound-dow-eyes-potential-head-and-shoulders-support-2012-04-24", "https://www.nasdaq.com/articles/amgen-q1-profit-and-revenue-beat-expectations-amgn-2012-04-24", "https://www.nasdaq.com/articles/abbott-presents-data-on-humira-analyst-blog-2012-06-07", "https://www.nasdaq.com/articles/earnings-preview%3A-amgen-analyst-blog-2012-04-19", "https://www.nasdaq.com/articles/earnings-preview%3A-abbott-labs-analyst-blog-2012-04-17", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-the-goldman-sachs-group-lloyds-bank-of-america-0", "https://www.nasdaq.com/articles/amgen-reaches-for-kai-pharma-analyst-blog-2012-04-11", "https://www.nasdaq.com/articles/amgen-astrazeneca-team-up-analyst-blog-2012-04-10", "https://www.nasdaq.com/articles/amgen-psoriasis-candidate-impresses-analyst-blog-2012-04-04", "https://www.nasdaq.com/articles/positive-data-on-lilly-psoriasis-drug-analyst-blog-2012-04-02", "https://www.nasdaq.com/articles/dow-takes-back-13000-cant-reclaim-key-trendline-support-2012-04-20", "https://www.nasdaq.com/articles/encouraging-data-on-amgen-candidate-analyst-blog-2012-03-27", "https://www.nasdaq.com/articles/davita-downgraded-to-neutral-analyst-blog-2012-03-08", "https://www.nasdaq.com/articles/hospira-back-to-neutral-analyst-blog-2012-02-28", "https://www.nasdaq.com/articles/amgen-a-step-closer-to-micromet-analyst-blog-2012-02-22", "https://www.nasdaq.com/articles/davita-outperforms-affirms-outlook-analyst-blog-2012-02-17", "https://www.nasdaq.com/articles/earnings-preview%3A-davita-inc.-analyst-blog-2012-02-14", "https://www.nasdaq.com/articles/amgen-inc.-amgn-bull-of-the-day-2012-02-09", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-sanofi-regeneron-alnylam-and-coach-press-releases", "https://www.nasdaq.com/articles/3-biotechnology-stocks-short-term-traders-2012-02-09", "https://www.nasdaq.com/articles/amgen-upped-to-outperform-analyst-blog-2012-02-08", "https://www.nasdaq.com/articles/market-wrap-feb6-has-syy-hum-pnc-dis-more-2012-02-06", "https://www.nasdaq.com/articles/how-many-stocks-should-you-own-investment-ideas-2012-02-03", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-2012-01-31", "https://www.nasdaq.com/articles/five-etfs-started-2012-strong-2012-01-31", "https://www.nasdaq.com/articles/amgen-misses-2012-outlook-strong-analyst-blog-2012-01-27", "https://www.nasdaq.com/articles/zacks-bull-and-bear-of-the-day-highlights%3A-amgen-montpelier-re-holdings-cisco-systems", "https://www.nasdaq.com/articles/watson-buys-ascent-pharmahealth-analyst-blog-2012-01-24", "https://www.nasdaq.com/articles/market-wrap-jan23-hal-pg-pru-blk-cop-more-2012-01-23", "https://www.nasdaq.com/articles/biosimilars%3A-the-next-big-thing-analyst-blog-2012-01-13", "https://www.nasdaq.com/articles/hospira-upped-to-neutral-analyst-blog-2012-01-05", "https://www.nasdaq.com/articles/fda-panel-to-review-amgens-xgeva-analyst-blog-2011-12-30", "https://www.nasdaq.com/articles/amgens-price-target-raised-citigroup-amgn-2011-12-27", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-friday-tale-of-the-tape-2011-12-23", "https://www.nasdaq.com/articles/davita-upgraded-to-outperform-analyst-blog-2012-01-25", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-2011-12-20", "https://www.nasdaq.com/articles/micromets-blinatumomub-data-at-ash-analyst-blog-2011-12-13", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-friday-tale-of-the-tape-2011-12-09", "https://www.nasdaq.com/articles/micromet-stays-neutral-analyst-blog-2011-12-08", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-wednesday-tale-of-the-tape-2011-12-07", "https://www.nasdaq.com/articles/mid-day-update%3A-stocks-sitting-higher-as-europe-hope-rises-ism-services-index-falls-2011", "https://www.nasdaq.com/articles/amgen-corporation-value-2011-12-05", "https://www.nasdaq.com/articles/watson-amgen-to-develop-biosimilars-analyst-blog-2011-12-20", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-friday-tale-of-the-tape-2011-12-02", "https://www.nasdaq.com/articles/largest-option-buying-equities-so-far-2011-12-01", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-alleghany-transatlantic-tyson-foods-tech-data-and-amgen", "https://www.nasdaq.com/articles/eu-label-expansion-for-amgen-drug-analyst-blog-2011-11-21", "https://www.nasdaq.com/articles/investing-house-2011-11-21", "https://www.nasdaq.com/articles/3-cheap-stocks-shrinking-share-count-2011-11-17", "https://www.nasdaq.com/articles/largest-option-buying-equities-so-far-2011-11-16", "https://www.nasdaq.com/articles/micromet-begins-new-trial-analyst-blog-2011-12-05", "https://www.nasdaq.com/articles/pfizer-poised-introduce-blockbuster-arthritis-pill-2011-09-11", "https://www.nasdaq.com/articles/amgen-started-outperform-bmo-capital-valuation-call-amgn-2011-09-08", "https://www.nasdaq.com/articles/hearty-profits-companies-racing-develop-next-big-cholesterol-drug-2011-08-30", "https://www.nasdaq.com/articles/want-be-venture-capitalist-invest-these-2-stocks-2011-08-01", "https://www.nasdaq.com/articles/opening-view-debt-vote-cancelled-stocks-spiral-lower-2011-07-29", "https://www.nasdaq.com/articles/healthcare-takeovers-targets-express-scripts-buys-medco-2011-07-22", "https://www.nasdaq.com/articles/overlook-sector-and-it-could-cost-you-2011-07-20", "https://www.nasdaq.com/articles/mid-day-update%3A-stocks-give-up-gains-at-sessions-half-europe-worries-linger-2011-11-15", "https://www.nasdaq.com/articles/mid-day-update-stocks-down-housing-industrial-production-earnings-weigh-2011-05-17", "https://www.nasdaq.com/articles/3-holdrs-etfs-low-fees-and-low-valuations-2011-05-05", "https://www.nasdaq.com/articles/7-ailing-health-care-stocks-sell-2011-04-27", "https://www.nasdaq.com/articles/stocks-higher-ahead-next-weeks-earnings-economic-data-supports-2011-04-15", "https://www.nasdaq.com/articles/mid-day-update-stocks-firmer-following-data-deluge-corporate-earnings-2011-04-15", "https://www.nasdaq.com/articles/10-health-care-stocks-have-flatlined-2011-04-13", "https://www.nasdaq.com/articles/mid-day-update-stocks-manage-another-rally-investors-eye-positive-employment-data-2011-03", "https://www.nasdaq.com/articles/us-indexes-lower-industrial-production-housing-data-weighs-hp-guidance-disappoints-2011-05", "https://www.nasdaq.com/articles/stocks-broadly-higher-libyan-crisis-eases-japan-g-7-aid-reassures-investors-2011-03-18", "https://www.nasdaq.com/articles/mid-day-update-stocks-shooting-higher-investor-attention-turns-back-libya-2011-03-18", "https://www.nasdaq.com/articles/companies-lend-helping-hand-2011-03-18", "https://www.nasdaq.com/articles/how-play-biotech-etfs-2011-02-18", "https://www.nasdaq.com/articles/do-mergers-mean-billions-biotech-2011-02-16", "https://www.nasdaq.com/articles/did-you-know-2011-02-01", "https://www.nasdaq.com/articles/undervalued-biotech-stock-buy-2011-2010-12-17", "https://www.nasdaq.com/articles/us-indexes-higher-sessions-half-despite-crude-prices-bubbling-higher-disappointing-durable", "https://www.nasdaq.com/articles/stocks-skid-mid-day-investors-seek-direction-ahead-fed-gdp-numbers-2010-10-27", "https://www.nasdaq.com/articles/mid-day-update-bearish-sentiment-sends-major-indexes-broadly-lower-2010-10-27", "https://www.nasdaq.com/articles/amgen-celgene-and-novartis-fight-against-pancreatic-cancer-2010-10-26", "https://www.nasdaq.com/articles/5-things-drive-biotech-etfs-2010-10-21", "https://www.nasdaq.com/articles/using-etfs-mimic-mutual-fund-ideas-2010-09-13", "https://www.nasdaq.com/articles/option-activity-alert-amgen-inc-and-dendreon-corporation-2010-09-13", "https://www.nasdaq.com/articles/10-stocks-should-pay-dividend-dont-goog-aapl-brka-amzn-more-2010-08-18", "https://www.nasdaq.com/articles/opening-view-djia-futures-edge-higher-ahead-fomc-2010-12-14", "https://www.nasdaq.com/articles/11-famous-health-care-stocks-sell-2010-07-20", "https://www.nasdaq.com/articles/betting-long-term-upside-amgen-nasdaqamgn-2010-07-15", "https://www.nasdaq.com/articles/affymax-fate-may-be-decided-today-2010-06-21", "https://www.nasdaq.com/articles/sidewinder-update-amgen-nasdaq-amgn-2010-02-09", "https://www.nasdaq.com/articles/11-health-care-stocks-sell-2010-08-02"], "Content": []}